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Abstract  
Research evidence suggests that first degree relatives of patients with end-stage renal 
disease, particular ethnic groups and multiple components of metabolic syndrome may 
contribute to the development and exacerbation of chronic kidney disease. The study 
setting is Miri, in Sarawak, Malaysia. The participants were from a variety of ethnic 
and socio-demographic backgrounds. 
The aim of this study is to synthesise a coherent explanation of health-related beliefs, 
behaviours and knowledge contributing to abnormal clinical parameters that may 
predict the development of chronic disease in participants. The quantitative objectives 
are to determine what socio-demographic, biochemical and lifestyle factors are 
associated with the risk of chronic kidney disease and metabolic syndrome. The 
qualitative objectives are to analyse the health-related beliefs, behaviours, knowledge, 
barriers, cultural practices and lifestyle choices that may be potential predictors of 
chronic kidney disease and metabolic syndrome.  
This study employs a two-phased Mixed Methods sequential explanatory design. Phase 
One, a case-control study, involves the collection and analysis of statistical data by 
which to screen participants (n = 270) for chronic kidney disease and metabolic 
syndrome. An intermediate stage connects the two methodologies and determines what 
exposures of interest warrant further investigation. The Phase Two interview 
participants (n = 32) are a purposefully selected subset of Phase One.  
The Phase One cases (n = 135) are the first degree relatives of end-stage renal disease 
patients at three Miri haemodialysis centres. The controls (n = 135) are the unaffected, 
non-genetic relatives of the first degree relatives‘ spouses, pair-matched by age and 
gender. Quantitative data from anthropometric measurements, laboratory results and a 
self-administered questionnaire was analysed using descriptive statistics. Multivariable 
logistic regression, with adjustment for potential confounders, was then applied to 
identify key associated risk factors. The adjusted odds ratios with 95% confidence 
interval for chronic kidney disease revealed that although alcohol was found to be 
protective (0.401 [0.179, 0.898]), being of Malay (5.666 [1.935, 16.593]) or Indigenous 
(2.347 [1.021, 5.395]) ethnicity, increasing age (1.048 [1.020, 1.076]) and having 
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metabolic syndrome (3.063 [1.527, 6.142]) predispose participants to developing 
chronic kidney disease. The adjusted odds ratios with 95% confidence interval for 
metabolic syndrome revealed significant markers being a first degree relative (2.409
*
 
[1.303, 4.454]) and having a family history of cardiovascular disease (2.650
#
 [1.146, 
6.130]). The odds of developing metabolic syndrome increase with age (1.027
#
 [1.005, 
1.049]), with living in low-cost housing (5.084* [2.301, 11.234]), with a personal 
history of smoking (3.163
*
 [1.344, 7.442]) and with increasing glucose intolerance: for 
impaired fasting glucose / impaired glucose tolerance (3.568
*
 [1.790, 7.110]) and being 
diabetic (14.308
*
 [4.662, 43.915]) (*p<0.01, # p<0.05). 
The qualitative data gathered from thirty-two in-depth semi-structured interviews was 
analysed and framework matrices created to explore the intersections between the 
participants and the themes that emerged. Qualitative themes derived from the 
interviews, identified lifestyle transitions, health beliefs surrounding traditional 
practices and herbal medicine, health behaviours including compliance with modern 
medical regimes, and environmental concerns. Many of those owning gardens or 
working in plantations hold mistaken beliefs and behaviours that expose them to 
multiple applications of potentially harmful agrochemicals. Food safety awareness and 
education in occupational health are needed, particularly among agriculture and 
plantation workers. 
This study identifies associated factors, beliefs and behaviours that in all probability 
contribute to chronic kidney disease in Sarawak. It is recommended that development 
of screening and intervention programs aimed at preventing the onset and progression 
of chronic kidney disease target first degree relatives of end-stage renal disease patients 
and persons with metabolic syndrome. Strategies implemented must include addressing 
erroneous beliefs, healthy lifestyle management practises and the control of chronic 
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There are a number of terms frequently used throughout this submission.  
The list below gives a brief explanation of terms used in Sarawak to help the  
reader to better understand the context of the terminology in this study. 
 
Bumiputra Malaysian term meaning ‗Sons of the Earth‘. The term refers to Malay, 
Orang Asli and Dayak people of Malaysia. 
Dayak   Sarawak term for Indigenous person originally from Sarawak.  
Desa Klinik Rural / remote outpost clinic. 
Indigenous   An Aboriginal person. 
Kampung An organised community often containing related members of one‘s 
family or ethnic group (Malay, Chinese, Indian or Indigenous). A small 
village-like community. Used (slang) to enquire where one comes from 
or grew up. 
Kedai Small stall or shop 
Longhouse A long building, between 10 and 100 doors or families, housing related 
members of a Dayak tribe. Sometimes one storey, sometimes two 
storeys. Usually built off the ground and underneath may be left open or 
enclosed.  
Native  Indigenous. An original inhabitant of the land. 
Orang Asli Peninsular Malaysian term for the Indigenous tribal people originally 
from Malaya. 
Orang Puteh Europid. Caucasian. Foreigner with European heritage. 
Penan The only nomadic / semi-nomadic tribal people remaining in Sarawak 
today. 
Poliklinik Government out-patients clinic. 
Tribal Belonging to an Indigenous tribe. 
Tuai Rumah Longhouse headman / chief  
xx 
Abbreviations 
There are abbreviations used, especially in the equations, tables and figures, throughout this submission. 
The list below will help the reader identify the abbreviations used in this study. 
 
ACR  Urine Albumin : Creatinine Ratio (mg Alb/mmol Cr)  
BMI  Body Mass Index defined by (WHO-WPR 2007) 
CKD  Chronic Kidney Disease defined by (KHA 2007)  
CNCD  Chronic Non-Communicable Diseases 
CVD  Cardiovascular Disease 
eGFR  Estimate Glomerular Filtration Rate (mL/min/1.73m
2
)  
ESRD  End-Stage Renal Disease 
FDR  First Degree Relative 
FH  Family History 
GFR  Glomerular Filtration Rate 
HbA1C Haemoglobin A1C Assay 
HDL-C High Density Lipoprotein Cholesterol 
HT  Hypertension / High Blood Pressure 
IFG   Impaired Fasting Glucose / Glycemia 
IGT   Impaired Glucose Tolerance 
LDL-C Low Density Lipoprotein Cholesterol 
MetS  Metabolic Syndrome defined by (Alberti, Eckel et al., 2009) 
OGTT  Oral Glucose Tolerance Test 2hrs post 75g glucose challenge 
SCG  Spousal Control Group 
TC:HDL-CR  Total Cholesterol : High Density Lipoprotein-Cholesterol Ratio 
T2D  Type 2 Diabetes  
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Chapter 1 Introduction 
This introductory chapter provides the background and delves into the reasons 
underpinning this research. It explains the selection of the topic and the participants, 
describes the study setting, identifies the research questions, and outlines the aim, 
objectives and study focus. Finally a brief overview of the organisation of this thesis is 
presented. 
1.1 The Background 
Our kidneys are designed to function efficiently throughout our lifetime. Unfortunately 
for many people their kidneys become damaged to the point where they cease 
functioning. When this happens, and if a person does not receive medical intervention, 
they will die within two weeks (NKF [National Kidney Foundation US], 2013; NKF, 
2008). Chronic kidney disease (CKD) is progressive, and deteriorates to end-stage renal 
disease (ESRD) and premature death (Levy, Morgan, & Brown, 2001; Levey, Eckardt, 
Tsukamoto, Levin, Coresh, Rossert et al., 2005). Chronic kidney disease often develops 
undetected as patients are asymptomatic until the disease is advanced and the kidneys 
have almost failed (Gaw, Murphy, Cowan, O‘Reilly, Stewart, & Shepherd, 2008). If 
recognised early however, with appropriate clinical management, the rate of chronic 
kidney disease progression can be slowed (Mahon, 2001; Tonelli, Wiebe, Culleton, 
House, Rabbat, Fok et al., 2006).  
The incidence of chronic kidney disease is increasing globally, and there is as yet no 
known cure for end-stage renal disease (Levy et al., 2001; Levey, Eckardt et al., 2005; 
Jha, Garcia-Garcia, Iseki, Li, Naicker, Plattner et al. 2013). This study investigates 
adverse health determinants and abnormal clinical parameters that may predispose to 
chronic kidney disease in an at risk population, and then considers the health beliefs 
and behaviours of a sample from a Malaysian population in Miri, Sarawak. Its findings 
may be valid for other states as well as other developing countries in South East Asia. 
The leading risk factors of chronic kidney disease for all ethnicities includes being a 
first degree relatives (FDR) of a patient with end-stage renal disease, having diabetes 
mellitus, high blood pressure, and being over 50 years of age (KHA [Kidney Health 
Australia], 2006b). Having multiple risk factors increases the probability of developing 
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chronic kidney disease (KHA, 2006d), regardless of age or ethnicity (KHA, 2006a). 
Studies show that the first degree relatives of end-stage renal disease patients 
(Goldfarb-Rumyantzev, Cheung, Habib, Wang, Lin, Baird et al., 2006) and particular 
ethnic groups (Feehally, 2005) are at enhanced risk of chronic kidney disease as there is 
a significant and independent familial component, from shared environment and 
heredity (Freedman, Volkova, Satko, Krisher, Jurkovitz, Soucie et al., 2005). 
Population screening aimed at family members of end-stage renal disease patients has 
been recommended (Ramirez, Hsu, & McClellan, 2003; Hamer & El Nahas, 2006), but 
in Malaysia funding is unavailable for screening.  
The incidence of chronic kidney disease and the two leading risk factors, type 2 
diabetes (T2D) and hypertension (HT), are rapidly increasing in the developing world 
(ISN [International Society of Nephrology], 2006) and closely mimics trends in 
economically developed countries. Other reasons for the development of chronic 
kidney disease include aging, injury, disease, inheritance, congenital conditions, 
inflammation of the kidney glomeruli, infections of the urinary tract, medications, 
drugs, toxins, pesticides, pain relievers, traditional herbs, and illegal substances (NKF, 
2013). Reasons that cannot be identified at the time of diagnosis are labelled as 
‗unknown causes or aetiology‘. The renal morbidity statistics from various registries 
worldwide note that for persons with chronic kidney disease (Rashidi, Ghanbarian, 
Azizi, & Adler, 2007b) and those with end-stage renal disease (Levey, Bosch, Lewis, 
Greene, Rogers, & Roth, 1999; Bakris, Sarafidis, Weir, Dahlöf, Pitt, Jamerson et al., 
2010), cardiovascular events are responsible for more than 50% of reported deaths. In 
Malaysia death from complications of cardiovascular disease (CVD) are reported at 
36% while sepsis is 24% (MSN [Malaysian Society of Nephrology], 2014). Similar 
data for Miri is unavailable because of confidentiality issues.  
Chronic non-communicable diseases (CNCD) are usually progressive, degenerating to 
disability, poor quality of life and untimely death (NCCDPHP [National Centre for 
Chronic Disease Prevention and Health Promotion], 2009). Globally, 60% of all deaths 
are attributed to chronic non-communicable diseases (Alwan, MacLean, Riley, 
d‘Espaignet, Mathers, Stevens et al., 2010) with 80% of these deaths recorded in 
developing countries (Abegunde, Mathers, Adam, Ortegon, & Strong, 2007). This 
statistic is expected to increase by 17% over the next decade (WHO [World Health 
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Organization], 2013a). Apart from the genetic component, chronic non-communicable 
diseases can be prevented or modified by addressing the social, economic and physical 
environments, and behavioural aspects, such as smoking, alcohol, diet and physical 
activity (WHO, 2013a). Obesity is a common denominator and predictor of many 
nutrition-related chronic non-communicable diseases (Grundy, 2004). As developing 
countries become urbanised, obesity correlates with their industrialisation (Noor, 2002; 
L. Rampal, S. Rampal, Khor, Zain, Ooyub, Rahmat et al. 2007) and economic 
prosperity (Misra & Khurana, 2008). Obesity is independently associated with each of 
a combination of metabolic abnormalities that are often observed to cluster, referred to 
as the metabolic syndrome (MetS) (Alberti, Zimmet, & Shaw, 2005). Two metabolic 
syndrome components, type 2 diabetes and hypertension, mechanistically link obesity 
to chronic kidney disease (Abrass, 2004; Guarnieri, Zanetti, Vinci, Cattin, Pirulli, & 
Barazzoni, 2010). A person with multiple components of metabolic syndrome criteria 
has an increased likelihood of developing and exacerbating chronic kidney disease 
(Lea, 2006). Likewise, if a person has chronic kidney disease there is the likelihood of 
having multiple components of metabolic syndrome and obesity (Sowers, 2005), which 
in turn increase the risk of cardiovascular disease complications (CDCP [Centers for 
Disease Control and Prevention], 2010). In this study, this interplay between chronic 
non-communicable diseases in the participants is explored. 
In many of the world‘s low-resource countries people die from end-stage renal disease 
because haemodialysis is unavailable, inaccessible and unaffordable (WHO [World 
Health Organization], 2003; Arogundade, Sanusi, Okunola, Soyinka, Ojo, & Akinsola, 
2006). Malaysia reported that at the end of December 2012 there were 28,725 end-stage 
renal disease patients dialysing at 40 dialysis centres (government public, non-
government organization (NGO), private, university or armed forces), a treatment rate 
of 979 persons per million (MSN, 2014). Those receiving haemodialysis therapy are 
assessed on a sliding scale according to their family income, and a government subsidy 
may be granted. The average cost for one dialysis session in Malaysia is between 
RM150 and RM250 and, with thirteen treatments per month needed, this amounts to 
RM3,250 per month (Loh & Shagar, 2013). That is equal to the entry monthly wage of 
full-time general staff at university in Sarawak and is more than many people‘s 
monthly income. Although they depend upon subsidies and donations, these may not 
cover costs, and family members have to meet the shortfall or raise funds from the 
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public. The number of persons on haemodialysis is currently doubling every six years, 
and it is predicted that this exponential escalation of end-stage renal disease in 
Malaysia will significantly increase the economic impact of kidney disease on the 
national healthcare system (Hooi, 2006). 
Apart from such economic costs, identifying causal risk factors and preventing the 
progression of chronic kidney disease to end-stage renal disease has immediate and 
long-term benefits for the patient, the family and the community, especially in 
developing countries (Khwaja, El Kossi, Floege, & El Nahas, 2007). Health behaviour 
modification can affect the onset and progression of chronic diseases through 
prevention (avoiding disease), detection (screening), control of risk factors, self-
management and control of the progression of the disease (Berwick, 2004; Bandura, 
2011). A symptom of illness may trigger health behaviour changes (Rosenstock, 1974; 
Bowling, 2004; Rosenstock, 2005). Screening people with hypertension and type 2 
diabetes is an effective strategy to detect persons at risk of chronic kidney disease 
(Hallan, Dahl, Oien, Grootendorst, Aasberg, Holmen et al., 2006), and taking a 
community public health approach delays its development and progression (Ramirez, 
Hsu et al., 2003; Hamer & El Nahas, 2006).  
In Malaysia only opportunistic screening is available. This means that a person may 
only be incidentally screened and diagnosed for a disease when they visit their doctor. 
However, this only applies to a small percentage of the population as the conditions 
may be asymptomatic for many years before an individual presents with complications. 
Sponsored community health campaigns are sometimes organised in shopping centres 
but are not always well advertised or attended. Basch (1999) suggests that poor 
participation in community health screening may be due to a wariness of finding out if 
one has a medical condition as this accelerates the process of becoming a patient. 
Bowling (2014) comments that there may be a social stigma attached to being labelled 
sick if it is seen as a form of social deviance and a breach of society‘s norm. In this 
study, reasons why participants were reluctant to visit the doctor were explored. 
Traditional practitioners from various ethnic groups in Sarawak dispense traditional 
herbs and medicine, some to maintain health, some to cure. Communities with strongly 
ingrained belief systems share similar values and ideas about health and illness, and 
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such culturally influenced behaviours have health consequences (Basch, 1999; 
Rosenstock, 2005). Strategies for chronic kidney disease health promotion, screening 
and intervention programs need to include local knowledge regarding health behaviour 
and practices if they are to be successful (Wilson, Jungner, & WHO, 1968; KHA, 
2006c).  
Malaysia has limited social welfare for persons in extreme poverty, and only those 
working for large multi-national companies have health-care insurance. Healthy 
lifestyle choices depends on each person‘s personal financial situation, and health is 
often a low priority ( Bowling, 2004; Arogundade, 2006; Bowling, 2014), especially if 
abnormal clinical findings for a chronic non-communicable disease are in an 
asymptomatic stage. Response to illness by persons who are of low socio-economic 
status may be one of fatalism or powerlessness (Bowling, 2004; Bowling, 2014), denial 
and ‗the will of God‘. There is limited data published on the health status of first degree 
relatives of Malaysian end-stage renal disease patients. This study aims to address some 
aspects including their knowledge of and predisposition for chronic kidney disease, and 
the impact their beliefs and behaviours may have on their health. This will garner 
insightful information regarding first degree relatives in Sarawak.  
1.2 Research Questions Arising  
 How prevalent is chronic kidney disease among first degree relatives and their 
spousal family members?  
 How prevalent is metabolic syndrome among the participants and is it a 
predictor of chronic kidney disease?  
 Are there socio-demographic or socio-economic risk factors that may contribute 
to developing chronic kidney disease / metabolic syndrome?  
 Are there behavioural or environmental risk factors that may contribute to 
developing chronic kidney disease / metabolic syndrome?  
 How knowledgeable are the participants in this study with regard to preventing 
and coping with chronic non-communicable diseases? 
 Are there traditional or culturally influenced beliefs and barriers preventing 
participants from seeing a medical doctor or heeding his advice?  
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 Is there evidence to support the need for targeted, rather than opportunistic, 
population screening and awareness campaigns for chronic kidney disease / 
metabolic syndrome in Miri? 
1.3 The Study  
This study was conducted in Miri, the second largest city in the state of Sarawak, 
Malaysia, situated on the central west coast of the island of Borneo. All the patients 
from all three haemodialysis centres that are operational in Miri were invited to 
participate in recruiting their first degree relatives and spousal families. Participants 
were from a variety of ethnic, demographic and socio-economic backgrounds.  
Staff shortages and financial constraints at the dialysis centres in Miri demand that 
every end-stage renal disease patient attending dialysis must be accompanied by a 
family member who assists during the session: four hours, every second day, for the 
remainder of the patient‘s life. This creates inconceivable stress on patients and also 
places financial, physical and emotional anxiety on the carers who accompany them to 
dialysis sessions.  
Prior to commencing this study, my work brought her into direct contact with end-stage 
renal disease patients and their carers, most often members of their immediate family. 
A significant number of these family members expressed apprehension that they too 
might develop the disease. This thesis seeks to better understand the local situation, in 
order to facilitate knowledge transfer with the purpose of empowering family members 
to make wise decisions regarding their health and lifestyle, to reduce their risk of 
chronic kidney disease and to help allay their fears and trepidation.  
Photograph 1.1  Connecting to the dialising machine   
Photograph by researcher 
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1.4 Rationale of the Study  
1.4.1 Aim  
The aim of this study is to synthesise a coherent explanation of health-related beliefs, 
behaviours and knowledge contributing to abnormal clinical parameters that may 
predict the development of chronic disease in participants at risk. 
1.4.2 Objectives 
1. Identify the socio-demographic characteristics associated with the abnormal 
clinical findings among the participants. 
2. Ascertain the behavioural lifestyle factors associated with the abnormal clinical 
findings among the participants.  
3. Describe the housing and environmental features associated with the abnormal 
clinical findings among the participants.  
4. Establish the abnormal clinical parameters for chronic kidney disease in the 
participants. 
5. Determine the abnormal clinical parameters for metabolic syndrome and 
associated chronic metabolic disease comorbidities in the participants. 
6. Analyse the health related beliefs, behaviours and stress factors of the 
participants with specific regard to determinants compounding the development 
of chronic kidney disease and metabolic syndrome. 
7. Enquire into health-related attitudes, barriers and cultural practices delaying 
early recognition of the precursors of, and diagnosis of, clinical chronic non-
communicable diseases in participants.  
8. Develop an account of traditional beliefs and customs, as opposed to modern 
medical and health preferences, influencing the self-management of chronic non-
communicable diseases in participants. 
9. Document the modern myths, marketing and health knowledge that impinge on 
participants‘ health-related lifestyle choices and behaviours that may play a role 
in the development of chronic kidney disease and metabolic syndrome. 
10. Provide evidence regarding high risk locales, vulnerable groups and topics 
identified, in order to develop targeted intervention strategies and programs.  
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1.5 Structure of the Thesis 
Drawing on the literature review and employing a mixed methods research design, this 
study focuses on: (1) the first degree relatives of end-stage renal disease patients (cases) 
and the spousal control group (SCG) (controls); (2) screening for the main risk factors 
and causes of end-stage renal disease in Malaysia: chronic kidney disease, type 2 
diabetes, hypertension and cardiovascular disease - all chronic metabolic diseases; (3) 
determining the abnormal clinical parameters for metabolic syndrome; (4) identifying 
socio-demographic and lifestyle exposures of interest; (5) considering the role of 
beliefs, behaviours and health-related lifestyle choices with regard to risk factors for 
chronic kidney disease and metabolic syndrome.  
Photograph 1.2  End of dialysis session   
Photograph by researcher 
 
This thesis follows a sequential framework. A brief overview and description for each 
of the chapters of this thesis follows.  
Chapter 1: Introduction delves into the background and reasons underpinning the 
research. It explains the selection of the topic, the participants and study setting, 
identifies the research questions and outlines the aim and objectives of the study.  
Chapter 2: Context examines the major geographical, historical, political, economic, 
socio-demographic and health components that have shaped Sarawak. It highlights the 
country‘s health status in transitioning from infectious to chronic diseases. 
Chapter 3: Literature Review explores the views of other researchers, what is known 
regarding chronic kidney disease and its interconnectedness with metabolic syndrome. 
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Risk factors, prevention and progression of chronic kidney disease, metabolic 
syndrome, and management are discussed.  
Chapter 4: Research Methodology gives an overview of the benefits of using Mixed 
Methods and outlines the study design and ethical issues considered. The quantitative 
Phase One methods for the data collection and analysis are presented.  
Chapter 5: Results – Quantitative Phase One presents the quantitative outcomes 
following analysis using SPSS software. It determines if participants can be classified 
as having chronic kidney disease or metabolic syndrome.  
Chapter 6: Intermediate Connecting Stage draws on the results of the quantitative 
Phase One, identifies concerns of interest to investigate further, and determines the 
protocols for purposefully selecting participants for Phase Two. The qualitative Phase 
Two methods for the interview data collection are outlined. 
Chapter 7: Findings – Qualitative Phase Two presents the outcomes of the 
qualitative analysis using the NVivo program. The qualitative data gathered from the 
interviews is organised into sub-themes which reveal the major theme. 
Chapter 8: Discussion individually examines both the quantitative results and the 
qualitative findings. Each section concludes with a summary of the study outcomes for 
the relevant objectives and notes the associated risky behaviours of the participants.  
Chapter 9: Integration of the Two Data Sets brings together the quantitative and 
qualitative outcomes from this study. It presents a coherent interpretation and 
understanding of the lifestyle aspects revealed from the qualitative findings that 
endorse and may impact and influence the quantitative results.  
Chapter 10: Conclusion presents the study conclusions and insights into the reasons 
why some participants may have developed chronic kidney disease and metabolic 
syndrome. It closes with the study strengths, limitations and suggested future practice 
and research directions.  
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Appendices include copies of all relevant emails requesting permission to conduct the 
study, the recruitment letter and information sheets, informed consent forms, data 
collection sheets and other associated documents and diagrams.  
1.6 Conclusion  
Chapter 1 sets the scene for this dissertation. The background introduces end-stage 
renal disease, chronic kidney disease and the chronic non-communicable disease 
comorbidities of metabolic syndrome as the focus of this study and outlined why these 
conditions are creating a public health dilemma for developing countries such as 
Malaysia. The key contributing risk factors for chronic kidney disease, the reasons why 
urbanisation amplifies the problem and the reasons why the health-care systems of low-
resource countries are unable to cope, was examined. This chapter defined the rationale 
for the study including the focus, research questions, aim and objectives. An overview 
of the scope and organisation of the thesis has been presented.  
This chapter has established the framework for the thesis and shows how the study 
flows with continuity. The next chapter summarises the major events leading to the 
development of modern Malaysia and Sarawak, where this study was conducted. 
 
Photograph 1.3  A dialising hall 
Photograph by researcher 
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Chapter 2 Context 
This chapter positions the study in the context of governance, demographics, 
environment, socio-economic development and health attributes that have shaped 
Sarawak, distinct from yet comparable with Malaysia‘s development in recent times. It 
highlights the shift in emphasis as the country‘s health status transitions from having to 
contend with infectious diseases to tackling chronic diseases. It compares the country‘s 
health indicators with other South East Asian countries and notes the disparities 
between Sarawak, the focus of this study, and Peninsular Malaysia. 
Where in the world is Borneo? Australia is the smallest continent in the world and any 
land mass smaller is considered an island. The island of Borneo (740,000 square 
kilometres) is the third largest island in the world after Greenland and New Guinea (J.  
Payne, Cubitt, & Lau, 1994) and is surrounded by Indonesia to the south and east, 
Philippines to the north and Peninsular Malaysia to the west (Figure 2.1). It comprises 
of three countries: the Sultanate of Brunei; Kalimantan, Indonesia; and the eastern 
territories of Malaysia, Sarawak and Sabah. Sarawak (124,449.5 square kilometres) lies 
along 800 kilometres of the west coast of Borneo, north of the equator between latitude 
0° 50‘ and 5°N, and longitude 109° 36‘ and 115° 40‘ E (Sarawak Government, 2011).  
Figure 2.1  Maps of South East Asia and Borneo  
Source: Creative Commons Map: South East Asia, 2014;  Borneo, 2007 
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2.1 Governance 
Malaysia.  The Federation of Malaysia consists of Sabah (‗Land Below the Wind‘) and 
Sarawak (‗Land of the Hornbills‘) on the island of Borneo; eleven states on Peninsular 
Malaysia; the three federal territories of Kuala Lumpur, Petra Jaya and Labuan; plus 
numerous islands. Dividing Peninsular Malaysia from Sabah and Sarawak, by a 
distance of 600 kilometres, is the South China Sea. Figure 2.2 shows the Malaysian 
states (white), with Sarawak highlighted (dark). 
 
Figure 2.2  Malaysian states (Sarawak highlighted)  
Malaysian States, 2009. Source: Creative Commons Map:  
 
The capital city of Malaysia is Kuala Lumpur and Putrajaya, where Parliament meets, 
is the administrative centre (Tourism Malaysia, 2013). The Malaysian government is a 
democracy modelled on the Westminster parliamentary system and has a constitutional 
monarch (Sarawak Government, 2012; Tourism Malaysia, 2013). In Peninsular 
Malaysia the sultans are the heads of state but in Sabah and Sarawak the head of state is 
appointed by the Malaysian king (Rowthorn, Benson, Kerr, & Niven, 2001). The chief 
minister of each state government is appointed from the majority party of the state 
legislative assembly (Rowthorn et al., 2001). The legal system in Malaysia is based on 
English common law and there is a Syariah court for Muslims who breach Islamic law 
(Tourism Malaysia, 2013). Islam is by constitution the state religion, however, freedom 
of religion is allowed for non-Malays (Tourism Malaysia, 2013). 
Sarawak.  English law was established in Borneo in 1867, the oldest legislature in 
Malaysia (Miller, 1914; History of Malaysia, 2012). The British Colonial Government 
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(1946-1963) adopted the natural watershed running through central Borneo as the 
boundary between Sabah and Sarawak, Malaysia, and Kalimantan, Indonesia (Porritt, 
1997). Many Indigenous tribal families living along the political line were separated, 
and Bala (2001) notes that social, health and economic disparities have developed. By 
the time the Japanese occupation and World War Two ended, headhunting among the 
Indigenous tribes of Borneo had been suppressed (Rowthorn et al., 2001). Sarawak 
joined the newly formed Federation of Malaysia in 1963 (Rowthorn et al., 2001). With 
the conclusion of the 1962–1966 ‗confrontation‘ along the Sarawak-Kalimantan border, 
backed by the Indonesian Communist Party and disaffected Malaysian Chinese 
(Rowthorn et al., 2001), Sarawak experienced rapid urban growth and the beginning of 
a widespread rural to urban migration (Bala, 2001). 
The state of Sarawak is divided into six divisions for administrative and political 
purposes. All the participants in this study live in the Miri and Baram District. Figure 
2.3 illustrates the Miri and Baram District boundary extending to the Kalimantan, 
Indonesian border.  
 
Figure 2.3  Map of Sarawak districts 




Malaysia.  The nation of Malaysia is multi-racial, multi-ethnic/tribal, multi-religious, 
multi-cultural and multi-lingual. In 2014 Malaysia had an estimated population of 31.7 
million, broken down into ethnic groups as Malay and Indigenous (Bumiputra) 
(67.4%), Chinese (24.6%) and Indian (7.3%) (MDOS [Malaysian Department of 
Statistics], 2014). The predominant group in Peninsular Malaysia are the Malays 
(63.1%), in Sabah the Kadazan/Dusun (24.5%) and in Sarawak the Ibans (30.3%) 
(MDOS, 2014). The religious breakdown for Malaysia is Islam (61.3%), Buddhism 
(19.8%), Christianity (9.2%) and Hinduism (6.3%); the remainder includes other 
religions, including traditional, unknown or no religion (MDOS, 2014). Malaysian 
government statistics are kept to track intra-state, inter-state and international 
population movements (MDOS, 2011) and it shows that population diasporas has not 
led to cultural assimilation and each ethnic group continue to practice their traditions. 
Beng (2006) suggests that Malaysians identify with their own family‘s cultural roots 
and if of mixed parentage will celebrate both parents‘ cultural heritage. Most 
Malaysians appreciate each other‘s traditions and visit friends of different ethnicity for 
‗open house‘ during festivals. Of the 137 languages spoken in Malaysia, the official 
language is Bahasa Melayu (MDOS, 2011) however, most Malaysians speak two or 
more languages or dialects fluently. 
Sarawak.  In Sarawak there are 27 main ethnic groups and many sub-ethnic/tribal 
groups, each with discrete cultural identities and dialects (Sarawak Government, 2011). 
In total there are 78 Land Dayak, Malayic and North Borneo language families in 
distinct communities throughout Sarawak (SIL [Summer Institute of Linguistics], 
2015). Many of the Indigenous people do not have a written language and until recently 
their family trees, history and legends were only passed down orally from one 
generation to the next, often in the form of songs about family exploits, especially from 
the headhunting days. The major languages spoken and taught in Sarawak schools are 
Malay, Mandarin, English and Iban (Sarawak Government, 2011). 
The religious breakdown for Sarawak is Christian (1,052,986) Islamic (796,239) 
Buddhist (332,883) Traditional (148,645) and Hindu (4,049); the remainder includes 
other, unknown, or no religion (MDOS, 2014). Sarawak is the only state in Malaysia 
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with a Christian majority however, all live together respectfully, harmoniously and with 
tolerance for each other‘s beliefs. There are numerous cultural celebrations throughout 
the year and Sarawak is a favourite destination for tourists to experience the vast array 
of traditional music, costumes, dances, foods, crafts and customs of the different 
ethnicities and religions.  
Sarawak has a population of 2.66 million with the highest concentration found in the 
capital Kuching (681,901), followed by Miri (358,020); the state‘s annual population 
growth rate is 0.8% (Sarawak Government, 2014). Sarawak is the largest state in 
Malaysia yet has a population density of 20 people per square kilometre, the lowest 
density of any Malaysian state (Sarawak Government, 2012). Comparing all the 
Malaysian states, Sarawak and Sabah have the lowest percentage of nuclear family 
households (53.1%) and the highest percentage of extended family households (31.4%) 
(MDOS, 2014). Records from the last two government censuses show that Sarawak has 
the lowest literacy rate, the lowest computer literacy rates for both urban and rural 
populations, and together with Sabah is the least urbanised of all of the Malaysian 
states (MDOS, 2014).  
2.3 Environment 
Malaysia.  Sabah, Sarawak and Peninsular Malaysia are all fairly sheltered from 
typhoons, unlike Vietnam and the Philippines, and unlike neighbouring Indonesia have 
no active volcanoes, fewer earthquakes and tsunamis. Therefore Malaysia has had 
fewer natural disasters affecting the health and well-being of its citizens. The climate of 
Malaysia is equatorial (25–35
o 
C) and humid (80–90%) with monsoon seasons 
however, the coastal areas are hotter and drier (Sarawak Government, 2014). The 
temperature in the highland areas above 1,200 metres can be as low as 10
o 
at night and 
on the highest mountain in South East Asia, Mount Kinabalu (4,095 meters) in Sabah, 
can drop as low as 4
o
 at night (Sabah, Sarawak & Brunei, 1993).  
Sarawak.  The steamy Borneo climate, which evenly receives between 2,000 mm and 
4,500 mm of rain annually, feeds a rich and diverse tropical rainforest (Christensen, 
2002; Sarawak Government, 2012) in which new animal and vegetable species are still 
being identified (Bruno Manser Foundation, 2014). Sarawak has established a number 
of national parks to preserve some of the pristine rainforest and the primeval limestone 
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caves of the Gunung Mulu National Park, said to be 140 million years old, have 
UNESCO World Heritage Site status (Sarawak Government, 2014).  
The tropical rainforest has been intensively logged over the past few decades and 
replaced with oil palm plantations (Hansen, Potapov, Moore, Hancher, Turubanova, 
Tyukavina et al., 2013). The copious amounts of agrochemicals used and machinery 
discharge threaten river ecosystems. The World Bank estimates that in Malaysia the 
timber and oil palm industries are cutting down the rainforest trees at four times the 
sustainable rate (Colchester, 1994). Christensen (2002) cautions that rapid 
ethnobotanical loss is likely over the next ten to twenty years unless steps are taken to 
preserve the unique species-rich ecosystems of Sarawak and in 2007 UNESCO urged 
the preservation and conservation of the Borneo rainforests (Thiessen, 2012). The 
Indigenous people supplement their diet by hunting animals, catching fish and 
gathering fruits, nuts and vegetables from the rainforest (Janowski, 1991). Wild 
vegetables are eaten at almost every meal in the longhouses (Christensen, 2002) and the 
nomadic Penan depend totally upon the rainforest for their food and shelter needs 
(Rowthorn et al., 2001). The consequences of deforestation are catastrophic and include 
the extinction of endemic species; polluted rivers, landslides and flooding; the loss of 
traditional foods and medicines; and the displacement of Indigenous people from their 
native customary homelands (Colchester, 1993).  
2.4 Socio-economic Development 
Malaysia.  Strategically placed for trade, Peninsular Malaysia is linked to the island of 
Singapore by a bridge and a causeway, has a land border with Thailand, a maritime 
boundary with Vietnam and the Philippines, and is separated from Sumatra Indonesia 
by the Straits of Malacca (Miller, 1914; History of Malaysia, 2012). From colonial 
trading outpost to industrialisation, Malaysia is now ranked as the third leading 
economy of South East Asia (MDOS, 2014). From the 1980s Malaysia has seen rapid 
economic growth and urbanisation and has a GDP growth rate of 6.3% per annum 
(Tourism Malaysia, 2013). The currency differences for the Malaysian Ringgit (RM) 
hovers around (Australian) AUD$1:RM3.03; (United States) US$1:RM3.22; 
(European) EURO1:4.26; (Great Britain Pound) GBP1:5.46.  
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Sarawak.  Borneo was considered an inhospitable land inhabited by fierce headhunting 
tribes (Lo, 1986) however, artefacts dating from the fourth century AD indicate early 
barter trade with India, China and other Middle-eastern and Asian countries (J. Payne et 
al., 1994). Trade ships also brought explorers, archaeologists and missionaries (J. 
Payne et al., 1994). As coastal security improved the villages of Borneo, once terrorised 
by pirates and slave-traders (Cunningham, 2002; Lo, 1986; Tate, 1988), grew and 
developed independently from Malaya (Adelaar, 1995). 
The main export commodities for Sarawak are crude petroleum, liquefied natural gas, 
timber and agricultural products including pepper, palm oil, rubber and coconut oil 
(Sarawak Government, 2012). To accelerate economic growth and transform Sarawak 
into a developed state, the Sarawak Corridor of Renewable Energy development, which 
sanctions the construction of 50 hydroelectric dams, was launched in 2008 (Sarawak 
Government, 2014). Opposition to this initiative cites large-scale environmental 
destruction, little recompense and no equity for the affected communities, the 
displacement of tens of thousands of Indigenous people from the fertile river valleys 
(Colchester, 1993) and the demise of their tribal lifestyle forever (S. Osman, 2000).  
                     
Photograph 2.1  Dry season    
Photograph by researcher‘s family members. 
 
Sarawak's road network between major towns and cities are well developed with good 
standard airports, sealed roads, electricity, treated water supply, telecommunication 
systems, shopping centres and housing. However the Pan-Borneo Highway linking the 
west coastline from Pontianak in Kalimantan Indonesia through Sarawak and Brunei to 
Kota Kinabalu, Sabah is incomplete and would contribute to the eastern states‘ 
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infrastructure and development but it is in dire need of completion, repair and 
maintenance (J. Fernandez, 2014). Many interior areas of Sarawak are still inaccessible 
and only the larger population centres have small plane runways. The timber companies 
have opened up most of the interior areas but their roads are dangerous to use and, 
depending upon the season, can be feet deep in dust or mud. 
 
Photograph 2.2  Monsoon season 
Photograph by researcher‘s family members. 
 
Miri and Baram District.  The sparsely populated interior of Sarawak often depends 
upon rivers as the main means of transport between rural communities (Sarawak 
Government, 2014). The Baram River (466 kilometres long) is the second longest river 
in Sarawak and enters into the South China Sea just north of Miri (Hoebel & Hoon, 
1986; Sabah, Sarawak & Brunei, 1993). Miri is the major urban centre for the Miri and 
Baram District and many of the participants in this study originate from small towns 
and longhouses situated along the Baram River system (Figure 2.4).  
Miri has developed rapidly to city status, spurred on by the oil, timber and oil palm 
industries (Hutton, 1993; Sarawak Government, 2011). Curtin University Sarawak 
branch opened in Miri fifteen years ago and this has elevated Miri to an intellectual 
hub, especially in engineering and commerce. The current population of the city of Miri 
and of Miri Division is expected to rise, from natural increase and the migration of 
tribal folk from rural to urban areas in search of work or education (Sarawak 
Government, 2011). Statistics for Miri indicate the population is Iban (105,036) 
 19 
Chinese (81,977) other Bumiputra tribes such as Kenyah, Kayan, and Kelabit (60,574) 
Malay (57,627) Melanau (9,285) Bidayuh (4,100) and Indian (1,271) (MDOS, 2014).  
 
Figure 2.4  Map of Miri district and Baram River basin 
 Baram River Basin Sarawak. 2012. Source: commons.wikimedia.org  
 
 
2.5 Health Indicators for Malaysia  
Numerous waves of invasion and immigration saw various ethnicities, dissimilar to the 
Indigenous locals, settle in Malaysia and Borneo, bringing their culture and religion 
with them (Kamarudin, 2010). History records that many invaders and immigrants died 
from malaria, typhoid and cholera (Miller, 1914; Rowthorn et al., 2001). While the 
local Indigenous population had adapted to endemic diseases due to natural selection 
(Baer, 2000) many succumbed to newer introduced diseases.  
When examining a country‘s principal causes of death one can deduce how developed a 
country is by the degree to which its‘ health problems have transitioned from infectious 
diseases towards chronic diseases. It is a reflection of a country‘s economic and 
industrial status and progress. Singapore is compared to as it is the most developed 
country of the South East Asian region (SMOH [Singapore Ministry of Health], 2014). 
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Table 2.1 shows the ten principle causes of death for Malaysia, Singapore and 
Myanmar. 






(MOHM, 2011)  
1 Ischaemic heart disease  Cancer Human immunodeficiency 
virus (HIV 
2 Pneumonia  Ischaemic heart disease Septicaemia  
3 Cerebrovascular disease (incl. 
stroke 
Pneumonia Other diseases of respiratory 
system 
4 Septicaemia Cerebrovascular disease (incl. 
stroke 
Respiratory tuberculosis 
5 Transport accident  Accidents, poisoning and 
violence 
Other diseases of the liver 
6 Chronic lower respiratory 
disease  
Other heart diseases Foetal malnutrition/slow 
growth, disorders of short 
gestation and low birth weight 
7 Malignant neoplasm of 
trachea, bronchus and lung 
Urinary tract infection Stroke, not specified as 
haemorrhage 
8 Diabetes mellitus Chronic obstructive lung 
disease 
Heart failure 
9 Conditions of peri-natal 
period 
Nephritis, nephrotic syndrome 
and nephrosis 
Malaria 
10 Diseases of the liver  Diabetes mellitus Other heart diseases 
Sources: (MDOS, 2014) (SMOH, 2014) (MOHM, 2011) 
 
Table 2.1 shows the ranking differing widely between Malaysia, Singapore and 
Myanmar. From the ten principal causes of death, it can be seen that Myanmar still 
struggles with the effects of infectious diseases (MOHM [Ministry of Health 
Myanmar], 2011). The situation in Malaysia on the other hand, is shifting towards that 
of industrialized and developed countries, from infectious diseases to having more 
chronic non-communicable diseases as the main causes of death in the population. 
Save the Children International and its 30 member organisations annually compile a 
world ranking order and report on the best to the worst country to live in, if a mother or 
a child, by evaluating their well-being and the availability of resources (Save the 
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Children, 2014). There are 178 countries on the list (1 being the best) and highlights 
those countries assessed to be in a ‗fragile‘ state.  
Table 2.2 shows the Save the Children 2014 mothers‘ index ranking for some South 
East Asian countries and Australia, the developed country closest to Malaysia. 
Australia has a ranking of 9, Singapore 15 and Malaysia is ranked number 68, in the 
better half of the list. Myanmar has the worst Save the Children 2014 Mothers‘ Index 
Ranking of any South East Asian country. It is ranked at 157 and listed as ‗fragile‘ and 
in need of aid and improvement (Save the Children, 2014). 
Table 2.2  Save the Children 2014 mothers‟ index ranking  
 Malaysia Singapore Brunei Indonesia Thailand Myanmar Philippines Australia 
Lifetime risk of 
maternal death 
1:1,300 1:25,300 1:1,900 1:1:210 1:1,400 1:250 1:300 1:8,100 
Under-5 mortality 
rate (per 1,000 
live births) 
8.5 2.9 8.0 31.0 13.2 52.3 29.8 4.9 
Expected number 
of years of 
schooling 
12.7 14.4 14.5 12.7 13.1 8.7 11.3 19.9 
Gross national 
income per capita 
(US$) 
9,820 47,210 31,590 3,420 5,210 1,130 2,500 59,360 
Participation of 
women % govt 
seats 
13.9 25.3 – 18.6 15.7 4.3 27.2 31.1 
Mother‟s Index 
Rank (out of      
178 countries) 
68 15 – 113 72 157 105 9 
Source: Save the Children, 2014 
 
The health indicator figures for Malaysia and Sarawak were obtained from the official 
Malaysian government department of statistics website. The data for 2014 was updated 
and published online in July 2016. The years 2015 and 2016 are yet to be published at 
the time of writing.  
Table 2.3 presents demographic statistical comparisons given for Malaysia, Sarawak 
and Singapore. This is to identify the statistical differences for Sarawak as compared 
with Malaysia as a whole and compared with Singapore the most developed of all 
South East Asian countries. 
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Table 2.3  Demographic statistical comparison  
 Malaysia  
(MDOS, 2014) 
 Sarawak 
(S‘wak Govt, 2014) 
Singapore 
(SDOS, 2014) 
Population (millions) 31.7 2.66  5.54  
Gender ratio (males : females) 107 : 100  107 : 100  965 : 1000  
Annual population growth 1.5%  0.8% 1.0%  
Crude birth rate (per 1,000)  13.1  14.9  9.8  
Total fertility rate 2.0  1.9  1.25  
Crude death rate (per 1,000)  4.8  4.3  4.7  
Infant mortality rate (per 1,000 
live births) 
6.6  7.1  1.8  
Male life expectancy (years) 72.5  75.2  80.5  
Female life expectancy (years) 77.4  78.3  84.9  
 
Sources: (MDOS, 2014) (Sarawak Govt, 2014) (SMOH, 2014) 
 
From Table 2.3 it can be seen that for 2014 Sarawak has the least annual population 
growth (0.8%) which the ministry suggests may be due to movement of people to 
Peninsular Malaysia for education and in search of work (Sarawak Govt, 2014). 
Compared to Malaysia and Sarawak, Singapore has the lowest total fertility rate 
(1.25%) due to a decline in the average family size. The difference in infant mortality 
rates per 1,000 live births is glaring: Singapore (1.8) to Malaysia (6.6) and Sarawak 
(7.1). This figure reduces as a country develops and the health system improves.   
Summarised verbal information for various statistics were also given by the Malaysian 
department of statistics for 2014, however, the charts were not available to view. 
Malaysia‘s rapid urban development and rural to urban migration has increased the 
urban population to 71.0%, up 10% in one decade from 2004 (MDOS, 2014). The 
Malaysian all mortality indicators declined in the two years prior to 2014 and crude 
birth rates also decreased (MDOS, 2014). There is a difference in birth rates when 
divided into the major ethnic groups: Malay (20.7) Indigenous (19.0) Chinese (12.7) 
and Indian (12.6) (MDOS, 2014). The Malaysian annual population growth decrease 
correlates with the decline in fertility rates, international migration and as the country 
becomes an aging population (MDOS, 2014).  
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2.6 Health Transition in Sarawak      
Education.  Education and health advanced jointly together in Sarawak. The first 
schools were set up by the Christian missionaries and followed a standardised English 
education system which helped to unify a multi-lingual society (J. H. Tan, 2012). The 
Christian mission schools were handed over to district councils to administer in 1954 
(J. H. Tan, 2012). From 1950 to 1970, in response to the devastation of Asian countries 
from the second world war, Australia sponsored more than 40,000 Asian students to 
study in tertiary institutions in Australia under the Colombo Plan (Downer, 2005). My 
husband was one of these students. The then Australian prime minister Robert Menzies 
believed that ‗improved living standards would foster political stability and counter the 
spread of communism in the region‘ (Downer, 2005, p. 2). Other countries also sent 
volunteer workers and teachers to the rural and remote areas to establish schools and 
give health instruction to the Indigenous Dayak tribes (Toynbee, 1997).  
Health.  Books documenting the early settlement of Europeans in Borneo note that 
many succumbed to malaria, cholera (Lo, 1986), typhoid fever (Cunningham, 2002), 
dysentery (Leong, 2011), plague brought in with the rats from the trading ships and 
unknown fevers (R. Payne, 1960). Westerners exploring Borneo introduced pneumonia, 
tuberculosis, diphtheria, sexually transmitted diseases and measles and, as the 
Indigenous people had no immunity from these, at least 50% of their number 
succumbed and many tribes were expected to die out (Lees, 1979). A number of the 
missionaries were qualified medical and health personnel who set up clinics near 
longhouses and the medical care they provided earned the respect of the animist 
Dayaks (Cunningham, 2002). Hygiene training for mothers, children‘s health 
instruction and home cleanliness (Cunningham, 2002) helped to raise the standard of 
living, particularly in the longhouses and remote areas (Southwell, 1999) and tribal 
population numbers began to increase again from around 1952. The Borneo 
Evangelical Mission planes supplemented the limited government planes and opened 
up many airstrips in the central interior areas and were used to fly sick people to 
hospitals in the major towns (C. L. Tan, 2006). By 1980 the Sarawak Health 
Department Flying Doctors Service took over the role.  
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Today Sarawak, like the rest of Malaysia, has seen rapid development and most urban 
centres have good hospital facilities offering adequate medical services. Patients come 
from a wide radius that includes many smaller outlying villages, and if a needed service 
is not available they are referred to a government or private specialist clinic in Miri, 
Kuching or Kuala Lumpur. However, for those who live in Sarawak‘s interior, the 
scenario is quite different. In remote areas people sometimes have to walk a number of 
days through thick rainforest carrying a sick person on a stretcher, or navigate the 
rapids of the upper Rejang and Baram rivers in longboats to get to a desa klinik (district 
clinic). In rural districts closer to urban centres, it may take three or more hours‘ 
driving on rough, boggy roads to reach a clinic, sometimes to find there is no doctor or 
nurse there. Indigenous women of the highlands and interior of Sarawak usually deliver 
their babies in their longhouses, and if there are complications it is too late to get 
medical help, resulting in maternal death rates for Sarawak and Sabah Dayaks being 
much higher than for Penninsular Malaysian ethnicities (Jegasothy, 2002).  
It is ironic that Sarawak, the richest natural resources state in Malaysia, spends RM422 
(AUD$140) per person on the health care budget (Sarawak Government, 2011) 
compared to Peninsular Malaysia, where the World Health Organization (WHO) 
recorded the annual average health budget per person as RM1,800 (AUD$597) 
('Sarawak‘s Hidden Health Scandal', 2011). The doctor-to-population ratio (including 
private) for Malaysia is 1:758 (MDOS, 2014) and for Sarawak is 1:918 (MDOS, 2014). 
In Australia it is 1:320 (ABS [Australian Bureau of Statistics], 2013) including urban 
and remote areas, general practitioners and specialist doctors. There is still an acute 
shortage of doctors and nurses in the rural government service in Sarawak and nurses 
and assistant medical officers (medics) run most of the small rural and remote clinics. 
This sometimes leads to imprecise medical diagnoses and mistakes. For example, 
erroneous epidemiological data and lack of information systems and registries has led 
the International Agency for Research on Cancer (IARC) to use comparative estimates, 
or data from major cities, to assess South East Asia‘s cancer burden, presented in 
Global Cancer Statistics 2008 (Jemal, Bray, Center, Ferlay, Ward, & Forman, 2011). 
Basch (1999) notes various reasons why accurate health statistics are lacking in 
developing countries, including lack of knowledge, understaffing and the 
inaccessibility of registry offices to people in isolated rural and remote areas. This is 
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still true for the remote interior of Sarawak. However, lifestyle changes bring different 
medical challenges once the rural folk migrate to the urban areas of Sarawak. 
2.7 Why This Study? 
Living in Miri over four decades, I have been a subjective observer of many of my 
husband‘s relatives as their lives have transitioned from a remote subsistence 
agricultural community to an urban western lifestyle. I have seen relatives become 
obese, grapple with diabetes, hypertension and stroke, and unfortunately some who 
have died from untimely cancer, heart disease and kidney failure. With a rising number 
of end-stage renal disease patients, haemodialysis therapy centres were set up by the 
Sarawak state government in collaboration with non-government organisations (Hooi, 
2006). Currently there are three haemodialysis centres in Miri. At the time of writing, 
the Miri Hospital serves 160 patients and is solely government funded and usually 
reserved for the very sick or poor. The privately run Miri City Medical Centre serves 20 
patients whose therapy is self-funded or funded from employers‘ benefits. The 
Malaysian Red Crescent Kidney Dialysis Centre serves 313 patients and is funded by 
the patients‘ family, public donations and employers‘ benefits (MRC [Malaysian Red 
Crescent], 2014). All the patients on haemodialysis from all three centres were invited 
to enlist their family members to participate in this study on a ‗first come, first recruited 
basis‘. Sadly, a number of end-stage kidney disease patients from all ethnicities 
lamented how being on dialysis has depleted their savings and burdened their family. It 
was my work with renal dialysis centre patients and their families that drew my 
attention to their difficult circumstances and their incessant need to raise funds for their 
dialysis fees. Of concern to me were the patients‘ immediate family members and of 
interest to me, were their transitional lifestyles, the fallacies and misinformation that 
surround beliefs on the causes of end-stage kidney disease and the contradiction of their 
practices and behaviours. 
There are no mass population screening programs in Malaysia, but hospitals, clinics, 
private doctors and voluntary organisations provide opportunistic screening services for 
cervical pap smears, diabetes, hypertension and proteinuria, incidentally for people who 
may have turned up for another reason. Those recorded as having infectious diseases or 
non-communicable diseases represent the tip of the proverbial iceberg. This study will 
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benefit the individuals participating in a number of ways. The clinical and biochemical 
screening tests conducted will identify those persons who are at higher risk for 
developing a chronic non-communicable disease, metabolic syndrome or chronic 
kidney disease. These tests were done free of charge for the participants. All laboratory 
reports were issued to each participant for them to take to their doctor for advice and 
follow-up. If detected early, intervention measures to slow the progression of and 
reduce complications from the disease can be initiated. The participants will be given 
the summary, conclusions and recommendations of the study, to share with their family 
and friends. This study will also be of value to the general Miri community. Analysis of 
the results will identify if there are local factors that may be associated with an 
increased risk for the development of chronic kidney disease in the Miri population. 
Appropriate intervention programs and strategies should be developed to target, screen 
and educate high risk groups identified from the study. This will contribute to health 
awareness, improve chronic non-communicable disease forecast and bring economic 
benefits for the community. 
2.8  Conclusion  
Over the last half century Malaysia has reaped huge profits from natural resources and 
developing industries, has created a yearning for wealth and education in the younger 
generations and progressed towards developed-nation status. Sarawak has also evolved 
within Malaysia and all ethnic groups, Malay, Chinese, Indian and Indigenous, are 
caught up in a transition from their traditional heritage to a modern lifestyle. Parallel to 
this lifestyle exchange is a corresponding health and medical transition from infectious 
diseases to chronic non-communicable diseases. 
This chapter has discussed both the development of and the divide between Sarawak 
with Peninsular Malaysia and how health statistics quoted as Malaysian do not always 
reflect the reality of the situation in Sarawak. Researchers are gradually building up a 
repertoire relevant to Sabah and Sarawak and perhaps, as these territories develop, the 
statistical gap will also close.  
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The resultant physical and medical problems related to chronic kidney disease and 
metabolic syndrome and the consequences to effected individuals as well as the local 
community will be discussed in the next chapter. 
 
Photograph 2.3  Mulu Tourism cultural dancers: Malay, Iban, Orang Ulu male, Orang 
Ulu female and Bidayuh dancers. Photograph by researcher. 
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Chapter 3 Literature Review 
This literature review explores chronic kidney disease and its interconnectedness with 
the metabolic syndrome as a potential risk factor for chronic kidney disease. This 
literature review specifically focuses on chronic non-communicable diseases and 
environmental factors that may predict and advance the development of chronic kidney 
disease. It discusses the aetiology of chronic kidney disease and the progression to end-
stage renal disease. The review includes discussion of the metabolic syndrome chronic 
comorbidities of type 2 diabetes, hypertension and cardiovascular disease. Written from 
the perspective of public health and lifestyle medicine, special reference is made 
regarding developing countries to help provide further context for this study. The 
chapter concludes with best public health management practices for chronic kidney 
disease and metabolic syndrome and uncovers research gaps in knowledge and 
information. 
3.1 Literature Review Methods 
3.1.1 Aims for the background, context and literature review 
In order to underpin the research, the aims for the chapter 1 background, chapter 2 
context and chapter 3 literature review of this study was to investigate fully:   
 those areas determined to be relevant from the study‘s research questions;  
 areas pertinent to achieving the aims and objectives of the study; 
 research gaps and a niche in order to position this thesis for future directions 
when planning community education awareness and intervention programmes. 
 
Prerequisite guidelines included the following: 
 directly relating to the topics under research and applicable to this study; 
 immersed in the medical and health knowledge surrounding the topics; 
 assessing conflicting research to determine the best study plans;  
 evaluating this intended study against other research study designs; 
 appraising this study‘s methodology and approach in light of other research. 
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3.1.2 Selection of peer-reviewed studies 
A contents outline was established in order to keep the background, context and 
literature review within the confines of the aims. The context chapter 2 explored factors 
contributing to the current public health challenges faced by the participant population 
source. This chapter relied heavily upon hard-cover books from the museum and 
libraries for factual information; government websites for demographic and health 
statistics; and local newspaper articles filled in gaps of knowledge that were 
unavailable on the websites. The background chapter 1 gave an overview of the study 
areas of concern and guided the literature review in defining those areas in more detail.  
A detailed search strategy was employed for the selection of appropriate studies to 
consider for the background and literature review. 
1. The source for retrieving reference material was through the online Curtin 
University library website. The electronic databases most often used for the 
literature search included Pubmed, Medline (Ovid), Medline (Proquest), 
Cochrane Library Database (updated 2011) and Google Scholar. Journal articles 
were also sought after from specific journal websites. Academic hard-copy 
books and journal magazines were also sourced as reference material. 
 
2. A thorough key-word Boolean search approach using ‗and‘ ‘not‘ ‘or‘ ‘near‘ was 
conducted. The key words and various combinations that were searched 
included end-stage renal disease, chronic kidney disease, metabolic syndrome, 
chronic non-communicable diseases, type 2 diabetes mellitus, hypertension, 
cardiovascular disease, obesity, immediate family members, first degree 
relatives and other associated topics.  
 
3. Peer-reviewed Google Books, journal reviews and journal abstracts relevant to 
the background and literature review contents outline were inspected. Those 
that fell within the inclusion and exclusion parameters had the full-text retrieved 
and read. Historical and significant references found in the reference lists of 
pertinent journal articles were also retrieved and read. After reading, relevant 
sections were marked and filed according to the contents category.  
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4. During the literature writing process the relevant sections were reviewed again 
and if suitable the idea was used and referenced in-text. Due care was taken to 
ensure literature research integrity by the proper citing of references. These 
were imported into the bibliography manager EndNote reference database and 
over five hundred references were found to be relevant. 
 
3.1.3 Journal article inclusion and exclusion criteria 
Throughout the thesis quantitative, mixed-methods and qualitative research studies 
were referenced. In searching for appropriate reference material, a pre-determined 
inclusion exclusion criteria list and a trials summary review table was followed. The 
limitations placed on the inclusion exclusion criteria list included being in English 
language; dates greater than 2000, although this was difficult for historical references; 
core clinical books and journals and peer-reviewed full-text articles only.  
Quantitative studies were evaluated according to The Newcastle Critical Appraisal 
Worksheet which was originally sourced from Darzins, Smith & Heller, (1992). 
Updated versions were acknowledged and incorporated into the review table (Young & 
Solomon, 2009; van Raan, 2013). To ensure evidence-based research was optimal, 
aspects pertaining to validity, reliability and how research bias was minimised, were 
appraised (NHMRC, 1999; Cochrane Handbook, updated 2011). Checklists from 
different study designs were consulted, including for random control trials 
(CONSORT, 2010) and for cohort, case-control trials and cross-sectional observational 
studies (STROBE, 2000). The Singapore-Statement on Research Integrity (Resnik & 
Shamoo, 2011) and clinical and best practice guidelines for chronic kidney disease for 
Malaysia (MMOH, 2006a) and Australian (AIHW [Australian Institute of Health and 
Welfare], 2014) were also referred to. The Mixed-Methods studies were evaluated by 
assessing the methods used, forms of coding and analysis used, interpretation of the 
findings, mechanisms used in designing a conceptual framework and generalizability 
(Tashakkori & Teddlie, 2010; Creswell & Plano Clarke, 2007). Criterion examined for 
review or discussion of qualitative studies included recruitment method, sample size 
and trustworthiness. The trustworthiness of the study was assessed according to its 
credibility, transferability, dependability and confirmability (Patton, 2002; Lincoln, 
Lynham & Guba, 2011; Lincoln & Guba, 1985).  
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The different methodologies, the expansive range of topics reviewed in the literature 
search and the paucity of available literature in some areas, meant that it was not 
feasible to follow a systematic review approach as that would have led to the exclusion 
of numerous historic and pertinent references. Therefore, some decisions for the 
inclusion of the literature was based on relevance and not always on research rigor, 
however, every endeavour to correctly document the literature search in line with 
recognized protocol on reporting these studies ensued.  
3.2 End-Stage Renal Disease and Chronic Kidney Disease 
3.2.1 International perspective and magnitude of end-stage renal disease and 
chronic kidney disease 
Adverse health determinants may lead to chronic kidney disease, which is progressive 
and may deteriorate to end-stage renal disease and premature death (Levy et al., 2001; 
Levey, Eckardt et al., 2005;  Anderson, Halter, Hazzard, Himmelfarb, Horne, Kaysen et 
al., 2009). Worldwide more than 1.1 million patients with end-stage renal disease 
require dialysis to survive (Lysaght, 2002; WHO, 2015). This figure excludes many 
people in the world‘s low-resource countries, who are unable to receive therapy 
because dialysis is inaccessible, unavailable or unaffordable, the nearest centre has 
limited machines, or they are deemed too old to receive treatment (WHO, 2003; 
Ayodele & Alebiosu, 2010). Various international registries indicate that the incidence 
of kidney failure is increasing in all countries (Levy et al., 2001; Levey, Eckardt et al., 
2005; Jha et al, 2013). In the United States end-stage renal disease has climbed from 
150 new cases per million population to 287 in ten years (United States Renal Data 
System, 1999), a rate of 5% per year, an incidence similar to that of AIDS (Reikes, 
2000) and representing a prevalence rate of more than one in every 1,000 persons. In 
the United Kingdom in 2004 there were 101 new patients per million population 
(PMP), and the incidence of end-stage renal disease had doubled over the past 10 years 
(1994-2004), but it was still below the European figure of 135 PMP (Renal 
Association, 2004). In developed countries the number of patients with end-stage renal 
disease is increasing at a yearly rate of 7% (Lysaght, 2002). In Malaysia there are no 
community-based studies of the incidence of end-stage renal disease, but in 1991 it has 
been estimated at 86 per million population (PMP) and prevalence rates at 46 PMP 
(Hooi, 1993). By 2005 the prevalence rate had increased to 497 PMP and globally, 
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Malaysia had one of the highest percentages for incident haemodialysis patients with 
type 2 diabetes (Hooi, 2006). In 2013 the vice-chairman of the NKFM [National 
Kidney Foundation Malaysia] announced there were 4,000 Malaysians diagnosed with 
kidney failure every year and that 14 of every 100,000 people in Malaysia have kidney 
failure (NKFM, 2013b; Cheng, 2013). This means there has been an exponential 
escalation of rates over twenty years. 
The burden of disease is disproportionate between richer and poorer countries, and 
there is a double burden for developing countries as they move from coping with 
infectious diseases to chronic diseases (WHO, 2003; WHO, 2015). In many of the 
lowest-resource countries the majority of people with kidney disease do not receive 
renal replacement therapy and die (Moosa & Kidd, 2006). Without renal replacement 
therapy, or if a person with end-stage renal disease decides to discontinue dialysis, 
death is caused by the toxic waste products accumulating in the blood, causing 
electrolyte imbalances (National Service Framework for Renal Services, 2005) and 
leading to a rapid decline in physical and mental functions. For every person with end-
stage renal disease there are a significantly greater number with chronic kidney disease 
(Levey, Eckardt et al., 2005).  
Worldwide there are approximately 250,000 new cases of chronic kidney disease 
diagnosed per year in developed countries alone (Collins, Couser, Dirks, Kopple, 
Reiser, Riella et al., 2006). The National Health and Nutrition Examination Surveys 
determined the prevalence of chronic kidney disease is 13.1% in the United States 
(Coresh, Selvin, Stevens, Manzi, Kusek, Eggers et al., 2007) and affects one in nine 
Americans regardless of age or ethnicity (Langman, 2006), meaning up to 10% of the 
population suffer from some degree of kidney disease. Of other developed countries, 
the Netherlands has the same percentage (Collins et al., 2006). In Australia there was a 
prevalence of chronic kidney disease of 11.2% (Chadban, Briganti, Kerr, Dunstan, 
Welborn, Zimmet et al., 2003; AIHW, 2014) and one in seven persons has at least one 
indicator of kidney damage (KHA, 2006c; KHA, 2015) and therefore is at increased 
risk of developing end-stage renal disease and cardiovascular disease. In Singapore, the 
most developed of South East Asian countries, the prevalence for chronic kidney 
disease is 12.8%; the Chinese have lower rates than the Malay or Indian groups 
(Sabanayagam, Lim, Wong, Lee, Shankar, & Tai et al., 2010).  
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In a sample of 876 persons, taken from the National Health and Morbidity Survey 2011 
in Peninsular Malaysia, the prevalence was 9.07% for chronic kidney disease (Hooi, 
Ong, Ahmad, Bavanandan, Ahmad, Naidu et al., 2013). Of particular concern is that 
only 4% of those diagnosed were aware that they had the disease (Hooi, Ong et al., 
2013). It is estimated that 4.2 million Malaysians have chronic kidney disease, many of 
them unaware (‗Malaysian patients spend $286mil‘, 2011). In response to the pandemic 
of kidney and associated cardiovascular disease throughout the world, the International 
Federation of Kidney Foundations and the International Society of Nephrology 
established World Kidney Day in an attempt to increase global public awareness of 
kidney disease (Collins et al., 2006; ISN, 2006). 
As a country develops and its per capita GNP increases to about US$3,000 per year, 
studies show that the poor especially face an increased risk of obesity and type 2 
diabetes which may lead to chronic kidney disease then end-stage renal disease 
(Hossain, Kawar, & El Nahas, 2007). This phenomenon is also being observed in 
Malaysia. In 1966 centres were set up to cater for the increasing number needing renal 
replacement therapy, and since 1990 the new haemodialysis acceptance rate has grown 
exponentially, in line with the economic development of the country (Hooi, Wong, & 
Morad, 2005). As well as between countries, inequality also exists within countries and 
inequality in Malaysia corresponds to the economic development of each state. Sabah 
and Kelantan have fewer than 300 PMP; Pahang, Terengganu, Kedah, Perlis and 
Sarawak have between 300 and 600; and the remaining six states have a prevalence of 
more than 600, with Penang the highest at 787 PMP (Hooi, Lim, Ghazali, Wong, Tan, 
Ahmad et al., 2005). 
The direct and indirect costs to governments and societies are incalculable. In Australia 
in 2013 there were almost 12,000 people receiving haemodialysis and 15% of all 
hospitalisations were related to kidney disease; it is the third most common reason for 
palliative care (ABS, 2014). In Malaysia it is estimated that there are 30,000 people on 
dialysis, and the number increases by approximately 6,000 per year (Cruez, 2014) 
which costs the government around RM700 million per year, or RM33,000 per year per 
patient (‗Malaysian patients spend $286mil‘, 2011). In 2005 patients were being 
dialysed in units run by the government (37%), private centres (31%) and non-
government organisations (32%), and were funded by the government (51%), self-
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funded (23%), charity (12%) or other means (14%) (Hooi, 2006). At one Miri non-
government organisation run haemodialysis centre the normal charge per dialysis 
session is RM150, but ninety per cent of the patients are subsidised and pay between 
RM1 and RM80 per session depending upon their individual financial situation ('MRC 
Miri to build kidney dialysis substation', 2015). The average monthly running costs for 
this haemodialysis centre is RM200,000.00 and this is mostly raised through donations 
from the public, corporate bodies and non-governmental organisations (‗MRC Miri to 
build kidney dialysis substation‘, 2015). As the number of patients entering 
haemodialysis therapy escalates, both the government and the private healthcare 
systems become overstressed (Hooi, Lim, et al., 2005). For this reason halting the 
progression of chronic kidney disease to end-stage renal disease is beneficial, as well as 
being financially better for the family and more economical for the community at large 
(Khwaja et al., 2007).  
3.2.2 Mortality of end-stage renal disease 
Patients undergoing end-stage renal disease treatment have a higher mortality rate, even 
when adjusted, than the general population and are at increased risk for atherosclerotic 
disease, left ventricular hypertrophy, malnutrition and infection (Reikes, 2000; CDCP 
[Centers for Disease Control and Prevention], 2007). Once a person has established 
end-stage renal disease, the underlying cause of the disease, usually determines the 
survival outcome (Reikes, 2000). In the United States end-stage renal disease mortality 
rates are highest in the elderly, those with type 2 diabetes, and Europid Americans with 
cardiovascular disease, accounting for about 50% of these deaths; infections are the 
second main cause of death (United States Renal Data System, 1999). Other developed 
countries are similar. In Malaysia, the demand for renal transplant is high but due to the 
shortage of donor kidneys the transplant rate remains at 5–7 per million population per 
year (Hooi, Lim et al., 2005). Ten per cent of patients on haemodialysis die while 
waiting for a donor organ (Cruez, 2014). There is little difference in mortality between 
haemodialysis and peritoneal dialysis patients in the United States (Vonesh & Moran, 
1999), but mortality is lower in kidney transplant patients (United States Renal Data 
System, 1999), especially those receiving kidneys from live donors (Reikes, 2000). In 
Malaysia the annual average death rate in end-stage renal disease patients for 
haemodialysis is 10%, comparable to other countries, and in the chronic ambulatory 
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peritoneal dialysis (CAPD) group it is 15% (Lim, Lim, Lee, Wong, Ong, Shaariah et 
al., 2008). 
3.2.3 Morbidity of end-stage renal disease and chronic kidney disease 
There are many causes of kidney failure, and when patients first present for 
haemodialysis their primary underlying renal disease is recorded. In Malaysia there has 
been little fluctuation over the last ten years and the recorded causes for end-stage renal 
disease are type 2 diabetes (58%), hypertension (11%), glomerulonephritis and 
systemic lupus erythematosus (4%), polycystic kidney (1%) and obstructive 
nephropathy (1%); the remaining 25% are registered as of unknown cause (MSN, 
2013). In most countries the two leading causes of end-stage renal disease are 
hypertension and type 2 diabetes (Reikes, 2000; Hallan, Coresh, Astor, Asberg, Powe, 
Romundstad  et al., 2006). WHO has forecast that by 2030 the highest number of type 2 
diabetes patients will be in Asia (Wild, Roglic, Green, Sicree, & King, 2004). All 
Peninsular Malaysians commencing haemodialysis have hypertension (9%) and type 2 
diabetes (58%) (Cruez, 2014; Lim, Ong, & Goh, 2011; MSN, 2014), but the leading 
causes of end-stage renal disease in Miri are hypertension (32.5%) and type 2 diabetes 
(30.4%) (MRC, 2014). Why there is this discrepancy is not presently known.  
In addition to complications arising from type 2 diabetes and hypertension, there is a 
high degree of morbidity from other causes in persons with end-stage renal disease. 
Haemodialysis complications (e.g., infection, haemorrhage, arteriovenous access 
thrombosis); peritoneal dialysis infection (e.g., peritonitis); and kidney transplant 
problems (e.g., infection and cancer due to long-term immunosuppression) are 
complications intrinsic to end-stage renal disease therapy modes (Reikes, 2000). 
Haemodialysis has limitations and cannot completely compensate for the kidneys, and 
toxins may accumulate (e.g., beta-2-microglobulin-associated amyloidosis, poor urea 
and acidic by-products of metabolism clearance) (Reikes, 2000). Nutritional 
consequences of end-stage renal disease include osteodystrophy, malnutrition and 
anaemia, although treatment with recombinant human erythropoietin for anaemia 
(Mallick & Gokal, 1999) and improved dialysis membrane technology to clear 
nitrogenous solutes (Krivitski & Depner, 1998) have improved patient outcomes 
(Mallick & Gokal, 1999; Reikes, 2000). 
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As with chronic kidney disease, other chronic non-communicable diseases are 
asymptomatic and may go undetected for many years until the person presents with an 
advanced disorder (Hooi, Ong et al., 2013). As well as in combination with kidney 
disease, type 2 diabetes, hypertension and cardiovascular disease individually have 
major morbidity and mortality consequences that contribute to society‘s economic costs 
(ISN, 2006). Type 2 diabetes and hypertension predispose patients to atherosclerotic 
disease and renal failure, and type 2 diabetes can also affect a person‘s sight, 
neuropathy leading to limb amputations and susceptibility to infection (Reikes, 2000; 
ISN, 2006). Global comorbidity statistics on renal failure show that 34% of patients 
with chronic kidney disease have heart failure and 25% have coronary artery disease 
(Levy et al., 2001; Jha et al, 2013). More than half of reported end-stage renal disease 
deaths (Levy et al., 2001; Jha et al, 2013) and half of chronic kidney disease deaths 
(Rashidi, Ghanbarian, Azizi & Adler, 2007b; McCullough, Li, Jurkovitz, Stevens, 
Wang, Collins et al., 2008) are caused by cardiac events. Whether these percentages are 
similar in Miri is yet to be determined.  
Disease complications, income and address can influence quality of life. Malaysian 
women on dialysis experience a lower quality of life than men and all genders with 
advanced chronic non-communicable diseases had a lower quality of life (Liu, Chew, 
Chiu, Zaki, 2005). There was inequality in availability and facilities available to rich 
and poor patients receiving dialysis, and those especially at risk were unemployed 
elderly patients without medical insurance (Liu et al., 2006). Where a patient lives can 
affect quality of life as well. In Australia it was found necessary to set up modern 
community-based satellite dialysis centres when there were clusters of patients in an 
area living a great distance from metropolitan centres (Kneipp, 2002). Following the 
Australian example, a non-government organisation in Miri is intending to set up a new 
kidney haemodialysis substation on the outskirts of Miri city to relieve the demand 
currently faced at the main centre (‗MRC Miri to build kidney dialysis substation‘, 
2015). This will be near a bus stop and close to a large area of low-cost housing so will 
make it easier for poorer people needing the haemodialysis services.  
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3.2.4 Clinical diagnosis and prognosis of chronic kidney disease  
3.2.4.1 Anatomy and function of the kidneys 
Weighing approximately 150 grams each, the kidneys contain around one million tiny 
filters called nephrons, each comprising a glomerulus encased in a Bowman‘s capsule 
and a renal tubule (Lamb, Tomson, & Roderick, 2005) (Figures 3.1 and 3.2). Each day 
the kidneys process approximately 200 litres of blood, and excretes 1–2 litres of 
metabolic waste products and excess water as urine every day (Wills & Savory, 1981; 
KHA, 2015). The process of ultrafiltration occurs at the barrier between the blood and 
the filtrate in the glomerulus (Paulev & Zubieta-Calleja, 2004). An osmotic pressure 
gradient called the Starling forces compels small molecules including water, glucose, 
sodium, chloride, amino acids and urea through the filtration barrier (Paulev & Zubieta-
Calleja, 2004); larger substances cannot cross. The kidneys regulate the blood volume 
and electrolyte balance, and some minerals such as sodium, potassium and phosphorus 
that seep through the glomerulus membrane into the tubules are reabsorbed into the 
bloodstream (NIDDK [National Institute of Diabetes and Digestive and Kidney 
Diseases], 2014).  
 
Figure 3.1  The physiology of the kidney  
Source: Creative Commons. Open Stax College, 2013a 
 
 
The physiology of the kidney is shown in Figure 3.1 and the route of blood flow 
through the kidneys and nephrons in Figure 3.2. 
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The kidneys also produce and regulate three important hormones: erythropoietin 
(EPO), vital for red blood cell production in the bone marrow; rennin to regulate and 
control blood pressure; and the active form of vitamin D, calsitriol, that promotes 
calcium absorption of the bone structure (NKF, 2013; NIDDK, 2014).   
3.2.4.2 Pathophysiology of the kidney 
Pathophysiology describes the biochemical and functional changes associated with a 
disease, as an organ, in this case the kidney, deteriorates. Irrespective of the disease 
aetiology of the chronic kidney disease, the end result is progressive renal damage 
through loss of functioning nephrons (Remington, Brownson, & Wegner, 2010). If this 
occurs over a few hours or days it is called acute renal failure and may or may not be 
reversible (Gaw et al., 2004; KHA, 2006b). Chronic kidney disease is the destruction of 
the kidney tissue by disease and develops over many months even years, is irreversible 
in the later stages, and eventually leads to end-stage renal disease (Gaw et al., 2004; 
KHA, 2006a).  
 
Figure 3.2  Blood flow in the kidney and nephrons 
Source: Ketchum & Bright, 2013a. Creative Commons. 
Abnormal mineral metabolism (Levin, Bakris, Molitch, Smulders, Tian, Williams et al., 
2006) and biochemical disturbances commence with about 50% of kidney function 
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deterioration (Brocklebank & Wolfe, 1993; Kopple, 2001). Up to 90% of kidney 
function may be damaged before some people experience any signs or symptoms of 
disease (Levey, Coresh, Balk, Kausz, Levin, Steffes et al., 2003; KHA, 2015).  In 
Australia 10% of people with chronic kidney disease do not know they have the disease 
(KHA, 2015). If diagnosed early, and with good clinical management, the rate of 
nephron loss may be slowed (Schieppati & Remuzzi, 2004; Stevens, Coresh, Greene, & 
Levey, 2006). Unfortunately even if the original cause of deterioration no longer exists, 
further deterioration is inevitable, as kidney damage has occurred and is irreversible 
(Brocklebank & Wolfe, 1993; Chadban et al, 2003).  
3.2.4.3 Assessing kidney function and kidney damage 
When less than 50% of the kidneys are functioning, the rate of deterioration declines 
substantially but symptoms such as tiredness, itchy skin and decreased urine output are 
often dismissed (KHA, 2006a) or associated with another chronic disease that the 
person may have. As the kidneys further deteriorate to 25% changes in the urine 
volume and colour, blood and/or pus in the urine, nausea, vomiting, loss of appetite, 
oedema and numbness in the hands and feet, a metallic taste and bad breath, darkening 
of the skin and cramping muscles may, or may not, begin to be noticed (KHA, 2006a). 
Anaemia, hyperthyroidism and cardiovascular disease also accompany kidney decline 
(Lamb et al., 2005).  
Once suspected of kidney disease, a person will be sent for blood and urine tests. 
Normally the kidneys remove potassium from the blood; however, if they are damaged 
the potassium remains and can cause irregular heartbeat (KHA, 2007). Red blood cells 
leaking into the urine, known as haematuria, is a sign of urinary tract infection, kidney 
or bladder disease (KHA, 2007). Early in chronic kidney disease the protein albumin 
leaks into the urine in micro amounts and is a good marker of kidney damage. 
Creatinine is a waste product from body muscle breakdown and repair. Urea, the main 
nitrogenous waste from dietary protein, is formed in the liver and is the final stage, via 
the Kreb‘s cycle, of the protein catabolic process (Wills & Savory, 1981; NIDDK, 
2014).  
If the kidneys are functioning inadequately, these metabolites and other organic 
substances accumulate in the blood, become toxic, and may inhibit enzyme and 
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hormone activity in the body (Wills & Savory, 1981; NIDDK, 2014). Both urea and 
creatinine are concentrated in the blood as the kidneys lose their function. Urea may be 
reabsorbed but urine creatinine is not reabsorbed once it crosses the ultrafiltration 
barrier, and is a good indicator of kidney function (KHA, 2006b). The rate of 
ultrafiltration, called the glomerular filtration rate (GFR), is 140 mL/min in a normal 
healthy individual (Lamb et al., 2005); when this rate decreases and only 10% of the 
normal kidney function remains, the person needs to make preparations to commence 
renal replacement therapy before there is little or no more urine produced (Gaw et al., 
2004; KHA, 2007). This is a major life-changing event. 
In 2002 The National Kidney Foundation in the United States defined chronic kidney 
disease using glomerular filtration rate and stratified it into stages (Hooi, Lim et al., 
2005) (Table 3.1).  
Table 3.1  Categories and staging of chronic kidney disease using the glomerular filtration 
rate 
Stage GFR Description  
1   >90 ml/min/1.73m²* Kidney damage with normal GFR 
2 60-89 ml/min/1.73m²* Kidney damage with mildly reduced GFR 
3 30-59 ml/min/1.73m² Moderately reduced GFR 
4 15-29 ml/min/1.73m² Severely reduced GFR 
5  <15 ml/min/1.73m² Kidney failure (end-stage renal disease) 
* To classify as stage 1 or 2 chronic kidney disease, there must be evidence of chronic kidney damage (present for at 
least three months); for example, structural or functional abnormalities of the kidney such as proteinuria and 
haematuria.  
 
Source: (KDIGO, 2012; KHA-CARI, 2012; NKF, 2008) 
 
 
When the glomerular filtration rate drops below 15 ml/min/1.73m² it is referred to as 
end-stage renal disease and renal replacement therapy is commenced. 
A survey and series of international controversies conferences organised by the Kidney 
Dialysis Outcomes Quality Initiative (KDOQI) programme, provided evidence-based 
clinical practice guidelines which gained international acceptance and improved 
diagnosis and management of chronic kidney disease, providing a consistent definition 
and classification of kidney disease (Levey, Eckardt et al., 2005).  
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The initiative defines chronic kidney disease as  
―… kidney damage or Glomerular Filtration Rate of <60 mL/min/1.73m² for 3 
months or more, irrespective of cause … Kidney damage in many kidney 
diseases can be ascertained by the presence of albuminuria, defined as albumin-
to-creatinine ratio >30 mg/g in two of three spot urine specimens.‖ (Levey, 
Eckardt et al., 2005, p. 2091) 
The original conceptual model depicting the stages of chronic kidney disease 
deterioration, modified and published by Levey, Eckardt et al. (2005), was designed to 
clarify the five stages to lay-people so they might better understand the deterioration of 
chronic kidney disease to end-stage renal disease. In the conceptual model, this 
deterioration is shown to produce more severe complications with progression over 
time, until death occurs.  
3.2.4.4  Estimate of the glomerular filtration rate 
Creatinine, a waste product produced by the muscles, is removed from the blood by the 
kidneys (KHA, 2006b). There is a reciprocal correlation between the serum creatinine 
and glomerular filtration rate, and different equations have been devised to interpret the 
results using creatinine plus age, gender, ethnicity, or body size of the person (ACCWG 
[Australasian Creatinine Consensus Working Group], 2005). The results are reported in 
mL/min/1.73 m
2
 and are corrected for an average person‘s body surface area (Gribbles, 
2007). Serum creatinine concentration is a common measure used to determine kidney 
function, but the blood test measurements alter with age, gender, muscle mass and diet, 
and measurements may vary by up to 20% (KHA, 2006d). Glomerular filtration rate is 
an accurate measure of creatinine clearance (KHA, 2006d), but it is cumbersome for an 
individual to save the 24 hours of timed urine output that it requires. A number of 
predictive equations to estimate glomerular filtration rate (eGFR) has been developed 
that do not require a weight measurement, are more accurate in calculating the level of 
kidney function, and enhance the ability to determine the extent of kidney damage at an 
early stage (KHA, 2006d). The eGFR formula only requires the person‘s age and 
ethnicity in order to determine the kidney function (Langman, 2006). It requires stable 
serum creatinine for its predictive accuracy therefore is not suitable for use with acute 
renal failure patients (Lamb et al., 2005). For chronic kidney disease it is accepted by 
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both KDOQI (Levey, Eckardt et al, 2005) and the later revised Kidney Disease: 
Improving Global Outcomes (KDIGO, 2012; Inker, Astor, Fox, Isakova, Lash, Peralta 
et al. 2014). The eGFR method is now preferred, as it facilitates early diagnosis and 
management of the disease (Stevens, Manzi, Levey, Chen, Deysher, Greene et al., 
2007) when the individual is still asymptomatic (Mathew, Johnson, & Jones, 2007). 
The same staging as glomerular filtration rate is used when presenting eGFR formula 
results to determine the kidney function: stage 1 is normal; stages 2, 3 and 4 gauge the 
deterioration of chronic kidney disease, and stage 5 is end-stage renal disease 
(Langman, 2006).  
Table 3.2 shows the equations for estimating renal function validated for a multi-ethnic 
Malaysian population (NKFM [National Kidney Foundation Malaysia], 2013a). The 
Cockcroft–Gault Creatinine Clearance method still uses the 24 hour urine collection 
sample as well as serum creatinine in the equation, and therefore is not the preferred 
estimate formula in Australia (ACCWG, 2005) but still accepted in Malaysia.  
Table 3.2  Equations for estimation of renal function 




 x 1.212 [if 
black] x 0.742 [if female], where GFR is expressed as ml/min/1.73m
2
 of body 
surface area and sCr is expressed in mg/dl. 
(Levey, Bosch  
et al., 1999) 
2. CKD-epi eGFR = 141 x min (sCr /k,1)
α





[if female] x 1.159 [if black], k = 0.7 (females) and 0.9 (males), 
α 
= -0.329 
(females) and -0.411 (males); min indicates the minimum of sCr /k or 1, and max 
indicates the maximum of sCr /k or 1.  
(Levey, 
Stevens et al., 
2009; Stevens, 
Schmid, et al., 
2010)  
3. Cockcroft–Gault Creatinine Clearance = CrCl (ml/min) = (140 – age (yrs)) x 
body weight (kg)/ sCr (μmol/l) x constant (1.23 for males; 1.04 for females). 
(Cockcroft & 
Gault, 1976). 
Note. sCr = Serum Creatinine; CrCl = Creatinine Clearance; MDRD = Modification of Diet in Renal Disease; 
chronic kidney disease-epi = chronic kidney disease-epidemiology 
 
Source: (National Kidney Foundation Malaysia, 2013a) 
 
Although convenient, results using eGFR have limitations and may lack  
 generalisability from one population group to another without evaluation and 
testing (Stevens, Manzi et al., 2007) 
 inaccuracies in precision of the various formulas when measuring different 
populations such as those with diabetes mellitus (Beauvieux, Moigne, Lasseur, 
Raffaitin, Perlemoine, Barthe et al., 2007)  
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 or with those of a different ethnicity (Maple-Brown, Lawton, Hughes, Sharma, 
Jones, Ellis et al., 2010)  
 or in populations without chronic kidney disease (Stevens, Coresh et al., 2006)  
 calibration consistency of the creatinine assay (Stevens, Manzi et al., 2007)  
 reliability in persons under 18 years of age (ACCWG, 2005)  
 reliability for those on dialysis (ACCWG, 2005) 
 nor is it suitable to use in cases of acute renal failure (Lamb et al., 2005) 
Obesity has been validated for the MDRD formula (ACCWG, 2005). A number of 
other conditions may also affect the eGFR result using the MDRD estimate formula, 
and a change in 15% glomerular filtration rate result may indicate one of the following 
and require further testing to confirm (ACCWG, 2005):  
 extreme diets such as vegetarian or high protein  
 extreme exercise regimes  
 pregnancy  
 severe liver disease  
 variation with drug dosage  
 amputation (ACCWG, 2005) 
In 2007 changes to reduce the range of variability, recommended by the Australasian 
Creatinine Consensus Working Group (2005), were adopted by all Australian 
laboratories (Matthew, Johnson et al, 2007). Notably this included a revised equation 
(Table 3.3) based on a different assay measurement and calibration of the serum 
creatinine, published as the Modification of Diet in Renal Disease revised ‗175‘ 
formula (rMDRD ‗175‘), to align with international reference methods recommended 
by the National Kidney Disease Education Program in the United States (Levey, 
Coresh, Greene, Stevens, Zhang, Hendriksen et al., 2006) (Mathew, Johnson et al, 
2007). Gribbles Pathology Malaysia, who handled the urine and blood collection and 
laboratory assessments for this study, follow the Australasian Creatinine Consensus 
working Group (2005) and provide automatic reporting whenever a serum creatinine 
test is requested (Gribbles, 2007).  
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Table 3.3  Revised equation for MDRD estimation of renal function 
4. rMDRD „175 formula‟ =  
eGFR = 175 x (sCr
 
x 0.0113) – 1.154 x (age) – 0.203 x (0.742 [if female])  
where MDRD = Modification of diet in renal disease (the name of the study where this formula was 
developed) 
eGFR = estimate glomerular filtration rate (ml/min/1.73m
2
)  
sCr = serum creatinine concentration (μmol/l)  
age is expressed in years. 
Source: (The Australasian Creatinine Consensus Working Group, 2005; Levey, Coresh, Green et al., 2006;  Mathew, 
Johnson et al, 2007). 
 
3.2.4.5 Urinary albumin to creatinine ratioIf the kidneys are damaged, protein 
leaks into the urine along with waste products filtered from the blood (KHA, 2006a). 
An increase in albumin and other water-soluble serum proteins (total proteins) in the 
urine is referred to as proteinuria and is an early marker for kidney damage from 
diabetes mellitus, high blood pressure and glomerular diseases in adults (KHA, 2006a) 
and a risk factor for early mortality (KHA-CARI [Kidney Health Australia - Caring for 
Australians with Renal Impairment], 2013). A number of factors can temporarily 
increase proteinuria including urinary tract infection, exercise stress, high muscle mass, 
fever and heart failure, ketosis and hyperglycaemia (KHA, 2006a).  
Albuminuria and haematuria are indicators of kidney disease progressing to end-stage 
renal disease, whatever the cause of chronic kidney disease. Proteinuria is a good 
indicator of progressive renal disease but it is already in an advanced stage before it is 
detected. Traditional screening for proteinuria using urine dipsticks in patients without 
diabetes mellitus has been debated with regard to the sensitivity and specificity of the 
test, and high screening costs to low detection rates of end-stage renal disease (Johnson, 
Jones, Matthew, Ludlow, Chadban, Usherwood et al., 2012). The lower threshold for 
most reagent strips is set at 150 mg albumin per litre, a macroalbumin level, whereas if 
there is diabetic glomerular leakage the concentration of albumin in the urine is 20–100 
mg per litre, which is a microalbumin level (Gribbles, 2007). Urine dipsticks do not 
adequately pick up microalbuminuria; a high proportion five false-positive results 
requiring recall of patients; and importantly, only they address end-stage renal disease 
and not cardiovascular disease; they are no longer recommended in Australia (KHA-
CARI, 2013).  
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Based on the Kidney Disease, Improving Global Outcomes (KDIGO) position 
Statement in 2006, The Australasian Proteinuria Consensus Working Group 
recommend that a urinary albumin-to-creatinine ratio (ACR) should be used as it is a 
suitable measure for both those with diabetic nephropathy and those without diabetes 
mellitus, is more reliable than total protein tests, and is predictive of both end-stage 
renal disease and cardiovascular disease (APCWG [Australasian Proteinuria Consensus 
Working Group], 2012). Persons with risk factors for chronic kidney disease, including 
hypertension and cardiovascular disease, should be tested using ACR annually if they 
have diabetes mellitus, and those without diabetes mellitus bi-yearly (APCWG, 2012). 
Persons with type 2 diabetes and hypertension of Asian ethnicity should be tested for 
microalbuminuria to prevent complications from chronic kidney disease and 
cardiovascular disease developing (Wu, Kong, De Leon, Pan, Tai, Yeung et al., 2005). 
It is also recommended that all pathology laboratories follow standard definitions and 
sex-specific cut-off points for albuminuria (APCWG, 2011). Gribbles Pathology 
Malaysia (2007) confirm they follow this.  
The ACR Range for kidney damage (Table 3.4) is shown below. 
Table 3.4  Ratio of albumin to creatinine: range for kidney damage  
                                                                   Urine albumin / creatinine ratio (mg/mmol) 
 Males Females 
Normal <2.6 mg  <3.6 mg  
Microalbuminuria (trace protein)  2.6–25.0 mg/mmol  3.6–35.0 mg/mmol  
Macroalbuminuria (overt proteinuria) >25.0 mg/mmol  >35.0 mg/mmol  
Source: (KHA-CARI, 2012; Gribbles, 2007)  
 
Cut-off points for increased levels of albumin in the urine are in two stages. 
Microalbuminuria has an albumin excretion rate of 20–200 ug/min and may be an early 
predictor of chronic kidney disease (Gribbles, 2007; KHA, 2007). It is referred to as 
incipient diabetic nephropathy. If type 2 diabetes is well controlled this may be 
reversible; however, macroalbuminuria is irreversible and has an AER of >200 ug/min 
(Gribbles, 2007).  
Females have a higher threshold for microalbuminuria than males (APCWG, 2011). A 
first morning void is the preferred sample (APCWG, 2011), but if a random spot urine 
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sample is taken the patient must rest one hour first as exercise, even normal daily 
activity, increases the albumin excretion rate (Gribbles, 2007).  
3.2.4.6 Classification and staging of chronic kidney disease 
A large, multiracial study from Singapore, a relatively small but rich nation, advocates 
nation-wide screening to identify persons at risk of chronic kidney disease (Ramirez, 
McClellan, Port, Stephen, & Hsu, 2002), but screening the whole population is not 
considered cost effective or suitable for most countries (Mathew, Corso, Ludlow, 
Boyle, Cass, Chadban et al, 2010). The conclusion from The AusDiab Kidney Study, 
using data from the1999 to 2000 Australian Diabetes, Obesity and Lifestyle Study, 
recommends screening all persons with hypertension and/or abnormal plasma glucose 
levels for microalbuminuria and macroalbuminuria (Atkins, Polkinghorne, Briganti, 
Shaw, Zimmet, & Chadban, 2004).  
A study using the results from NHANES III suggests that screening for albuminuria 
and eGFR at the same time identifies a greater percentage of persons with kidney 
disease from different population sectors (Garg, Kiberd, Clark, Haynes, & Clase, 2002) 
and predicts cardiovascular disease (Johnson, Jones, et al., 2012). This is now the 
benchmark. Kidney function is determined by the glomerular filtration rate or eGFR 
result and kidney damage is indicated by the ACR result (KDIGO, 2012; KHA 2007; 
KHA-CARI, 2013).  
Combining both eGFR and ACR enhances the detection and risk stratification of 
chronic kidney disease and cardiovascular disease (Johnson, Jones, et al., 2012). The 
matrix allows for easy assessment and plotting of chronic kidney disease progress and 
aids health workers in explaining to patients the two variables, glomerular filtration 
rate/eGFR and ACR involved in chronic kidney disease. This initiative to enhance the 
classification of chronic kidney disease by KDIGO (2012) has been adopted 
internationally.  
Table 3.5 presents this as it is adapted and used by Kidney Health Australia (KHA-
CARI, 2012).  
 
 47 
Table 3.5  Stages of chronic kidney disease by glomerular filtration rate and albumin to 
creatinine ratio  








Normal (urine ACR 
mg/mmol)  
Male: < 2.5  
Female: < 3.5 
Microalbuminuria     
(urine ACR 
mg/mmol)    Male: 
< 2.5-25   Female: < 
3.5-35 
Macroalbuminuria     
(urine ACR 
mg/mmol)    Male: > 
25   Female: > 35 





    
2 60-89     
3a 45-59       
3b 30-44       
4 15-29       
5 <15 or on dialysis       
     
Key: Green - Low Risk Yellow - Moderate Risk Orange - High Risk Red - Very High Risk 
Note. Conversion factor for ACR is 10 for converting Metric Units (g/dl) to SI Units (g/l) (NKFM, 2013b) 
Source: (KHA-CARI, 2012) Reproduced with permission (see Appendix.G).  
 
Different clinical action plans are needed for each stage of chronic kidney disease, and 
management needs to be individualised for each patient as the lower the glomerular 
filtration rate the greater the metabolic consequences and thus the more complicated the 
disease management (Lamb et al., 2005; Mathew & Corso, 2009). In the early stages of 
chronic kidney disease greater than 60 mL/min/1.73 m
2
, clinical intervention focuses 
on diagnosing and treating comorbidities, especially hypertension and proteinuria 
(Lamb et al., 2005). As the glomerular filtration rate declines further cardiovascular 
disease risk factors are addressed and lifestyle modification, especially smoking 
cessation, emphasised (Mathew & Corso, 2009). Although symptoms are still sub-
clinical, stage three, less than 60 mL/min/1.73 m
2
 to 30 mL/min/1.73 m
2
, is the 
commencement of metabolic disturbances such as hypertension , parathyroid hormone 
, calcium absorption , phosphate excretion , anaemia (erythropoietin deficiency) , 
nutritional status , and left ventricular hypertrophy onset (KHA-CARI, 2013; Lamb et 
al., 2005). Anti-proteinuric drugs (ACE angiostensin converting enzyme inhibitor or 
ARB angiostensin receptor blockers) are commenced (Mathew & Corso, 2009). In 
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stages four to five, 30 mL/min/1.73 m
2
 to 15 mL/min/1.73 m
2
, glomerular filtration rate 
is severely decreased, the patient starts experiencing symptoms as metabolic 
disturbances effect whole body systems including triglycerides , hyperphosphataemia, 
metabolic acidosis, hyperkalaemia and decreased libido (Lamb et al., 2005; NKF, 
2008) and the patient is referred to a nephrologist and prepared for RRT or kidney 
transplant (Mathew & Corso, 2009). Stage five, less than 15 mL/min/1.73 m
2
, presents 
with anorexia, vomiting, pruritus, saline retention and often heart failure (Lamb et al., 
2005) and once uraemia occurs, RRT must be commenced (Mathew & Corso, 2009). 
When developing an algorithm framework outlining the procedures for detecting 
chronic kidney disease, a health department or hospital must take into consideration the 
budget and the local state of affairs of that country. The Malaysian Ministry of Health 
algorithms for the management of chronic kidney disease (NKFM, 2013a) are different 
from those of the Australasian Proteinuria Consensus Working Group (Johnson, Jones, 
et al., 2012). The algorithms for both, however, enable medical staff to properly assess 
the patient, monitor deterioration of the kidneys, and determine the time at which to 
commence haemodialysis therapy (KHA-CARI, 2013; MMOH [Malaysian Ministry of 
Health], 2006a). 
3.2.5 Selected risk factors of chronic kidney disease and end-stage renal disease 
The aetiology of chronic kidney disease is not well understood and nor is the rate of 
progression and development of chronic kidney disease to end-stage renal disease, but a 
number of contributing risk factors are known. One seventh of the Australian 
population have a chronic non-communicable disease which increases their risk of 
developing kidney disease (KHA, 2015). Although most countries have the same 
contributing risk factors there may be local variation and anomalies. Apart from aging, 
being a first degree relative, type 2 diabetes and hypertension, Malaysia lists other 
possible risk factors for kidney failure as obesity and metabolic syndrome, 
cardiovascular disease, glomerulonephritis, abuse of non-steroidal antiinflammatory 
drugs (NSAIDs) and analgesic pain killers, smoking, anaemia, herbs including those 
containing aristolochic acid, and physical trauma (MMOH, 2006a). Biomedical risk 
factors include infectious and genetic diseases that may initiate kidney disease (KHA, 
2006d). Lack of basic knowledge about diagnosing and treating disease-initiated kidney 
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problems can lead to unnecessary morbidity and mortality in some countries (ISN, 
2006). Poor clinical management can accelerate kidney damage and hasten end-stage 
renal disease; and conversely, kidney damage can exacerbate these diseases (KHA, 
2006d). Discussion of these diseases are outside the parameters of this literature review, 
and the discussion of risk factors of chronic kidney disease will focus on chronic non-
communicable diseases, socio-demographic and environmental factors. 
3.2.5.1 Predisposing factors 
The distribution of the causes of end-stage renal failure may vary between different 
socio-demographic and population clusters. In Miri distribution differences for age, 
gender, ethnicity and inherited predisposing factors need to be determined before 
intervention programs can be planned for specific target groups.  
Age.  Chronic kidney disease diagnosis is multi-factorial, but the rise in incidence is 
associated with an aging population (Mahon, 2001; Zhang, Zuo, Xu, Wang, Wang, 
Wang et al., 2007). It was once thought that a mildly increased serum creatinine level 
was a normal feature of ageing, but new research shows that in fact it is chronic kidney 
disease as there is also a reduction in the glomerular filtering function of the kidney 
(Langman, 2006). In Australia 42% of new patients on renal dialysis are 65 or older 
(Kneipp, 2002). In the United States one in every 770 people aged over 65 has end-
stage renal disease (United States Renal Data System, 1999). The incidence of end-
stage renal disease increases with age, especially the median age, but this could be in 
response to other factors such as more efficient diagnosis, an increase in type 2 diabetes 
incidence with age, or a greater acceptance of undergoing haemodialysis (Reikes, 2000) 
however the risk of death is greater than the risk of end-stage renal disease in the aged 
(O'Hare, Choi, Bertenthal, Bacchetti, Garg, Kaufman, & McClellan, 2007). In Malaysia 
the number of younger patients starting dialysis remains static, but the incidence 
continues to rise in those over 65 years of age, who often have comorbid conditions 
including cardiovascular disease (Hooi, Lim et al., 2005). 
Gender.  In Australia 57% of new patients entering renal dialysis treatment are men 
and 43% women (Kneipp, 2002). In the United States 54% of end-stage renal disease 
patients are men (Reikes, 2000). The disparity between gender in Malaysia is similar to 
that of Australia, with 56% men and 44% women commencing dialysis in 2005 (Hooi, 
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Lim et al., 2005). Premenopausal women have a much less pronounced incidence of 
heart and kidney disease, but in diabetic women heart and kidney disease incidence 
equals or exceeds that of age-matched men (Maric, 2010).  
Ethnicity.  Populations of non-European origin have higher susceptibility to renal 
disease, and the prevalence of chronic kidney disease and end-stage renal disease will 
continue to increase more rapidly in other ethnic communities than European-
descended populations (Feehally, 2005). The prevalence of chronic kidney disease and 
end-stage renal disease also varies significantly between different ethnic groups 
(Feehally, 2005; Mau, West, Shara, Efird, Alimineti, Saito et al., 2007). In the United 
Kingdom, for example, there is a higher incidence of diabetes mellitus in people from 
South Asia but a higher incidence of hypertension in people of Africa and Afro-
Caribbean ethnicity; both these conditions are linked with a greater risk of chronic 
kidney disease (Mahon, 2001). In the United States end-stage renal disease is four 
times more common in African-Americans (3.6 cases per 1,000 population) than 
among European-descended Americans (0.8 cases per 1,000) (Reikes, 2000; Norris, 
Tareen, Martins, & Vaziri, 2008). The Pima American Indians have 20 times the rate of 
new cases of kidney failure than the general US population (Cho, Burrows, Roberts, 
Bullock, & Toedt et al., 2014). It was found that mortality for American Indians and 
Alaskan natives was different from Europid Americans and influenced by type 2 
diabetes, smoking, alcohol and social determinants (Esprey, Jim, Cobb, Bartholomew, 
Becker, Haverkamp et al., 2014). Another study found that American Indians and 
Alaskan natives had longer survival rates than European-descended people with type 2 
diabetes and attributed it to hereditary factors (Burrows, Cho, McKeever Bullard, 
Narva, & Eggers, 2014). 
Comparing the diverse ethnic groups of the Asian and Pacific Islanders of Hawaii to 
mainland United States revealed a number of disparities which are likely due to cultural 
factors, language barriers, and health access factors (Mau, West, Sugihara, Kamaka, 
Mikami, Cheng, 2003): higher rates of diabetes mellitus, glomerulonephritis and 
hypertension are reported. In the National Kidney Early Evaluation Program (KEEP-2), 
a community screening program found that chronic kidney disease was four times 
greater in the Hawaiian population than in mainland Americans (Mau, West, Shara et 
al., 2007). Each ethnic group was also found to have different risk factors for chronic 
 51 
kidney disease (Mau, West, Shara et al., 2007). Hypertension was the main risk factor 
for Japanese, Caucasians, native Hawaiians and Filipinos; diabetes and lower 
educational attainment for the native Hawaiians; diabetes and being over the age of 65 
years for Filipinos. The Chinese were found to have no significant risk factors for 
chronic kidney disease (Mau, West, Sugihara et al., 2003).  
The cause of end-stage renal disease can vary within the same ethnic group if residents 
live in different environments. Since migrating to London, Punjabi Indians have had a 
greater risk of coronary heart disease, including a greater body mass index (BMI), than 
their siblings in India (Patel, Winterbotham, Britt, Sutton, Bhatnagar, Mackness et al., 
1995). It was found that Aborigines in New South Wales had different patterns of 
cause, incidence and outcomes than Aborigines in the Northern Territory (Feehally, 
2005). From a racial perspective, in Australia 81% of new patients on renal dialysis to 
date were Caucasoid, 8% Aboriginal, 7% Asian, 2% Pacific Islander, and 2% other 
(Kneipp, 2002); the incidence of end-stage renal disease in the Australian Aboriginal 
population is greater than that of non-Aboriginal people for many reasons (White, 
Wong, Sureshkumur, & Singh, 2010; Jha et al. 2013).  
Family Medical History.  Ethnicity and family history (FH) go hand in hand, and it is 
not easy to distinguish ethnic links from family history. There are many genetic 
diseases affecting the kidney, such as polycystic kidney disease, a genetic abnormality 
that runs in families (ISN, 2006). Some diseases affects whole communities: for 
example, it is thought that the high rate of nephritis in some Australian Aboriginal 
communities may indicate a family trait of increasing susceptibility to post-
streptococcal glomerulonephritis (PSGN) known to contribute to renal disease (A. 
White, Wong et al., 2010).  
Chronic non-communicable diseases are also thought to be heritable. Diabetes mellitus 
and hypertension, the two leading causes of kidney disease, may have familiar genetic 
linkages (ISN, 2006). Diabetic nephropathy clusters in families and there is a 
considerable genetic component of kidney complications in type 1 diabetes with a high 
mortality among this group (Savage & Maxwell, 2008). The Reasons for Geographic 
and Racial Differences in Stroke (REGARDS) cohort concluded that the first degree 
relatives of end-stage renal disease patients were more likely to be obese and have type 
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2 diabetes and should be targeted for chronic kidney disease detection and intervention 
programs (McClellan, Speckman, McClure, Howard, Campbell, Cushman et al., 2007). 
End-stage renal disease patients and their families also tend to have increased 
cardiovascular disease complications and death, suggesting a genetic component is 
involved (Naiman, Cheung, Goldfarb-Rumyantzev, Naiman, Cheung, & Goldfarb-
Rumyantzev 2009). 
There are ongoing studies to find genetic markers and there appears to be a genetic link 
between chronic kidney disease and hypertension (Drawz & Sedor, 2011), and a variant 
in a gene on chromosome 10 has been identified as a marker for type 2 diabetes (Ng, 
Tam, Lam, So, Ma, & Chan, 2007), and there are a number of studies linking 
albuminuria to various chromosomes (Freedman et al., 2005). In the future there may 
be routine genetic tests available for high-risk persons. 
3.2.5.2 Socio-demographic and socio-economic factors 
A number of socio-demographic and socio-economic factors are associated with 
chronic kidney disease, although whether these factors directly contribute to its 
development is still under appraisal. Socio-economic factors such as environment and 
low income were found to contribute more in elderly African-Americans (Peralta, Ziv, 
Katz, Reiner, Burchard, Fried et al., 2006). Swedish, US and UK studies all show that 
in deprived areas there is a higher incidence of chronic kidney disease (Mahon, 2001; 
Levey, Atkins, Coresh, Cohen, Collins, Eckardt, & Powe, 2007). There is also a higher 
prevalence of chronic kidney disease in those with lower levels of education (CDCP, 
2007; W. Y. Lee, Jung, Park, Rhee, & Kim, 2004; Levey, Atkins et al, 2007), in 
minority or disenfranchised population groups (Remington et al., 2010) and in 
developing countries and areas of developed countries where living standards and 
hygiene are lacking (Atkins et al., 2004). As well as infectious diseases, there is also 
evidence that many chronic non-communicable diseases are associated with inadequate 
housing and environmental conditions (Braubach, Jacobs, & Ormandy, 2011). 
Housing.  Poor housing and environmental conditions are related to socio-economic 
status and ultimately can affect the health of an individual (Braubach et al., 2011). 
Studies associating socio-economic status to chronic kidney disease have had mixed 
outcomes. The socio-economic status of 1,657 patients at the Sheffield Kidney Institute 
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(Sheffield, UK) was determined and the association between it and chronic kidney 
disease assessed (Bello, Peters, Rigby, Rahman, & El Nahas, 2008). This retrospective 
cross-sectional study used the British Index of Multiple Deprivation score and the 
National Kidney Foundation K-DOQI classification of chronic kidney disease to 
compare socio-economic status with estimated glomerular filtration rate (eGFR) (Bello 
et al., 2008). Adjusted logistic regression models determined that a low socio-economic 
status correlated with lower chronic kidney disease scores at presentation, supporting 
the view that it is associated with the development and progression of chronic kidney 
disease (Bello et al., 2008). Conversely, in a large US case-control study of almost 
24,000 end-stage renal disease dialysis patients and controls, after adjustments for 
demographics, no statistically significant association was found for family history and 
socio-economic status (Song, McClellan, McClellan, Gadi, Hadley, Krisher et al., 
2009). Indicators employed for socio-economic status included ‗median household 
income, percentage high school graduates, percentage vacant housing units or ethnic 
composition‘ (Song et al., 2009, p. 1). Familial clustering in lower socio-economic 
areas was attributed to the patient no longer being able to work and moving to cheaper 
housing, and not to other socio-economic factors; inherited factors for type 2 diabetes, 
hypertension and chronic glomerular disorders had a greater effect on familial 
clustering, and the study recommended earlier screening for chronic kidney disease for 
family members (Song et al., 2009).  
Comparing the prevalence of physical, mental and cognitive diseases and impairments 
among elderly persons in the United States and the Dominican Republic, it was found 
that chronic non-communicable disease prevalence and possibly cardiovascular disease 
were associated with a higher socio-economic status, but higher education was not; 
however, physical disabilities were inversely associated with affluence and higher 
education (Acosta, Rottbeck, Rodriguez, Gonzalez, Almanzar, Minaya et al., 2010) . 
An aging population requires that health inequalities be monitored and as economically 
disadvantaged communities become more affluent there is a need for chronic non-
communicable disease prevention programs (Acosta et al., 2010). There are many 
studies of socio-economic status and chronic non-communicable diseases but few of 
the association with chronic kidney disease. The correlation is not known for the 
Sarawak end-stage renal disease and their first degree relatives. WHO is encouraging 
more research into socio-economic status and health transition in developing countries.  
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3.2.5.3 Lifestyle behavioural factors  
Tobacco smoking.  A negative lifestyle behaviour that appears to be escalating in 
Malaysia is tobacco smoking. It is well established that smoking, and passive smoking 
to a lesser extent, have a detrimental effect on coronary heart disease, which is now a 
leading cause of death in many countries (J. He, Vupputuri, Allen, Prerost, Hughes, & 
Whelton, 1999). The findings of the International Tobacco Control Southeast Asia 
survey revealed that 23% of Malaysian male teenagers are daily smokers, with the 
majority commencing the habit at the mean age of 13.7 (SD = 1.8), a 67% rise in 
teenage smoking over ten years (Hammond, Kin, Prohmmo, Kungskulniti, Lian, 
Sharma et al. 2008). The relationship between smoking and chronic kidney disease in 
older Malaysians is unknown. 
Although the mechanism for the effect of smoking on kidney function is unclear, a 
study of 11,247 healthy Australian adults tested for indicators of renal damage showed 
smoking to be associated with the prevalence, development and progression of kidney 
disease in men but not in women (Briganti, Branley, Chadban, Shaw, McNeil, Welborn 
et al., 2002). In both type 1 diabetes and type 2 diabetes smoking affects renal 
haemodynamics and protein excretion and promotes the development of chronic kidney 
disease (Ritz, Ogata, & Orth, 2000). Orth (2000) emphasises that if a person has 
diabetes, smoking increases risk of development of nephropathy threefold. Smoking 
often plays an unrecognised role in chronic kidney disease (Ejerblad, Fored, Lindblad, 
Fryzek, Dickman, Elinder et al., 2004) with or without diabetes or hypertension (Orth 
& Hallan, 2008), regardless of blood pressure control with medication (Chuahirun, 
Simoni, Hudson, Seipel, Khanna, Harrist et al., 2004) and even in people who appear 
healthy (Ritz et al., 2000). Cardiovascular risk factors, including smoking, augments 
atherosclerosis of the kidney (Baggio, Budakovic, Casara, Gambaro, Saladini, Piccoli, 
et al., 2001), and even moderate chronic smoking may result in a person being 
susceptible for irreversible proteinuria (Halimi, Giraudeau, Vol, Caces, Nivet, 
Lebranchu et al., 2000; Remington et al., 2010). Smoking also hastens the progression 
of chronic kidney disease to end-stage renal disease in addition to increasing 
cardiovascular disease risk (Orth & Hallan, 2008); however, as soon as a person quits 
smoking, progression to end-stage renal disease decelerates and outcomes for the 
kidney immediately improve (Ritz et al., 2000). 
 55 
Diet and physical activity.  There are often health consequences when developing 
countries modernise. Adopting a modern lifestyle brings increasing economic affluence 
and status while lack of dietary restraint and of physical activity often accompanies the 
transition and leads to obesity and lifestyle diseases (Forouhi & Sattar, 2006). Poor 
nutrition increases the risk of obesity, which increases the risk of developing type 2 
diabetes, a primary cause of kidney failure (KHA, 2006d). Simultaneous malnutrition 
and over-nutrition is a paradox many developing countries face today. A study using 
anthropometric measurements and three 24-hour diet recalls from the mothers and 
children of 182 households of the Indigenous Orang Asli of Selangor, Peninsular 
Malaysia, found that in 25.8% of households the mother was overweight (31%) or 
obese (20%) while the children were underweight (58%) and stunted (64%); only 14.8% 
of households had both a mother and child of normal weight (Saibul, Shariff, Lin, 
Kandiah, Ghani, & Rahman, 2009). Processed food, urbanisation and transitional 
lifestyles are the drivers of the shift towards unhealthy diets and sedentary lifestyles 
(WHO [World Health Organization], 2013b).  
Protein diets and the amount of protein in a diet have mixed reviews. There is currently 
no firm evidence to suggest that a high protein intake can damage the kidneys in a 
normal healthy individual, as the kidneys respond by increasing the rate of filtration 
(Martin, Armstrong, & Rodriguez, 2005). There are conflicting study results for 
persons with chronic kidney disease. One study concludes that low-protein diets have 
not been shown to significantly slow chronic kidney disease deterioration and may 
instead increase the risk of malnutrition (Locatelli, Del Vecchio, & Pozzoni, 2002). 
Mandayam and Mitch (2006) do not agree that low-protein diets lead to malnutrition, 
arguing that, if compliant with dietary planning, people should be able to maintain body 
weight, serum albumin and electrolyte levels. Other studies offer evidence that for 
persons who have confirmed chronic kidney disease, protein restriction retards the 
progress of the disease (Fouque & Laville, 2009) although children and teenagers on 
renal replacement therapy need protein for growth (Brocklebank & Wolfe, 1993; 
Srivaths, Wong, & Goldstein, 2009). A study of 1,585 participants found that it took 
four months on a low protein diet for only small benefits to be seen in chronic kidney 
disease patients (Klahr, Levey, Beck, Caggiula, Hunsicker, Kusek et al., 1994). There 
was no significant benefit in following a low or very low protein diet for those with 
severe chronic kidney disease with no delay in reaching end-stage renal disease or 
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death (Klahr et al., 1994). Fouque and Laville (2009) in their review of low protein 
diets found that the more restricted the diet, the stronger the relative risk reduction in 
renal death. It is known that limiting dietary protein decreases creatinine production to 
a limit which ultimately lowers glomerular filtration rate and creatinine clearance, but 
more studies are required to determine the optimal threshold needed to halt the forming 
of lesions and the deterioration of the kidney in different stages of chronic kidney 
disease (Fouque & Laville, 2009). A vegetarian diet was found to lead to lower serum 
phosphorus levels and higher excretion of phosphorus compared with a meat diet, 
suggesting that the source of protein may be an important consideration (Moe, 
Zidehsarai, Chambers, Jackman, Radcliffe, Trevino et al., 2011). In Malaysia, a low-
protein diet is not advised until the patient is established on haemodialysis therapy.  
Traditional herbal medicine.  In Malaysia traditional Malay, Chinese and Hindu 
Ayurvedic herbal medicines and many Indigenous herbal products are available from 
traditional practitioners. In Miri little information is available as to the identification of 
herbs and the quantities of traditional herbs consumed by the local population. To 
complicate matters, some tribal ethnic groups call particular herbs, vegetables, which 
makes identification confusing. Malay, Indian and Chinese traditional herbal medicine 
is much more organised but no better researched, and it is not known if the products 
used in Sarawak contain nephrotoxic substances.  
Alternative and Indigenous medicines from poorer rural communities in developing 
countries are now being used in urban areas and in developed countries (Jha, 2010). 
The source, composition and toxicity of the herbs are neither tested nor controlled, and 
if unavailable a more noxious one may be substituted (Jha, 2010) or undisclosed drugs, 
hormones and glandular extracts added (Colson & De Broe, 2005). Traditional Chinese 
prescription herbal medicine is more potent than over-the-counter herbal soups and 
teas, but there is little standardisation (A. Lee, Chui, Aun, Lau, & Gin, 2006). 
Pesticides and heavy metals have been found in herbal preparations, and drug 
interactions with these substances may cause acute and chronic kidney toxicity (Colson 
& De Broe, 2005). Researchers from the Chinese University of Hong Kong found that 
traditional Chinese herbal medicine can cause complications if taken prior to 
anaesthesia and surgery, with patients twice as likely to have complications from low 
levels of potassium or impaired clotting (Chiu, Yau, & Epstein, 2009). The traditional 
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herbs liquorice, rehmannia, astragalus, atractylodes and eucommia have been named as 
potentially harmful if taken before surgery as they can cause arrhythmia (A. Lee, Chui 
et al., 2006).  
There are some promising ongoing studies of the efficacy of traditional Chinese herbal 
medicine for the treatment of adverse outcomes of chronic kidney disease (Li & Wang, 
2005). Large randomised trials are needed to test for active ingredients, toxicity, and 
effectiveness for use in chronic kidney disease (Zhong, Deng, Chen, Chuang, & He, 
2013). WHO acknowledges the use of traditional herbal medicine. The Malaysian 
National Health and Morbidity Survey II 1996 reported that 2.3% of Malaysians visited 
traditional medical practitioners and 3.8% used both Western and traditional medicines, 
often concurrently (Hasan, Ahmed, Bukhari, & Loon, 2009). Since 2006 the Malaysian 
Government Ministry of Health, Traditional and Complementary Medicine Division 
has supported a number of hospitals, including one in Sarawak, as pilot projects using 
traditional practices that are evidence-based and proven to be safe and effective (Hasan 
et al., 2009).  
3.2.5.4 Environmental factors  
Agrochemicals.  There is growing worldwide concern regarding excessive use of 
agrochemicals and the potential for kidney disease and kidney failure from long-term 
exposure in those using the chemicals. A number of studies based in under-developed 
tropical countries suggest that excessive, indiscriminate use of agrochemicals in 
plantations, combined with a lack of protective gear for workers, is linked to chronic 
kidney disease and end-stage renal disease (Almaguer, Herrera, & Orantes, 2014; 
Correa-Rotter, Wesseling, & Johnson, 2014; Wimalawansa & Wimalawansa, 2014). 
Common multi-factorial denominators have been uncovered in data from Sri Lanka, 
India and Central America, including hot humid conditions, occupational safety 
hazards, and the presence of chronic kidney disease without diabetes mellitus or 
hypertension (Chavkin, 2013; Herrera, Orantes, Almaguer, Alfonso, Bayarre, Leiva et 
al., 2014; Orantes, Herrera, Almaguer, Brizuela, Hernandez, Bayarre et al., 2009; 
Trabanino, Aguilar, Silva, Mercado, & Merino, 2002).  
Most studies examine the association of multiple chemical exposure with chronic 
kidney disease, but some studies and reviews target particular individual chemicals or 
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chemical groups. A case-control study of the effect of the herbicide paraquat on 
Peninsular Malaysian plantation workers found no significant difference in health 
effects for those who had been spraying for less than five years, although it was 
projected that they would suffer long-term health effects (Howard, Sabapathy, & 
Whitehead, 1981). Reviews or fact sheets on paraquat (Bairaktari, Katopodis, 
Siamopoulos, & Tsolas, 1998; Watts, 2011), glyphosate (Cox, 1995) and 2,4-D 
herbicide (Azman, 1997; Cox, 1999) all conclude that these chemicals have toxic 
effects on the kidney. In Malaysia there are 30 registered pesticide manufacturing 
companies whose products may contain 250 active ingredients (‗The Different Types of 
Pesticides Available‘, 2014), and 3,000 pesticide packaging outlets (I. Fernandez, 
Joshi, & Network, 2002). Surfactants and solvents, used to assist plants absorb the 
chemicals, are not required to be listed among the ingredients and may also contribute 
to organ dysfunction (Azman, 1997). The Ministry of Health Sri Lanka has 
recommended that fertilisers and pesticides containing heavy metals, if proven to cause 
chronic kidney disease, be banned (Weeraratna, 2012).  
The National Health and Examination Survey 1999–2002 (NHANES), using a cross-
sectional study design, found that organochlorine and Dioxin-like polychlorinated 
biphenyls pesticides were most strongly and consistently associated with five 
components of metabolic syndrome, suggesting that cardiovascular and diabetes risk 
factors relate to a background exposure to these pesticide chemicals (D. H. Lee, Song, 
Steffes, Toscano, Baker et al., 2006). The US National Toxicological Program 
workshop in 2011 found and reviewed 29 articles that had found a positive association 
between some environmental chemicals and diabetes (D. H. Lee, Lee et al., 2006): 
although there was insufficient evidence to conclude causality, the workshop 
recommended future studies including research into dose-response and joint exposure 
(C. C. Kuo, Moon, Thayer, & Navas-Acien, 2013). A study of type 2 diabetes among 
the Indigenous people of Canada concluded that obesity may be linked to toxic 
chemicals in the food chain, called endocrine disruptors, that interfere with the 
endocrine system, and may factor into the development of diabetes (Sharp, 2009).  
Malaysia‘s small-scale farmers and cash crop plantation companies, in efforts to reduce 
crop damage and food loss, use multiple applications of agricultural pesticides, 
insecticides, herbicides and fungicides produced and distributed by over 30 companies 
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(‗Pesticides—a double-edged sword‘, 2014). There are 1,600 pesticide products (I. 
Fernandez et al., 2002) and hundreds of different herbicides (Azman, 1997) distributed 
throughout Malaysia, and different names are often used for one substance or product. 
Many of the agrochemicals available and used in Sarawak are banned in Europe and the 
United States—including paraquat, which, following recommendations by the 
Chemical Review Committee of the Rotterdam Convention on Prior Informed Consent, 
has been banned by 36 countries including Malaysia (Watts, 2011). Its ban in Malaysia 
was reversed in 2006 after pressure from the manufacturing and plantation industries 
(Krishnamoorthy, 2006). On 2006 Brunei banned all vegetables from Miri because the 
pesticide content was excessive (‗More and Younger Patients Starting Dialysis‗, 2006) 
and almost ten years later the ban is still in force. The increasing demand for 
agrochemicals is not being matched by health and safety awareness and education 
campaigns (Lum, Mamat, Cheah, Castaneda, Rola, & Sinhaseni et al., 1993) or 
government regulations (Watts, 2012).  
‗Pesticides—a double-edged sword‘ (2014) reported that the Sarawak Dayak Iban 
Association and the Pesticide Action Network Asia and the Pacific conducted a survey 
of pesticide applicators in the Suai District, one to two hours drive from Miri, and 
found that agrochemicals, mostly paraquat dichloride, glyphosate, d-phenothrin, 
cypermethrin, pallethrin and chlorpyrifos, were extensively used throughout Sarawak. 
Pesticide applicators and sprayers complained of ‗excessive sweating, dizziness, 
blurred vision, headache, narrowed pupils and excessive salivation‘ (‗Pesticides—a 
double-edged sword‘, 2014). The National Poison Centre of Malaysia reported that the 
largest proportion (47.2%) of the 3,057 reported poisoning exposures from Peninsular 
Malaysia were unintentional agrochemical poisoning of adult males working as 
agrochemical applicators; 84.2% of these needed hospital admission (Haslina, 
Fathelrahman, Rahman, Shalihin, Razak, Rahmat et al., 2007). As a method of suicide, 
ingestion of agrochemicals, such as paraquat, is common because of its availability 
(Haslina et al., 2007). In 2002 the Drug Information Unit, Hospital Universiti Sains 
Malaysia, reported on the disturbing number of farmers admitted with accidental 
pesticide poisoning (A. F. Ab. Rahman, 2002). A study of the health of Malaysian 
plantation sprayers found that, at the concentrations used, long-term paraquat spraying 
was harmful to their health (Howard et al., 1981). A Malaysian article, written on 
possible ways to reduce health risk among farmers in developing countries from 
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excessive use of pesticides, does not use any examples of or make reference to 
Malaysia (Rathinam, Kota, & Thiyagar, 2005), but infers the need for regulations and 
enforcement of regulations there. In Sarawak there is scant research on the agricultural 
use of pesticides, consequences for sprayers, or the impact on the environment 
including the rivers and water supply; such studies are urgently needed. A quarter of 
patients admitted for haemodialysis in Miri are recorded as have an unknown cause of 
chronic kidney disease / end-stage renal disease (MRC, 2014;  'MRC Miri to build 
kidney dialysis substation‘, 2015). Agrochemical poisoning may well be one.  
3.2.6 Screening and intervention for chronic kidney disease   
There are few kidney donors in Malaysia (Cruez, 2014), and other than undergoing a 
kidney transplant there is no known cure for end-stage renal disease. As finances and 
resources improve, developing countries may lift restrictions on age and comorbid 
conditions, essentially allowing anyone with end-stage renal disease access to 
haemodialysis but this has profound logistic and economic repercussions (Reikes, 
2000; Bello et al., 2008). The most effective way to contain the escalation of end-stage 
renal disease cases is to prevent or delay the development of chronic kidney disease 
(Ayodele & Alebiosu, 2010; Locatelli et al., 2002). In 1986 WHO published guidelines 
for screening for diseases, which are still relevant today and can be adjusted and 
applied to different diseases and countries. These guidelines suggest how to assess and 
justify setting up a screening program, address the disease condition, choose which 
detection tests to use, determine treatment options, and deal with program details such 
as facilities, policy, budget and continuity plans (Mathew & Corso, 2009).  
3.2.6.1 Community strategies to detect chronic kidney disease 
Screening Programmes.  The intention of medical screening is to detect a disease in 
the early stage of development and refer the person to an appropriate place for 
diagnosis and intervention (Jaar, Khatib, Plantinga, Boulware, & Powe, 2008). Due to 
its sub-clinical nature, the only way chronic kidney disease can be detected is to 
undertake a protein dipstick test or a urine and blood test. In Malaysia most clinics and 
public screening campaigns only use a protein dipstick to save costs; and, as explained 
previously, only those with advanced proteinuria are detected. Laboratory testing can 
be costly for poorer people, and sponsorship for organised screening programs that 
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include eGFR and ACR are scarce. Public screening campaigns in Malaysia are often 
organised by politically motivated groups sometimes using non-medical staff. It is 
recommended that those running screening programs have to have a good knowledge of 
the tests performed and assessment skills (de Jong & Gansevoort, 2005).  
Large screening programs for chronic kidney disease are impractical: they are not cost-
effective (Mathew & Corso, 2009) and the incidence of end-stage renal disease in the 
general population is low (Garg et al., 2002; Hallan, Dahl et al., 2006). Even in a 
developed country such as Australia, screening for early kidney disease in the total 
population is not pursued (KHA, 2006d) and focus has been on targeting individuals 
who are deemed ‗high risk‘ for developing chronic kidney disease (AIHW, 2014). In 
Australia it is recommended that all high risk persons, with and without diabetes, also 
have a urine ACR assessment to detect microalbuminuria (KHA-CARI, 2013). 
Microalbuminuria has been detected in 58% of type 2 diabetes and hypertension 
participants (n = 6,482) from multiple ethnic groups throughout ten Asian countries: a 
worrying result requiring urgent targeted intervention to avert chronic kidney disease 
and cardiovascular disease complications (Wu et al., 2005). China is becoming more 
affluent and urgently needs to formulate strategies (N. Chen, Wang, Huang, Shen, Pei, 
Yu et al., 2009) and interventions to limit the surge of chronic kidney disease (Zhang et 
al., 2007). Chronic kidney disease in Peninsular Malaysia is common, and early 
detection is considered the best way to reduce the economic impact of end-stage renal 
disease (Hooi, Ong et al., 2013), but population-based screening is left to health clinics 
or public programs, who run opportunistic screenings on people who randomly appear 
(Hooi, Wong, et al., 2005). The Malaysian healthcare system recommends testing for 
proteinuria using urine dipsticks (Hooi, Lim et al., 2005), followed, if positive, by a 
referral for an eGFR using serum creatinine measurement by medical personnel (Hooi, 
2006). 
Early diagnosis.  There are no randomised controlled trials for this area, but 
retrospective and prospective studies conclude that screening for early chronic kidney 
disease provides the best intervention opportunities and improves outcomes (KHA-
CARI, 2013) and the yield detected must be sufficient to have a cost benefit (Jaar et al., 
2008). The Kidney Early Evaluation Program (KEEP) concludes that targeting family 
members of end-stage renal disease, especially African-Americans (Laville, Juillard, 
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Deleaval, Fave, Charlois, Touzet et al., 2007) who have hypertension or type 2 diabetes 
is an effective means of detecting previously unidentified persons with chronic kidney 
disease (Brown, Peters, Ohmit, Keane, Collins, Chen et al., 2003). Persons at risk of 
developing chronic kidney disease in most countries include those of certain ethnicity 
(Feehally, 2005; Forouhi & Sattar, 2006), those who have a chronic non-communicable 
disease and those with a family history or other genetic predisposition for kidney 
problems (Ong, Punithavathi, Thurairatnam, Zainal, Beh, Morad et al., 2013). First 
degree relatives are usually motivated to undergo target screening as they know first-
hand the outcomes of a disease and are often compliant to interventions (Jaar et al., 
2008). Screening limited to those with a family history of end-stage renal disease and 
chronic non-communicable diseases finds that 93% of those screened have chronic 
kidney disease (Hallan, Coresh, et al., 2006). Opportunistic screening targeting high-
risk populations (Feehally, 2005; Hallan, Coresh, et al., 2006), by physicians (KHA-
CARI, 2013) or in combination with other community screening programs (Mathew, 
Corso, Ludlow, et al., 2010) such as cardiovascular disease (Rakhit, Armstrong, Beller, 
Isbel, Marwick, Rakhit et al., 2006), are evidence-based and recommended.  
3.2.6.2 Medical intervention and barriers to screening 
Interventions and management.  Early diagnosis of chronic kidney disease is vital as it 
extends a person‘s life span and saves money (James, Hemmelgarn, & Tonelli, 2010) 
and facilitates a less distressing transition to haemodialysis therapy  (Mathew, Corso, 
Ludlow, et al., 2010) . Late referral to a nephrologist and commencing dialysis as an 
emergency affects future independence and quality of life (Laville et al., 2007). Early 
therapeutic interventions can ameliorate complications (Jaar et al., 2008; Levey, 
Eckardt et al., 2005). Those who are detected as having chronic kidney disease in 
community or opportunistic screening must be followed up in order for any benefits to 
be gained, and their high risk factors must be intensively managed in order to prevent 
end-stage renal disease and cardiovascular disease (Mathew, Corso, Ludlow et al, 2010; 
M. V. Rao, Qiu, Wang, & Bakris, 2008). Chronic kidney disease accelerates 
cardiovascular disease through unknown mechanisms (McCullough, Li, Jurkovitz, 
Stevens, Collins, Chen et al., 2008) and the person‘s life-span is shortened 
(McCullough, Li, Jurkovitz, Stevens, Wang, Collins et al., 2008) unless early referral to 
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a nephrologist (Locatelli et al., 2002; Johnson, 2012) and optimal management is given 
(Rossert & Wauters, 2002; Johnson, Atai et al., 2013).  
With better medication, greater compliance in taking medication, and greater 
acceptance of dialysis, the overall survival of patients with end-stage renal disease is 
improving (Reikes, 2000; Jaar et al., 2008). In certain populations the incidence rates 
for chronic kidney disease / end-stage renal disease is slowing down, consistent with 
rigorous blood pressure and glucose control, lipid lowering and kidney-protective 
medications (ISN, 2006;  James et al., 2010). Interventions for chronic kidney disease 
should also include correction of calcium-phosphate disorders and anaemia, cessation 
of smoking (Locatelli et al., 2002) and healthy lifestyle management (Egger, Binns, & 
Rossner, 2009). When developing a mass screening initiative, death, suffering, 
economic and social costs need to be considered in the program (Council of Europe, 
1994). Pain often accompanies chronic non-communicable diseases and pain relief is a 
basic human right. In poor countries with limited resources, given the affordability and 
availability of analgesic medications, WHO (2007) has recommended that interventions 
should only be instigated if there is a high probability of a cure rate and pain relief 
against cost effectiveness.  
Barriers to screening.  A US review found that among health care workers including 
physicians, awareness of chronic kidney disease was low, resulting in incorrect and 
delayed diagnosis, missed treatment, unprepared entry into RRT (Jha et al., 2013) and 
under-reporting of kidney disease (WHO, 2015). A review of the NHANES data 
determined that high-risk groups were more likely to be unaware of having chronic 
kidney disease, even with good health care available to them (Crook, Washington, 
Flack, Crook, Washington & Flack, 2002; Nickolas, Frisch, Opotowsky, Arons, & 
Radhakrishnan, 2004). Media attention, community awareness programs and 
professional education are all needed to change public attitudes and behaviours towards 
chronic kidney disease (ISN, 2006) and is fundamental to improving health outcomes 
in the community (Johnson, Jones, et al., 2012) (Jaar et al., 2008).  
A study of why people refused health screening found that non-participants thought the 
screening limited, were worried the results would be made public, did not want to know 
if they had an illness, felt they had good health, felt it was their responsibility to go to 
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the doctor if ill, and did not want to have their feeling of enjoying good health disturbed 
(Crook et al., 2002). Identifying causal risk factors for the local population and making 
chronic kidney disease a health education priority will help lessen the economic burden 
of end-stage renal disease in developing countries (Khwaja et al., 2007). Programmes 
must be culturally sensitive and appropriate for the whole community (Hostetter & 
Lising, 2003). Effective morbidity outcomes depend upon early interventions to delay 
the progression of chronic kidney disease to end-stage renal disease and to prevent the 
development of cardiovascular disease. Ways to motivate the target community to 
become involved should be considered when planning screening strategies. If persons 
with chronic kidney disease miss the opportunity for early intervention their quality of 
life is greatly reduced (Locatelli et al., 2002) and they are more likely to die from 
cardiovascular disease events than to survive long enough to start renal replacement 
therapy (KHA-CARI, 2013). 
3.3  Metabolic Syndrome 
3.3.1 Epidemiology of metabolic syndrome 
A chronic non-communicable disease is a non-infectious medical condition that usually 
is of long duration. Chronic non-communicable diseases include autoimmune diseases, 
heart diseases, cancers, respiratory disease, diabetes mellitus, and others. It is not to be 
mistaken for a ‗chronic disease‗, which may be infectious, such as HIV/AIDS. WHO 
(2014) estimates that 38 million people die from a chronic non-communicable disease 
each year, almost three quarters from low and middle income countries, and 82% under 
the age of seventy. Chronic non-communicable disease morbidity and mortality affect 
working aged adults who should be productive (Unwin & Alberti, 2006). Unhealthy 
diets, physical inactivity, drinking alcohol, and smoking, correlate with rapid 
urbanisation in developing countries and contribute to an increased risk of death from a 
chronic non-communicable disease (WHO, 2014), although these risk factors can often 
be prevented or reversed (Unwin & Alberti, 2006). Total global mortality from chronic 
non-communicable diseases includes cardiovascular disease (30%), cancer (13%), 
chronic respiratory disease (7%) and diabetes (2%) (Unwin & Alberti, 2006). 
Unhealthy lifestyles, environmental factors and genetics may contribute to the 
development of chronic non-communicable diseases (Bagby, 2004; Abegunde et al., 
2007) but obesity, high blood pressure, high blood glucose levels and high blood lipid 
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levels are the four main metabolic risk factors (WHO, 2014). These are also the 
contributing risk factors for metabolic syndrome.  
Metabolic syndrome is defined as a set of comorbid metabolic abnormalities found to 
increase a person‘s risk for heart disease, stroke and diabetes (Alberti, Zimmet, & 
Shaw, 2006). Epidemiological data show that chronic non-communicable diseases 
(WHO, 2014) and metabolic syndrome are escalating problems worldwide (Alberti et 
al., 2006) and Asian developing countries‘ prevalence statistics resemble those of 
Western nations (Nestel, Lyu, Low, Sheu, Nitiyanant, Saito & Tan, 2007). 
3.3.2 Historical timeline  
Following is a timeline for the development and interpretation differences of the 
metabolic syndrome. 
1923.  A Swedish physician, Eskil Kylin, first made the association between risk 
factors (Kumar, Chitra, & Reddy, 2013). A combination of metabolic 
disturbances was observed to cluster together especially in patients with type 2 
diabetes and cardiovascular disease (Alberti et al., 2006).  
1947.  A study by J. Vague mentioned that people with diabetes tended to have 
abdominal obesity (Kumar et al., 2013). 
1965.  P. Avogaro and G. Crepaldi described a syndrome with hypertension, 
hyperglycaemia and obesity, all metabolic syndrome criteria (Kumar et al., 
2013). 
1981.  The phrase ‗metabolic syndrome‘ was first used by Hanefield and Leonhardt to 
describe chronic non-communicable diseases associated with cardiovascular 
disease (Kumar et al., 2013).  
1988.  Reaven  (1988) described the relationship between insulin resistance and 
glucose intolerance in patients with non-insulin dependant diabetes mellitus and 
was the first to use the term ‗syndrome X‘ (Bagby, 2004; Grundy, Brewer, 
Cleeman, Smith, & Lenfant, 2004). 
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1989.  Kaplan (1989) described upper body obesity, glucose intolerance, 
hypertriglyceridemia, and hypertension as ‗the deadly quartet‘ that precedes 
cardiovascular disease (Kumar et al., 2013). He noted that ‗obesity, 
hypertension, hypertriglyceridemia, and glucose intolerance are common and 
they often coexist‘. 
1992.  The San Antonio Heart Study on diabetes and cardiovascular disease, renamed 
metabolic disorders ‗insulin-resistance syndrome‘ due to the hyperinsulinema 
that was observed prior to their development (Haffner, Valdez, Hazuda, 
Mitchell, Morales, & Stern et al. 1992).  
1998.  WHO published position statements for the definition and diagnostic criteria for 
metabolic syndrome that included impaired glucose tolerance or type 2 diabetes 
and/or insulin resistance as prerequisites and used body mass index and waist-
hip ratio as the measures of obesity; they also included microalbuminuria 
(Alberti & Zimmet, 1998; IDF [International Diabetes Federation], 2006; Kassi, 
Pervanidou, Kaltsas, & Chrousos, 2011). There was some criticism regarding 
the combination of components and criteria, and debate over whether 
microalbuminuria was a syndrome or an underlying cause (Alberti et al., 2006).  
1999.  The European Group for the Study of Insulin Resistance (EGIR) recommended 
modifications be made to include measurement for non-diabetic persons and to 
exclude microalbuminuria (Balkau & Charles, 1999; Kassi et al., 2011). The 
EGIR version depended on fasting insulin levels in place of impaired fasting 
glucose (IDF, 2006) 
2000.  It was suggested that visceral fat as a measurement of waist circumference and 
fasting triglyceride was an inexpensive screening tool to identify men at high 
risk of heart disease (Lemieux, Pascot, Couillard, Lamarche, Tchernof, Almeras 
et al., 2000), which has been termed cardiometabolic risk (Kassi et al., 2011). 
2001.  The US National Cholesterol Education Program: Adult Treatment Panel III 
(NCEP-ATPIII) was the first to identify cardiovascular disease risk as the main 
focus of metabolic syndrome (NCEP, 2002). Their approach was to diagnose 
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three or more metabolic syndrome criteria, and insulin resistance (was not 
considered compulsory (Kassi et al., 2011).  
2003.  The American Association of Clinical Endocrinologists (AACE) proposed a 
hybrid of the 1998 WHO and the 2001 NCEP-ATPIII definitions (Einhorn, 
2003), but this was found to be vague in diagnosis and outcomes (Kumar et al., 
2013). Differences in definitions and variations in obesity cut-off marks made it 
difficult to compare studies, especially of people of various ethnicities (Kumar 
et al., 2013). The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) 
noted a wide variation across the population in the assessment of metabolic 
syndrome, using the three different criteria of WHO, EGIR and NCEP-ATPIII 
(Dunstan, Zimmet, Welborn, de Courten, Cameron, Sicree, et al., 2002).  
2004.  The American Heart Association/National Heart, Lung and Blood Institute 
(AHA/NHLBI) organised a symposium to examine the scientific evidence and 
discuss issues related to metabolic syndrome (Grundy, Brewer et al., 2004). 
Most WHO criteria were adopted without any prerequisite criteria such as 
abdominal obesity (Grundy, Cleeman, Daniels, Donato, Eckel, Franklin et al., 
2005).  
2005.  All metabolic syndrome definitions failed to predict clinical endpoints. To 
eliminate the measurement variations when comparing different population 
groups, the International Diabetes Federation provided a new definition in 
collaboration with EGIR and NCEP, including ethnic-specific waist 
circumference measurements as an obligatory prerequisite plus any two of the 
other risk factor criteria (Alberti et al., 2006; IDF, 2006; Kassi et al., 2011; 
Kumar et al., 2013). 
2007.  An International Diabetes Federation consensus report on metabolic syndrome 
in children and adolescents (IDF, 2007) stressed the point that the syndrome 
pathway should be prevented, and halted if already commenced, to reduce adult 
complications (Zimmet, Alberti, Kaufman, Tajima, Silink, Arslanian, 2007). 
Although simplified the criteria remain basically the same as the adult version 
except for waist measurement (WHO, 2007). This will facilitate studies to plot 
growth patterns, define values for younger people and determine predictors for 
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adult metabolic syndrome, cardiovascular disease and type 2 diabetes (Zimmet, 
Alberti et al., 2007).  
2009.  To refine and unify the metabolic syndrome definition further, the International 
Diabetes Federation, AHA/NHLBI and the International Association for the 
Study of Obesity published a joint statement outlining a new consensus 
definition; this is currently widely accepted (Alberti, Eckel, Grundy, Zimmet, 
Cleeman, Donato et al., 2009). There was agreement to eliminate all 
compulsory elements such as abdominal obesity; a person is diagnosed with 
metabolic syndrome if they have three abnormal findings of the five criteria; the 
set cut-off points are all unified except for an ethnic-specific waist 
circumference. 
3.3.3 Clinical criteria and rationale  
According to the International Diabetes Federation workshop, ‗A syndrome is defined 
as a recognisable complex of symptoms and physical or bio-chemical findings for 
which a direct cause is not understood … When causal mechanisms are identified, the 
syndrome becomes a disease‘ (as cited in Alberti, Zimmet, & Shaw, 2006, p. 473).  
Having a cohesive metabolic syndrome diagnostic criteria to determine the abnormal 
clinical parameters for all ages helps validate metabolic syndrome as a useful screening 
and clinical tool for health professionals in all countries (Zimmet, Magliano, 
Matsuzawa, Alberti, & Shaw, 2005) and allows valid comparison of data between 
different populations and ethnicities (Alberti et al., 2006). Any three of the five risk 
factors of the criteria constitute a diagnosis of metabolic syndrome. These medical 
conditions, under the umbrella of metabolic syndrome, are driving the rampant global 
pervasiveness of type 2 diabetes and cardiovascular disease (Dunstan et al., 2002; 
Misra & Khurana, 2008).  
Table 3.6 sets out the metabolic syndrome criteria. A clinical diagnosis is based on 




Table 3.6  Criteria for clinical diagnosis of the metabolic syndrome  
  Measure          Categorical Cut Points  
  Elevated waist circumference       Population and country specific definitions* 
            Male    Female 
 *Causasian (Australian          94 cm         (increased risk)   80 cm 
   of European decent)     102 cm      (still higher risk)  88 cm 
 *Asian (including Malaysian)    90 cm     80 cm 
  Elevated triglycerides      150 mg/dL     (1.7 mmol/L) 
  (Alternate indicator: drug treatment for elevated triglycerides) 
  Reduced HDL-C     Males       < 40 mg/dL     (1.0 mmol/L) 
         Females   < 50 mg/dL     (1.3 mmol/L) 
  (Alternate indicator: drug treatment for reduced HDL-C) 
  Elevated blood pressure   Systolic     130 mm Hg and/or     
         Diastolic    85 mm Hg  
(Alternate indicator: antihypertensive drug treatment with a history of hypertension) 
  Elevated fasting glucose    100 mg/dL     (5.5 mmol/L) 
  (Alternate indicator: drug treatment for elevated glucose levels) 
 
   “Any 3 of 5 risk factors constitutes a diagnosis of metabolic syndrome”.  
 
   Source: (International Diabetes Federation, 2006; Alberti, Eckel et al., 2009) 
Table 3.7 is a schematic presentation of risk factors, pathogenesis, outcomes and 
interventions for metabolic syndrome. There are a number of other metabolic criteria 
that appear to correlate with metabolic syndrome and have systemic consequences, 
outside the scope of this literature review. The bolded areas are those addressed in the 
following section, and the focus is on chronic non-communicable diseases that 
contribute to the pathogenesis or outcomes of metabolic syndrome. 
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Table 3.7  Risk factors, pathogenesis, outcomes and interventions for metabolic syndrome 
 
Thrifty genotype Abdominal obesity Type 2 Diabetes 
Screening for                                                                                                                               
metabolic syndrome 
Thrifty phenotype Hyperglycaemia    
In utero environment Atherogenic  
Cardiovascular 
Disease  
Lifestyle                  
Intervention 
 
                                           
Dyslipidaemia  
  
Energy dense foods 
                                                                                                         
Hypertension  
   
Physical inactivity 
Proinflammatory state Chronic kidney disease                                                                                                                                                                                                  
and 
End-stage renal disease 
Pharmacological 
Intervention 








3.3.4 A summary of the pathogenesis of the metabolic syndrome 
Genetic and environmental factors, obesity and inactivity all influence the development 
of metabolic syndrome (Kaur, 2014; NCEP, 2002). The pathogenesis of metabolic 
syndrome is complex, with no direct route but a network of ‗interconnected pathways 
that mediate interactions among multiple organs and … impair energy homeostasis in 
multiple organs simultaneously‘ (Bagby, 2004, p. 2). Environmental and genetic factors 
may influence a positive energy balance and contribute to abdominal adipose tissue 
deposits, eventually making a person obese (Kaur, 2014). This initiates mechanisms 
that alter both the free fatty acid metabolism and the release of adipokines, resulting in 
dysfunctional conditions that escalate in severity and lead to disease (Kaur, 2014). 
Metabolic syndrome can present in a variety of ways, depending upon a person‘s 
susceptibility to the combination of components (Eckel, Grundy, & Zimmet, 2005); and 
questions about its underlying pathogenesis remain unanswered (Unwin, 2006).  
3.3.4.1 Abnormal body fat distribution (abdominal obesity) 
Obesity increases the risk of a chronic non-communicable disease and the International 














metabolic syndrome (IDF, 2005). The metabolic complications associated with obesity 
are now referred to as metabolic syndrome. Although the pathogenesis of the metabolic 
syndrome is not entirely understood, abnormal fat distribution (abdominal obesity) is 
recognised as a significant causal factor (Alberti et al., 2006). Although obesity is a 
predictor of the metabolic syndrome, the risk can be mitigated by reducing one‘s 
weight (Alberti, Zimmet, & Shaw, 2007). Adipose tissue affects the endocrine system 
and promotes the development of metabolic syndrome (Bagby, 2004; Després & 
Lemieux, 2006) and the multiple components of the metabolic syndrome interact to 
cause chronic low-grade systemic inflammation generated from obesity-related 
comorbidities (Kaur, 2014) and may exacerbate metabolic syndrome (Grundy, Cleeman 
et al., 2005). Obesity-initiated metabolic syndrome is characterised by large quantities 
of circulating free fatty acids, increased inter-cellular lipid content and insulin 
resistance, but reduced levels of adiponectin and leptin (Bagby, 2004), both insulin-
sensitising adipokines that promote metabolism and free fatty acid oxidation (Eckel et 
al., 2005). Hyperglycaemia, hypertension, high serum triglycerides, low HDL-C and 
insulin resistance are all influenced by obesity, and it is associated with a greater type 2 
diabetes and cardiovascular disease risk (Alberti et al., 2006).  
Epidemiological studies show that with an increasing body mass index there is a greater 
prevalence of type 2 diabetes, dyslipidaemia and cardiovascular disease, but that an 
increasing excess of visceral adipose tissue adversely alters the metabolic risk profile of 
a person independent of body mass index (Alberti et al., 2006). Central abdominal 
obesity and insulin resistance are constant features of the metabolic syndrome; waist 
circumference is a more predictive measure of central abdominal obesity, and 
correlates with insulin resistance; both are predictive of metabolic syndrome (Alberti et 
al., 2005). It has been found that once body mass index is greater than 30, the majority 
of people will have a waist circumference above gender and ethnic-specific cut-off 
points (Alberti et al., 2006). Data from Asian population studies shows that the risk of 
developing metabolic syndrome is greater at waist circumference cut-off point values 
below those of Europids (Alberti et al., 2006). The International Diabetes Federation 
therefore, have allowed for population specific cut-off points for waist circumference 
which vary by gender and ethnic group, regardless of the country a person resides in 
(IDF, 2005).  
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3.3.4.2 Insulin resistance (and hyperglycaemia) 
The second potential causal factor in the pathogenesis of the metabolic syndrome is 
insulin resistance, which is almost always present when correlated with the various 
metabolic syndrome components (Alberti et al., 2006). Insulin resistance (IR) or its 
related hyperinsulinaemia is associated weakly with hypertension and prothrombotic 
state, but strongly with atherogenic dyslipidaemia and proinflammatory state; the link 
with cardiovascular disease needs further research (Alberti et al., 2006) even though all 
the metabolic syndrome components are associated with insulin resistance (Kahn, 
Buse, Ferrannini, & Stern, 2005). Normally free fatty acids can stimulate the secretion 
of insulin, but this secretion declines if there is protracted exposure (Eckel et al., 2005). 
When defective, the insulin hormone is unable to suppress glucose metabolism by the 
liver and kidney and unable to control the muscle and adipose tissue from glucose 
uptake (Eckel et al., 2005), eventually resulting in hyperglycaemia. Abdominal fat 
uniquely contains more triglyceride, displays more insulin resistance, and secretes less 
leptin than other fat deposits (Bagby, 2004). Individuals with insulin resistance will 
have impaired glucose tolerance (IGT) and/or hyperglycaemia and a decrease in insulin 
response; they will also have an obese abdomen (Kaur, 2014) and all these factors 
invariably lead to type 2 diabetes (Stern, 1994; Després & Lemieux, 2006). If a 
person‘s fasting plasma glucose is between 5.6–6.9 mmol/L (100 – 125 mg/dL) it is 
recommended they have an Oral Glucose Tolerance Test (OGTT) to identify impaired 
glucose tolerance or undiagnosed type 2 diabetes (Alberti et al., 2006). The clinical 
criteria for hyperglycaemia includes either Impaired Fasting Glucose (IFG), impaired 
glucose tolerance or type 2 diabetes (Alberti et al., 2006). Insulin resistance can be 
determined using the homeostasis model assessment (HOMA) (Chitturi, 
Abeygunasekera, Farrell, Holmes-Walker, Hui, Fung et al., 2002).  
3.3.4.3 Atherogenic dyslipidaemia 
Insulin resistance, through a number of pathways, results in atherogenic dyslipidaemia 
(Kaur, 2014) and ‗consists of abnormal levels of triglycerides and apolipoprotein B 
(apoB), small Low Density Lipoprotein–Cholesterol (LDL–C) particles, and low High 
Density Lipoprotein–Cholesterol (HDL–C)‘ (Grundy, Cleeman et al., 2005, p. 2742). 
Metabolic syndrome patients usually present with these abnormal laboratory lipid 
results (Alberti et al., 2006). In the liver free fatty acid increases, synthesis and storage 
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of triglyceride increases and triglyceride and apoB is secreted as very low density 
lipoprotein (Lewis & Steiner, 1996; Grundy, Cleeman et al., 2005). Treatment needs to 
target LDL-C even in the metabolic syndrome (Grundy, Cleeman et al., 2005). Persons 
with hepatic steatosis or non-alcoholic fatty liver disease (NAFLD) have been found to 
be insulin resistant (Angelico, Del Ben, Conti, Francioso, Freole, Fiorello et al. 2005) 
and those with metabolic syndrome are more severely resistant. Chitturi et al. (2002), 
however, found that non-alcoholic fatty liver disease is associated with insulin 
resistance irrespective of obesity. In hypertriglycidaemia, HDL-C decreases while 
triglyceride and LDL-C increases, and the particles become small and dense and 
atherogenic (Eckel et al., 2005). A person has dyslipidaemia if the triglyceride level is 
> 1.7 mmol/L (150 mg/dL), or low HDL-C, measured as < 0.9 mmol/L (40 mg/dl) for 
men and <1.29 mmol/L (50 mg/dL) for women; or if they have previously been 
diagnosed with hypertriglycidaemia (Alberti et al., 2006). 
3.3.4.4 Elevated blood pressure (hypertension) 
High blood pressure is found in close association with obesity and type 2 diabetes 
(Eckel et al., 2005). In a study to test if insulin resistance was associated with 
hypertension independent of obesity and type 2 diabetes, it was found that glucose 
uptake was inversely correlated to hypertension but insulin resistance directly 
correlated with hypertension (Ferrannini, Buzzigoli, Bonadonna, Giorico, Oleggini, 
Graziadei et al., 1987). Elevated blood pressure found in persons with obesity, glucose 
intolerance and insulin resistance (Alberti et al., 2006) is exacerbated by type 2 
diabetes, smoking, excessive salt intake, obesity and kidney disease. A study noted that 
type 2 diabetes and insulin resistant patients with metabolic syndrome retain more 
sodium than those without (Barbato, Cappuccio, Folkerd, Stazzullo, Sampson, Cook et 
al., 2004). Their results showed that sodium re-absorption was increased in people of 
European descent (Europids) but not in African or South Asian patients (Barbato et al., 
2004). They argued that their results endorsed another study showing that in severe 
cases, when insulin resistance increases so does sodium retention (Nosadini, 
Sambataro, Thomaseth, Pacini, Cipollina, Brocco et al., 1993) and may indicate 
inherent renal abnormality in Europid people with insulin resistance (Barbato et al., 
2004). Whether this is also the case with South East Asian and Chinese persons is not 
known. Increased sodium re-absorption affects the cardiac output which causes the 
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arteries to respond with vasoconstriction, leading to hypertension; endothelial 
dysfunction hastens atherosclerosis (Kaur, 2014).  
The clinical criteria for metabolic syndrome for a person with a raised blood pressure is 
over >130 mmHg systolic and >85 mmHg diastolic, or being on antihypertensive 
treatment (Alberti et al., 2006). An English study (n = 4,801) found that for every 10 
mmHg systolic blood pressure decrease there was a 12% statistically significant risk 
reduction of complications from diabetes and 15% for diabetes deaths, 11% for 
myocardial infarction and 13% for microvascular complications, with the lowest risk 
reduction being for those who had less than 120 mmHg systolic blood pressure (Adler, 
Stratton, Neil, Yudkin, Matthews, Cull, et al., 2000). Patients with hypertension have a 
2.5 greater risk of developing type 2 diabetes (Gress, Nieto, Shahar, Wofford, & 
Brancati, 2000; Bakris, Ritz & World Kidney Day Steering Committee, 2009) and 
researchers have found that Pima American Indians who have hypertension are more 
likely to get diabetic kidney disease (Cho et al., 2014).  
It is advised that patients with diabetes mellitus keep their blood pressure below 
>130/>80 mmHg using antihypertensive drugs to protect from cardiac and renal 
damage (Alberti et al., 2006). 
3.3.4.5 Proinflammatory state 
There are a number of hypotheses regarding the association of the metabolic syndrome 
and chronic inflammation although obesity appears to activate the mechanism 
contributing to the proinflammatory state of the metabolic syndrome (Monteiro & 
Azevedo, 2010). Proinflammatory cytokines, including C-reactive protein (CRP) and 
tumour necrosis factor  (TNF), overproduced by excess adipose tissue (Eckel et al., 
2005), may in turn stimulate the production of hepatic C-reactive protein in the liver 
(Sutherland, McKinley, & Eckel, 2004). Ethnic differences and fitness can affect C-
reactive protein levels. C-reactive protein has been found to be higher in South Asian 
Indians than to European people because of greater abdominal obesity and insulin 
resistance in Indians (Stern, 1994; Mohan, Deepa, Velmurugan, & Premalatha, 2005). 
As the level of C-reactive protein rises, the level of adiponectin, an anti-inflammatory 
cytokine, inversely declines (Eckel et al., 2005; Sutherland et al., 2004). It is suggested 
that adiponectin may be the link between intra-abdominal fat with reduced insulin 
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sensitivity, increased insulin resistance and inflammation (Calton, Miller, & Soares, 
2013; Cnop, Havel, Utzschneider, Carr, Sinha, Boyko et al., 2003). In addition, there is 
an associated decrease in HDL-C levels and an increase in free fatty acids and LDL-C 
particles (Eckel et al., 2005). A proinflammatory state is recognised in people with the 
metabolic syndrome by a raised C-reactive protein ( 3 mg/L), which rises with an 
increase in number of metabolic syndrome components; and a significant association is 
found between plasma C-reactive protein levels, adiposity and insulin resistance 
(Alberti et al., 2006). Studies show that genetics, a proinflammatory state and hormonal 
dysregulation may well vary between different ethnic populations (Alberti et al., 2006). 
3.3.4.6 Prothrombotic state 
A proinflammatory state may be metabolically linked to the prothrombotic state as 
there is a corresponding increase in procoagulant factors such as fibrinogen, and also 
endothelial dysfunctions, and lead to a hypercoagulable state (Kaur, 2014). Fibrinogen 
is a prothrombotic marker that rises when cytokine levels increase (Sutherland et al., 
2004). A prothrombotic state refers to the association between components of the 
metabolic syndrome with both coagulation and fibrinolytic proteins (Alberti et al., 
2006), reactant anomalies that increase with rising cytokine levels (Kaur, 2014). 
Persons with atherogenic dyslipidemia, elevated hypertension and elevated plasma 
glucose will usually also have a prothrombotic state and a proinflammatory state 
(Alberti, Eckel et al., 2009).  
3.3.5 Microalbuminuria  
There is a question whether microalbuminuria can be considered an integral part of the 
pathogenesis of metabolic syndrome. This study follows the International Diabetes 
Federation Joint Scientific Statement listing microalbuminuria as an area requiring 
more research (Alberti, Eckel et al., 2009). WHO, however, is the only organisation to 
include microalbuminuria in the definition of metabolic syndrome (Kaur, 2014). 
Microalbuminuria is defined as having a ‗urinary excretion rate of >20 mg/min or 
albumin : creatinine ratio of >30 mg/g‘ (Kaur, 2014, p. 2) and is part of the new 
assessment diagnosis algorithm for chronic kidney disease (KDIGO, 2012).  
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Association of microalbuminuria with individual metabolic syndrome components.  
Studies have looked at the mechanism to understand how microalbuminuria is involved 
in the development of chronic kidney disease. A study using a pre-existing Electronic 
Health Record-based chronic kidney disease registry from Cleveland, Ohio, found that 
the metabolic syndrome was associated with end-stage renal disease but not death, and 
that 60% of chronic kidney disease patients had metabolic syndrome, although when 
adjusted for proteinuria the association was less; they suggested that metabolic 
syndrome leads to kidney damage (Navaneethan, Schold, Kirwan, Arrigain, Jolly, 
Poggio et al., 2013). Many studies suggest a link but the causal mechanisms remain 
hidden. Study results often indicate the presence of microalbuminuria with metabolic 
syndrome diagnosis (Palaniappan, Carnethon, & Fortmann, 2003; Hao, Konta, 
Takasaki, Abiko, Ishikawa, Takahashi, ... & Kubota, 2007) but an association is not 
always found between microalbuminuria and the individual comorbidities of the 
metabolic syndrome. 
Obesity, Hyperglycaemia, Insulin Resistance.  Obesity-initiated metabolic syndrome 
glomerular hypertrophy in morbid obesity is thought to induce macroproteinuria 
(Kambham, Markowitz, Valeri, Lin, & D‘Agati, 2001). A large number of studies 
associate microalbuminuria with hyperglycaemia, usually via type 2 diabetes; one such 
study is the MicroAlbuminuria Prevalence (MAP) Study (Wu, Kong, De Leon, Pan, 
Tai, Yeung et al., 2005). A Korean study of 1006 subjects, however, found that those 
who had microalbuminuria had a higher body mass index and waist-to-hip 
circumference ratio irrespective of having type 2 diabetes or not (Kim, Kim, Choi, 
Chung, Lee, Lee et al., 2001). Following multiple logistic regression analysis, 
microalbuminuria has been shown to be associated with hyperinsulinemia and central 
obesity, independent of hypertension or type 2 diabetes, and that it is a feature of 
insulin resistance, at least in a Korean population (Kim et al., 2001). A study of 
Indigenous Australians found that ACR was associated with waist–hip ratio but not 
body mass index; there was also an ACR association with insulin resistance and 
worsening microalbuminuria (Rowley, O‘Dea, & Best, 2003). This study concluded 
that among Australian Aboriginal people type 2 diabetes, hypertension and abdominal 
obesity contribute to the high rates of albuminuria (Rowley et al., 2003). 
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Dyslipidaemia.  Findings for dyslipidaemia vary with different studies. During a 
nephrology forum, conflicting evidence of the association between lipids and 
microalbuminuria was discussed, with the conclusion that it was unclear whether 
dyslipidemia contributed solely to cardiovascular disease or was also implicated in 
progressive chronic kidney disease (Keane, 1994). More up-to-date data now suggests 
increasing albumin is an independent risk for cardiovascular disease morbidity and 
mortality as well as a marker for progressive chronic kidney disease independent of 
renal function, blood pressure and dyslipidemia (Keane, 2000). In a review Maclsaac, 
Jerums and Cooper (2004) were more cautious about microalbuminuria and its direct 
association with chronic kidney disease progression, suggesting that it is an 
independent risk factor for cardiovascular disease morbidity and mortality in both 
diabetes mellitus and non-diabetes mellitus.  
Hypertension.  A cross-sectional study using the data of 5,659 men and women from 
the NHANES III: 1988–1994 found that 7.8% of women and 5.0% of men had 
microalbuminuria and that it was more common in those with metabolic syndrome 
(Palaniappan et al., 2003). When broken down into the metabolic syndrome 
components, hypertension was found to have the strongest association with 
microalbuminuria (Palaniappan et al., 2003). In a population-based cohort of 517 type 1 
diabetes participants, it was found that ‗microalbuminuria and hypertension are 
infrequent in the first nine years of diabetes. Microalbuminuria is less frequent than 
expected‘ (Allen, Pulta, Lecaire, Huang, Brazy, D'Alessio, 2002, p. 1). Redon and 
Pascual (2006) recommend that microalbuminuria in essential hypertension should be 
addressed to preserve the kidney and guard against cardiovascular disease. 
Proinflammatory and Prothrombotic State.  Microalbuminuria may be a risk marker 
for chronic kidney disease and coronary heart disease, and although the mechanism is 
still unclear, microalbuminuria in metabolic syndrome may be a sign of renin-
angiotensin system activation and subsequent oxidant stress and inflammation through 
a common pathway (Gobal, Deshmukh, Shah, & Mehta, 2011). These eventually leads 
to endothelial impairment and cardiac and renal fibrosis (Gobal et al., 2011). 
Association of microalbuminuria to metabolic syndrome outcomes.  As described in 
Section 3.1.3.5, microalbuminuria is predictive of both end-stage renal disease and 
cardiovascular disease (APCWG, 2011). It was found that as the number of the 
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metabolic syndrome components increased, and elevated blood pressure and plasma 
glucose levels increased, the odds of developing chronic kidney disease and/or 
microalbuminuria became significantly greater (J. Chen, Munter, Hamm, Jones, 
Batuman, Fonseca et al., 2004). Gobal et al. (2011) have suggested that 
microalbuminuria may be a reliable predictive marker for chronic kidney disease and 
coronary heart disease. 
Type two diabetes outcome.  Strongly associated with insulin resistance and a warning 
sign of diabetic nephropathy, having microalbuminuria signifies endothelial damage 
(Pistrosch, Herbrig, Kindel, Passauer, Fischer & Gross, 2005). For people with type 2 
diabetes, microalbuminuria compounds the risk for cardiovascular disease and related 
death, and increases the risk of chronic kidney disease (Hossain et al., 2007).  
Cardiovascular disease outcome.  Metabolic syndrome has been found to be an 
independent risk factor for cardiovascular disease and to increase the risk of 
microalbuminuria, moderately in the early stages and more strongly later (Thorn, 
Forsblom, Waden, Saraheimo, Tolonen, Hietala, et al., 2009). There is wide variation 
between study results and no one individual metabolic syndrome component can be 
indicated as solely or directly associated with microalbuminuria. Mechanisms for 
insulin resistance, hypertension, dyslipidemia and inflammation may cause renal 
fibrosis (Singh & Kari, 2013). Changes in glucose metabolism (Redon & Pascual, 
2006), insulin resistance and hypertension are the clinical factors most associated with 
microalbuminuria (Redon & Pascual, 2006; Ruan & Guan, 2009) but are not yet 
included in the International Diabetes Federation definition of the metabolic syndrome. 
The question is if proteinuria intervenes consequentially between the metabolic 
syndrome and the progression of chronic kidney disease, or if microalbuminuria should 
be considered as a entity separate from the metabolic syndrome. 
3.4 Association between Metabolic Syndrome and Chronic Kidney Disease  
3.4.1 Metabolic syndrome complex implicated in both chronic kidney disease 
and microalbuminuria 
The benchmark for gauging chronic kidney disease deterioration is glomerular filtration 
rate for kidney function and ACR for kidney damage. Studies have attempted to link 
the metabolic syndrome to microalbuminuria independently as well as within the 
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context of chronic kidney disease however, the outcomes, as seen especially in a 
number of different subset studies taken from NHANES III 1988–1994, vary widely. 
Microalbuminuria but not glomerular filtration rate.  Sometimes microalbuminuria is 
detected before chronic kidney disease begins to appear and progress (Hostetter & 
Lising, 2003). Sometimes, especially in persons with diabetes, non-diabetic 
hypertensives or the elderly, there may be microalbuminuria without any indication of 
glomerular filtration rate (Garg et al., 2002).  
Glomerular filtration rate but not microalbuminuria.  Not all persons with stages 3-5 
glomerular filtration rate also have microalbuminuria. A cross-sectional type 2 diabetes 
subset of NHANES III 1988–1994, adults with type 2 diabetes, found that one third 
who had an eGFR <60 mL/min per 1.73 m2 did not have microalbuminuria (Kramer, 
Nguyen, Curhan, & Hsu, 2003).  
Both chronic kidney disease and microalbuminuria.  In one study, following the 
APTIII definition, a large subsample from NHANES III was used to determine if the 
metabolic syndrome was a risk factor for chronic kidney disease, using the two 
measures eGFR and microalbuminuria ACR, and found that 24.7% were classified as 
having metabolic syndrome and that there was a graded relationship between chronic 
kidney disease or microalbuminuria (J. Chen, Munter et al., 2004).  
Ethnicities.  It has been found that different ethnicities, other than European and with 
or without diabetes mellitus, are more likely to have microalbuminuria especially if 
they have stages 3–5 chronic kidney disease (Bryson, Ross, Boyko, & Young, 2006). In 
a study of 213 Japanese participants metabolic syndrome was associated with, and 
albuminuria was independently associated with, the progression of chronic kidney 
disease (Saito, Mochizuki, Uchida, Tsuchiya, & Nitta, 2013). Asian ethnicities have an 
increased risk of developing end-stage renal disease and different epidemiologic 
features compared to Caucasians; their risk for microalbuminuria may also be different 
(Ramirez, McClellan et al., 2002; Hamer & El Nahas, 2006). 
There is a strong, positive and significant association between the metabolic syndrome 
and chronic kidney disease and an independent two-fold risk of having 
microalbuminuria, but no causal relationship has been uncovered (Singh & Kari, 2013). 
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J. Chen, Munter et al. (2004) found that with about three to five metabolic syndrome 
components there was an increased risk for chronic kidney disease and 
microalbuminuria, independent of age, sex, ethnicity, NSAID use, education, physical 
activity or smoking. It is recommended that both glomerular filtration rate and ACR be 
assessed in the determination of chronic kidney disease so that the whole spectrum 
within a population are screened (Hostetter & Lising, 2003; KDIGO, 2012).  
3.4.2 Clinical consequences and outcomes of both chronic kidney disease and 
metabolic syndrome 
Chronic non-communicable diseases, in particular diabetes mellitus, hypertension and 
cardiovascular disease, interact in a complicated way. The people most at risk for 
chronic kidney disease, who have a higher rate of kidney sequelae, complications and 
cardiovascular disease, are those with diabetes mellitus and/or hypertension (National 
Service Framework for Renal Services, 2005).  
3.4.2.1 Type 2 diabetesThere are a number of different types of diabetes. 
Diabetes insipidus is due to the malfunctioning of the hormone vasopressin in 
adequately controlling the blood water levels resulting in dehydration and electrolyte 
imbalance (IDF, 2007). Diabetes mellitus is a chronic disease involving blood sugar 
levels and insulin imbalance and includes a number of different types (IDF, 2007). Two 
forms of diabetes mellitus auto-immune diseases are type 1 diabetes, also called 
insulin-dependant diabetes, which attacks the insulin producing cells (insulin 
deficiency) and adult-onset latent autoimmune diabetes (LADA) (Li, Liao, Yan, 
Huang, Lin, Lei et al., 2009). Gestational diabetes mellitus is a complication of 
pregnant women having high blood glucose levels and may or may not revert to normal 
after delivery (IDF, 2007).  
Type 2 diabetes is three times more prevalent than type 1 diabetes; both often present 
with similar symptoms, have similar outcomes and there is no cure for either although 
following healthy lifestyle habits improves glycaemic control (Reikes, 2000). The 
major focus of this review is on the unhealthy lifestyle-initiated type 2 diabetes, also 
called non-insulin dependant diabetes, adult-onset diabetes or simply diabetes. The 
hormone insulin, produced by the beta cells in the pancreas, facilitates glucose to be 
absorbed by the body‘s cells; but when the liver, muscles and adipose tissue become 
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less sensitive more insulin is needed, leading to hyperinsulinaemia (IDF, 2006). If a 
person persistently consumes a high glycaemic diet the beta cells eventually cease 
producing enough insulin and the blood becomes saturated with glucose; over time the 
person becomes hyperglycaemic and will be diagnosed as having type 2 diabetes (IDF, 
2006). Obesity is associated with insulin resistance, and as triglycerides also build up 
with hyperglycaemia this further impairs insulin sensitivity (IDF, 2007). 
The link between increasing blood glucose levels associated with diabetes mellitus and 
end-stage renal disease is still unclear, but current research links a pathway between a 
protein modified by hyperglycaemia and the initiation of kidney damage (Levey, 
Eckardt et al., 2005). Postprandial hyperglycaemia is one of the main causes of both 
macrovascular and microvascular damage and cardiovascular disease risk, but the risk 
of vascular disease decreases with a reduction in oxidative stress and improved 
glycaemic control (Bavenholm & Efendic, 2006) optimal blood glucose and lipid 
levels, a lowering of blood pressure and maintenance of a healthy weight (Beeharry, 
Joseph, Ewins, & Nair, 2014).  
Obesity-initiated metabolic syndrome has the potential to cause chronic kidney disease 
via abdominal obesity, and independently through insulin resistance (Bagby, 2004). 
Impaired Fasting Glucose or Impaired Glucose Tolerance and hypertension are 
associated with an increased risk for type 2 diabetes (Alberti et al., 2005) and end-stage 
renal disease (Navaneethan et al., 2013). Research using the data from the Finnish 
Diabetic Nephropathy (FinnDiane) study found that persons with type 1 diabetes who 
have metabolic syndrome have an increased risk of diabetic nephropathy (Thorn et al, 
2009). Those persons with metabolic syndrome and diabetes mellitus have three to four 
times greater risk of developing cardiovascular disease and stroke (Alberti et al., 2006; 
Eckel et al., 2005; Thorn et al, 2009; Verdecchia, Reboldi, Angeli, Borgioni, 
Gattobigio, Filippucci, et al., 2004). Studies have shown that impaired fasting glucose / 
impaired glucose tolerance is also often present in non-diabetic people with metabolic 
syndrome, putting them at five times a higher risk for developing type 2 diabetes than 
non-diabetic people without impaired fasting glucose / impaired glucose tolerance 
(Alberti et al., 2006; Eckel et al., 2005).  
An Australasian position statement was presented in response to the new updated 
classification of and criteria for diabetes mellitus (Colman, Thomas, Zimmet, Welborn, 
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Garcia-Webb, Moore et al., 1999; WHO, 2006). The Australasian Working Party on 
Diagnostic Criteria recommended accepting (1) the new criteria proposed for 
diagnosing diabetes mellitus; (2) the new category impaired fasting glucose in addition 
to the category of impaired glucose tolerance; (3) the use of oral glucose tolerance test, 
as some cases of diabetes might be missed if not performed on suspect persons. The 
Australian Diabetes Society give the parameters for the 75 g oral glucose tolerance test 
as fasting glucose >7.0 mmol/L and 2 hour glucose as >11.1 mmol/L; the oral glucose 
tolerance test cut-off points are <5.6 mmol/L normoglycaemic, 5.6-7.8 mmol/L 
impaired fasting glucose, >7.8 mmol/L impaired glucose tolerance and >11.1 mmol/L 
diabetes mellitus (ADS [Australian Diabetes Society], 2014). The International 
Diabetes Federation recommends oral glucose tolerance test as the gold standard for 
diagnosing persons with diabetes and defining impaired glucose tolerance (IDF, 2006), 
and this is followed in this study. The Royal Australian College of General 
Practitioners advise all doctors on proper guidelines for administering the oral glucose 
tolerance test (Phillips, 2012).  
Haemoglobin A1C (HbA1C) assay is the measurement for assessing whether a person 
has their diabetes under control: it is a three-month average glucose assessment 
measuring glycated haemoglobin (Hicks, Muller, Panteghini, & Garry, 2007). It was 
noted that HbA1C had an acceptable specificity and sensitivity for diagnosing diabetes 
(Saudek, Herman, Sacks, Bergenstal, Edelman and Davidson, 2008). The American 
Diabetes Association‘s International Expert Committee reported on the role of HbA1C 
in diagnosing diabetes, emphasising that it is a precise laboratory measurement and 
should be reported as a percentage rather than mmol/mol (ADA [American Diabetes 
Association], 2009). There was much debate and the International Diabetes Federation 
Chairman, who was from Cameroon, Africa, expressed concern that it might be too 
expensive for poorer countries with few good laboratories, compared with using the 
glucometer. HbA1C is now recognised generally as a diagnostic criterion for type 2 
diabetes with the percentage of >6.5% (48 mmol/mol) as the cut-off point for diabetes 
mellitus; however, using the HbA1C does not exclude using other methods to diagnosis 
the disease (ADS, 2014; WHO, 2011).  
It is estimated that by 2030 the number of persons with type 2 diabetes will increase to 
360 million, with at least 40% of these persons developing chronic kidney disease and 
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more than 10% developing end-stage renal disease (ISN, 2006). A review of cause-of-
death certificates of the Pima American Indian people found that the highest cause of 
death listed was diabetes-related (Cho et al., 2014). The Pima have the highest rates of 
diabetes of any ethnicity in the world, with the average age of onset 36 years, compared 
with 60 for Europids (Cho et al., 2014). Despite this, Burrows et al. (2014) found that 
American Indians and Alaskan Natives with type 2 diabetes lived longer and better than 
Europid Americans with type 2 diabetes. The incidence of diabetic end-stage renal 
disease in Malaysia increased from 30% in 1996 to 54% of the population in 2005 
(Ong, Punithavathi, Thurairatnam, Zainal, Beh, Morad et al., 2013). In the UK it is 
11%, Australia 26%, Pakistan 42%, Japan 37% and United States 14.8% (Mahon, 
2001). In Malaysia the prevalence of type 2 diabetes prevalence is 8.2%, and the 
country is listed by WHO as having the highest percentage of haemodialysis patients 
with diabetes in the world (Hooi, Lim et al., 2005).  
3.4.2.2 Cardiovascular disease and coronary heart disease 
Diabetes is the driving force behind escalating rates of cardiovascular disease in all 
developing and developed counties. Even before type 2 diabetes is diagnosed an 
increase is triglyceride and a decrease in HDL-C increases a person‘s risk of 
cardiovascular disease (IDF, 2006). cardiovascular disease is an umbrella for a number 
of cardiac conditions including coronary heart disease, angina, heart attack, 
cerebrovascular disease including stroke and transient ischaemic attack, all having an 
impact on the circulatory system or heart (Parfrey & Foley, 1999). Atherosclerosis, the 
narrowing of the arteries by fatty deposits, is often the cause of all of these conditions. 
Associated with hypertension, dyslipidemia and insulin resistance, atherosclerosis is a 
chronic process developing over a number of years and directly contributes to coronary 
heart disease; Global et al. (2011, p. 1) have suggested that ‗microalbuminuria, chronic 
kidney disease, and coronary heart disease share common pathways involving 
inflammation and oxidative stress‘.  
cardiovascular disease rises exponentially as chronic kidney disease worsens 
(Langman, 2006), and many chronic kidney disease patients die of their heart disease 
before they reach the stage of requiring renal replacement therapy (C. S. Fox, Muntner, 
Chen, Alexander, Roe, Cannon et al., 2010). cardiovascular disease deaths account for 
half of all deaths on haemodialysis (Parfrey & Foley, 1999). Among the end-stage renal 
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disease population in the United States, 25% have hypertension; 40% of haemodialysis 
patients have coronary artery disease (US Renal Data System, 1999) and 75% have 
ventricular hypertrophy (R. Foley,  Parfrey, Harnett, Kent, Martin, Murray et al., 1995). 
If a person has both chronic kidney disease and metabolic syndrome the risk of 
cardiovascular disease mortality is higher (Prasad, 2014), and as the number of 
metabolic syndrome components increases, the higher and sooner the risk of 
cardiovascular disease mortality (Grundy, 2004; IDF, 2006). A number of components 
of the metabolic syndrome are independent risk factors for cardiovascular disease and 
therefore metabolic syndrome is a strong (Alberti et al., 2006), but not an absolute, risk 
predictor (IDF, 2006). Persons with the metabolic syndrome but no diabetes mellitus 
have up to three times the risk of coronary heart disease (Eckel et al., 2005). The 
Framingham Offspring Study found that men (34%) had a greater risk of coronary heart 
disease than women (16%) (Rutter, Meigs, Sullivan, D‘Agostino, & Wilson, 2005) and 
men (62%) also had a greater risk of type 2 diabetes than women (47%) (Eckel et al., 
2005). Both the metabolic syndrome and insulin resistance have been related to 
incident cardiovascular disease, and a study of 2,898 people without diabetes mellitus 
or cardiovascular disease, found that the metabolic syndrome and insulin resistance 
were individually associated with cardiovascular disease (P < 0.007 in both), pointing 
out that the metabolic syndrome may not identify all persons associated with risk of 
insulin resistance-cardiovascular disease (Rutter et al., 2005). Different ethnicities also 
have risk variation: for example, South Asians tend to have more coronary heart 
disease and cardiovascular disease than European-British, African–Americans have 
more coronary heart disease and stroke than European-British and Africans-Caribbeans 
have lower coronary heart disease but higher stroke rates than European British 
(Forouhi & Sattar, 2006). 
The underlying major risk factor for cardiovascular disease is obesity, which also raises 
the risk factors for hypercholesterolemia, hypertension and hyperglycaemia and is 
presumed to be a risk for atherogenic dyslipidemia, insulin resistance, proinflammatory 
state and prothrombotic state (Grundy, 2004). ‗Inflammation, hemodynamic effects, 
and imbalanced adipokine secretion‘ are thought to be mechanisms linking the 
metabolic syndrome with the risk of chronic kidney disease (Nitta, 2010, p. 4). Insulin 
sensitivity decreases with the accumulation of excessive saturated fatty acids (J. S. Lee, 
Pinnamaneni, Eo, Cho, Pyo, Kim et al., 2006c) eventually resulting in insulin resistance 
 
85 
and insulin dysfunction in the liver and skeletal muscles (Boden, 2003) and changing 
the ‗insulin-mediated glucose transport and metabolism‘ mechanism of the metabolic 
syndrome and many other manifestations not included in the metabolic syndrome 
criteria, such as microalbuminuria (Eckel et al., 2005, p. 1418). Insulin resistance is 
strongly associated with cardiovascular disease, type 2 diabetes (Eckel et al., 2005) and 
all the metabolic syndrome diagnostic criteria except for hypertension, which only has 
a mild to moderate association (Hanley, Karter, Festa, D‘Agostino, Wagenknecht, 
Savage et al., 2002).  
3.4.3 Best public health practices for the management of chronic kidney disease 
and metabolic syndrome 
The chronic low-grade inflammation of the metabolic syndrome has grave systemic 
consequences on various body systems and organs, renal, hepatic, skin, ocular, sleep, 
reproductive and cardiovascular, and is linked with certain cancers (Kaur, 2014). The 
only way to improve one‘s quality of life and longevity is to address the causes and 
commence a combination of lifestyle intervention programs and pharmacological 
management if needed, with the aim of preventing or slowing the progression of the 
particular chronic non-communicable disease condition. 
3.4.3.1 Risk assessment 
Risk assessment should include anthropometric measurements, laboratory 
investigations and a basic questionnaire survey noting family history, diet and exercise 
habits, and other general information. A Canadian study using the revised National 
Cholesterol Education Program data found that half of those studied had one or two 
metabolic syndrome risk markers and, although not diagnosed with the metabolic 
syndrome, every metabolic syndrome risk factor a person has becomes an increased 
risk for developing some chronic non-communicable disease and inflammation (D. 
Rao, Dai, Lagace, & Krewski, 2014). Before commencing an intervention program, 
medical and health personnel need to first give patients a risk assessment and medical 
examination, especially for those over 50 years of age. There is some discussion 
regarding the best risk score to assess a person‘s risk of a chronic non-communicable 
disease and end-points, and the Framingham Risk Score is often compared with the 
metabolic syndrome assessment. In a prospective study (n = 5,128) of men with no 
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history of cardiovascular disease, CHD or stroke and using the Framingham Risk Score, 
Wannamethee, Shaper, Lennon and Morris (2005) established that it was a better 
predictor of coronary heart disease and stroke than metabolic syndrome however 
metabolic syndrome was still a strong predictor of cardiovascular disease and type 2 
diabetes. The National Kidney Foundation Kidney Early Evaluation Program (KEEP) 
concluded that chronic kidney disease is independently associated with myocardial 
infarction or stroke, noting that cardiovascular disease was associated with hastened 
death in chronic kidney disease (McCullough, Li, Jurkovitz, Stevens, Wang et al., 
2008). At the present no one risk assessment covers all areas; and more research is 
needed on lifestyle and pharmacological intervention outcomes in order to recommend 
the best combinations for treating chronic kidney disease patients with metabolic 
syndrome (Nitta, 2010). It also depends upon who is doing the assessment: whether a 
doctor or health personnel are assessing and instructing the person (both are required 
for optimal management). The metabolic syndrome was developed as an education and 
diagnostic tool to help identify people at high risk for type 2 diabetes and 
cardiovascular disease (Alberti et al., 2006) and may well be easier to use in the 
absence of a medical doctor. 
3.4.3.2 Genetic factors: chronic non-communicable diseases 
A South Carolina, USA study found that a low birth weight increased the risk of end-
stage renal disease suggesting that adverse in-utero conditions may impair kidney 
development (Lackland, Bendall, Osmond, Egan, & Barker, 2000). Gene-environment 
interaction may result in obesity, even in-utero (Monasta, Batty, Cattaneo, Lutje, 
Ronfani, Van Lenthe et al., 2010) and if overweight babies are overweight at seven 
years of age they tend to become obese adults (Valerio, D‘Amico, Adinolfi, 
Munciguerra, D‘Amico, & Franzese et al., 2006). Another study has found that infants 
who had a low birth weight and were thin at two years of age but rapidly put on weight 
as children, gaining a higher than average body mass index by 11 years old, were more 
likely to have insulin resistance and heart problems as adults (Barker, Osmond, Forsen, 
Kajantie, & Eriksson, 2005). As Malaysia‘s health status transitions to economic 
development and affluence the incidence of type 2 diabetes and diabetic nephropathy 
will continue to increase (Jha et al., 2013). Poor environmental factors contribute to 
low birth weight (A. White et al., 2010) and overweight children, and it is of utmost 
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importance to educate young women and pregnant mothers in healthy lifestyle tactics 
as ‗prenatal undernourishment makes a person permanently at higher risk for 
developing diabetes‘ (Barker et al., 2005). A variant in a gene on chromosome 10 has 
been identified as a reliable marker for type 2 diabetes and may be used in the future as 
a genetic test to determine persons of high risk (Ng et al., 2007). 
Metabolic syndrome could also have a genetic aspect (Grundy, Cleeman et al., 2005), 
and diabetes mellitus and hypertension, the two leading causes of chronic kidney 
disease, tend to have familiar genetic linkages (ISN, 2006). In the United States, of 
those persons with end-stage renal disease, African–Americans are more likely to have 
hypertension but Native Americans are more likely to have type 2 diabetes (Reikes, 
2000; Esprey et al., 2014). The Genetics of Kidneys in Diabetes study notes that 
diabetic nephropathy clusters in families, and there is a considerable genetic component 
of kidney complications and a high mortality in those with type 1 diabetes (Mueller, 
Rogus, Cleary, Zhao, Smiles, Steffes, et al., 2006). 
3.4.3.3 Pharmacological management 
If a person is diagnosed early, in the mild beginning stages of a chronic non-
communicable disease, lifestyle intervention measures are usually the first line of 
treatment. Medication is added if the individual is uncompliant or if the condition is 
unstable or has advanced. Insulin resistance, hypertension and dyslipidemia are often 
found together but need to be treated separately from each other until such time as drug 
therapies targeting the whole metabolic syndrome multi-component cluster are 
developed (Alberti et al., 2006). (Medical and drug intervention measures are outside 
the parameter of this review.) 
High blood pressure (hypertension).  Hypertension is both a cause and an outcome of 
chronic kidney disease. The Malaysian Clinical Practice Guideline Working Group 
determined that 61% of the population had undiagnosed high blood pressure and only 
35% of those being treated for hypertension were well controlled (A. R. Ab. Rahman, 
2014). Suboptimal treatment for hypertension increases the risk of cardiovascular, 
cerebrovascular and renal morbidity and mortality (A. R. Ab. Rahman, 2014). Risk of 
diabetic complications is reduced further with tight blood pressure control (144/82 mm 
Hg) as compared with less tight control (154/87 mm HG), and to gain tight control 
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there is a need to combine antihypertensives, tailored to suit the individual‘s needs 
(Mustafa, Kamarudin, Ismail, Khir, Ismail, Musa et al., 2011). 
Blood glucose control, hyperglycaemia and insulin resistance.  It is vital for persons 
with metabolic syndrome, especially if diabetic, to attain optimal glycaemic control, 
and interventions by medical therapy and lifestyle modification will improve diastolic 
dysfunction and help prevent heart failure (Von Bibra & Sutton, 2010). Drugs that 
reduce insulin resistance in persons with metabolic syndrome are thought to delay the 
onset of type 2 diabetes and reduce the risk of cardiovascular disease (Alberti et al., 
2006). Insulin resistance and atherogenic dyslipidaemia worsens with high doses of 
diuretics and β-blockers in people with diabetes (Alberti et al., 2006), so it is necessary 
for knowledgeable medical management to be given patients with a chronic non-
communicable disease.  
Dyslipidaemia (cholesterol).  Patients with metabolic syndrome and elevated LDL-C 
levels are at extreme risk of cardiovascular disease and may require drug therapy to 
lower levels to within the acceptable range (Alberti et al., 2006). The Framingham 
Heart Study (n = 2,471) examined the chronic kidney disease and cardiovascular 
disease shared risk factors and found that there is a higher cardiovascular disease risk in 
chronic kidney disease if the person also has a low HDL-C (N. I. Parikh, Hwang, 
Larson, Levy, & Fox, 2008). One study has highlighted the fact that few patients reach 
an acceptable lipid level quickly enough and therefore dosage needs to be aggressive 
(K. Foley, Simpson, Crouse, Weiss, Markson, Alexander, 2003). 
Chronic kidney disease.  Many patients presenting with chronic kidney disease have 
had undiagnosed type 2 diabetes and hypertension for some time (Reikes, 2000; Xue, 
Ma, Louis, & Collins, 2001). The minority groups in the United States have higher end-
stage renal disease rates due to type 2 diabetes and hypertension (Xue et al., 2001) and 
metabolic syndrome (Lea, 2013). Strict control of blood glucose, blood pressure and 
HbA1C and medication is recommended by the American Diabetes Association, to 
prevent complications and progression to end-stage renal disease (American 
Telemedicine, 2005). Patients undergoing end-stage renal disease treatment have a 
higher mortality rate, even when adjusted, than to the general population and are at 
increased risk for atherosclerotic disease, left ventricular hypertrophy, malnutrition and 
infection (Reikes, 2000). The survival of a person with established end-stage renal 
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disease is correlated with the underlying cause of their renal disease (Reikes, 2000), 
but, as described, the management of one condition often has a positive effect on 
another inter-related one. Metabolic syndrome can be modified to delay progression of 
chronic kidney disease (Lea, 2013) and with good medication control for hypertension 
and type 2 diabetes, compliance in taking medication and acceptance of renal 
replacement therapy, survival time of end-stage renal replacement patients should 
improve (Reikes, 2000; Lea, 2013). 
3.4.3.4 Lifestyle factors: diet and nutrition 
In all cultures there is a trend to eat foods high in energy, fats, sugar and salt, and less 
fruit, vegetables and whole grains; and this, coupled with inactivity, increases the risk 
of death from a chronic non-communicable disease, especially cardiovascular disease 
(WHO, 2013b). For those who are obese a moderate calorie restriction aiming for 5–
10% weight reduction in the first year should be pursued by changing the composition 
of the diet to reduce saturated fat, sugar and salt and to increase fibre intake (Alberti, et 
al., 2006). If an obese person loses weight, inflammation and insulin sensitivity 
improve (Monteiro & Azevedo, 2010).  
Kidney organisations have different food and protein dietary guidelines for different 
countries. KDOQI has detailed guidelines for adults with chronic kidney disease, but 
often patients will not accept a rigid protein diet once they commence renal 
replacement therapy (Kopple, 2001). Other patients go into starvation mode, drastically 
reducing their protein and energy intake and becoming malnourished when they are 
diagnosed with end-stage renal disease and commence haemodialysis. Good dietary 
advice, intervention and control, good hypertension control, patient motivation and 
compliance and a good working relationship with the doctor and the dietitian should be 
available to every person diagnosed with chronic kidney disease (Kopple, 2001). 
3.4.3.5 Lifestyle factors: physical activities and exercise 
Genetic, environmental and psychosocial factors interact, and when lifestyle stress, 
low-quality excessive energy food intake and little exercise dominate, the body reacts 
negatively (Monteiro & Azevedo, 2010). Physical inactivity coupled with obesity 
modifies muscle insulin sensitivity (Alberti et al., 2006). Interestingly it is known that 
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some non-obese people have insulin resistance and some who are obese have a benign 
form that does not lead to a chronic non-communicable disease or metabolic syndrome 
(Monteiro & Azevedo, 2010). More research is needed to link insulin resistance with 
the metabolic syndrome in all of its components (Unwin, 2006), but it appears that 
aging, accompanied by muscle mass loss and an increase in abdominal body fat, can 
increase insulin resistance and influence the development of metabolic syndrome 
(Alberti et al., 2006). Weight loss and increased physical activity can improve insulin 
sensitivity along with blood pressure and blood glucose levels (Monteiro & Azevedo, 
2010). 
To reduce weight, moderate increases in physical activity, including muscle 
strengthening, are encouraged with the long-term aim of achieving a normal body mass 
index and/or waist circumference (Alberti et al., 2006). With the escalation in obesity 
in children, the Commission on Ending Childhood Obesity has been established, to find 
ways to counter this problem (WHO, 2013b). Persons with chronic kidney disease 
should engage in proper exercise, even walking, every day to prevent or reduce obesity 
and improve their comorbidities, and patients with end-stage renal disease on dialysis 
should be encouraged to lead active and fulfilling lives (Ong et al., 2013) as this also 
helps mental health. 
3.4.3.6 Lifestyle behavioural changes: smoking, alcohol and drugs  
Many chronic non-communicable diseases are considered preventable because the 
condition can be greatly improved if the individual ceases at-risk lifestyle behaviour. 
The best example of this is cigarette smoking. Cigarette smoking exacerbates 
glomerular filtration rate decline in persons with macroalbuminuria and type 2 diabetes, 
but as soon as a person stops smoking, kidney injury improves (Chuahirun et al., 2004; 
Ritz et al., 2000; Xue et al., 2001). Smoking is highly addictive and it is a difficult 
challenge to stop, so patients need to be motivated (Chuahirun et al., 2004) and 
educated about helpful tools and techniques such as nicotine patches, gum or hypnosis. 
A study using data from NHANES II 1976 through 1980 found no association between 
chronic kidney disease and alcohol consumption, although smoking, physical inactivity 
and morbid obesity were risk factors (Stengel, Tarver-Carr, Powe, Eberhardt, & 
Brancati, 2003). A Singapore study found that compared with non-smokers, people 
exposed to smoking and who more than four alcoholic drinks per day had almost five 
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times the odds of developing chronic kidney disease (odds ratio = 4.93, 95% CI: 2.45, 
9.94). (Shankar, Klein & Klein, 2006). A US study of 647 veterans at a hypertension 
clinic found that there was a significant, positive, and independent association between 
illicit drug use and risk for mild kidney function decline in hypertensive men 
(Vupputuri, Batuman, Muntner, Bazzano, Lefante, Whelton, et al., 2004). Persons 
engaging in negative lifestyle behaviours need to be advised appropriately regarding 
their risk of developing and progressing chronic kidney disease and given help to 
overcome their bad habits if they ask. 
A healthy lifestyle is essential for preventing and treating chronic non-communicable 
diseases. Those persons with metabolic syndrome need to undertake lifestyle behaviour 
modification to control their risk of chronic kidney disease, cardiovascular disease and 
coronary heart disease (Gobal et al., 2011). It is important for people who have a 
chronic non-communicable disease to endeavour to improve their longevity, and they 
need the support of both medical and health professionals to achieve a better quality of 
life. Both preventable and non-preventable risk factors need to be recognised. For 
example, it has been found that overeating and under-exercising has different vascular 
and metabolic dysfunctional effects on different ethnicities (Forouhi & Sattar, 2006). 
Environmental and economic development, and changes in lifestyle and diet, have led 
to metabolic syndrome being highly concentrated in urban areas of China but not in 
rural areas (Y. He, Jiang, Wang, Feng, Chang, Fan et al., 2006). It is necessary for 
organisers to understand that, before commencing any intervention program, they must 
be familiar with the ethnic groups who are participating, their circumstances and 








3.5 Research Gaps Identified 
From the literature review a number of gaps in knowledge and information have been 
uncovered, with particular reference to chronic kidney disease, metabolic syndrome 
and outcomes, in Miri, Sarawak.  
There is a scarcity of epidemiological studies from Malaysia on 
 chronic kidney disease and metabolic syndrome in Malaysia that include data on 
the Malay, Chinese and Borneo Indigenous peoples from the Eastern Malaysian 
states of Sarawak and Sabah 
 socio-demographic and socio-economic risk factors for chronic kidney disease / 
metabolic syndrome for the different ethnic groups of Sarawak 
 lifestyle behavioural and environmental risk factors for chronic kidney disease / 
metabolic syndrome for the different ethnic groups of Sarawak 
 whether Miri end-stage renal disease patient‘s household members have 
metabolic syndrome components or microalbuminuria which may indicate 
undiagnosed chronic kidney disease.  
No research studies in Sarawak have determined if there is clustering within 
 ethnic and family groups susceptible to chronic kidney disease / metabolic 
syndrome. 
 socio-demographic and socio-economic groups susceptible to chronic kidney 
disease / metabolic syndrome. 
 groups living in particular housing and environments that make them more 
susceptible to chronic kidney disease / metabolic syndrome. 
There are currently no published studies for Sarawak reporting on  
 abnormal clinical parameters for diabetes mellitus, hypertension, chronic kidney 
disease and cardiovascular disease in the first degree relatives of patients with 
end-stage renal disease. 
 whether the first degree relatives are predisposed to a family history of chronic 
non-communicable diseases implicated in the development of chronic kidney 
disease or metabolic syndrome and outcomes. 
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 the health status of the first degree relatives or spousal family relatives of end-
stage renal disease patients on haemodialysis. 
Only limited studies of chronic kidney disease / metabolic syndrome risk factors 
address 
 a predisposition for chronic non-communicable diseases in end-stage renal 
disease patients; households.  
 social determinants such as home environment, in the Miri community. 
 health determinants such as obesity, type 2 diabetes, smoking, alcohol drinking.  
 whether metabolic syndrome is a risk factor for chronic kidney disease and 
whether chronic kidney disease is a risk factor for metabolic syndrome in Miri. 
There are no Sarawak qualitative investigations regarding the  
 health-related beliefs and behaviours of the Malay, Chinese and Borneo 
Indigenous ethnic groups 
 decision-making processes involved in choosing a modern medical doctor or a 
traditional practitioner 
 cognitive process of choosing modern medicine or traditional herbal medicines. 
 barriers preventing persons from seeking medical attention for chronic non-
communicable diseases. 
There are no published Sarawak research recommendations for  
 using the metabolic syndrome criteria as a diagnostic tool for chronic kidney 
disease / metabolic syndrome. 
 public health awareness and education promotion, to recognise and prevent 
chronic non-communicable diseases, in the community 
 identifying at-risk population groups for targeted for chronic kidney disease 
screening and intervention programs  
 future public health intervention strategies and programs for chronic kidney 
disease / metabolic syndrome in the community with the intention of delaying 




In summary, there is a need for  
 research on chronic kidney disease, metabolic syndrome and chronic non-
communicable disease comorbidities, cardiovascular disease and outcomes 
 information on chronic non-communicable diseases in this multi-ethnic 
population 
 high risk factors and clustering for chronic kidney disease / metabolic syndrome 
to be documented for end-stage renal disease patients‘ families 
 information on the family history and health status of the participants 
 information on the social and health determinants of the participants 
 information on participants‘ health-related beliefs and behaviours 
 recommendations for chronic kidney disease / metabolic syndrome screening 
and intervention programs. 
3.6 Conclusion 
This literature review was divided into two areas, end-stage renal disease / chronic 
kidney disease and metabolic syndrome, in order to fully understand each area before 
reviewing the connections between them. Chronic kidney disease is asymptomatic in 
the pre-clinical stage, and if detected early may be prevented from progressing to end-
stage renal disease; this may also reduce mortality from cardiovascular disease.  
Community strategies and barriers to screening for chronic kidney disease were 
discussed, including the cost of screening for a disease with a low pick-up rate such as 
end-stage renal disease. It addresses some ethnic, social and economic disparities found 
between populations. Studies show that it is cost-effective to screen for chronic kidney 
disease using the ACR in high-risk persons with a family history of end-stage renal 
disease and who have type 2 diabetes and hypertension, but not for others.  
The metabolic syndrome is not a disease in itself but a number of different chronic 
disorders that contribute to this syndrome. There is an intricate relationship and type 2 
diabetes and cardiovascular disease may be both a cause of and an outcome of chronic 
kidney disease and metabolic syndrome.  
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Evidence-based best public health lifestyle practices for the prevention and 
management of chronic kidney disease and metabolic syndrome was discussed.  
This literature review has identified a niche in which to locate the research and bridge a 
gap between the existing knowledge regarding chronic kidney disease and the 
metabolic syndrome with the intention of informing future lifestyle intervention 
programmes in Sarawak.  




Chapter 4 Research Methodology 
The Mixed Methods methodology is the design that underpins this thesis. A brief 
overview of the benefits of using a Mixed Methods approach and the value it brings to 
health research is presented. Ethical issues and the protocol for the data collection and 
analysis are detailed. 
4.1 Mixed Methods  
Mixed Methods research has advanced significantly and is now an established 
methodology in its own right (Teddlie & Tashakkori, 2010). The data for this research 
was drawn from both quantitative and qualitative phases, analysed separately then 
combined (Creswell & Plano Clarke, 2007). The rationale for using this approach was 
to facilitate a deeper understanding of the local nuances and health beliefs among the 
Miri population. Saks and Allsop (2013) have suggested that Mixed Methods is a 
suitable methodology to follow when investigating people of different ethnicities, 
languages and cultures as I can decipher information from a number of different angles.  
The Mixed Methods design can be of a number of different sequence combinations 
,and the methods used can vary in emphasis, depending on what is considered the most 
appropriate way to address the research questions and produce trustworthy results (Saks 
& Allsop, 2013). In this study, an explanatory quantitative to qualitative sequence was 
chosen. The Phase One quantitative data collection identified those at risk for chronic 
diseases like chronic kidney disease and metabolic syndrome and the analysis identified 
phenomena for follow-up. The Phase Two qualitative collection explored and clarified 
these phenomena in more depth and also investigated the participants‘ beliefs and 
behaviours with regard to chronic kidney disease and metabolic syndrome risk factors.  
A scheme for the Mixed Methods sequential explanatory design is presented below 
(Figure 4.1). Equal emphasis and precedence was given to both the quantitative and 







Figure 4.1  Mixed methods sequential explanatory design: participant selection model 
Adapted from Creswell and Plano Clarke (2007, 71-75; 119) 
 
Certain quality standards unique to Mixed Methods, as discussed in Creswell and Plano 
Clarke (2007), Saks and Allsop (2013), Tashakkori and Treddlie (2009) and Treddlie 
and Yu (2007), were addressed in this study.  
 With respect to the weighting of the quantitative to qualitative components, the 
study design was intended to have an equal balance.  
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 Being a sequential design, with the Phase Two recruitment of participants 
dependent upon the Phase One results, inevitably meant more expense and a 
lengthy study time frame.  
 The rationale for the selection of the participants for both phases was explicitly 
stated in the proposal and participant information sheets. This ensured the study 
had rigour as it intentionally and deliberately gathered both the quantitative 
Phase One and the qualitative Phase Two data from the same set of participants.  
 A number of procedures have enhanced the confidence and validity of the 
research. In addition to expounding the quantitative results, in Phase Two 
meaningful information was extracted by guiding the dialogue towards known 
predictors of chronic kidney disease. The quantitative outcomes were also 
compared and contrasted with the qualitative findings, similar to Triangulation 
Design methods, to corroborate or contradict results. All aspects of the study 
process were rigorous and systematic, in accordance with Mixed Methods 
quality standards.  
4.1.1 Explanatory design purpose statement 
This research undertook to investigate significant risk factors, beliefs and behaviours 
that might contribute to the development of chronic kidney disease in the household 
family members of end-stage renal disease patients. It had two phases, with the 
outcome of Phase One framing Phase Two; an intermediate stage connected the two 
methodologies and an interpretation stage synthesised the results and findings to draw 
coherent conclusions. Phase One was a matched case-control study in which 
quantitative data regarding the participants‘ socio-demographic, anthropometric and 
biomedical information was gathered. In the intermediate stage significant results from 
this data were identified, and these formed the basis of the Phase Two interview 
schedule. Participants from Phase One who were determined to have both high and low 
clinical parameters for chronic kidney disease were purposefully selected for follow-up 
in Phase Two, which gathered qualitative data through in-depth semi-structured 
interviews. The qualitative data expounded the quantitative results and contributed to 
new knowledge and understanding of health-related beliefs and behaviours that could 
be contributing factors for chronic kidney disease in the household members of end-
stage renal disease patients. 
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4.2 Ethical Considerations 
Information set out in the National Statement and Guidelines for Research has been 
referred to (NHMRC [National Health and Medical Research Centre], 2007a,b,e) and 
pertinent issues addressed. In addition, guidelines set out by the World Medical 
Association Declaration of Helsinki, Ethical Principles for Medical Research Involving 
Human Subjects, have been consulted and addressed in this study (World Medical 
Association 2013). The Curtin Human Research Ethics Committee (HREC) guidelines 
approved the study via protocol approval number HR 07/2009 (see Appendix H). 
I obtained permission from the Malaysian Ministry of Health (MMOH) to use the 
Malaysia Non Communicable Disease Surveillance 2006 questionnaire (MMOH, 
2006b). This questionnaire was standardised following the WHO STEPS Instrument 
(WHO, 2005; WHO, 2008) and had already been used by the Malaysian Ministry of 
Health (MMOH, 2006b) and validated for a mixed ethnic Malaysian population. I was 
granted permission to use this by both WHO Geneva and the Malaysian Ministry of 
Health, Putra Jaya, Kuala Lumpur (see Appendixes I; J). 
The Divisional Medical Officer for 4
th
 Division of the Sarawak Health Department, the 
Miri General Hospital Haemodialysis Unit and the Miri City Medical Centre Dialysis 
Centre approved verbally based upon the above mentioned approval letters (see 
Appendixes H; I; J). The Malaysian Red Crescent Kidney Dialysis Centre gave a letter 
of approval (see Appendix K). Once the three dialysis centres had sanctioned this study 
and allowed access to the end-stage renal disease patients, recruitment of the family 
members commenced.  
Sarawak Shell Berhad made a financial contribution toward the conduct of the study 
and the analysis of the urine and blood. No other financial assistance was received, and 
additional costs were borne by me. Columbia Hospital, Miri, provided a double 
hospital ward for the Phase One anthropometric and questionnaire data collection. 
Gribbles Pathology Laboratory Malaysia conducted the laboratory data collection and 
provided a discount on all clinical chemistry measurements; and Dr Roland Mattu 
allowed the use of his clinic for the Phase Two interviews.  
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As far as possible, gender-appropriate assistants and translators were used to address 
cultural gender sensitivities. There was no coercion of anyone to participate and those 
approached had the right to refuse without explanation. There was no remuneration 
given. The laboratory tests were conducted without charge to the participants, and 
packet drinks and biscuits were provided in Phase One. In Phase Two a bottle of water 
and petrol money, based on mileage from each participant‘s home, was provided to 
those who were interviewed. Invitations were given each phase (see Appendixes L; M). 
In order for everyone to understand fully and respond appropriately, every person who 
was selected and agreed to participate in Phase One and Phase Two had their mother 
tongue noted for this study. A translator in the language they preferred was made 
available to them during data collection, for the questionnaire, and during the interview 
sessions.  
Translation of the information sheets, consent form and the interview guide involved 
testing for cultural equivalence and sensitivity, following the procedure outlined by 
Bowling (2004). The interview guide was reviewed by the reference group, four 
persons not involved in the study, to ensure it was accurate and appropriate. All 
information from the questionnaire and interviews in a language other than English was 
transcribed into English text before analysis.  
During recruitment all participants were given information sheets outlining the purpose 
of the research, the data collection procedures, and the risks and benefits of 
participation in the study. Prior to the Phase One data collection session, the 
participants were given a consent form and the questionnaire. Prior to the Phase Two 
interview session the participants were given another consent form and a brief outline 
of the purpose of the interview. Questions the participants had regarding the study was 
explained verbally in their language and also in an information sheet (see Appendix N). 
Consent forms were signed by participants prior to both Phase One and Phase Two data 
collection sessions. When they signed the Phase One Consent form they were asked to 
consider participating in the Phase Two interviews, which required allowing me to 
identify and contact them. Those who did not agree were excluded from Phase Two. 
Participants were also asked for consent to record the qualitative interviews (see 
Appendixes O; P). 
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Confidentiality and privacy issues were stressed to all nurse assistants and translators 
helping during the study. Privacy during data collection sessions was respected. The 
anthropometric measurements were taken in a private cubical in the hospital ward. 
Blood was collected in a separated private area at the laboratory. The participants filled 
out the questionnaire on their own, although translators were present to help if they 
didn‘t understand the questions or couldn‘t read or write. All participants were 
protected through anonymity. Malaysians hold identification cards, and the card 
number and a sequence number were used rather than names. No names, identity card 
numbers or identifying features were used in any papers or publications, and only 
anonymous group results have been, or will be, released.  
In accordance with the Joint NHMRC/AVCC Statement (2007e,c,d), original data is 
retained in the research office. All data files were coded so that participants could not 
be identified directly from the data sheets. The recruitment sheets holding the code 
numbers and matching participant names, identity card numbers, address, particulars, 
contact information and signed informed consent form, were kept in a separate file and 
locked in a cabinet at the office. This was only consulted to identify persons from their 
identity card numbers for the Phase Two interviews. All research data and test results 
were entered onto a password-protected computer. All data sheets have been stored in a 
locked cabinet in an alarm-monitored office, including a backup hard drive of the data, 
the data analysis and results, the questionnaires and interviews, the laboratory reports, 
and the anthropometric measurements. I am the only one with access to this cabinet. 
All hard data and an electronic copy of results have been handed to the main supervisor 
for safe upload on Curtin R drive. 
All clinical measurements and laboratory tests were handled with strict medical 
confidentiality. The Malaysian Ministry of Health requires laboratory reports to be 
issued to patients personally. The assessment and medical reports were made available 
to the participants to take to their personal doctor for follow-up, and a copy of their 
laboratory report and clinical information sheets were retained in the locked cabinet at 
the research office.  
A number of factors contribute to ‗research fatigue‘. One such problem, occurring in 
situations of unique interest, when participants are not fed back information from the 
study outcomes, they refuse to cooperate with researchers another time (Clark, 2008). 
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Information from this research will be distributed to all participants, end-stage renal 
disease patients, their families and the community. Clark (2008) remarks that over-
researching a social group, without any evidence of change for the better occurring, 
may lead to annoyance in the participants. A summary of the results and suggestions 
for future practice improvements will be given to Sarawak Shell Berhad, the 
participating haemodialysis centres and the Government Health Department. Local 
newspapers circulate public health announcements, and public seminars will be 
organised to disseminate information relating to this study. Already a number of 
community health awareness talks have been presented by me, including interactive 
workshops where participants take responsibility for lifestyle behaviour changes to 
improve their health.  
4.3 Quantitative Overview 
From the literature review, a number of determinants that may lead to the risk of 
developing chronic kidney disease were identified. The exposures of interest included: 
 socio-demographic – predisposing factors: age; gender; ethnicity; level of 
education; place of residence; socio-economic status; personal and family 
medical history 
 lifestyle – behavioural risk factors: tobacco smoking; alcohol / drug 
consumption; physical activity / inactivity; diet – Western / traditional; 
medication – Western / traditional; use of agrochemicals 
 metabolic syndrome comorbidities – metabolic disorders: obesity; diabetes; 
hypertension; dyslipidaemia; cardiovascular disease; chronic kidney disease. 
The quantitative methods used to investigate the exposures of interest and to screen the 
participants for chronic kidney disease and the metabolic syndrome included:  
 a standardised self-administered questionnaire on participants‘ background: 
socio-demographic, lifestyle, diet and physical activity 
 anthropometric measurements to determine participants‘ physical characteristics: 
height; weight; waist circumference; waist–hip ratio; body mass index; skinfold 
fat; blood pressure 
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 laboratory investigations for biomarkers of chronic kidney disease and metabolic 
syndrome components contributing to chronic non-communicable diseases and 
chronic kidney disease: central obesity; triglycerides; HDL-C; LDL-C; plasma 
glucose; microalbuminuria. 
From this data, significant local factors associated with chronic kidney disease were 
determined and trends contributing to abnormal clinical parameters among the 
participants identified.  
4.4 Quantitative Phase One Research Methods  
To achieve the study objectives, 270 participants were recruited. The socio-
demographic questionnaire, the anthropometric measurements and the laboratory 
investigations gave a range of results relating to chronic metabolic disorders that came 
under the auspices of contributing to associated risk factors for chronic kidney disease 
and the metabolic syndrome.  
4.4.1 Recruitment of participants and selection criteria  
The three major racial groups residing in Miri are Malay, Chinese and Indigenous 
people. The recruitment population was all the end-stage renal disease patients being 
treated at all three haemodialysis units in Miri; they were invited to enlist their first 
degree relatives and in-laws to participate in the study. The first degree relatives and 
their spousal in-laws were provided with an information sheet. Those who wished to 
participate contacted me for an appointment date, providing their name, age, gender, 
relationship to the patient, preferred language and mobile phone number. Only those 
fitting the selection profile were invited to participate. The inclusion criteria were being 
a first degree relative (parent, sibling or child) of the end-stage renal disease patient and 
over the age of eighteen. The spousal control group inclusion criteria were being a non-
affected, non-genetic relative of the patient‘s spouse, or a spouse of a patient‘s sibling 
or child, with no family history of end-stage renal disease.  
4.4.2 Matching cases with controls 
One hundred and thirty-five first degree relatives of end-stage renal disease patients 
were compared with the same number of controls. The reason for using spousal groups 
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as controls was that they often shared a similar environment, diet and socio-economic 
status as the case group, but not the genetic component of being closely related to 
someone with end-stage renal disease. 
  
Figure 4.2  Study recruitment diagram 
4.5 Sample Size  
The sample size was based on an abnormal kidney function indicating chronic kidney 
disease as eGFR (less than) <60 mL/min/1.73m
2
 versus normal / not indicated chronic 





To detect an odds ratio of 2.0 with type 1 error at 5%, and equal proportions of cases 
and controls a study sample size of 270 is needed: i.e., 135 cases and 135 controls.  
The sample size number was calculated to include drop-outs, however this was a highly 
motivated group (n=272) and only two recruits dropped out before data collection 
commenced, because of off-shore work commitments, and these were replaced. 
4.6 Validity and Reliability 
Validity is addressed in both the quantitative and qualitative sections (Chapters 4 and 
6). Although validity is interpreted differently, ‗in both approaches it serves the 
purpose of checking on the quality of the data and the results‘ (Creswell & Plano 
Clarke, 2007, pp. 133). In this study, potential threats to validity were identified 
(Creswell & Plano Clarke, 2007) and minimised during the data collection sessions by 
ensuring that all techniques and the instruments used were standardised (Golafshani, 
2003). Validity was also reinforced in the intermediate connecting stage by using the 
significant predictors for chronic kidney disease and metabolic syndrome, identified 
from the analysis of the quantitative Phase One, to inform the qualitative Phase Two; 
and drawing a small sub-set of the same participants from the Phase One large sample 
for follow-up in Phase Two.  
 In Phase One of this study research reliability, being able to replicate or repeat the 
results (Golafshani, 2003), was ensured in a number of ways. The research assistants 
and the translators were briefed by on aspects of the study and how they should assist. I 
trained the assistants in the correct techniques for gathering the anthropometric 
measurements and blood pressure readings. To avoid errors of measurement, I insisted 
on consistency and monitored accuracy during all data collection sessions. The 
anthropometric measurements followed standardised procedure. The procedures were 
written up and kept in an operations manual. The questionnaire had been validated by 
the Ministry of Health Malaysia for a Malaysian population.  
4.6.1 Quantitative data collection protocol 
Standardised protocol following international guidelines was used for all 
anthropometric measurements and the clinical data collection. The metabolic syndrome 
set cut-off points were used to identify abnormal clinical parameters for central obesity, 
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HDL, LDL, triglycerides, blood pressure, plasma glucose and microalbuminuria. The 
metabolic syndrome diagnostic criteria followed the set cut-off points outlined in 
Harmonizing the Metabolic Syndrome (Alberti, Eckel et al., 2009) (see Appendixes Q). 
These were meticulously adhered to, ensuring the validity and reliability of the results. 
International measurements, standardisation and calibration were used for all the 
clinical tests, performed by Gribbles Pathology. The machinery used and the validity 
and reliability of test results are outlined on their comprehensive website (Gribbles 
Pathology Malaysia, 2008). The validity and reliability of the equipment used, the 
anthropometric measurements and the clinical assessments are displayed in the 
appendices (see Appendixes R; S). The oral glucose tolerance test was administered and 
the samples collected by laboratory technicians who follow strict laboratory guidelines 
set by Gribbles Pathology Malaysia (see Appendixes R; S). To ensure validity and 
reliability of the clinical samples, the participants were given a detailed instruction 
sheet and informed on how to correctly fast overnight, in order to obtain optimal 
clinical results (see Appendix T). 
4.6.2 Research tools, instruments and data collection 
The tools used during the quantitative Phase One included Microsoft Office 2007 Excel 
and Word, Endnote X1 Referencing Manager and SPSS 16.0. The instruments used for 
this phase, including information sheets, consent forms and data collection sheets, were 
tested prior to the quantitative data collection.  
For logistic reasons, all participants were asked to report to Columbia Hospital, Miri, 
where they were asked to read and sign a consent form (see Appendix N) before having 
their details, height and weight recorded. The signed consent also asked for agreement 
to participate in Phase Two if selected. Participants then proceeded to the adjoining 
Gribbles pathology laboratory where fasting urine and fasting plasma blood samples 
were taken and the oral glucose drink given. An instruction sheet on how to fast the 
night before and the procedure order during the data collection day was given to each 
participant during the recruitment (see Appendix T).  
The questionnaire was completed and anthropometric measurements taken while 
waiting for the second urine and blood sample collection two hours later. Including 
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time for registration, the data collection session took approximately two and a half 
hours, and upon completion refreshments were given to all participants. All the 
participants were informed when their clinical results were available for collection. 
They personally received their copy from me at Dr Mattu‘s clinic, and were advised to 
take the results to their family doctor for discussion and advice. 
4.6.2.1 Questionnaire 
A standardised self-administered questionnaire was used to address socio-demographic, 
lifestyle, diet and physical activity issues. Local doctors and nurses who attended the 
end-stage renal disease patients reviewed the questionnaire to ensure it covered all 
areas relevant to the research and that it was locally and ethnically sensitive. It was 
pilot tested on five volunteers and informed consent was sought prior to the 
administration of the trial questionnaire. This data was not used in the actual study data 
collection. The questionnaire was assessed for content validity and then modified 
where necessary (see Appendix U).  
The Phase One questionnaire was specifically to gather socio-demographic information 
to combine with the anthropometric and clinical data, using the SPSS programme. The 
participants were graded according to their CKD and MetS results then screened for 
selection for the Phase Two interviews. Data on a wide range of exposures of interest 
were obtained and the outcomes from these, highlighted in the multivariable logistic 
regression, were identified for further enquiry in the interviews. 
The intra-observer variability check for the questionnaire was through having two 
questions, rephrased differently and on different pages of the questionnaire. The 
answers were then compared and if different, the participant was questioned regarding 
this. Inter-observer variability check was done through comparing the same question in 
the questionnaire responses to the interview responses. 
4.6.2.2 Anthropometric measurements 
The equipment for taking anthropometric and blood pressure measurements was 




Age.  The participants‘ current age was calculated at the time of the questionnaire and 
data collection date. 
Height.  Wearing only light clothing and no shoes, participants stood with their back 
and heels to a fixed wall, eyes facing forward. A right-angle triangle was placed flat to 
the wall and a gauge used to ensure the crown of the participant‘s head was correctly 
marked against a measuring tape secured to the wall. Height was taken to the nearest 
centimetre. 
Weight.  Wearing light clothing and no shoes or items in their pockets, the participants 
stood on a digital Salter spring balance scales, placed on a hard horizontal tiled floor, to 
record their weights. This scale was regularly tested for accuracy against a weighing 
machine using weights at the Columbia Asia Hospital, Miri. Two measurements in 
succession were taken to ensure accuracy, and the result recorded to the nearest half 
kilogram. 
Abdominal obesity  is one of the risk factors for metabolic syndrome and has specific 
values for different gender and ethnic groups, not country of residence (Alberti, Eckel 
et al., 2009; WHO-WPR [World Health Organization-Western Pacific Region], 2007). 
Waist circumference.  Participants were asked to stand erect, heels together and 
relaxed. The waist was measured on the horizontal, midway between the iliac crest and 
the lower ribs, without compressing the participants‘ skin (Welborn & Dhaliwal, 2007; 
WHO–WPR 2007). To ensure it did not stretch in the tropical heat, a metal measuring 
tape was used, and the nearest one centimetre was recorded.  
Hip circumference.  Participants were asked to stand erect, heels together and relaxed. 
The hips were measured on the horizontal plane at the maximum extension point of the 
buttocks when viewed from the side (Welborn, Dhaliwal, & Bennett, 2003). A metal 
measuring tape was used without compressing the participants‘ skin, to take a 
measurement to the nearest centimetre. 
Waist-hip ratio  was calculated by dividing the waist circumference (cm) by the hip 
circumference (cm) (Welborn, Dhaliwal & Bennett, 2003). 
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Body mass index  was calculated using the participant‘s height and weight following 
WHO clinical criteria (Weight (Kg) divided by the height squared (m²)). Obesity for an 
Asian population was defined using the WHO Asia Pacific guidelines (Obesity 
>25kg/m².) (WHO–WPR 2007). 
The intra-observer variability check for the anthropometric measurements involved 
having the same participant measured twice, once before they went to the laboratory 
then once after they returned, by the same assistant. Inter-observer variability check 
was by having two different assistants take the same person‘s measurements and then 
compare them. If the measurements differed then the assistants were instructed in the 
proper techniques again. This was done regularly. 
4.6.2.3 Blood pressure  
The auto-inflate digital electronic ‗Omron HEM7322 Ultimate Premium Blood 
Pressure Monitor was used. A standard adult-size cuff (9–12.5 inch circumference) 
delivered a cuff pressure of 0-300 mm Hg (+3 mm Hg). This was checked regularly 
against a mercury sphygmomanometer (Diamond Delux BP apparatus, Pune, India) 
used at Columbia Hospital, Miri,. The cuff was placed on the right arm of the seated 
and rested participant. Blood pressure readings were taken after at least 15 minutes of 
rest. In this study, high blood pressure is considered as greater than 130 mm Hg 
systolic over greater than 85 diastolic mm Hg (Alberti, Eckel et al., 2009).  
4.6.2.4 Laboratory investigations 
The study participants were instructed to fast for 8–12 hours overnight and not to eat or 
drink anything prior to arriving at the laboratory. The laboratory technicians drew a 
fasting blood, administered the oral glucose solution, then collected the two-hour 
sample and labelled the blood. A spot urine sample was collected for testing. The blood 
was analysed for fasting glucose, creatinine, total cholesterol, HDL-C, LDL-C and 
triglycerides. The two-hour sample was assessed for glucose. The urine specimen was 
used to determine the urine ACR and creatinine excretion.  
The eGFR for kidney function was calculated using four different formulae: Cockcroft-
Gault (Cockcroft & Gault, 1976), Modification of Diet in Renal Disease MDRD 
(Levey, Bosch et al., 1999), Revised rMDRD (Levey, Coresh, Green et al., 2006) 
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(Mathew, Johnson, et al., 2007), and CKD-epi eGFR (Levey, Stevens, Schmid, Zhang, 
Castro, Feldman et al., 2009) (Stevens, Schmid, Zhang, Coresh, Manzi, Landis, & 
Poggio et al., 2010). These formulae are provided and discussed in the literature review 
(Chapter 3, Tables 3.2 and 3.3). 
4.6.2.5 Chronic kidney disease and metabolic syndrome definitions for 
abnormal parameters  
The quantitative phase of this study screened the participants for chronic kidney disease 
and metabolic syndrome using a one cut-off point to determine their risk for chronic 
non-communicable diseases.  
Chronic kidney disease.  Chronic kidney disease was determined taking into account 
both estimated glomerular filtration rate and urine Albumin : creatinine ratio results and 
staging (Table 3.5), following Kidney Health Australia recommendations; (KHA-
CARI, 2013).  
ACR.  Albumin : creatinine ratio was considered abnormal if ≥ 2.5 mg Alb/mmol Cr 
for males or ≥ 3.5 mg Alb/mmol Cr for females (KHA-CARI 2006).  
eGFR.  estimated Glomerular Filtration Rate for kidney function, using a person‘s age 
and ethnicity and plasma creatinine, was calculated following the Modification of Diet 
in Renal Disease revised ‗175‘ formula (rMDRD) (Mathew, Johnson, et al., 2007). An 
eGFR of <60 mL/min/1.73m2 was considered to indicate kidney deterioration.  
Metabolic Syndrome.  Metabolic syndrome was determined using set cut-off points 
(Table 3.6) to identify abnormal clinical and biochemical results of the component risk 
factors (Alberti, Eckel et al., 2009).  
Blood pressure  was considered elevated if the systolic BP ≥ 130 mm Hg or diastolic 
BP ≥ 85 mm Hg or the participant was receiving treatment for hypertension (IDF 2006) 
(Alberti, Eckel et al., 2009).  
Waist circumference  was considered elevated for a Malaysian participant if  ≥90 cm 
for males and  ≥80 cm for females. The values used were for a South Asian (Indian, 
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Malay and Chinese) reference population (Alberti, Eckel et al., 2009; IDF 2006; 
WHO–WPR 2007) 
Triglycerides  were considered raised if ≥ 150 mg/dL (1.7 mmol/L), for males and 
females, or if the participant was receiving treatment for lipid abnormality (Alberti, 
Eckel et al., 2009; IDF 2006). 
HDL cholesterol  was considered reduced if < 40 mg/dL (1.0 mmol/L) in males or < 50 
mg/dL (1.3 mmol/L) in females or if the participant was receiving treatment for this 
lipid abnormality (Alberti, Eckel et al., 2009; IDF 2006). 
LDL cholesterol  was considered abnormal if ≥ 100 mg/dL (2.58 mmol/L) (Tonkin, 
Barter, Best, Boyden, Furler, Hossack, et al., 2005). 
TC:HDL-CR.  Total cholesterol : HDL-cholesterol ratio was considered raised if ≥ 200 
mg/dL (≥ 4.5 mmol/L) for males and females (Tonkin et al., 2005). 
FPG.  Fasting plasma glucose was considered raised if ≥ 100 mg/dL (5.6 mmol/L) or if 
the participant was receiving treatment for type 2 diabetes and under drug treatment 
(Alberti, Eckel et al., 2009; IDF 2006). 
OGTT.  The oral glucose tolerance test was used to determine the fasting plasma 
glucose for metabolic syndrome. The study ascertained the blood glucose results from 
the participants including impaired fasting glucose, impaired glucose tolerance and type 
2 diabetes (Alberti, Eckel et al., 2009; IDF 2006). The parameters of determining 
fasting plasma glucose is shown in the following Table 4.1. 
Table 4.1  Fasting plasma glucose and oral glucose tolerance test cut-off points 
Level Minimum Maximum Time 
Normal  <6.1 mmol/L FPG <7.0 mmol/L 2 hours OGTT 
Impaired fasting 
glucose  
>6.1 – <6.9 mmol/L FPG  7.8 mmol/L 2 hours OGTT 
Impaired glucose 
tolerance. 
<7.0 mmol/L FPG <7.8– 11.0 mmol/L 2 hours OGTT 
Diabetes mellitus  >7.0 mmol/L FPG and/or  >11.1 mmol/L 2 hours OGTT  
 
Source: (Colman, Zimmet, Welborn, Garcia-Webb, & Moore, 1999; Gribbles Pathology Malaysia Sdn. Bhd., 2007; 




4.6.3 Quantitative data analysis procedure 
Three forms were used for recording the quantitative data collected from the 
participants: the anthropometric measurement sheet which included the blood pressure 
readings, the laboratory report on the urine and blood samples tested, and the 
questionnaire survey (see Appendix V). The Statistical Package of Social Sciences 
(SPSS) Version 22 statistical computer software program was used to facilitate the 
analysis of all the statistical data.  
Comparisons of the socio-demographic and anthropometric characteristics of the first 
degree relatives and the spousal control group were made using descriptive statistics 
and cross-tabulations. The metabolic syndrome diagnostic criteria were used as a 
benchmark for assessing the clinical outcomes. Characteristics of the cases and 
estimates of the strength of the association between each predictor variable and the 
presence or absence of the disease (Hulley, Cummings, Browner, Grady, & Newman, 
2007) was performed by screening for clinical risk markers of chronic kidney disease 
and components of the metabolic syndrome in the study participants. Data was 
expressed as a number and percentage for the categorical variables and as mean ± 
standard deviation for the continuous variables. A p-value of less than 0.05 indicated 
statistical significance. The crude odds ratio (with 95% confidence interval) then later 
the adjusted ratio, after adjustment of potential confounders, was calculated for all the 
variables of interest that might contribute to developing chronic kidney disease and the 
metabolic syndrome. 
Multiple logistic regression analysis was performed to determine associated risk factors 
for the dependent variables, firstly chronic kidney disease then for the metabolic 
syndrome. Potential confounders, variables found to be statistically insignificant, were 
removed to moderate their interaction or effect on the analysis. A p-value of less than 
0.05 indicated statistical significance. The adjustment on the model was both a forward 
and a backward stepwise procedure, but the backward elimination method best suited 
the objectives of determining the predictor variables. 
The significant expected outcomes, and the strategies and instruments employed to 
achieve the quantitative results, are presented in Table 4.2.  
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Table 4.2  Quantitative objective rationales, strategies and expected outcomes 
 
4.7 Conclusion 
The rationale behind the choice of utilizing a mixed methods methodology and study 
design to address the study objectives was outlined. Ethical and confidential 
considerations relevant to the study were discussed and issues regarding language, 
translation and local sensitivities, were highlighted. The recruitment of participants and 
the selection criteria were described. The Phase One research methods employed for 
the quantitative data collection were described in detail.  
The chapter concluded with the quantitative data analysis procedures used. Guided by 
the Mixed Methods sequential explanatory design, the qualitative Phase Two research 
methods are outlined in chapter 6.3 and the qualitative interview findings in chapter 7. 
The Phase One quantitative results are presented in the following chapter.  
Objective Rationale Strategies and 
instruments 
Expected outcomes 
1 Chronic kidney disease 
assessment including eGFR and 
ACR 
Urine and blood 
laboratory tests and 
formulae used 
All participants have eGFR                                                                                                                                               
and ACR results verified and 
their chronic kidney disease 
staging calculated 
2 Metabolic syndrome 
assessment ,including chronic 
metabolic disorders associated 
with metabolic syndrome. 
 
Anthropometric results; 
blood pressure results; 
urine and blood 
laboratory tests; OGTT; 
questionnaire. 
All the participants have their 
metabolic syndrome score 
calculated from results of their 
central waist measurement, 
abnormal clinical parameters and 
medication self-reports 
3  Socio-demographic factors, 
including age, ethnicity, 
employment, qualification, and 
income 
Questionnaire SPSS quantitative analysis 
identifies socio-demographic 
characteristics in first degree 
relatives and spousal control 
group 
4 Lifestyle factors, including 
physical activity habits, dietary 
habits, taking herbs, taking 
supplements, smoking and 
drinking alcohol 
Questionnaire SPSS quantitative analysis 
identifies lifestyle behaviours                                                                                                                               
of first degree relatives and 
spousal control group 
5 Housing and environment 
factors, including origins, type 
of housing, gardens, chemical 
exposure, parks nearby 
Questionnaire SPSS quantitative analysis 
identifies housing and 
environment factors experienced 
by first degree relatives and 




Chapter 5 Results: Quantitative  
Chapter 5 presents the quantitative results. The appropriate variables obtained from the 
questionnaire survey, anthropometric and clinical results and recorded in the SPSS 
program were used to determine if participants could be classified as having chronic 
kidney disease or metabolic syndrome. The socio-demographic characteristics, family 
history and medical history, anthropometric, clinical and biochemical results of the first 
degree relatives and the spousal control group were compared. Multiple logistic 
regression analysis, after adjustment for confounding variables, was then performed to 
ascertain what variables were associated with having chronic kidney disease or the 
metabolic syndrome.  
5.1 Socio-demographic Characteristics 
The participant‘s socio-demographic profiles (study objective 1) are presented in Table 
5.1. The first degree relatives case group (n = 135) were compared to a spousal control 
group (n = 135) consisting of 108 males and 162 females of the same ethnicity: 37 
Malay (13.7%), 108 Chinese (40.0%) and 125 Indigenous (46.3%) (p = 0.424), with no 
statistically significant difference between groups.  
The gender distribution between the first degree relatives (M 55 (40.7%) / F 80 
(59.3%)) and the spousal control group (M 53 (39.3%) / F 82 (60.7%) (p = 0.804) was 
similar, as was age (first degree relatives 40.8 ± 15.5 / 42.1 ± 14.6 v‘s spousal control 
group 44.7 ± 14.9 / 44.1 ± 12.0; p = 0.101).  
When comparing the lifestyle habits of current smokers, alcohol drinkers or betel nut 
users (study objective 2), there was no statistically significant difference between the 
first degree relatives and the spousal control group. The percentage of current smokers 
for the first degree relatives was 17.0% and for the spousal control group was 12.6%; 
37.0% of the first degree relatives and 38.5% of the spousal control group had drunk 
alcohol and the rest never had; and betel nut use was limited to five persons (3.7%) 










 (n=135 p-value 
Age     0.101 
 male 40.8 ± 15.5  44.7 ± 14.9  
 female 42.1 ± 14.6   44.1 ± 12.0  
Gender    0.804 
 male 55 (40.7) 53 (39.3)  
 female 80 (59.3) 82 (60.7)  
Ethnicity    0.424 
 Malay 22 (16.3) 15 (11.1)  
 Chinese 54 (40.0) 54 (40.0)  
 Indigenous 59 (43.7) 66 (48.9)  
Origin of Birth    0.517 
 urban 77 (57.0) 84 (62.2)  
 semi-urban 21 (15.6) 15 (11.1)  
 rural / remote 37 (27.4) 36 (26.7)  
 Employment     0.664 
 government /NGO
c
 12 (8.9) 13 (9.6)  
 private company 42 (31.1) 51 (37.8)   
 self-employed 28 (20.7) 24 (17.8)   
 unemployed 53 (39.3) 47 (34.8)  
Education Level     0.139 
 no schooling 13 (9.6) 10 (7.4)  
 primary only 15 (11.1) 25 (18.5)  
 secondary only 81 (60.0) 66 (48.9)  
 tertiary 26 (19.3) 34 (25.2)  
Income (RM
d
)     0.308 
 below rm1,999 94 (69.6) 86 (63.7)  
 rm 2,000-3,999 29 (21.5) 29 (21.5)  
 rm 4,000 and above 12 (8.9) 20 (14.8)  
Housing     0.185 
 detached / semi-detached 64 (47.4) 56 (41.5)  
 terraced low-cost 36 (26.7) 50 (37.0)  
 self-built / longhouse 35 (25.9) 29 (21.5)  
Current Smoker     0.304 
 (ever vs. never) 23 (17.0) 17 (12.6)  
Alcohol Drinker     0.802 
 (ever vs. never) 50 (37.0) 52 (38.5)  
Betel Nut     0.735 
 (ever vs. never)  5 (3.7) 4 (3.0)  
 
 
Note: Data is expressed as number (percentage) for categorical variables or as mean ± standard deviation for 
continuous variables. Statistically significant at 5% level. 
aFDR = first degree relative; bSCG = spousal control group; cNGO = non-government organisation;  




5.2 Family and Medical History 
The participant‘s family history and personal medical history were self-reported in the 
questionnaire. Comparing the first degree relatives group with the spousal control 
group, a family history of hypertension (102 (75.6%) vs. 87 (64.4%) p = 0.135) was not 
significantly different however, having a family history of diabetes (71 (52.6%) vs. 47 
(34.8%) p = 0.007) or of high cholesterol (58 (43.0%) vs. 45 (33.3%) p = 0.014) were 
statistically significantly different for the first degree relatives (Table 5.2). There was 
no statistically significant difference in the reporting of their medical history.   





 (n=135) p-value 
Family history
c
 (FH) of diabetes (vs. no)    0.007 
 yes 71 (52.6) 47 (34.8)  
 not sure 19 (14.1) 19 (14.1)  
     
FH of hypertension (vs. no)     0.135 
 yes 102 (75.6) 87 (64.4)  
 not sure 11 (8.1) 15 (11.1)  
FH of high cholesterol (vs. no)    0.014 
 yes 58 (43.0) 45 (33.3)  
 not sure 40 (29.6) 30 (22.2)  
     
FH of cardiovascular disease (vs. no)    0.298 
 yes 22 (16.3) 20 (14.8)  
 not sure 29 (21.5) 20 (14.8)  
Diabetes (vs. no)    0.520 
 yes 8 (5.9) 10 (7.4)  
 not sure 29 (21.5) 22 (16.3)  
Hypertension (vs. no)    0.836 
 yes 35 (25.9) 31 (23.0)  
 not sure 21 (15.6) 23 (17.0)  
 
 
Note: Data is expressed as number (percentage) for categorical variables.  
Statistically significant at 5% level. 




5.3 Anthropometric Measurements 
The anthropometric characteristics (Table 5.3) of the first degree relatives and spousal 
control group were compared, contributing to Objective 5 of the study. There were 
anthropometric differences between the genders of first degree relatives and spousal 
control group. Male first degree relatives on average were 1.8 centimetres taller than 
males in the spousal control group. First degree relatives scored statistically greater for 
weight (81.4 ± 17.6 vs. 69.8 ± 13.5; p = <0.001), body mass index (28.6 ± 5.4 vs. 25.1 
± 4.3; p = <0.001), waist circumference (94.8 ± 13.8 vs. 87.5 ± 10.4; p = 0.002), and 
waist–hip ratio (0.94 ± 0.05 vs. 0.9 ± 0.06; p = 0.010) (Table 5.3). There was no 
statistically significant difference between the females of the two groups on any of the 
variables measured (Table 5.3).  





 (n=135) p-value 
 Male     
 height (cm) 168.4 ± 6.6  166.6 ± 5.9 0.151 
 weight (kg) 81.4 ± 17.6 69.8 ± 13.5 <0.001 




) 28.6 ± 5.4  25.1 ± 4.3 <0.001 
 waist circumference
d
 (cm) 94.8 ± 13.8 87.5 ± 10.4 0.002 
 hip circumference
e 
(cm) 100.6 ± 10.5  97.9 ± 12.9 0.231 
 waist-hip ratio
f 
(cm)  0.94 ± 0.05   0.9 ±0.06 0.010 
Female     
 height (cm) 155.1 ± 6.1  155.7 ± 6.5 0.581 
 weight (kg) 61.4 ± 15.0 65.1 ± 15.3 0.127 




)  25.4 ± 5.6  26.7 ± 5.6 0.135 
 waist circumference
d
 (cm) 82.5 ± 11.8 84.0 ± 13.6 0.444 
 hip circumference
e 
(cm) 98.5 ± 10.7 100.9 ± 16.4 0.263 
 waist-hip ratio
f 
(cm)  0.83 ± 0.07  0.83 ± 0.09 0.773 
 
 
Note: Data is expressed as mean ± standard deviation for continuous variables.  
Statistically significant at 5% level. 
aFDR = first degree relative; bSCG = spousal control group; cBMI = body mass index defined by WHO–WPR 
(2007); dwaist circumference defined by WHO–WPR (2007); ehip circumference defined by Welborn et al. (2003); 




5.4 Clinical and Biochemical Results 
The clinical and biochemical results for the participants are presented in Table 5.4. 
These results include the components that make up the metabolic syndrome and 
contribute to study Objective 5. There were very little differences between the first 
degree relatives and the spousal control group in the clinical measurements for the 
systolic blood pressure (129 ± 16.4 vs. 127 ± 18.6; p = 0.258) and diastolic blood 
pressure (81 ± 12.0 vs. 80 ± 11.8; p = 0.459) (Table 5.4).  
Table 5.4  Clinical and biochemical results and components of metabolic syndrome in the 





 (n=135) p-value 
Metabolic syndrome (MetS)
c
    0.012 
 present (3 of 5) 50 (37.0) 31 (23.0)  
 Absent (<3) 85 (63.0)  104 (77.0)  
Chronic kidney disease (CKD)
d
    0.776 
 present (<60) 7 (5.2) 6 (4.4)  
 absent (>60) 128 (94.8) 129 (95.6) 
 
 
Blood pressure systolic (mm Hg) 129 ± 16.4 127 ± 18.6 0.258 
 diastolic (mm Hg) 81 ± 12.0 80 ± 11.8 0.459 
 
Fasting plasma glucose 
(mmol/L) 
 5.0 ± 1.0 4.9 ± 0.8 0.363 
OGTT
e
 2-hour glucose 
(mmol/L) 
 7.1 ± 3.1 6.7 ± 2.8 0.242 
Total cholesterol (mmol/L)  5.2 ± 1.1 5.2 ± 1.0 0.876 
Triglycerides (mmol/L)  1.8 ± 1.2 1.4 ± 1.1 0.012 
HDL
f
 cholesterol (mmol/L)  1.3 ± 0.3 1.4 ± 0.4 0.092 
LDL
g
 cholesterol (mmol/L)  2.9 ± 1.2 3.1 ± 1.1 0.188 
TC : HDL-C Ratio
h
 (mmol/L)  4.1 ± 1.2 3.8 ± 1.1 0.025 
ACR
i





)  81.6 ± 13.2 82.4 ± 11.5 0.620 
 
Note: Data is expressed as number (percentage) for categorical variables or as mean ± standard deviation for 
continuous variables. Statistically significant at 5% level. 
a
FDR First Degree Relative; 
b
SCG = spousal control group; 
c
MetS Metabolic Syndrome defined by 
(Alberti, Eckel et al., 2009); 
d
CKD Chronic Kidney Disease defined by (KHA 2007); eOGTT Oral Glucose 
Tolerance Test at 2 hours post glucose (75g) challenge (Twigg et al 2007); fHDL High Density Lipoprotein 
Cholesterol (Alberti, Eckel et al., 2009); gLDL Low Density Lipoprotein Cholesterol (Tonkin et al., 2005);  
hTC : HDL-C R Total Cholesterol : High Density Lipoprotein - Cholesterol Ratio (Tonkin et al., 2005);  
iACR Urine Albumin : Creatinine Ratio (mg Alb/mmol Cr) (KHA 2007); jeGFR estimated Glomerular 
Filtration Rate (mL/min/1.73m2) based on adjusted_rMDRD revised ‗175‘ formula (Mathew et al 2007). 
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In the biochemical results there were no statistically significant differences between the 
first degree relatives and the spousal control group for fasting blood glucose (5.0 ± 1.0 
vs. 4.9 ± 0.8; p = 0.363), two hour blood glucose (7.1 ± 3.1 vs. 6.7 ± 2.8; p = 0.242), 
total cholesterol (5.2 ± 1.1 vs. 5.2 ± 1.0; p = 0.876), HDL-C (1.3 ± 0.3 vs. 1.4 ± 0.4; p = 
0.092), LDL-C (2.9 ± 1.2 vs. 3.1 ± 1.0; p = 0.188) or eGFR (81.6 ± 13.2 vs. 82.4 ± 
11.5; p = 0.620) (Table 5.4). There were statistical differences between the groups in 
the laboratory results recorded for triglycerides (1.8 ± 1.2 vs. 1.4 ± 1.1; p = 0.012), 
Total Cholesterol : High Density Lipoprotein-Cholesterol Ratio (TC:HDL-C R) (4.1 ± 
1.2 vs. 3.8 ± 1.1; p = 0.025), and ACR (mg Alb/mmol Cr) (6.9 ± 23.8 vs. 2.3 ± 7.5; p = 
0.030) (Table 5.4).  
 
The chronic kidney disease score as defined by KHA (2007) and the metabolic 
syndrome score as defined by Alberti, Eckel et al. (2009) was calculated for each 
participant. The first degree relatives (5.2%) showed no statistically significantly 
greater association with having chronic kidney disease less than <60 mL/min/1.73m
2
 
than the spousal control group (4.4%) (Table 5.4). There was however, a statistically 
significant difference with 50 (37%) of the first degree relatives compared with 31 
(23%) of the spousal control group (p=0.012) being assessed as having metabolic 
syndrome (Table 5.4). 
5.5 Probability for Chronic Kidney Disease 
Since there was no statistically significant difference between first degree relatives and 
the spousal control group for chronic kidney disease, analysis proceeded to multiple 
logistic regression to determine the variables associated with the probability for chronic 
kidney disease, analysing all participants together.  
The probability and results, after adjustment for potential confounders, are shown in 






Table 5.5  Multiple logistic regression analysis of associated risk factors for chronic 
kidney disease in all participants after adjustment for potential confounders* (n=270) 





Age (years)  270 1.076 (1.051, 1.101) 1.048 (1.020, 1.076)  0.001* 
Alcohol no, never 168 1 1  
 yes, consumed 102 1.025 (0.614, 1.710)  0.401 (0.179, 0.898)  0.026* 
MetS
a
 no, absent 189 1 1  
 yes, present 81 1.764 (0.998, 3.119)  3.063 (1.527, 6.142)  0.002* 
 Ethnicity Chinese 108 1 1  
 Malay 37 1.97 (0.562, 2.552) 5.666 (1.935, 16.593)  0.002* 
  Indigenous 125 1.680 (0.792, 3.566) 2.347 (1.021, 5.395)  0.045* 
 
-2 log likelihood = 269.344, d.f =9. 
All variables of interest were included in the full model in the initial step and backward elimination procedure was 
applied to obtain the final model, using 5% critical value of χ2 test for the appropriate degrees of freedom. 
*Non-significant variables were gender, BMI body mass index, chewing betel nuts, smoking status, chewing 
tobacco status, family history of diabetes, family history of high cholesterol, family history of hypertension, 
hypertension, the status of FDR of patients with ESRD and SCG, TC : HDL-C R, HDL, LDL, Triglycerides, 
IFG/IGT, diabetes, salty food intake, and sugary food intake.   
†OR =Odds Ratio; ‡CI= Confidence interval;  
*p<0.01, # p<0.05. 
a
MetS = Metabolic Syndrome defined by (Alberti, Eckel et al., 2009). 
 
Table 5.5 leads to the following conclusions: 
 Age is a significant factor of having chronic kidney disease: with one year older, 
the association with having chronic kidney disease is increased by almost 5% 
(95% CI [2%, 7.6%]), after controlling for ethnicity, alcohol consumption, and 
the metabolic syndrome. 
 Drinking alcohol is found to be a protective factor against developing chronic 
kidney disease. Compared to people who reported never having consumed 
alcohol, the adjusted OR for chronic kidney disease is lower at 40% (95% CI 
[18%, 90%]). For those who have consumed alcohol the association with chronic 
kidney disease is estimated to decrease after controlling for ethnicity, age and 
metabolic syndrome status. There was no data on the amount of alcohol 
consumed [standard drinks per day or duration]; nor was adjustment for energy 
intake possible.  
 As expected, people with metabolic syndrome have a significant higher 
association for having chronic kidney disease. Compared to healthy people, 
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having metabolic syndrome was estimated to be 306 (95% CI [1.53, 6.14]) times 
greater after controlling for ethnicity, age and alcohol consumption. 
 Ethnicity is also found to be positively associated with having chronic kidney 
disease. Compared to Chinese people, having chronic kidney disease was 
estimated to be 5.67 (95% CI [1.94, 16.59]) times higher for Malays and 2.35 
(95% CI [1.02, 5.40]) times higher for Indigenous people after controlling for 
age, metabolic syndrome and alcohol consumption. 
5.6 Probability for Metabolic Syndrome 
The metabolic syndrome is a composite of metabolic abnormalities (Alberti, Eckel et 
al., 2009; R. M. Parikh & Mohan, 2012) therefore further multiple logistic regression 
analysis was performed to determine the associated risk factors for metabolic syndrome 
in the participants. The initial analysis included all of the dietary variables recorded in 
the Phase One questionnaire return (Appendix W) that was based on WHO Steps and 
validated by the Malaysian Ministry of Health (MMOH, 2006b; WHO, 2005). It is 
suggested that dietary questions regarding salt can be attached to the WHO STEPwise 
survey (L‘Abbé, Legetic, Legowski, Claro & Levy, 2010) therefore, some questions 
were added to the sparse food section of the questionnaire.  
In the recommendations, the WHO/PAHO Regional Expert Group for Cardiovascular 
Disease Prevention through Population‐wide Dietary Salt Reduction state that to 
accurately assess salt in the diet, the methods used need to be precise (L‘Abbé et al., 
2010). The questionnaire was not a standard Food Frequency Questionnaire therefore, 
to eliminate any suggestion regarding the precision of the salt and dietary questions, 
multiple logistic regression analysis of risk factors associated with the metabolic 
syndrome was performed again with the exclusion of all the dietary variables (Table 
5.6). 
There were two differences between the initial analysis (Appendix W) and Table 5.6: 
First, salt is missing and second, family history of hypertension (Appendix W) is 
replaced by family history of cardiovascular disease (Table 5.6). Apart from these, all 
the other significant variables remained the same after adjustment for potential 




The variables of interest, after the adjustment for potential confounders, and the results, 
are shown in Tables 5.6 below (study Objective 5).  
 
Table 5.6  Multiple logistic regression analysis of risk factors associated with metabolic 
syndrome excluding dietary factors* (n=270) 
Variable  No.  Crude OR
†













  no 135 1 1 
 yes 135 1.932 (1.135, 3.287) 2.409
*
 (1.303, 4.454) 
FH of CVD
b
 no 179 1 1 
 unknown 49 1.362 (0.687, 2.698) 0.835 (0.374, 1.864) 
 yes 42 2.106 (1.050, 4.224) 2.650
#
 (1.146, 6.130) 
Age (years)  270 1.026 (1.007, 1.045) 1.027
#
 (1.005, 1.049) 
House detached  120 1 1 
 terraced / low cost 86 2.038 (1.098, 3.782) 5.084
*
 (2.301, 11.234) 
 self-built / longhouse 64 2.169 (1.113, 4.226) 3.772
*
 (1.680, 8.468) 
Smoking no 230 1 1 
 yes 40 1.692 (0.845, 3.390) 3.163
*
 (1.344, 7.442) 
Diabetes     





 116 2.296 (1.287, 4.096) 3.568
*
 (1.790, 7.110)  
 diabetic 24 7.000 (2.750, 17.820) 14.308
*
 (4.662, 43.915) 
 
-2 log likelihood = 269.344, d.f =9. 
All variables of interest were included in the full model in the initial step and then forward selection procedure was 
applied to obtain the final model, using 5% critical value of χ2 test for the appropriate degrees of freedom. 
*Non-significant variables were gender, ethnicity, income, alcohol drinking status, chewing betel nuts, chewing 
tobacco, family history of diabetes, family history of high cholesterol, family history of stroke, fitness status, times 
doing moderate/vigorous activities per week, Urine_ACR and eGFR (adjusted_rMDRD).  
†OR =Odds Ratio; ‡CI= Confidence interval;  
*p<0.01, # p<0.05. 
aFDR = first degree relative; bFH of CVD = family history of cardiovascular disease (self-reported); cIFG = 
impaired fasting glucose or glycaemia defined by (Twigg et al., 2007); dIGT = impaired glucose tolerance 
defined by (Twigg et al., 2007). 
 
Conclusions from Table 5.6 follow: 
 The first degree relatives group has a significantly higher association with 
having metabolic syndrome than the control group. The odds of having 
metabolic syndrome for the first degree relatives group are 2.41 (95% CI: [1.30, 
4.45]) times higher than for the control group.  
 
123 
 Compared to those people without a family history of cardiovascular disease, the 
odds of having metabolic syndrome for those with a family history of 
cardiovascular disease are 2.65 times higher (95% CI: [1.15, 6.13]). 
 The odds of having metabolic syndrome increase by 2.7% for every one year 
increase in age, after controlling for other covariates. The population odds of 
having metabolic syndrome are estimated with 95% certainty to increase by 
between 0.5% and 4.9% with every year‘s increase in age. 
 Compared to people living in detached houses, those who live in terraced or low 
cost houses (OR = 5.08, 95% CI =[2.30, 11.23]) or in self-built and longhouses 
(OR = 3.77, 95% CI =[1.68, 8.47]) have a significantly higher association with 
having metabolic syndrome. 
 Current smokers are more likely to have metabolic syndrome than non-smokers. 
The odds of having metabolic syndrome for smokers are 3.16 (95% CI [1.34, 
7.44]) times higher than for non-smokers. 
 Compared to people with a normal result, those with impaired fasting glucose / 
impaired glucose tolerance (OR = 3.57, 95% CI = [1.79, 7.11]) and those with 
type 2 diabetes (OR = 14.31, 95% CI = [4.66, 43.92]) have a significant higher 
correlation with having metabolic syndrome.  
5.7 Key Results of the Quantitative Phase One 
5.7.1 Summary of factors associated with chronic kidney disease in Sarawak 
Four factors were found to be associated with chronic kidney disease. The adjusted 
odds ratios (AOR) (95% confidence interval) found to be of increasing significance 
were:  
 age (1.048 (1.020, 1.076) p = 0.001) 
 metabolic syndrome (3.063 (1.527, 6.142) p = 0.002).  
 alcohol was found to be protective (0.401 [0.179, 0.898] p = 0.026). 
 those of Malay ethnicity (5.666 [1.935, 16.593] p = 0.002), followed by those of 
Indigenous ethnicity (2.347, [1.021, 5.395] p = 0.045), compared to Chinese. 
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5.7.2 Summary of factors associated with metabolic syndrome in Sarawak 
Six factors were found to be associated with having metabolic syndrome. The adjusted 
odds ratios (AOR) (95% confidence interval) found to be of increasing significance and 
markers associated for developing metabolic syndrome were:  
 age (1.027 (1.005, 1.049) p = <0.05)  
 first degree relatives of an end-stage renal disease patient (2.409 (1.303, 4.454) p 
= < 0.01)  
 family history of cardiovascular disease (2.65 (1.146, 6.130) p = <0.05). 
 living in terraced or low-cost housing (5.084 [2.301, 11.234] p = <0.01), 
followed by those living in self-built or longhouses (3.772, [1.680, 8.468] p = 
<0.01), compared to those living in detached houses.  
 smoking (3.163 (1.344, 7.442) p = <0.01).  
 diabetes (14.308 (4.662, 43.915) p = <0.01), followed by those having impaired 
fasting glucose and/or impaired glucose tolerance (3.568, (1.790, 7.110) p = 
<0.01), compared to those with normal blood glucose levels. 
Consistent with the Mixed Methods sequential study design for this thesis, the Phase 
One results were carried forward to inform the next chapter; the discussion of these 




Chapter 6 Intermediate Connecting Stage 
In this study the intermediate connecting stage draws on the results of Phase One and 
determines the criteria for purposefully selecting a sub-set of participants for the 
qualitative Phase Two of the study. The Phase Two protocol for data collection during 
the interview sessions are outlined here. 
6.1 Intermediate Connecting Stage 
Mixed Methods research requires the integration of quantitative and qualitative data 
sets (Teddlie & Tashakkori, 2010). The intermediate connecting stage is the interface 
where the methodologies intentionally link and the data is connected (Creswell & Plano 
Clarke, 2007).  
In this study three steps were taken to facilitate the flow from the quantitative to the 
qualitative phase. The first step was to determine the direct links between the phases by 
scrutinising the key Phase One findings for factors that might contribute to chronic 
kidney disease in the participants. 
Table 6.1  Key Phase One results identified for exploration in Phase Two 
Age  Probability of getting CKD increases 5% with each passing year.  
Alcohol  Maybe a protective factor of getting CKD. 
Metabolic syndrome  Those with metabolic syndrome have a 306% higher probability of getting 
CKD as they age. 
 Ethnicity  5.67% Malay and 2.35% Indigenous people are more likely than Chinese 
to get CKD. 
Note: Summary of data presented in Table 5.5 
 
Multiple logistic regression identified four key factors associated with chronic kidney 
disease. Although alcohol was found to be protective, three factors were found to 
predispose participants to developing chronic kidney disease: age, metabolic syndrome 
and ethnicity. 
6.1.1 Connecting Phase One to Phase Two 
Figure 6.1 illustrates the determinants of chronic kidney disease linking to the 




Figure 6.1  The determinants of chronic kidney disease in the study population that 
informed the qualitative phase 
Note: MetS metabolic syndrome; FH of CVD family history of cardiovascular disease; FDR of ESRD first degree 
relatives of end-stage renal disease; T2Diabetes type two diabetes mellitus.   
 
The key factors for having metabolic syndrome included only one of the factors for 
chronic kidney disease, age (see Table 5.6). However, as well as having an increased 
risk of metabolic syndrome in the chronic kidney disease results, the first degree 
relatives of end-stage renal disease patients was a factor correlating with metabolic 
syndrome. A number of factors were considered unsuitable for guiding the Phase Two 
research. As there was a wide age range among the participants, the small number 
selected for Phase Two might not be representative. In this phase half the participants 
were first degree relatives and half were the spousal control group and therefore were 
different population groups although their socio-demographic characteristics were 
similar. Not all the participants selected for Phase Two had a metabolic syndrome 
diagnosis and therefore not all had the same condition. Ethnicity, however, was a 
constant determinant that remained unchanged and representative.  
The sub-set for Phase Two was chosen from each of the ethnic categories of Phase 
One, and a direct connection between the quantitative and qualitative phases can be 
established unequivocally through ethnicity. On this basis, the analysis in Phase Two 











6.1.2 Key Phase One categories identified for Phase Two exploration 
The second step was to identify questions arising from, and local peculiarities 
encountered in, Phase One that required explanation. These issues provided a 
connection between the phases. Concerns of interest were identified and grouped into 
four categories that formed and informed the major broad topics outlined in the 
interview schedule and identified for further exploration in Phase Two. They were also 
used as labels for the free nodes in the initial coding in the NVivo software.  
Table 6.2  Phase One concerns of interest identified for exploration  
Transitional changes  Including migration, education and vocation 
Environment  Including lifestyle, home surroundings and activities 
Health beliefs  Including the influence of traditional practices; medicine  
Health behaviours  Including ignorance and detrimental behaviour 
 
Constructing the interview schedule in this manner followed a deductive ‗top-down‘ 
approach (Creswell & Plano Clarke, 2007), with the findings of Phase One determining 
the interview schedule. Later, during the interviews, an inductive ‗bottom-up‘ approach 
was used to build upon the information received (Laverack, 2004) and the interview 
schedule was continually revised or expanded to accommodate new findings. This 
‗cyclical‘ research process allowed ideas to be built upon and tested as more interviews 
were undertaken, until such time as the participants‘ responses were similar, with 
reoccurring themes and patterns, and saturation of information was considered to have 
been reached (Saks & Allsop, 2013).  
6.1.3 Purposeful selection of participants for Phase Two 
The third step in the intermediate connecting stage entailed purposefully selecting a 
sub-set of the participants from Phase One, in accordance with the Mixed Methods 
explanatory design (Creswell & Plano Clarke, 2007). The participants for Phase Two 
were specifically taken from those who had participated in the initial data collection 
phase. A maximum variation sampling approach (Patton, 2002) is the best fit for this 
study as the participants are diverse in terms of socio-economic, educational and 
demographic characteristics, and ethnicity. There are, however, aspects that also 
identify with other sampling techniques set out by Patton (2002), including extreme 
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sampling (comparing extreme outliers to equate experiences) and criterion sampling 
(selected from pre-determined criteria considered significant).  
Patton (2002, p. 230) writes that ‗the logic and power of purposeful sampling lies in 
selecting information-rich cases for study in depth … information-rich cases whose 
study will illuminate the questions under study.‘, Phase Two recruitment criteria 
purposefully selected participants from both cases and controls, and included 
representatives who had low or high likelihoods of developing chronic kidney disease. 
Comparing the responses from participants who had the best and worse chronic kidney 
disease scores was considered the best way to inform the qualitative study.  
As metabolic syndrome was found to be associated with chronic kidney disease in 
Phase One, participants were also sorted by their metabolic syndrome score then 
compared with the chronic kidney disease. It was found that, as expected, many who 
were most likely to develop chronic kidney disease also had the greatest number of 
metabolic syndrome components. Curiously, there was a subset of normal and 
underweight people who also had lower eGFR and chronic kidney disease scores; this 
was noted for further exploration during the interviews.  
6.2 Qualitative Overview 
The findings and questions arising from the Phase One survey formed the basis for the 
development of the interview schedule. Observations of frequency distribution from the 
quantitative descriptive statistics triggered some curiosity, and a number of special 
interest questions were identified and developed in more detail in the interview 
schedule.  
Table 6.3  Phase Two interview topics and questions arising from Phase One 
Transitional 
changes  
Including their past history and whether they moved from where they were born and 
grew up. If yes, do they still maintain connections / visit their family / ethnic home? 
How did the transition affect them? 
Environmental  Has the change of environment altered their lifestyle / diet / activities / health status? 
Do they have a house with a garden / own a garden? Do they grow / eat fruit and 
vegetables? Is there a green space to go for walks nearby?  
Health beliefs  How do they view traditional practices? Medicines? If a Western doctor gives them 
medicine are they compliant? If not, why not?  
Health 
behaviours  
Are they or family members obese? Do they smoke / drink alcohol / take herbs / 




The research areas selected were chosen in order to explore possible influences that 
might have an effect on the development of chronic kidney disease and metabolic 
syndrome in the participants. Questions and prompts were developed to aid the 
interview process. The detailed interview schedule was photocopied, and each 
participant‘s responses were transcribed and recorded into it. It was hoped that further 
information and an explanation for the Phase One results would be forthcoming 
through the interview enquiry of the participants in Phase Two.  
6.3 Qualitative Phase Two Research Methods 
The selection parameters for the qualitative phase included the total number of 
participants (n=270) who completed the quantitative phase of the study and had 
consented to be included in the follow-up interviews. The best participants to interview 
are those who will deliver the richest information (Patton, 2002). By purposefully 
selecting participants for the semi-structured interviews, it was anticipated that a deeper 
understanding and comprehension regarding the situation in Miri might be gleaned. 
6.3.1 Recruitment of participants for the interviews 
A matrix was arranged to ensure that male and female participants with the worst and 
best scores among the first degree relatives and spousal control group were recruited. 
All ethnic groups were represented and it was hoped that commonalities and 
differences between ethnicities would be revealed through the qualitative interviews 
(see Appendix X). 
SPSS code numbers were used to access the master file and retrieve the names and 
contact mobile numbers of participants who had agreed to participate in Phase Two. 
They were contacted by telephone and provided with information regarding the 
qualitative study. If they declined to take part, the next outlier person on the list was 
invited. If they agreed to partake, an appointment date and time was made. This was 
repeated until the matrix for the interviews was completed. No money or compensation 
was offered to participants during recruitment. All those who participated in Phase Two 
were thanked for volunteering and told that their participation was a valued 
contribution to this community study.  
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6.3.2 Sample size 
The final sample size for the qualitative interviews was 32 persons. A matrix was 
designed by ethnicity, grouped as Malay, Chinese, Indigenous Orang Ulu and 
Indigenous Iban and Bidayu on the vertical. The horizontal indicated male or female, 
case or control participant. These participants were grouped for interviews according to 
whether they had a low or high score for chronic kidney disease. Sixteen persons were 
interviewed from among the cases and 16 from the controls, meaning eight persons 
each from the low and the high score groups were conducted. Men and women were 
equally represented (see Appendix X). 
6.3.3 Trustworthiness 
The qualitative primarily adhered to the criteria, terminology and techniques set out by 
Lincoln and Guba (1985). Appropriate and efficient strategies to deal with validity 
threats (Maxwell, 2008) was considered for this study, including research design focus, 
participant selection, and choosing the most appropriate data gathering methods 
(Graneheim & Lundman, 2004). Reliability and validity are treated as one entity in 
qualitative research (Golafshani, 2003) and the trustworthiness of the study can be 
gauged by its credibility, transferability, dependability and conformability (Lincoln & 
Guba, 1985). 
6.3.3.1 Credibility 
Credibility is the confidence a researcher has that the findings regarding the phenomena 
of interest are truthful (Lincoln & Guba, 1985). Lincoln and Guba (1985) have the 
viewpoint that prolonged engagement and persistent observation is beneficial in the 
collection of credible data. Having lived and worked in the community from which the 
participants were drawn means that over the years I gained an understanding and 
insight into the various ethnic cultures. A relationship with the participants was 
established during the quantitative data collection and questionnaire sessions, and this 
aided trust in the interview sessions. In this study, triangulation was carried out by 
comparing the questionnaire answers of a participant with their interview statements 
(Shenton, 2004). If there was a contradiction that particular participant was contacted 
and asked again what they meant and to clarify. 
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Peer debriefing with members of the reference group and peer review of the database, 
coding and themes, was conducted by persons unfamiliar with the research. Feedback 
given during a poster presentation at a national conference provided some objective 
insight into the research. Due to transportation logistics, only member checking of the 
transcription with participants living in Miri was carried out only by mobile phone; 
each confirmed that their transcription was accurate.  
6.3.3.2 Transferability 
This is the first time research in this field of study has been made in East Malaysia, and 
for this reason, to facilitate transferability, a ‗thick description‘ of the contextual factors 
and the phenomena under investigation (Lincoln & Guba, 1985; Shenton, 2004) was 
carried out in order to give ‗generalisability‘ to other geographical and cultural 
situations. (Graneheim & Lundman, 2004). 
6.3.3.3 Dependability 
Dependability refers to the data gathered and whether similar results would be 
produced if repeated (Shenton, 2004). In order to gather reliable data, the participants 
must be honest. In this study, before they signed the consent form, they were asked to 
be truthful; however, if they felt uncomfortable answering they could decline and were 
free to leave. Two reliability methods were employed to check on their honesty: 
another similar prompting question regarding suspect information was asked later on in 
the interview schedule; and answers given in each participant‘s questionnaire paper 
were compared with their interview responses. No participant‘s response was excluded. 
In order to maintain consistency during data collection (Graneheim & Lundman, 2004) 
the broad areas within the semi-structured interview schedule did not change 
significantly, although because of the ‗evolving process‘ of the interviews there was 
flexibility within these areas. An inquiry audit was kept, detailing alterations and when 
changes in inquiry direction were made to the interview schedule. 
To ensure dependability and trustworthiness of the translation, a group of professional 
and lay linguistic translators living in Miri checked the transcribed material against the 




Confirmability is the concept of neutrality and other issues regarding researcher bias. 
An ‗audit trail‘ was maintained throughout this study, sequential, sufficiently detailed 
to outline the methods, and transparent enough that the study and findings may be 
reproduced. A reflexive journal was kept to address progressive study and researcher 
issues.  
Researcher influence and lack of trust produced during the research process (Denzin & 
Lincoln, 2009) and acknowledgment and disclosure of researcher bias (Miles & 
Huberman, 1994) was considered. I was sensitive of being objective even though I was 
immersed in the culture. Berger (2013) lists a number of studies showing how having a 
‗dual identity‘ especially when studying minority groups, brings the possibility of 
overlaying one‘s own experiences onto the data. From personal experience, Berger 
(2013, p. 6) explains, it requires ‗a constant deliberate effort to maintain the 
separation‘. I felt this, and in the interview sessions had to continually control myself 
from interjecting with my experience, and to focus on each participant‘s story and point 
of view only.  
6.3.3.5 Overview of trustworthiness of the study 
In assessing Cohen & Crabtree‘s (2008) ‗paradigms in health care research‘, although 
simplified, I found myself aligning with the ‗realism‘ paradigm although I also agreed 
with parts of the ‗positivism‘ and ‗interpretivism‘ paradigms. They emphasised that our 
perspective, our training and our beliefs affect our research, and researchers need to be 
impartial in their approach. This study also addressed the criteria advocated by Saks 
and Allsop (2013). There appears to be some disagreement but a lot of crossover 
between different qualitative authors, and the general consensus is that different 
problems require different methodological approaches (Patton, 2002) and that there is 
no single standard for qualitative research (Denzin & Lincoln, 2009). Merriam (1995, 
p. 51) stated that ‗rigor is needed in all kinds of research to ensure that findings are to 
be trusted and believed‘. Ultimately trustworthiness depends upon telling the truth and 
being truthful, in order for the truth to be revealed. This applies equally to participants 
and researchers.  
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Discussion with a few select persons participating as the reference group monitored 
trustworthiness, questioned my biases and provided insight for me regarding 
peculiarities. They noted inaccuracies they felt were present in the translations and in 
my interpretation of the interview data, in accordance with Mixed Methods guidelines 
(Berger, 2013; Miles & Huberman, 1994; Tashakkori & Teddlie, 2009).  
6.3.4 Qualitative data collection protocol 
The pilot questionnaire tested language and the comprehensibility of the questions, and 
the pilot interviews tested the interview schedule. Minor changes were made after 
participants‘ feedback. The ethics, consent and protocol were the same as for the main 
data collection sessions. When requested, a translator in the participant‘s mother tongue 
was present to interpret for me when conducting interviews. The translators had been 
instructed in aspects of qualitative interview data collection techniques. 
Cultural sensitivity is of importance to this research. The interview question guide was 
tested with a culturally and linguistically appropriate reference group from the 
administrative staff and nursing pool at Columbia Hospital, Miri. Informed consent was 
sought prior to these sessions. The data gathered in these sessions was excluded from 
the actual study. Adjustments were made to the interview guide where indicated.  
 
Photograph 6.1  An Iban longhouse 
Photograph by researcher 
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6.3.5 Translators, transcripts and translation 
A number of translation issues were addressed in Phase Two. My researcher notes 
during Phase One were detailed, and any language and translation problems 
encountered then were noted in the planning and preparation of the Phase Two 
interviews. Temple and Young (2010, p. 164) note that ‗language is power‘: when a 
researcher has to rely upon translators, this gives power to the translators who control 
the flow of questions, ideas and responses across the divide. Consideration of how 
translators fitted into the study led me to deliver all the interviews myself, to ensure 
consistency. If a participant did not understand English, the appointed translator 
translated into their dialect directly from my words.  
Language cannot be translated verbatim, as context needs to be transferred. Since 
language is ‗value-laden … differences in power between languages also influence the 
translation of meaning‘ (Temple & Young, 2010, pp. 167). The translators were not 
always literal and had their own cultural biases and this also had to be continually 
checked. I have a basic knowledge of Malay and Kelabit so could generally follow 
what the translators said, but a number of times, after realising a translator was taking 
liberties, I organised briefing sessions to ensure the translators and she had a 
collaborative relationship.  
Malaysians live in a multilingual society and almost everyone speaks more than one 
language and a few dialects. When people need to communicate but do not understand 
each other, ‗Pasar Malay‘, a very simple common Malay idiom, is used throughout 
Sarawak (Kenyalang, 2010). Living in such a rich language medium has produced a 
uniquely Malaysian form of code-switching where Malay, Chinese, English and 
Indigenous jargon are frequently mixed within a sentence. To extract deep meaningful 
information and to avoid translation errors, as far as possible the translators came from 
the same ethnic group and used the same dialect as the participant, and actively used 
code-switching in that dialect.  
Following the interview the translator transcribed the interview from the recording into 
English onto the interview schedule, using Microsoft Word. A second translator who 
spoke the relevant dialect then listened to the recording of the participant‘s interview 
and read the translated transcript to ensure accuracy. All of the translators in this study 
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had experience in language translation skills, having worked as teachers, nurses, Bible 
translators, government servants and other professionals.  
Translation errors can occur from misunderstandings. If the translators disagreed about 
the English version, or unknown words or names were used or the language was vague 
or unclear, this was discussed and if necessary the participant was contacted to clarify 
what had been meant. Sometimes I had also to consider language in a social and 
cultural context (Nilep, 2006) but this was aided by my having lived in Sarawak for 
more than three decades. 
Cultural prejudice and bias may affect researchers in their assessment and expectation 
of others (Gumperz, 1970). My ability to chat in Malay helped establish a rapport, and 
having an understanding and appreciation of both urban and remote rural Sarawakian 
way of life has given me insight into the ethnographic effects on local language. This 
helped me adapt my methods, change communication strategies, and acknowledge 
overt bias and perceived subvert biases I might otherwise have brought to the study. 
6.3.6 Research dilemmas 
It is common in Sarawak to be requested to sponsor or contribute to community events. 
‗Community empowerment can be viewed as both a process … and an outcome … an 
interactive process‘ (Laverack, 2004, p. 12) and there is always an ethical debate as to 
whether sponsorship promotes community empowerment or hinders it. To avoid this 
‗expected donor-sponsor mentality‘ it was stated explicitly in the information sheets 
that no compensation would be given for participating in the study. Even so I was 
continually asked, ‗what is available for me?‘ and some people refused to be recruited 
in both phases when they learned there was no recompense.  
I did not want to be seen in a position of power, authority or expertise, and tried to keep 
a humble profile. I never used official details or letterheads on any information sheets, 
consent forms or the questionnaire. I consciously dressed ‗smart local‘ and did not wear 
make-up or jewellery, and asked translators and assistants to do likewise. I wanted to 
be approachable and I wanted the poorer participants to feel worthwhile, and that their 
voices were being heard, with the data collection sessions being purely about the 
participants. At the end of the sessions, however, any health questions were answered 
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and they were given pamphlets about hypertension, diabetes and kidney health 
education. When they collected their clinical results they were advised to see their 
doctor for medical advice.  
6.3.7 Reflexivity 
Although I have lived in Sarawak for two thirds of my life, I am Western raised and 
educated. As a Europid woman married to a professional local man I have certain status 
within Sarawak as well as personal biases that are different from the status quo. Berger 
(2013) has argued that the positionality of the researcher can have both positive and 
negative influences on the research and all researchers need to consider how their social 
position can affect reflexivity. As I shifted between insider and outsider roles during 
the study I experienced some conflict, both internally and externally. It has been noted 
that research should include continuous reflection, acknowledgement and critique 
during all stages (Saks & Allsop, 2013) in order to reduce subjectivity (Corbin & 
Strauss, 2008) and increase validity (Creswell & Miller, 2000). In the planning stages 
of this study, the benefits and constraints that might affect insider research (Teusner, 
2010) were contemplated and I was made aware of areas needing particular attention 
and adjustment.  
 
Photograph 6.2  A Kelabit longhouse 




It is important for researchers to acknowledge their own social values and prejudices, to 
reduce unwarranted influence (Hall & Callery, 2001) and an unintentional impact on 
the study (Patton, 2002) and it is especially important to develop a respectful 
relationship when doing Indigenous research (S. Wilson, 2001). Half of the participants 
were Indigenous but with the Chinese and Malay participants too, some topics, taboos 
and sensitivities had to be treated cautiously. I was very aware that if local mores are 
questioned by someone who has not established a respectful rapport, people become 
defensive. I can identify with many research aspects outlined by Kanuha (2000) and 
understand how being a member of the community under study can be both 
advantageous and challenging. Being aware of cultural missteps, who to contact, and 
how to negotiate tricky situations and protocol dilemmas, was an asset to me.  
I have membership with three ways of life: Australian (born in Tasmania), local 
Malaysian urban (Malay, Chinese, Indian, Indigenous and expatriates) and tribal 
Indigenous (through my husband and from our close personal ties with other 
Indigenous groups). I see things from both community subjective and objective 
perspectives, which makes it easier for me to pick up on local nuances, be insightful 
and innovative without offending. As one of the assistants said, ‗you see things 
differently to me, I never thought of it that way and I‘ve lived here all of my life‘. 
Although I am an ‗insider‘ aware of the broader social consciousness, I am also an 
‗outsider‘ to both a first degree relative and a spousal control group family member. 
Even though I have worked for years at a dialysis centre and have sympathy, I do not 
have empathy as I do not live within their frame of reference and cannot truly 
understand their situation. In this particular study it did not appear to affect the research 
negatively and helped me to be impartial; so in that respect I am not so close and so 
similar to those under study as to jeopardise objectivity (Kanuha, 2000).  
Local Miri citizens who know me treat me differently from a visitor or tourist. I have 
never not felt accepted as part of the community. I have pondered over the argument 
that ‗the researcher‘s perceptions might be clouded by his or her personal experience 
and that as a member of the group he or she will have difficulty separating it from that 
of the participants‘ (Dwyer & Buckle, 2009, pp. 58). From a researcher‘s perspective I 
am in a unique position as I am neither a total ‗insider‘ nor a total ‗outsider‘, but both. 
So long as I remained aware of my bias and preconceptions I found that being both was 
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beneficial (Dwyer & Buckle, 2009), especially in ‗breaking the ice‘ in the quantitative 
sessions and in the interviewing and analysis of the qualitative phase.  
Berger (2013, pp. 2) has said that researchers have to ‗carefully self monitor the impact 
of their biases, beliefs, and personal experiences on their research; and maintain the 
balance‘. I am forward-looking, inquisitive, equitable and tolerant; but a few things 
overtly challenged my world-view. Of most fascination to me was the variety of 
religious and ethnic subtleties, and social undercurrents I am not often privy to. Milner 
(2007) has written about a filtering that occurs in researchers when faced with 
conflicting views emanating from racial and cultural issues: that introspection 
(reflexivity) is required before one can build a relationship, understand, and represent 
participants with integrity. The researcher plays a role ‗in the construction of 
knowledge at all stages of the research process‘ (Saks & Allsop, 2013, pp. 449), and it 
is important to maintain its quality through reflexivity (Berger, 2013). From the 
conception of this project, I kept a reflective journal describing cultural issues that 
arose, the impact participants‘ stories had on me, the effect of their beliefs and 
knowledge on my own attitudes, and how my assumptions and perceptions changed 
through the course of the study. This continuous process of reflexivity kept me aware 
of my own subjectivity and made me pay more attention to my decision-making 
throughout the research.  
6.3.8 Research tools, instruments and data collection procedure 
The tools used in Phase Two included Microsoft Office 2007 Excel and Word, Endnote 
X1 Referencing Manager, and NVivo 12. Instruments included an information sheet 
and a semi-structured interview schedule, was pre-tested prior to the qualitative data 
collection.  
The Phase Two interviews took place in Dr Mattu‘s clinic next to Columbia Hospital, 
Miri, as the participants were familiar with the place from Phase One. The furthest any 
participant travelled from their residence for the interview was two hours by road. 
Signed consent was obtained before the interviews commenced. The participants had 
their weight and blood pressure taken to compare against their Phase One data. They 
were asked if they had taken their clinical results to their doctor for discussion, and if 




A semi-structured in-depth interview was chosen as the best approach to gather the 
qualitative data from the participants. The interviews were conducted in such a way as 
to encourage and provide ‗the opportunity for participants to impact the process and 
outcome of the research‘ (Berger, 2013, pp. 12). Flexibility was permissible, so 
participants could digress from the question topic (see Appendixes Y, Z). 
6.3.9 Analysis of the data 
The qualitative data analysis followed the procedure set out by Creswell and Plano 
Clarke (2007). The processes conducted in this research were:  
 preparing the data for analysis; translating and transcribing the interviews; 
preparing and entering the data into the computer software program  
 exploring the data; reading through the interview transcripts and researcher‘s 
notes; developing a codebook, coding the data and assigning labels  
 analysing the data; grouping the codes into themes; collapsing the number of 
themes  
 representing the data analysis; using narrative and visual models to discuss 
and present the findings  
 using validation strategies, as discussed previously. 
 
The remainder of this chapter, details aspects of these steps as applied to this study. 
6.3.9.1 Transcription of the interviews sessions 
I conducted all the interview sessions; a translator was available to translate into and 
back from the participants‘ dialect when needed. All data obtained from the interviews 
was transcribed into English, verbatim if the responses were in English, or in as close 
meaning as possible if translated, before analysis. Immediately following each 
interview I reflected on the session. I transcribed the recording into English at the 
soonest possible time. Translators transcribed all the sessions not conducted in English, 
then we discussed the translation and revised the interview guide if necessary. Being 
involved in both the interviews and their transcriptions allowed me to become 
immersed in the data and gave me a better understanding of participants‘ perspectives. 
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It was a dynamic process, and the schedule was continuously refined in order to 
improve its appropriateness and flow, and enhance data collection. The participants 
were not asked to check the transcripts of their interviews for logistical reasons, but 
were asked to contact me if they had any questions. They were told they would receive 
information on the outcomes of the study upon its completion. 
6.3.9.2 Notation used in the transcriptions  
Being a purposive sample, the findings are not fully applicable to the broader Miri 
community: they are representative of the Phase One first degree relatives and spousal 
control group. Thirty-two people were invited to participate in the qualitiative 
interviews. The number of participants and the languages the interviews were 
conducted in were: 13 English, 6 Malay, 2 Mandarin, 4 Iban, 3 Kayan, 2 Kelabit, 1 
Hokkian and 1 Fuchau.  
The advantage of qualitative methodology is that is can candidly record, interpret and 
report what a participant has to say about a particular matter (Patton, 2002). In these 
Phase Two interviews, the intention was to hear their voices and to record their views. 
The participants‘ words are reported as spoken with colloquial jargon, or as the 
interpreter transcribed it. They may not be grammatically correct, but are included in 
the following chapters without alteration. There were many responses to choose from in 
every area. Each participant‘s quote is indented in italics, followed by an identification 
label: P (Participant, followed by a number indicating which participant); I 
(Indigenous); C (Chinese); M (Malay); B (Best CKD score) or W (Worst CKD score); 
M (Male); F (Female); R (Relative FDR) or); S (Spousal control group).  
6.3.9.3 Entering the data into NVivo 12 for analysis 
QSR NVivo 12 software program was used to facilitate the evaluation and 
interpretation of all the qualitative data. Following the determination of the semi-
structured interview questions, the survey sheet was formatted in the same font and 
style as the auto-coding for NVivo, to aid in transferring and coding. Once all the 
interviews had been completed, translated and typed into Microsoft Word, the 
documents were exported into NVivo 12 under ‗Internals – Interviews‘ and auto-coded.  
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6.3.9.4 Exploring and coding the data 
A ‗memo link‘ was made for each participant, containing my notes and initial thoughts 
during each interview, as well as my later reflections. A codebook was set up, so that 
the steps in setting up the database could be repeated, in case it is needed in the future. 
Node classifications for attributes, such as code number, ethnicity, chronic kidney 
disease status, gender, case or control, metabolic syndrome status and age were made 
for all participants. 
Initial ‗nodes‘, ‗child nodes‘ and ‗baby nodes‘ were set up, based on the semi-
structured divisions of the interviews. The interview process was dynamic, so as the 
various texts were coded, various nodes were collapsed or added to. The qualitative 
data gathered and the knowledge gleaned from the interviews, once categorised into 
nodes, were organised in a hierarchy. Once this stage was completed, a word frequency 
search was performed to see if all avenues of thought from participants had been 
captured. For example, two nodes, labelled ‗Changes‘ and ‗Stress‘ were added as both 
terms appeared many times in the interviews. Different terms with similar meanings 
were searched by adjusting the slider on the word frequency tab; no further words or 
concepts of interest appeared. A text search query was run on a few outstanding words 
from the word search, such as ‗chemical‘ and ‗garden‘. A query was also performed on 
these words and the results depicted in a word tree, in order to understand the context 
and meaning given them by participants. One word that was particularly enlightening 
and informative about its use by participants was ‗traditional‘. For this term, the 
interpretation was complex, and a number of child nodes were added to accommodate 
its various meanings. A baby node was added to the child node if there was a need to 
expand. 
6.3.9.5 Establishing themes and analysing the data  
Following this broad-brush coding, a closer coding-on analysis was performed on each 
interview, and labels were assigned, some derived from the exact words of the 
participants (in vivo coding) (Creswell & Plano Clarke, 2007). This step assists in 
exploring and refining the coding to the nodes. The codes or categories were grouped 
into major themes; then, after reflection, the themes too were collapsed and reduced to 
be more manageable. The major themes identified followed thematic content analysis, 
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and a matrix analysis grid was constructed (Miles & Huberman, 1994). As the 
qualitative data was being gathered the analytical process began,
 
and the ongoing 
interview inquiry was constantly discussed with the reference group members and 
adjusted. There was continual comparison of the participants‘ responses, from both 
phases and between different participant groups. 
6.3.9.6 Representing the data through narrative and visual models 
Using QSR NVivo 12, Framework Matrices were constructed so that tables showing 
the intersections between different themes and nodes could be viewed. Displaying data 
this way aided understanding of different relationships and facilitated the comparison 
analysis. Of interest were the intersections between the X and Y axes in the NVivo 
matrix. The X axis included ethnicity, gender, first degree relatives and spousal control 
group, and whether the participant had chronic kidney disease and/or metabolic 
syndrome. The Y axis included answers from interviewees. The intersections recorded 
the number of responses made by participants, and were an indication of the strength of 
verbalisation on that particular subject. The most numerous responses were checked 
against the participants‘ verbal recordings to expose patterns.  
The matrices were first organised in two dimensions; later, meta-matrices were 
attempted. A record of decisions made in the development of the matrices was kept in 
the codebook so that they could be repeated or modified. The two-dimensional matrix 
gives an idea of the categories arising from the data (Miles & Huberman, 1994). These 
were then expanded to meta-matrices, conclusions written up and visual models of the 
results shown and validated (see 6.3.3). 
Although the circumstances and experiences revealed by the participants were diverse, 
common categories or codes emerged across all ethnic divides. With continual 
reflection and refinement, these codes were reduced and re-grouped (analytical coding). 
Using the NVivo Matrix Query, coding patterns were identified then checked against 
the written transcripts, which had been sorted into four categories for comparison. This 
led to the development of more complex sub-themes and the identification of the major 




6.3.10 Research methods employed to achieve the qualitative outcomes 
The significant expected outcomes, and the strategies and instruments employed to 
achieve the qualitative findings, are presented in Table 6.4.  






Objective Rationale Strategies and 
instruments 
Expected outcomes 
6 Determinants including diet and 
physical activities, education and 
employment changes, medical and 
health changes: all contributing to 
transitional life changes.  
Interviews  Identify beliefs, behaviours and 
stress factors of participants with 
regard to identified determinants 
compounding the development 
of chronic kidney disease and  
metabolic syndrome . 
7 Attitudes, barriers and practices 
including environmental issues such 
as housing, parks, surroundings, 
gardening, farming, agrochemical 
usage and land concerns.  
Interviews                                                                                           Identify attitudes, barriers and 
practices impeding the early 
recognition of precursors and 
diagnosis of clinical diseases in 
the participants. 
8  Health beliefs including traditional 
practices, medical preferences, 
traditional herbs and modern 
medicines, medical beliefs and health 
information, herbal supplements. 
Interviews  Identify contributing health 
beliefs and behaviours having an 
effect on participants‘ self-
management of chronic 
metabolic diseases. 
9 Health behaviours including 
compliance with doctor‘s orders, 
compliance with medication, mixing 
herbs, supplements and modern 
medicines, health habits and 
behavioural change. 
Interviews  Report on reasons contributing to 
non-compliance with doctor‘s 
orders; taking prescription 
medication; and how myths, 
marketing and knowledge affect 
one‘s choices of medication. 
10 Evidence including specific locales 
that are hazardous to health, topics of 
concern identified, at-risk population 
groups needing Government or NGO 
health promotion programs. 
Interviews  Compile a list of the high-risk 
locales, topics and risk groups 
emerging from quantitative and 
qualitative analysis to set up a 
task group to develop targeted 





The intermediate connecting stage is where Phase One connects with and informs 
Phase two of this study. The key findings and concerns of interest identified from Phase 
One guided the development of the interview schedule. The issues of trustworthiness 
and translators were discussed. A sub-set of both high and low chronic kidney disease, 
from both the first degree relatives and the spousal control group and from all of the 
major ethnic groups, were chosen as participants for Phase two. The research methods 
and the qualitative data analysis procedures employed for the Phase Two data 
collection were described.  
The Phase Two findings are presented in the following chapter.  
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Chapter 7 Findings: Qualitative Phase Two 
Chapter 7 introduces the accurately recorded ‗voices‘ of the participants, and the 
patterns that emerged are presented as the qualitative findings. I used the NVivo 
program matrix intersections to determine the initial categories from the qualitative 
data gathered during the interview sessions. As recruitment for Phase Two was multi-
layered (Appendix X), the findings compared and contrasted responses between 
ethnicities, the first degree relatives and the spousal control group, the best/worst 
chronic kidney disease scores and the best/worst metabolic syndrome scores in order to 
discern differences in the beliefs and lifestyles of the participants. This data was then 
organised into sub-themes which, when analysed, revealed the major theme.  
7.1 Transitional Changes  
Of the 32 participants recruited for Phase Two, surprisingly, only one first degree 
relative and one spousal control group were first-generation Miri. Three participants 
were born overseas, in China, Indonesia and Brunei. The remaining 27 participants 
were all born and raised elsewhere in Sarawak, split evenly between urban and rural, 
and over six divisions of Sarawak. Some participants lived one to two hours‘ drive 
from Miri city.  
7.1.1 Majority views 
Relocation issue.  There were many reasons why participants moved to Miri. Some had 
lived there previously and moved away, only to return because of life circumstances: 
Mid 1984 I moved to Miri then in 1986 I came back and stayed at the longhouse 
to do some farming work. Last three years now 2009–2013 we moved to Miri 
for youngest schooling. (P2 IWMR) 
The participant‘s comments below are representative and show the significance all 
ethnicities hold regarding festivities wherever their kampung is, even if they are unable 
to go:  
My parents still live in Bario. My mother still plant paddy. I go back at 
Christmas times. (P12 IBFS) 
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I return to my home village at least once a year at Hari Raya but sometimes 
other times if we can arrange it. (P32 MBFR) 
When I was in Sibu my home place is at Sungei Merah a bit country outside 
Sibu. I only go back twice a year to Sibu, during Chinese New Year and Ching 
Ming Festival. (P20 CBFR) 
They face difficulties in going back: 
Occasionally I would go back to visit the longhouse, 2–3 times per year. My 
transport back to kampung is by express boat [with outboard engines] from 
Kuala Baram and the journey takes about eight hours to destination. (P16 
IBMR) 
Kampung happenings were of high importance to those who had moved to Miri. Some 
participants were able to return regularly:  
I have just come back from Pa Ukat two weeks ago as just finished rani 
[harvesting the rice]. I go at least twice every year to plant rice then to harvest 
the rice. (P4 IWMS) 
Some are apprehensive of possible future responsibilities:  
My dad and mum are fairly healthy except my dad has hypertension. They also 
have their longhouse at Betong so go back to visit sometimes. He still has land 
there and still looks after it and has fruit trees there. I don’t go back with them 
as working. When my father passes on I will have to look after his land for him. 
I very seldom go back to the kampung. (P10 IWMS) 
7.1.2 Disparities between groups 
First degree relatives vs. spousal control group.  The biggest difference between the 
first degree relatives and the spousal control group, of course, are the horror stories 
about family members with end-stage renal disease. Most often the one receiving renal 
replacement therapy passes away from cardiovascular disease, type 2 diabetes or 
hypertension complications:  
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My eldest brother, the one on dialysis, was suspect to have diabetes. By the time 
when he took the medicine the sickness become worse and he stop taking the 
medicine, and do not follow-up check-up after stop taking the medicine and 
died. (P2 IWMR) 
Others spoke of incidents related to dialysis: 
My mother was on dialysis but already pass away about two year ago [2011] 
because of bleeding a lot after surgery. (P13 MWMR) 
Sadly, some who wanted to have renal replacement therapy were unable to because the 
family couldn‘t afford the treatment: 
The doctor didn’t say anything about my mother’s kidney failure, but I know my 
mother had diabetes and hypertension … the doctor advised her to do dialysis 
but last time … we were told we would have to buy a machine and be trained 
and all that but we couldn’t do anything about that … and then ten days later 
she passed away. (P28 CWFR) 
Some patients are known to refuse renal replacement therapy, fully aware that they will 
die: 
Last year, my mother who had hypertension and diabetes was told by the doctor 
that she had kidney failure and must go for dialysis, but she refused to go 
because she said, she old already and didn’t need to go for dialysis. She was 77 
years old when she died. (P30 CWFR) 
All family member caretakers have their lives changed for as long as the one on renal 
replacement therapy remains alive:  
My wife started dialysis ten years ago and she is 41 years old. She is still active 
but adjusting and I’m coping ok with it now too. My daughters help a lot. I take 
her to dialysis every time. My wife is suffering from migraine and she keep on 
taking Panadol and Ponstan and we believed that could cause her kidney 
failure. We asked around and this is what we found out. (P27 CWMS) 
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Worst vs. best chronic kidney disease / metabolic syndrome.  In both the first degree 
relatives and spousal control group, those who were classified as having the worst score 
for chronic kidney disease or metabolic syndrome were more likely to report having 
medical and health fears for themselves: 
My father is still alive but not really healthy. My mum was not well and she was 
put on kidney dialysis for two years. My mum she found out she had kidney 
problem after she do your blood test and scared. She died now. (P5 IBFR) 
A number of participants expressed their concern that they might be the next in their 
family to be struck down with chronic kidney disease: 
One of my brothers already passed away because of kidney failure, and my 
sister is on dialysis at Miri General Hospital, she’s now aged 52. I worry … 
(P18 MBMR) 
Or hypertension or diabetes: 
My father has been injecting himself with insulin for the last 50 years. That’s 
why I want to avoid that and I’m very worried about having to do that. I’ve 
never had a hypo but I’ve seen my father pass out from that. (P25 CBMS) 
My mother is very big size and having arthritis and diabetes. I have seven 
siblings, and two of them having hypertension like me and one of my brother is 
big size. I having hypertension and cholesterol, now I on medication. No 
diabetes. (P14 MBFS) 
My grandfather and father both have diabetes, this is why I’m scared and 
because of this, I have to control my food … Last my mother got kidney problem 
also from diabetes. As I have so many of my family are diabetic I have to be 
very careful with my health (P27 CWMS) 
Oddly, the best scorers for chronic kidney disease / metabolic syndrome, both in the 
first degree relatives and spousal control group, were twice as likely to return to their 
kampungs during the year and to be care-giver, than the worst scorers:  
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My mother was from Long Atip and my father from Long Bemang. My father 
already passed away ten years ago, now my mother stays with me. (P11 IBMS) 
 
Photograph 7.1  Iban longhouse veranda   
Photograph by researcher 
 
Male vs. female.  The reasons for relocating to Miri were varied but diverse between 
men and women. Some of the men‘s comments follow: 
 I am now able to sponsor and support my family with money. (P3 MWMS) 
I was born in Siburan, Kuching and I move to Miri because of my job. (P21 
CWMR) 
Some of the women‘s comments follow:  
I don’t stay at kampung but stay with my daughter in Miri now. With the 
daughter who’s been ten years plus at Miri Hospital dialysis. (P6 IWFR) 
I didn’t go to school, because we didn’t know how to speak Malay and anyway 
our family very poor and could not afford to send us to school. Since young 
when I married until old, I work as a farmer but now I cannot do any more 




Both genders wanted the best for their children:  
Coming to live in town means I can pay for my children to go on in school. If 
my children don’t have education they just stay in kampung at home on farm. 
(P2 IWMR)  
Ethnicities.  Across all groups the biggest difference between the ethnicities in this 
section is the returning to kampung of origin, especially if the family still owns land 
there, such as this Melanau participant: 
My grandfather on my father’s side is a farmer. My dad has passed away but 
my mum is still living in Daulat so I take my family back twice a year, we are 
going this weekend. (P31 MBMS) 
This Chinese participant laments that they no longer have land or a reason to return to 
visit the land of their parents: 
My great-grandparents … had a big plot of land and grew fruit trees and 
vegetables. My parents are already passed away … We have no other land for 
farming now. (P20 CBFR) 
Older Indigenous participants voiced their dissatisfaction with living in Miri, like this 
man now staying with his daughter: 
In the kampung we have a lot of interesting places to walk around and it makes 
me feel less stressed … I feel better at kampung than in Miri because I really 





Figure 7.1  Summary of sub-theme 1: allegiance vs betrayal 
 
7.1.4 Main differences seen between groups: 
 First degree relatives are disturbed, and have their lives disturbed, by a family 
member on dialysis. They are often the care-takers and providers, and this 
causes stress and fears for their own health. 
 The worst scorers for chronic kidney disease / metabolic syndrome group, 
whether first degree relatives or spousal control group, express more fears 
regarding getting a chronic non-communicable disease like their parents, or if 
they have one themselves, regarding their own future. 
 Males relocate to Miri because of work or money, females more often because 
of medical concerns for their dependants or themselves, or to follow their 
husbands. 
 The Orang Ulu ethnic groups are the ones most likely to want to return to their 
kampungs of origin in the remote highlands and Baram River areas of Sarawak. 
The Indigenous population was more likely to mention they experienced health 
















7.2 Health Beliefs and Behaviours 
In this section the dominant sub-theme running through all areas of enquiry was the 
difference between parents‘ and children‘s health practices.   
7.2.1 Majority views 
Different approaches acceptable.  The replies given by the participants to the prompt 
‗do you still follow traditional ways?‘ was overwhelming; however on closer inspection 
there were a number of degrees of obligation. The first group followed ethnic and 
religious lines. Following are Iban, Melanau, Chinese participants‘ comments: 
I’m not Christian but traditional religion practice. I am still a pagan we still 
practise the Spiritual Miring [Iban, Sacrifice]. (P24 IBMR) 
My grandparents and the rest of my family still actively practise traditional 
Melanau ways. (P31 MBMS) 
My brothers and sister, all of them, still follow our parent traditional way. Very 
traditional practices and lifestyle like my parents. I only take herbs when I am 
having fever, and see the sinseh [Chinese traditional doctor] and get the 
medicine from him when I’m sick. (P21 CWMR) 
In Raja Brooke times different denominations were given different areas to work 
amongst the Dayaks. These two Orang Ulu are from different areas of the Baram River: 
Only my grandparents follow the adat [old way] but we follow Christian way. 
My parents were RC Christian and I become Christian since I was born. (P16 
IBMR) 
My parents became Christian in 1953. Now with SIB [Sidang Injil Borneo or 
Borneo Evangelical Church] and don’t follow Bungan [Orang Ulu, traditional 
religion] any more. (P1 IWFS) 
Some participants who had strong traditional parental backgrounds were more likely to 
continue those traditions: 
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As my parents were from China they stayed very true to the traditional way of 
living. My father and mother never liked to take Western medicine especially as 
they knew a bit about Chinese medicine so preferred to take the traditional 
Chinese herbs and also small round Chinese pills. (P28 CWFR)  
I cannot compare the sinseh to a Western doctor. Umm I always get better so 
believe it works better than Western medicine. (P21 CWMR) 
In the next group the parents still practise the traditional way while the children do 
often mix traditions with modern ways: 
For traditional practices, my father was a Chinese sinseh … But when I am sick 
I would prefer to see Western doctor as I trust the Western doctor to Chinese 
traditional medicine. I’m not sick often, nor my children. I don’t have a regular 
doctor I see. (P20 CBFR) 
My grandfather on my mother’s side is a traditional Melanau medicine 
sharman. When I was growing up my parents used the sharman for traditional 
medicines if we were sick and for ceremonies until I left home for school… We 
now go to the company panel clinic if we need to see the doctor. (P31 MBMS) 
Last time my parents follow the traditional way, they practised Chinese 
lifestyle, follow the real Buddhist way and go to the temple. I practise Buddhism 
but it’s like this, since it’s inherited from my parents we just follow on. We don’t 
burn incense at home. I don’t practise Tai Chi. (P26 CBMR) 
My parents still go to traditional man. I don’t see a traditional healer now but 
go to the doctor at the poliklinik when sick. (P2I CWMR) 
My family is modern but my mum still believes in the traditional way... I see the 
work panel doctor. (P27 CWMS) 
Numerous participants visited both a traditional healer and a medical doctor. Some 
followed their own set of guidelines about whom to see: 
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If I have fever, flu and cough I would prefer to see sinseh to a Western doctor. I 
only go to the government hospital for hypertension, diabetes and cholesterol 
medicine or if I need injection. (P21 CWMR) 
I am still a pagan [animist]. We follow traditional belief and practices, but I 
never take herbs for my hypertension, and if I am sick I see the government 
doctor. (P22 IBFR) 
I am a Christian, RC [Roman Catholic]. Traditional practices, we still believe 
in the Chinese traditional doctor. We see the Chinese sinseh regularly … unless 
have a problem inside the body, or when the children are really ill. Maybe if 
really sick we’d go to hospital. (P19 CBFS) 
Sometimes I see a traditional Malay bomoh. If I sick with fever or pain I always 
go to see Dr M and I only go to poliklinik to get hypertension and cholesterol 
medicine. I only got tablets after I took your results to doctor when you asked 
me to. (P14 MBFS) 
If I am having hypertension I would prefer to see the Chinese sinseh for Chinese 
herbs and see the Western doctor for other problems. (P19 CBFS) 
Some participants only consulted doctors trained in Western medicine, and gave their 
reasons for doing so: 
My belief in Chinese medicine has changed a little, maybe with education … 
When I am sick I would prefer to see Western doctor as I trust the Western 
doctor more than Chinese traditional medicine man. (P20 CBFR) 
My wife doesn’t believe in traditional Chinese practice or herbs even though 
she’s from a Chinese school, she’s Western in her medicine taking. I’m the 
same. (P25 CBMS) 
I’m not really traditional, maybe because of education we are aware of how to 
help prevent of diabetes and hypertension and also the medicine has improved 
more and helps the kidney also. (P28 CWFR) 
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Photograph 7.2  Chinese ginseng   
Photograph by researcher 
 
 
7.2.2 Disparities between groups  
First degree relatives vs. spousal control group.  When comparing the first degree 
relatives to the spousal control group a number of issues arose. The first degree 
relatives recorded the most suspicion towards doctors and Western medicine: 
I try not to be given medicine and if I’m given by the doctor I try to bargain 
with the doctor. I know nothing about medical things but I try to avoid too much 
medicine and sometimes I notice that doctors here really like to over prescribe 
medicine even when we don’t need it. (P32 MBFR) 
One doctor at Poliklinik Tudan wanted to give me tablets for my blood pressure 
but I don’t want to take it for rest of life so he said I need to exercise more. (P5 
IBFR) 
Sometimes the participants, mostly first degree relatives, decide they know better than 
their doctor:  
On hypertension medicine but ran out of BP tablets many days now. I feel a bit 
pusing pusing [giddy] today. (P7 IWMR) 
Now about three months been eating new hypertension tablet … but I feel sicker 
and it doesn’t do good. I stop eating. (P22 CWMR) 
Medicine I stop to take if I feeling better … I don’t finish it. (P5 IBFR) 
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I stop, the medicine is very bad, very strong for me, my stomach rots. (P3 
MWMS) 
The spousal control group were more likely to complain about costs: 
I do take medicine prescript from doctor but when I feel better I will stop to take 
the medicine and save for next time. (P12 IBFS) 
20 years already got tablets from the doctor. Doctor said to keep taking the 
tablets even when feel better. So take the doctors Western medicine from the 
poliklinik so it’s not so expensive. (P1 IWFS) 
First degree relatives noted a number of barriers to seeing the doctor that were not 
mentioned by the spousal control group. The first group of participants complained 
about the pharmacies. One in particular had a bad experience with drugs he bought 
from the pharmacist: 
Now I go to Tudan clinic and they give me good very expensive medicine, 
advised by the kidney doctor. Last time I bought medicine from outside but later 
doctor tested me and found I had high blood pressure and also I had kidney 
problem and my legs were all swollen. I don’t take the medicine from 
pharmacies now but just what the doctor gives me. (P28 CWFR) 
The poliklinik is the government outpatient clinic. The majority of all the complaints 
were by the first degree relatives. These women sum it up: 
If I’m sick I always go see doctor at Poliklinik Tudan and he checks my blood 
pressure, my blood sugar, then after that they give me vitamins and only that. 
There’s always a different doctor every time I go there. If I go to see a doctor 
they only give me vitamins, so no need go-lah. (P5 IBFR) 
 I see a different doctor every time I go to poliklinik. (P4 IWMS).  
Another barrier, which again was only noted by first degree relatives, in particular of 
Indigenous participants, is summarised by this comment: 
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No government doctor comes to our longhouse, only when we see the doctor in 
poliklinik in Miri, that only when we can have information but they don’t say 
anything. Why they don’t come and see us so they know how we are and about 
us. It takes too long a time for us to go to Miri much [two hours‘ travel by road, 
then back again]. (P22 IBFR). 
A disturbing barrier was described by a daughter translating for her mother: 
We don’t know why she now no taking any medicine and getting sicker. Doctor 
at hospital said she don’t need to take the medication and only to monitor the 
blood sugar at Klinik Desa [government outstation clinic] near the longhouse. 
Doctor said to go to Klinik Desa for check and monitor next time and if 
diabetes and hypertension bad again can continue medicine again but he never 
said when to go and there is never any doctor there anyway – so we never been 
yet. (P23 IWFR) 
Worst vs. best chronic kidney disease / metabolic syndrome.  This section deals with 
alternative medicine: herbs, supplements, special foods and drinks, and vitamins and 
minerals. Some people only consulted a Chinese herbalist when ill, to receive herbal 
medicine: 
When I am sick with cough or flu, I will buy the Chinese herb from the sinseh at 
back of Chinese Chamber of Commerce and the main Miri market. You boil the 
herbs then drink it like tea. (P19 CBFS) 
Some had Chinese herbs regularly: 
We always take Chinese herbal teas. I frequently do take herbs. (P20 CBFR) 
Others appear to have experimented with them once in a while: 
Except for cinnamon and misia kuching drinks, because people said it was good 
for diabetics, I don’t take much Chinese herbs. I also take misia kuching [a type 
of Chinese herb] to drink, and even cinnamon and all sorts of things, I have all 
these formulas and I’ve tried them at various times but it’s how to be consistent 
to continue using it. (P25 CBMS) 
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For the next section, supplements, the participants gave a host of names connected with 
direct sales and marketing and also pharmaceutical offerings. One particular product 
was mentioned by eleven of the worst chronic kidney disease and metabolic syndrome 
score participants from both the first degree relatives and the spousal control group, not 
mentioned at all by the best score group. The following participant is on blood 
pressure, diabetes and cholesterol medication, and also taking these supplements: 
I don’t take traditional herbs but I am taking supplement, spirulina elken 
product, the lady said it is necessary for good health, but so expensive. I also 
did take flaxseed oil tablets because they say it is good for the skin but makes 
me burp and get gastric. I also take monavie. But my body don’t feel any 
different effect from taking it. I buy it for RM145 [AUD48] for one small bottle 
of monavie, very expensive … doctor said that monavie is not suitable for 
diabetes patients as due to high sugar level it contain. (P15 IWFS)  
The next group for special foods and drinks mentioned products such as spirulina, 
ginseng, primrose oil, colonic water, flaxseed oil and gamat, again direct sales and 
pharmacy products. This man with metabolic syndrome refused to take medication for 
blood pressure and type 2 diabetes, and outlined what he took instead: 
My routine at home, I always take supplement like; gamat [sea cucumber] worth 
RM400 per month, spirulina calcium, salmon omega3 to reduce cholesterol, 
garlic tablet. RM200 per month of Amway product and gamat emas [golden sea 
cucumber]. It is not I alone that take the supplement but my wife and kids also 
take the same as mine. It costs a lot. (P18 MBMR) 
Comparing the best and worst scorers revealed strangely that only the best scorers, in 
both the first degree relatives and the spousal control group, took vitamin and mineral 
supplements:  
I take omega 3 and vitamin B complex daily. (P26 CBMR) 
I do take supplements such as vitamin E shakley fish oil and vitamin B complex 
every day. (P31 MBMS) 
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My family still eat traditional herbs for when not well and pain. And I take 
monavie, a supplement herbal tea if I have headache or not well. And Amway 
supplements. Supplements, vitamins and minerals, are very good and should 
use them every day. (P8 IBFS) 
 
Photograph 7.3  Supplements all taken daily by one type 2 diabetes participant in study  
Photograph by researcher   
 
Sometimes a little knowledge may be dangerous: 
The gurana tea is good for my children also because I believe when I use the 
product, I can treat my son’s asthma and the asthma become good since 
primary school now they big enough already. Now I also do the same thing for 
my grandchild who gets asthma every week. I give him half of a capsule a day. 
Hopefully it helps. (P5 IBFR) 
Male vs. female.  Interestingly, males and females held different preferences for 
traditional practices. Only males mentioned having massages; only females mentioned 
acupuncture‘ other practices mentioned by both were iridology and foot reflexology: 
Traditional practice, I went to urut [massage], but now hard to find someone 
who can really massage, and only can be found in village like Bekenu. I did go 
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to Brunei last year for massage … because Brunei still got old people who can 
do Malay traditional massage. I think it’s a skill. (P3 MWMS) 
When I went home last, I complained about not being able to lose weight, so my 
mother and sister-in-law dragged me to the acupuncturist, so I had to go there 
every day for one whole week. The acupuncturist was very good actually. He 
poked my tummy with needles, it hurt, he said I had problem with metabolism. I 
don’t know whether it works or not, probably not. (P32 MBFR) 
Two very popular herbs were one marketed for women instead of hormone replacement 
and one for men‘s virility: 
I also take supplement such as primrose oil and omega 3 which I purchase from 
the local pharmacy … I don’t know if it works and it costs money. (P20 CBFR) 
I only eat Malay traditional jamu [herbal] products. Some people say not to take 
tongkat ali every day as it can affect your kidney. Not sure if it actually works 
or all in the head. Gamat is for cleaning the colon after eating food. (P10 
IWMS) 
 
Photograph 7.4  Penan medicine  
Photograph by researcher 
Ethnicities.  There were distinct differences in the type of traditional herb taken by the 
ethnicities. Following are quotes from a Chinese man, a Malay woman and an 
Indigenous Orang Ulu man: 
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Chinese herbal leaf teas to drink. I only take the Chinese herbs. (P27 CWMS) 
My father was a professor in Pharmacy but his research was in traditional 
Malay medical herbs. He is evidence based medicine as he tested them in the 
lab. So I grew up with my parents boiling up herbs but I can’t stand the smell or 
taste. (P32 MBFR) 
I do take herb, because my brother always brings from the kampung, and there 
get the herb from the Orang Penan at Long Sait. I feel better when I eat it but I 
don’t want to mix it if I’m on doctor’s tablets. (P7 IWMR) 
I take herbs called sabah snake grass and the price is 15 leaves for RM30 very 
expensive, to reduce my blood pressure. We also take the herbs from ulu 
[remote, upper reaches] Baram from the Penan but don’t know where it comes 
from. Function of those herbs is to reduce the blood pressure, cholesterol, 
diabetes and blood poisoning – cures everything. (P16 IBMR) 
Photograph 7.5  Snake grass. 
Source: advertisement 
 
When taking prescribed Western medicines, Indigenous participants were the least 
compliant group:  
My blood pressure is high today because I didn’t take tablets as have run out 




I don’t like to go to the doctor and if he gives me some tablets I don’t like to eat 
it. Sometimes I do but I stop eating the tablets when I’m feeling better. (P1 
IWFS) 
Before doctor gave me tablets for my high blood pressure and told me to take it 
forever. But after a few months I stopped as I didn’t think I need it. (P31 
MBMS) 
A number of participants mentioned that they do not mix traditional with modern 
medicine. Upon enquiry it transpired that 
 Normally I will separate taking Western medicine and herbs, I mean I take the 
tablets at breakfast and the herbs at lunch … I’m not sure if the herbs work as 
sometimes good for the body but sometimes the doctor’s medicine is better. 
(P16 IBMR) 
I take medication but don‘t mind mixing it with herbal medicine. (P21 CWMR). 
 Mixing medication I take – but Dr R doesn’t know I taking mixed medicine. (P3 
MWMS). 
I still take medicine if doctor gives me as well as herbs and supplements. If I do 
see doctor I always take all the medicine the doctor gives me. (P8 IBFS) 
The surreptitious nature of all chronic non-communicable diseases is seen in this 
comment: 
I not sure why my results so bad. I don’t feel ill so can’t get off work and not 






Figure 7.2  Summary of sub-theme 2: traditional vs modern 
 
7.2.4 Main differences seen between groups: 
 The first degree relatives are the more suspicious of doctors and Western 
medicine and more likely to try anything they think might help their chronic 
non-communicable disease conditions.  
 The worst-scoring group for chronic kidney disease / metabolic syndrome 
appears willing to try multiple supplements they deem may help their chronic 
non-communicable disease, even at great expense. 
 Both males and females are likely to try traditional practices and take herbal 
products, especially those specifically for their gender. 
 People visit traditional herbalists and take traditional herbs peculiar to their 
ethnic group; however, all ethnicities tend to revere Chinese herbs. There are 
ethnic differences in compliance to doctor‘s advice. 
7.3 Attitudes and Barriers  
Contradictions surfaced in all areas of this section, with many of the participants telling 
















to compromise on standards. This made many feel disloyal toward themselves and their 
families, and because of this they felt uncomfortable talking about their lifestyle habits 
and laughed off their excuses. 
7.3.1 Majority views  
Life Stresses and Maintaining Health.  In Malaysia, if one does not work there is no 
social support system as backup. Private haemodialysis centres have to fund-raise. 
Government hospitals and clinics provide limited subsidised rates and medicines for 
hard-core poor, poor, mentally and physically challenged, and older citizens: 
Last time when all my brothers and I were still working, we actually could 
afford to buy the medicine from the hospital, but now we can’t because both of 
my brother passed away and I’m retired and also now we need support from the 
government to help us to reduce the burden to buy the medicine. (P21 CWMR) 
This man is under tremendous stress, working long hours, looking after a spouse with 
end-stage renal disease and their children, and ignoring his own health decline from 
two chronic non-communicable diseases: 
My wife is not working now due to her failing health and she gets depressed … I 
still can cope because I’m still working but once I stop working I’m scared. If 
anything happens, everything depends on me, if I stop working we stop eating, 
very stressful. (P27 CWMS) 
A number of participants offered advice on how to relieve stress: 
For me when I take the supplement, it was effective, why? Because I felt that it 
reduce my stress … but when I didn’t take the supplement, my blood pressure 
can be high. (P18 MBMR) 
If I am stressed I will share the problem … Positive thinking and sharing with 
friends and family help lift the burden and problems we experiences. (P19 
CBFS) 
I control stress in my life through religion and through the reading. Some 
readings helps you put down your stress, sorrow or trauma. You come to the 
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point where it gives you a way out instead of being backed into a corner. (P28 
CWFR) 
When I stressed then only I smoking as it makes me calm down. (P18 MBMR) 
Sometimes medical staff do not offer medicine if they think the patient cannot afford it, 
especially if needed over the long term: 
I did go to polyclinic for further medical checkup but the medical officer says 
there is no need to as I am only suffering from too much wind in my body, they 
only advised me to reduce on my coffee and tea intake. I always have backache, 
sometimes I cannot stand the pain, but don’t want to see a doctor so just tough 
it out because they only say its wind or gastric problem. I asked for 
investigation but they said no need just cut down on coffee and tea. (P15 IWFS) 
There is a lot of confusion and misguided advice given by health staff, sales people 
pitching products, the media, and well-intentioned family and friends:  
When I get up I drink colonic water before breakfast. I take advice from Madam 
M, at the Diabetes Association. (P27 CWMS) 
I only drink monavie, and after I started drinking it my blood pressure reduced, 
I feel less tired. (P29 MWFS) 
Supplement I take monavie but for me not much changes after I take monavie, I 
still feel the same. (P29 IBFS) 
A lot of marketing of supplements makes me feel I need to buy it to be healthy. 
(P27 CWMS) 
I normally buy vitamins and medicine direct from the ‘V’ Pharmacy but 
sometimes I get constipated with them. (P15 IWFS) 
I read one of newspaper article say that ‘spinach not good for kidney’ … I don’t 
drink soya bean. [Her daughter-in-law translating said ‗she 
misunderstanding/confused about the newspaper article she was believe for 
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person having kidney pain but the reality of article was meant for person 
already long-time on kidney dialysis‘]. (P15 IWFS) 
There are those who ignore professional advice anyway: 
The nurse at poliklinik gave me some diet information about the foods I should 
eat for diabetes. They checked me last time after the New Year’s celebration 
and I had eaten a lot of food and had a lot of beer with friends. They increased 
my dose [metformin] as my blood sugar was too high. (P2 IWMR) 
My biggest hindrance to following a healthy diet is my will power, or should I 
say won’t power [laughs], and all the distractions from my colleagues at work, 
we all feed each other. (P32 MBFR) 
7.3.2 Disparities between groups 
First degree relatives vs. spousal control group.  Upon examining the transcripts it 
appears that a higher percentage of the spousal control group smoke than of the first 
degree relatives group. Many of the first degree relatives declared that they used to 
smoke but gave up years ago:  
My brother used to smoke and drink … I also used to drink alcohol socially 
before but now I stopped drinking also. (P26 CBMR)  
Some first degree relatives with the worst chronic kidney disease / metabolic syndrome 
scores, said they stopped smoking on advice from their doctor: 
No smoking now but last time yes. I was told to stop when doctor said I had 
high blood pressure. (P10 IWMS) 
There were many comments relating to family members who smoke even though there 
is plenty of evidence why they should give up. For example, this female Iban lady said: 
Today I headache. I can’t sleep last night. I attend special occasion and did 
drink too much alcohol… I no smoking anymore but I still drink tuak [rice wine] 
with my friends at Gawai and for special functions. For me, my five brothers 
should be scared and stop smoking because my mother pass away caused from 
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lung infection due to heavy smoking but they are still heavy smokers, they can’t 
stop smoking … My mother was a heavy smoker. (P15 IWFS) 
Some participants gave up smoking but consume other addictive substances such as 
alcohol: 
I don’t smoke now but did when younger. Doctor advised me to quit smoking 
when I got high blood pressure. I often drink alcohol, like beer. Less now as I 
get gout sometimes, very painful toes. (P10 IWMS) 
I no smoking but I do drink alcohol but I had gout problem, so drink less now. 
Too much meat, too much alcohol, too much good food. (P9 IBMS) 
Or tobacco chewing and betel nuts: 
Once upon a time I smoked but no smoking now. Last time I also did drink too 
much alcohol but not now. I eat sepa [betel nuts] and sirih leaves put with 
tobacco and with betel nuts [they add lime and chew it with either betel nut or 
tobacco]. (P7 IWMR)  
I also take sugi [chewing tobacco] and smoking rokok lutang but I have stopped 
smoking cigarettes for many years already. (P16 IBMR) 
Some lament the fact that their children will not listen to their advice. This participant 
is one of the worst first degree relatives, who had a stent operation recently: 
Previously I do smoke and drink alcohol but now everything changed and now I 
stopped the habits. I have two children, one of my children follow me to become 
a vegetarian, and second child is drinking alcohol, smoking a lot and a very 
stubborn child, not listening to my advice. I advise everyone who smokes to stop 
smoking. I also stopped drinking alcohol and now I feel more health than 
before. (P21 CWMR) 
Worst vs. best chronic kidney disease/ metabolic syndrome.  Paradoxically, those who 
had the best chronic kidney disease scores and those with the worst metabolic 
syndrome scores were most likely to talk about experiencing stress in their lives. A 
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number of different areas causing stress were identified, including fears about one‘s 
health: 
I took your results as asked, to Dr R and he explained them to me. Doctor said 
my blood pressure was very high 189/125!! He said I could have had a stroke 
then! He put me on strong drugs to bring it down and I have to see him every 
week now. My sister took me to the doctor because I was scared I was going to 
die like my brother! (P3 MWMS) 
Some Indigenous participants experienced stress caused from relocating to Miri: 
I had stress in my younger days. When I first come to Miri, I have big problem 
with the food, as I didn’t know where to get the food from; I didn’t have very 
much money to buy; the food here was different and I didn’t know how it tasted 
or how to cook it. (P6 IWFR) 
At first I stay together with my sister in-law and brother-in-law [husband‘s 
brother] who was working ... That was a difficult time until my husband got a 
job and we got somewhere to live on our own, but now we’re old, we live with 
my daughter. (P6 IWFR) 
I stay with my brother-in-law about two years, I feel pressure stress because we 
stay with other people and it’s not my own house. (P7 IWMR) 
Life has changed since all the children have left home. I so stressed living in 
terrace housing in Senadin. I want to work, my husband didn’t give me 
permission to, because we keep getting our house robbed a lot when we go out. 
Even if at home it’s not safe as one old lady against two or three robbers is no 
match. So now very disturbing and a lot of stress. (P15 IWFS) 
The men were more likely to experience stress from responsibilities at work: 
Now my job I’m doing procurement for offshore and has big pressure and if 
anything goes wrong it’s my head. Am having too much stress. (P10 IWMS) 
I worked with civil aviation as a traffic controller in the tower for almost 20 
years. I’ve been all around. Very stressful job. (P26 CBMR)  
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And women from long hours at work: 
I now work at FA at Permy Mall. I work from 9am – 10 pm, very long hard 
hours with no breaks except for lunch hour. (P12 IBFS) 
Unforeseen circumstances also caused stress: 
It’s been very difficult adjusting at beginning when my husband started dialysis 
seven years ago. We are coping better now. (P14 MBFS) 
My husband died last year aged 53 years. When he was alive, he doesn’t take 
care of his health… The doctor said that he had kidney failure… Starting from 
that moment, our lifestyle changed drastically. (P29 MWFS) 
It is difficult for young people and people with young families to go on holiday: 
I always go out with my friends every day last time. We always go to Miri to eat 
but now very seldom because of work and I have to look after my mum. (P24 
IBMR) 
Very difficult when we go for holidays – we have to organise for dialysis for my 
wife at other cities before we go. (P27 CWMS) 
Participants with the worst metabolic syndrome scores spoke the most about 
information or lack of information and misinformation. Participants first searched for 
information from a wide range of sources including friends, siblings, parents, nurses, 
doctors, medical assistants, newspapers, magazines, leaflets, books, television, radio 
and internet. For some, 
I not really believe everything advertised on internet. (P8 IBFS) 
Others were more gullible and blindly followed misinformation and sales pitches: 
Datuk L said it [kidney disease] was because of the chemicals in the water, but I 
don’t think so it’s just an excuse but the hypertension part I think it’s caused 
from the fresh milk because it contains sawit from the oil palm so I always take 
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the UHT although sometimes when I’m out I cannot help it when I drink local 
coffee. (P25 CBMS) 
For health information always get from my friends and the person I get the 
supplements from. (P18 MBMR) 
Those very desperate may chase the elusive ‗cure‘ and ‗good health‘: 
I read about this diet in the newspapers, this Chinese lady from West Malaysia 
doing her Master degree in Nutrition in the UK, tried it on 100 patients and 
60% was cured from diabetes. The headline was ‘Possible Cure for Diabetes’ 
so I read about it in the newspaper then later on it came out in the Nature 
Magazine. So I put it together and did what I think she was doing for months... I 
almost died… Dr S was worried that I could have damaged myself… worried 
about my heart and my brain… I was thinking that I could cure myself. (P25 
CBMS) 
There were many comments on the need for authoritative information for the 
community: 
There are a lot of seminars on diabetes and hypertension in the community but 
mostly organised to sell supplements and such but doesn’t really help us to 
learn how to change our lifestyles like what foods to eat or not. Doctors should 
do more free talks for the community. I taught myself about diabetes and the 
changes you need to do in lifestyle in order to control it. For me it’s very 
difficult to advise others and have to give them time to change their diet and 
lifestyle. (P21 CWMR) 
And the disappointment they feel regarding the medical and health fraternity: 
The doctors and nurses at the dialysis centre never discussed or advised us our 
family about kidney disease when my sister was there and I think they should 
support us more. (P20 CBFR) 
Even end-stage renal disease patients had to organise their own information support 
groups. I spoke to Mr. L a few months before he passed away, and he expressed 
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frustration with the lack of professional support and information given to patients and 
families. His friend during the interview said: 
Not much information from the dialysis centre so now my wife teaches others on 
the machines as she’s been there eight years already so knows things. It’s very 
hard seeing your good friends pass away every day. She also gets advice from 
her friends and she gets a lot of support from our good friend Mr. L, you know 
him from Red Crescent Blood Recruitment Committee, he’s very scared about 
being on dialysis machine so he organises a support gathering every two 
months so they can discuss things. (P27 CWMS) 
More camps need to be organised for Miri people as it is expensive for many to go to 
Kuching: 
I’m always careful when I take food for my diabetes program. I have attended 
the diabetes camp organised by government in Kuching and from that program 
I learn a lot about diabetes and how to control my diet. I try to control most of 
my food but hard to though. I still try to watch my food. (P2 IWMR) 
They should include the spouses and carers: 
I don’t cook any different for my husband since he started dialysis. A dietician 
sometimes advises my husband but not me yet I’m the cook. Sometimes difficult 
to get protein and water balance right. My husband likes to eat chilli, and my 
husband doesn’t control the food he eats. (P14 MBFS) 
However if the doctor spends a little time with the patient they are less confused and 
more likely to be compliant about taking medication: 
Last time I confused about the medicine the doctor gave me and didn’t know it 
was for my hypertension so didn’t take it, but not now, as the doctor explained 
it to me. (P7 IWMR) 
Last time I always buy the painkiller from pharmacy but I notice I not sure of 
the content of the drug until Dr R ask me to stop buy drug from pharmacy due 
to high content of steroid. (P3 MWMS) 
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Some participants suggested the government do more: 
I recommend that government can advertise more about health information on 
television and newspaper because, like me, I only get information about 
diabetes by reading books or magazines. (P21 CWMR) 
I think the government should tell the children in schools how to live more 
healthy and have more sport, and promote not just at Sukma level [state and 
national level], so everyone have chance to do. (P3 MWMS) 
 
Photograph 7.6  Rainforest food  
Photograph by family member of researcher 
 
Male vs. female.  Food habits which are work-related, and socialising, are the biggest 
differences seen between men and women in this section.  
Five men worked offshore: 
Offshore I eat on the rigs and the food mostly cooked is Chinese fried food, rice 
and noodles. Food offshore is mostly heavy food. (P4 IWMS) 
Half of my time I’m offshore. The food they provide there is very rich. After very 
physical work all day I get hungry and eat a lot. (P31 MBMS) 
 
173 
Three men worked in restaurants. One summed it up: 
I like my job. I like to eat the hotel cakes and banquet pastry at the end of the 
meal but worry I’ll put on weight. Because I work in hospitality line, there’s a 
lot of salt and MSG and oil. Quite delicious and some time can make you ill or 
fat or gout. Mostly I don’t like to eat meat, for me eating a lot of meat can make 
people sick, like bad heart and blood pressure problems. (P9 IBMS) 
Work stress played havoc for a few men, such as for this overweight participant: 
My job covers both Sarawak and Sabah so a lot of travelling and I eat out a lot 
and skip meals often. (P27 CWMS)  
Although there is little control over ingredients when eating out, many men are 
considerate to their working wives: 
At home my wife cook, not every day, maybe just at weekend and because she is 
working and have not enough time to cook after come back from work, I will 
bring my family to eat outside or she will buy in from outside. (P18 MBMR) 
Gout is a big complaint among the men:  
Recently not well because of gout. I don’t drink beer but like to eat buri 
[intestines]. But I’m getting better at controlling what I eat now days. (P7 
IWMR) 
This pragmatic Chinese man made an astute observation: 
I have two friends on dialysis and one has just died. I don’t have an answer for 
why so many people in Miri are getting kidney disease. The one who just died 
he thinks it was because he drank so much arak [45%+ alcohol] when he was 
among the Penan in Mulu. But the other guy had a kidney problem I think 
because he just didn’t bother with controlling his diabetes. Also another guy 
who died ate really badly like samboi, chips, preserved black plum from China 
every day he snacks on that type of food … We have a lot of natives who are 
educated, hard working and very knowledgeable and live a healthy life but too 
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many others eat, drink and smoke too much and don’t look after their diabetes 
and hypertension, then end up on dialysis. (P25 CBMS) 
Women are more likely to complain of ‗gastric‘: 
I can’t control my food, because I having bad gastric and I’m hungry all the 
time. When I do housekeeping, I having gastric, it’s hard for me to do my work. 
(P15 IWFS) 
Women are more likely to diet and regain: 
I have tried several ‘fad’ diets including the low carb. I don’t take sugar 
usually, although yesterday I did drink barley. I have switched to red rice but 
one thing I cannot help, I do love carbs you know to chew on and I like deep 
fried stuff, that is my weakness. I don’t eat much sugar, much meat and fat, like 
I don’t eat nasi lemak, mee goreng and foods like that. After I went off the fad 
diets I bounced back fairly quickly afterwards. Once I went on the low carb diet 
and I lost lots of kilos of weight but gradually I gained again and I put on more 
than when I started the diet. (P32 MBFR) 
A number of retired women are looking after their grandchildren, busy and bored: 
Last time I did exercise walking I got down to 70 kilograms once because no 
one disturb me so I am free but after I got grandchildren to care for and no time 
I gained it all back again and some more because my exercise is different. When 
I exercised I got tired but a different tired. And different diet, I make cakes for 
my grandchildren and eat some too because I like it. (P5 IBFR) 
Festivals seemed to factor in gaining or losing weight with men saying they gain: 
I have tried to lose weight in the past ... but because we have a lot of Chinese 
New Year’s functions and gatherings I gained back a bit more weight. (P26 
CBMR) 
Some Malay women use the fasting month to try and lose weight: 
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My mother has diabetes tendencies so she exercises and watches her diet. She is 
almost 75, small size and very active. During Ramadan she lost 7 kgs while I 
only lost 2 kgs. She is very particular – around her we are not to eat any sweets. 
(P32 MBFR) 
A number mentioned that they ate differently when they had less money: 
Normal diet, seldom change our diet, only when we are poorer our diet 
changes. (P3 MWMS) 
We grew a lot of vegetables and ate kampong food. Meat and fish were a treat 
for the family. However when we move town and our life changed as we have a 
monthly earning and we can afford foods that we never could afford before thus 
our eating habit changed and we no more cook like my mother and 
grandmother used to. We go for fast food and desserts like cakes and sweets 
that we had not had before and many choices of food at the supermarket. (P15 
IWFS) 
There was a big difference between the types of food the men and women wanted. The 
men wanted spicy foods, at home and when eating out:  
At first I followed a diet after the doctor advised me to cut out fat, salt and 
sugar in my food but I got tired of it and it didn’t last long as I wanted to eat 
more tasty foods. So I stopped and nowadays I not really worry about my diet at 
all. (P4 IWMS) 
I take a lot of noodles, I love noodles very much sometimes I can even take two 
bowls at one time. I don’t like soup noodles, I prefer fried. I don’t like Kentucky 
much, I prefer noodles and rice meals. (P27 CWMS) 
Others admitted they could not control themselves, especially around durian: 
I was on Avandiamet [Metformin] because of the durian season in November, 
because when it comes to durian there is no stopping me, there was no lunch 
also only durian … trouble is with me anyway it is difficult to be consistent. 
(P25 CBMS)  
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During fruit season, because I like durian did eat some durian, cempedak and 
langsat, but I just control myself and take little only, hard to though. (P2 
IWMR) 
While the women mentioned they like to eat fast foods when they eat out: 
I like to eat fast food like KFC and local food also. Only eat curry when we 
attend special occasion. Even my husband on dialysis, 7 years already, the way 
I cooked still the same like before this. I don’t worry to follow healthy diet 
strictly as I think we are healthy. (P14 MBFS) 
The youngest lady in the study:  
I seldom cook at home and always go to Sugarbun or KFC, two or three times a 
week. I eat the meat [fried chicken] and rice at Sugarbun during lunch and 
dinner because it’s close to where I work. I get to eat some FA biscuits at work, 
that’s probably why I’ve gained weight. (P12 IBFS.) 
The vegetarians found it the hardest to eat outside the home: 
Myself, I’m a vegetarian for 10 years now and always cooked and eat at home 
as it is difficult to find a vegetarian café in Miri. (P21 CWMR) 
I changed my diet to vegetarian … I don’t really feel healthier but you must 
know how to eat in a way but at least eating a lot of vegetables you avoid eating 
a lot of meat and that temptation can help you to control your diet better. (P28 
CWFR) 
The older people found it difficult when they had to live with their children and they or 
their spouse were not doing the cooking any more. The older folk were very vocal 
about changes in their diet: 
Last time I did take food cooked by my sister but she uses a lot of salt and 
viching [monosodium glutamate or umami], until I realise one day I had pain at 
the back of my head. I remember before my brother pass away because of 
stroke, two or three day before, he was complaining back head pain … Doctors 
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said it was from high blood pressure problem. So now mostly my food I cook 
myself. (P3 MWMS) 
Food changes from kampung to town … I like to eat umai [Melanau traditional 
raw fish or prawn dish]. Then different kampung food to now. Then kampung 
food, we always boil and fish was cooked with kunyit [turmeric] and was less 
eating of sugaring food and drinks. (P17 MWFR) 
Different the kampung food compared to town. Changes in lifestyles… Living in 
town with my daughter, my diet changed and I eat what my children eat and 
they always eat fried food, seldom boil, and in a month we would go to eat 
outside two to three times at the kedai … My diet at home, I always eat 
vegetables, seldom fruit, sometimes meat like chicken, often eat fish, we eat only 
a little pork sometimes. (P16 IBMR) 
My diet food at town is different from kampong food. But I used to cook like 
kampong style because I like to eat kampong food but couldn’t properly in Miri 
… I don’t like sweet drinks. (P5 IBFR) 
The Orang Ulu often mentioned Bario or Kelabit salt:  
Cooking at home less using MSG [monosodium glutamate] but we use the Bario 
spring salt. No one in the kampung has goitre. (P16 IBMR) 
I always eat at home, and very seldom eat outside. I also seldom use vicin 
[monosodium glutamate]. I do use salt, it’s iodine salt and also Kelabit salt. (P5 
IBFR) 
Town people often chose the cheaper non-iodised salt and probably got their iodine 
from eating prawns and prawn paste: 
I don’t use a lot of MSG but I take some ingredient without MSG which can 
enhance the flavour. I do use the raw salt for cooking, ordinary RM1/packet 
[local Chinese non-iodised salt]. But I don’t like too salty. (P28 CWFR)  
I avoid salt, I use the pink Himalaya salt now. It’s not iodised like Saxa 
although they say there are minerals in it. They say it’s the same as Bario salt. I 
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don’t use MSG at all. People use too much MSG here it’s in every type of food. 
(P32 MBFR) 
 
Photograph 7.7  Cinnamon, Bario Salt 
Photograps by family member of researcher 
 
Ethnicities.  Activity transition was greatest for the Indigenous participants who 
relocated to Miri from rural or remote areas:  
Since living in Miri the worst thing is I don’t have hard work to do, like lack of 
sweating, because I seldom do heavy work like farming. Because of 
responsibility, it’s finding time to exercise a problem. (P2 IWMR)  
Across all ethnicities, religions and genders there was a unanimous dislike for exercise 
with a wide variety of excuses such as these Chinese ladies‘: 
No exercise because we have no time to do it, we get home then have to cook for 
the children, plus I have to send my kids for tuition and other activities. At work 
I walk around. (P19 CBFS) 
I’m not really exercising much. My exercise is my housework … I sometimes 
watch TV and I read books … I’m too lazy to do exercise because after I finish 
my housework I’m too tired and need to rest and sit down, then I have to cook, 




Both worst and best Malay ladies: 
I don’t exercise I feel deman [fever] when I do. Last time I used to go for 
exercise three times a week but now no more because I have no friend to go 
with. Also now no time as looking after my grandchildren. (P17 MWFR) 
Honestly, I very lazy do exercise for me when I do housekeeping work at home, 
it enough from doing the exercise. No exercise in a week [laughing] I have time 
if I want to go for exercise, but I too lazy to do it. I did exercise last time, three 
times a week. The doctor told me I should be exercising especially as I get 
older. (P14 MBFS) 
An Indigenous Orang Ulu grandmother: 
Now I take care of my grandchild I become don’t like to go exercise. I always 
do move a lot, maybe that’s why my hands feel painful [arthritis] some time 
now. I feel now because if we look after our grandchildren so I don’t have time 
to move so much, I don’t have time to walk around and put on weight. I don’t 
know how to control myself. (P5 IBFR) 
Men usually used work as their excuse for not exercising, such as these Chinese men: 
I’m getting older now so life has changed a little bit now, now less exercise 
activity. I seldom go to exercise now as I am being lazy. I’m retired now. I now 
prefer to watch television and read the newspaper. I don’t like tai chi to do and 
no group doing it anyway near my place. My son also doesn’t do exercise 
because he working morning till night. (P21 CWMR) 
I do very little exercise, not for a year, because I am very busy and travel a lot. 
When I travel and stay at hotels there are facilities like gym and swimming pool  
but I can’t use it as … I am too busy writing reports. I guess I have to managed 
my time more and fit the exercise in the between the busy schedule … last few 
years I’ve gained quite a bit. (P27 CWMS) 
And the largest, youngest male Malay participant: 
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At home I will do some housekeeping work and I seldom do exercise. Other 
activity at home I like to play are computer games. (P13 MWMR) 
Miri is extremely hot between 10.00 am and 4.00 pm, sometimes 40 degrees Celsius, 
and on the equator it is pitch black everyday by 7.00 pm, so for office workers 
returning home late there is not much time for outdoor exercise:  
I feel healthy at moment. But before I was 105.4 kg only and now increase to 
116.9 kg. Wow that’s 11.5 kilograms … I was big also in secondary school. 
Now I don’t go to exercise, because I my work time till 6 pm, get back home 
around 7.00 pm. (P13 MWMR) 
Only eight out of 32 said they exercise regularly. Of those who did, the Chinese were 
the most regimented: 
I think the most important thing for health is exercise. I do morning walk every 
day except Sunday. I walk about 40 minutes which covers about 5 km… If I 
don’t go for my routine exercise every morning I feel that something is missing. 
I look forward to going and meet up with a group of my friends as well [laughs]. 
(P26 CBMR) 
The Malay and Indigenous men were most likely to exercise with their children: 
I’m not allowed to use gym at work, just do my own program. I exercise only 
sometime, when I get time. My house is not far from the Jemu Padang and 
sometime when I have time I exercise there together with my children. I want to 
be a role model for them, that’s why I’m always keen for exercise. (P9 IBMS) 
I occasionally use the gym offshore … When I’m onshore I still stay active. 
Sometimes I go jogging, on bike, or go swimming with the children. (P31 
MBMS) 
The Indigenous men felt the most frustrated in Miri: 
No, I don’t exercise, only when I balik kampung [return to village] then I do 
heavy work on the farm … When I stay in Miri I have only the house to move 
around and we go by car a lot when we go to shopping malls and Emart. I 
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prefer to stay in the kampung so I can walk around the farm gardens and do the 
padi [rice] farming work. (P16 IBMR) 
Illness and disability prevented some from exercising:  
After my leg become worse and worse I stop to do my activities. Very hard to 
exercise when something wrong with you and you can’t because of pain. (P3 
MWMS) 
Others who exercised two to three times per week were concerned by the need to 
control a chronic non-communicable disease: 
When I stop exercise my blood pressure goes high. (P18 MBMR) 
Exercise is important to me because I old age already and because some of my 
family have diabetes and I don’t want high sugar and become diabetic. I feel 
better also after I do. (P20 CBFR) 
If there was encouragement and accountability the participants were more likely to 
exercise: 
I bring my evidence here [recent blood workup] instead of just telling you, I 
want to show you that I am improved since I saw you for tests. I lost weight and 
my cholesterol, hypertension and blood sugar is better. (P28 CWFR) 
My blood pressure is high and Dr A advice me, to do regular exercise rather 
than buying and taking supplement that cost a lot of my money. Now you say the 
same thing so I better take notice. Ok I’ve changed my mind I’ll now go to the 
gym and exercise more to get fit. At least at weekends. (P18 MBMR) 
The regular Shell check up every six months is good as the doctor may tell you 
that your blood sugar is too high or tell you to do more exercise so it motives 
you. (P25 CBMS) 
One lady did not follow advice: 
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I’m on medication for hypertension and cholesterol only I don’t have diabetes. 
Doctor did advice me go for exercise but I don’t follow his advice. (P14 MBFS) 
Those who did exercise regularly were eager to say how they felt afterwards: 
After I exercise I feel refreshed and feel relieved of stress. I also problem solve 
when jogging and sometimes I can think of the solution – either I solve it or it 
becomes a very small problem. (P31 MBMS) 
The hardest thing about trying to lose weight is that I feel my body is tired and 
my feet hurt. The best thing about losing weight is that I feel more energy, I can 
do more work, less sleepy. I feel sleepy after meals before I lose some weight. 
(P1 IWFS ) 
Some expressed frustration that their family members did not listen to them: 
I did advise my brother and sister to exercise and control their food habits but 
it’s hard for them to listen when they don’t want … so what you going to say. 
(P28 CWFR) 
I try to keep my same weight. I have three sisters … very big size … They don’t 
have children. I as brother try to get them to go for walks and lose weight and 
not eat so much – but not happening yet! (P9 IBMS) 
Difference between me and my mum is that my mum was having diabetes and 
arthritis and she also very big size. My brother also in big size. I tell him to go 







Figure 7.3  Summary of sub-theme 3: confusion vs compromise 
 
7.3.4 Main differences seen between groups: 
 The spousal control group smoked more than the first degree relatives, who 
were more likely to say they had given up when diagnosed with a chronic non-
communicable disease. 
 Lifestyle stress factors for the best chronic kidney disease group revolved 
around keeping themselves healthy so they could continue to support and look 
after their dependants. The worst metabolic syndrome group talked of the stress 
caused by trying to control their chronic non-communicable diseases. There 
were only patient gatherings and no support groups for first degree relatives or 
their families. 
 There were many food preference differences between men and women 
participants but the outcome was the same – frustration with weight matters. 
 Different ethnic groups showed divergent activity habits often related to their 
















or a herb or supplement rather than using time, effort or energy to exercise on a 
regular basis.  
7.4 An Aging Population  
The quantitative Phase One multiple logistic regression analysis determined that age 
was a risk factor for both chronic kidney disease and metabolic syndrome. When the 
actual responses of the qualitative interviews were inspected it was noted that there 
were double the number of participants in Phase Two in the 40–49 age group and only 
two above 70. Quotes are selected from the groups with the highest percentage of 
responses and are based on pertinence to the topic. 
7.4.1 Majority views  
Life Adjustments.  Those in their 40–50s were the majority in this subset. The older 
group showed most distress at relocating to Miri; for example, this 60-year-old lady 
and 50-year-old man: 
Last time I do work some farming. After coming to Miri we no longer make 
farms. When I was living in the kampong I felt healthy then first time come to 
Miri I felt lemah [not strong] but I recovered from sickness, then I did do some 
farming at Riam Miri for a while. Now I cannot make garden as old and weak. I 
miss gardens. (P6 IWFR) 
In the kampung my wife cooks the food I grow from our garden and we eat at 
home most of the time. When I moved to Miri Town my life and my food 
changed also … I’m bored, have nothing to do in spare time in Miri but to go to 
coffee shops and eat a lot with friends. (P2 IWMR) 
Many of the older participants took the chance to comment on their siblings‘ and 
children‘s habits, as did these 64- and 56-year-old men: 
I’m getting older now so life has changed a little bit now, now less exercise 
activity. I seldom go to exercise now as I am being lazy. I’m retired now. I now 
prefer to watch television and read the newspaper. I don’t like tai chi to do and 
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no group doing it anyway near my place. My son also doesn’t do exercise 
because he working morning till night. (P21 CWMR) 
My brother and sister… are concerned about their diabetes but you never know 
what they eat outside the home, they never listen to what you say. (P28 CWFR) 
There were some differences between the decades: the transitional changes lessened 
with age and time living in Miri. 
7.4.2 Disparities between groups 
30–39 Age Bracket.  Those who had relocated to Miri in their teenage and young adult 
years still held a strong attachment to their kampungs but lacked the money to return as 
often as the older groups due to having a mortgage; however, they were more flexible 
and able to adjust to urban living better than older groups:  
I feel stronger in the ulu and weaker when I stay in town. I still got land in my 
kampong I wish I could farm. (P7 IWMR) 
If I were still living in the kampung I’d be farming padi [rice] and lada 
[pepper]. Most of my cousins and friends are now living in towns, mostly Miri. 
When I first came to Miri it took half a day by boat and then a day by 4-wheel 
drive. Kampong is very difficult to get money. Many jobs in town that can do. 
Life is easier in town if you have a job. My life has changed and I’m more 
happy. Now we own a house, having a car, radio, watching TV, going to 
church, like that lah. (P1 IWFS) 
The biggest difference for me to my parents in Bario is that I have money and I 
live and can go shopping in Miri. (P12 IBFS) 
40-49 Age Bracket.  By 40 years of age most of the participants were married and the 
realities of providing for a growing family had set in. Activities for women tended to be 
more family orientated, and a number commentated that it was different from how they 
were raised: 
My mum never worked and she had one amah and one gardener to help her 
with all the work around the house whereas I work, raise my sons, feed my 
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family and do all the housework myself, except for the ironing I get a lady to do 
for me. Compared to my parents, I move and travel more … IT these days keep 
me constantly in touch. (P32 MBFR) 
The men were work and promotion orientated:  
Very seldom go for exercise, no time now. Last time I always play football. Now 
I just watch it on TV. I think my blood pressure better when I’m on holiday and 
when I jog regularly but no time now - work. (P10 IWMS) 
I seldom go for exercise now, because I always come home late from work. I 
stop exercise my blood pressure goes high. (P18 MBMR) 
Some had health issues or the added responsibility of family members relying on them 
like these 40+ year-old men: 
I was responsible for my mum and brothers after dad passed on. That was hard 
when I was younger. (P24 IBMR) 
Yes now I get treatment and have my leg checked also. The lowest I can get is 
125/95 for my blood pressure, if I not take tablets maybe higher than this then 
after two days I’ll have trouble again. I asked doctor if I get 125/80 can I give 
up my medicine but Doctor said no no no you need medicine for the rest of your 
life, so be it. (P3 MWMS) 
This is the age when first degree relatives said they stopped smoking cigarettes and 
many started to get hypertension, like this 43-year-old: 
I have been on hypertension medication since your blood test. I was sent back 
off-shore last week for high blood pressure and I cannot go off-shore again till 
it is lower and stable. (P31 MBMS) 
50-59 Age Bracket.  The 50- to 60-year-olds had the most concerns regarding nutrition 
and lack of activity and had started reining in excesses:  
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Actually it was last 10 years ago when things began to go haywire I think partly 
because of age, 51, but the other thing was my lifestyle changed and… through 
overeating everything went haywire. (P25 CBMS) 
Many participants in this age bracket were looking after their sickly parents or spouses: 
It’s been very difficult adjusting at beginning when my husband started dialysis 
seven years ago. We are coping better now. (P14 MBFS) 
Now my mum-in-law live with us because she has high blood pressure and 
kidney problem, and she’s been on dialysis … Very hard, my wife is upset about 
her mum. Mum in law cannot go home anymore to long house as too far and no 
dialysis there. (P9 IBMS) 
Almost without exception, for both the first degree relatives and the spousal control 
group, participants over 55 years of age mentioned they had a chronic non-
communicable disease or cardiovascular disease but many did not take it as life-
threatening. This participant was assessed as chronic kidney disease low stage 3 in this 
study: 
My next appointment to see doctor is at poliklinik in April. I go for follow-up 
every three months. I’ve never had my urine for kidneys checked for long time, 
not since you did for me. (P7 IWMR) 
Those who joined their children later in life could get very homesick for their kampung 
and friends at this age, like these 57-year-old men:  
I feel better at kampung than in Miri because I really love my kampung as I can 
meet other people in the longhouse. (P16 IBMR) 
The problem I cannot sleep at night, I think too much. If I in kampong I go early 
to bed because I’m happy seeing my friends. Then we get up early in the 
morning to talk around the fire. I feel happier in the kampung but cannot go 
back often because the transportation is very expensive and it is such a long 
way, many hours [16 hours by rough timber road]. (P7 IWMR) 
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60+ Age Bracket.  During this decade a number of participants had heart problems, like 
this 70-year-old, and some mentioned they had friends who had died from heart 
complications: 
In fact I feel that if you have some health problem we must not hide it, go and 
see the doctor early as we do not know our self. Like my, this balloon, in fact I 
don’t feel anything, it was just my children said I’m now quite old I should go 
for medical check-up. So I went to HSBC KL and doctor found that one of my 
vessel was 75% blocked so I either have to take medicine or have the balloon, 
so I chose the balloon. If I didn’t go for check-up I wouldn’t have known and it 
might be too late … I’ve been healthy lately but it was frightening then. (P26 
CBMR) 
Some reflected on their parents‘ health and how they were better controlled with 
knowledge and medication: 
Last time we were less informed about the content of coka-cola, and my brother 
always buy big amounts for mom. We found out my mother started having 
kidney failure when her sugar level was very high. (P21 CWMR)  
And later from the same 64-year-old Chinese man: 
My diabetes is under control now. I changed my eating diet because for me 
being a vegetarian was healthier. Being a vegetarian has improved my life yes. 
Not much different about my lifestyle. Some of my relatives ask me why I am a 
vegetarian ... When I still drank alcohol, I always was not feeling well but after 
I became vegetarian, I feel better. I always ask my friends around us to follow 






Figure 7.4  Summary of sub-theme 4: distress vs acquiescence 
 
7.4.4 Main Differences seen Between Groups: 
 The older participants showed maturity and wisdom from their years of 
experience but complained that the younger ones never listened to them.  
 Often it was the diagnosis of their own chronic non-communicable disease or 
cardiovascular disease that shocked participants to take action and change their 
own bad health habits. 
 
Photograph 7.8  Low-cost corner house  
















7.5 Environmental Concerns 
7.5.1 Majority views 
Housing environment.  This section, more than any other, showed the inequalities and 
difficulties the less wealthy participants struggled with daily:  
I like living here as we can jog around the complex or can walk across the road 
to the beach. (P32 MBFR) 
My house is at Piasau Garden [development of detached houses with large 
gardens]. A lovely area. (P26 CBMR) 
My house is a corner one and I have a garden at house. (P9 IBMS) 
I live in a detached house. My wife and I are on our own now that our children 
have grown up and married. (P26 CBMR) 
The Indigenous Iban preferred to live in their longhouses even if they needed to travel 
to Miri for work or their children‘s schooling, rather than relocate to Miri:  
All my extended family live together in the longhouse. (P23 IWFR) 
The land we built the longhouse on now is my brother’s land, its NCR Land and 
all my brothers and sisters and I and their children all live together in the same 
long house. (P22 IBFR) 
Living in a longhouse in a rural area is so very green around and lots of space 
and no traffic. (T3-P24 IBMR) 
I stay my own house at Taman Tunku [low-cost housing at Miri outskirts]. I live 
in Miri and manage to look for transportation for my youngest child to go to 
school, and when I have time I go back to longhouse to see my missus about two 
times every week. My own kampong land is near Sui [1½–2 hours‘ drive from 
Miri]. (P2 IWMR) 
Many of the Indigenous Orang Ulu had relocated to Miri years before:  
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Before we moved to our new terrace house at Permy Jaya, we stayed at Pujut 
Padang Kerbau for about 22 years. (P13 MWMR) 
Before I have my own house, I was renting a house at Kampung Wireless … 
Now about 12 year stay at my own house at Senadin [terrace housing]. Just my 
husband, children and myself in our very small house. (P14 MBFS) 
I have a low cost terrace house in Senadin. My wife and I share the mortgage. 
(P18 MBMR) 
We own our own house in Senadin by Naim Candra [low-cost]. My husband 
and I share the repayments. (P1 IWFS) 
Often when children got married the new couple moved in with the parents who had a 
house and space, until they got a place of their own. Sometimes, if the child had a good 
job and a house, the parent moved in with them, especially if the grandmother could 
look after the children: 
I have a house at Sungei Adong Pujut but I am now living with one of my 
daughters to help her look after the grandchildren. (P4 IBFR) 
I living at my own house, my children are stay with me, two daughter, my son 
and my two grandchilds. Her son I take care of now but her husband work still 
in Kuching. (P5 IBFR) 
Now I only stay at home living together with my daughter at Permy Jaya 
[terrace house]. (P16 IBMR) 
Many participants who lived in low-cost housing complained about the few children‘s 
playgrounds: 
There was no playground near our house and dangerous as too many cars 
along the road there … We community hope and want to build a padang nearby 
in future. The government could build the playground near to our house as 
there in an empty land available in front of my house. At the moment it is used 
by the neighbourhood for gardening. The people around there go plant banana, 
tapioca etc. so now children cannot use. (P21 CWMR) 
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There were few padang (playing fields), although some were lucky: 
No padang around just terrace housing. (P27 CWMS) 
I will walk around the housing area on the road. (P7 IWMR) 
There is no padang nearby to walk to exercise. I just walk around the house or 
sometimes along the road scary. (P1 IWFS) 
The padang near to my house only take 3 minute walking to the place but a 
jungle and can’t go jogging there now. Before could walk and jog there but not 
now, not cared for by council. (P14 MBFS) 
There’s a padang not far from my house. My children go there to play football 
with their friends. (P10 IWMS) 
There were few parks in new low-cost housing areas: 
I have my own house and a small garden. I live at Permy Jaya area, for about 3 
years already. We live in a new area but no park close around for exercising. 
(P21 CWMR) 
Nowhere to walk around near where I live. (P30 CWFS) 
My house is in the kampung at Lutong so more open space than housing 
developments. (P31 MBMS) 
When asked the question about gardens, one lady couldn‘t stop laughing: 
Now I am staying at Kampung Wireless [her house is on stilts in the river water 
village]. My activity at home is fishing in the river [people there literally throw a 
line out of the window to catch dinner]. (P17 MWFR) 
Even though some people were close to the beach or a park, this did not mean they 
exercised there: 
There is a park within walking distance from my house but I don’t bother to go 
there. (P14 MBFS) 
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The kampung is between the river and the sea [on the peninsula]. It is close to 
the beach so I can walk there, but don’t. (P29 MWFS) 
 
Photograph 7.9  Two low-cost houses  
Photograph by family member of researcher 
 
7.5.2 Disparities between groups 
First degree relatives vs. spousal control group.  The most comments concerning land 
were made by the first degree relatives, those with metabolic syndrome, and Indigenous 
from rural or remote regions. In the Indigenous community, family members quite 
often shuttle between their urban family and their rural farms: 
I am first in my family to be living in a town. My parents are still in the 
kampong, still in Long Terang. I go back to the kampong to see them maybe two 
three times a year to help with harvest and fruit seasons. (P1 IWFS) 
Malay and Melanau landowners on the outskirts of Miri had their land taken if they had 
no title: 
Last time we had land in Kuala Baram near the pottery factory there and we 
always plant something to eat there. Our land had no title papers so the 
government took all our land and gave it to someone else … So all the families 
had to leave about 10–15 years ago. My father and mother were very upset. (P3 
MWMS) 
The land that we were living on was NCR village land starting from my 
grandfather until my generations. Mostly the land is seaside land and has oil 
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palm further away from beach area. The Government offered us compensation 
for the land when they wanted to do a fish processing factory in the village. A 
lot of changes … even our daily expense is hardly enough. (P15 IWFS) 
A number of participants said they had relocated to Miri due to one of the multiple 
dams being built by the government: 
When they made the Ulu Baram dam all the land at Long Sunyei was flooded 
and we cannot go there anymore. I miss there. (P6 IWFR) 
Long Ikang kampung is … below the dam and my kampung will have to lose 
their farms when the dam floods. (P16 IBMR) 
My village is from Long Keses, Baram. My mum and dad inherited land from 
their parents there. The Murum Dam is above our kampung we are just below 
it, we will have to get out of the way. Don’t know what’s going to happen. (P5 
IBFR) 
Many traditional tribal lands have been taken over by large timber and oil palm 
companies. There were a number of mentions of this; one lady described the 
frustration:  
The oil palm company, Greenwood / IOI already come into my kampong Patah. 
They are causing problems for the old folk left there like when my mum and dad 
were forced off their traditional land. So we went by timber roads from Patah 
[Baram River] to Long Terang [Tinjar River] as the land in between the rivers 
were taken by other Kayan longhouses. So now my mum and dad have to live in 
Long Terang to rent land to grow rice but it’s not on their own land anymore. 
Now our land at Patah, we took them to high court, 4 years already. The oil 
palm company keeps postponing it, every time go to high-court appeal. So many 
delays, so much money to pay the lawyer. (P1 IWFS) 
Some of the small farmers and longhouses planted oil palm to sell to the plantation 
companies, to supplement their income: 
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Both of my brothers are on dialysis, that’s why, the expenses are tough to cover 
the dialysis charges, luckily we have planted oil palm and this helps to get 
money. They were still healthy, during the blood test for your research, and still 
doing some kebun [gardening] then. (P23 IWFR) 
Worst vs. Best chronic kidney disease / metabolic syndrome.  The NVivo matrix 
intersections showed that most comments on gardens were by these with the best 
chronic kidney disease scores and the worst metabolic syndrome scores. Most of the 
participants with the worst scores had gardens elsewhere outside Miri. Some went by 
motorbike or car and some by longboat with an outboard motor up the river: 
The land is just near the back [Taman Tunku], and can use motorbike to go to 
my garden. At Kampung Lusut and do gardening there, I plant some vegetable 
and fruit. (P2 IWMR) 
At my garden, I plant some vegetable and fruit. My garden at Batu Niah area it 
takes more than one hour to reach the area of my garden. When my husband 
has off-day we two together do gardening. (P5 IBFR) 
In the past all ethnicities grew their own food. Many living in town felt disconnected 
from not having a garden: 
In the kampung I liked to grow our own food but in Miri I have no kebun 
[garden] to grow vegetables, fruit even flowers. I have to buy all our food at the 
kedai [market] … In front of the house is only just enough cement to park a car. 
(P1 IWFS) 
We have a small garden at back of the house where we plant vegetables but we 
have to grow fruit trees at Bakum [one hour‘s drive away]. (P4 IWMS) 
It transpired that those living in low-cost housing did not have enough garden area to 
grow fruit or vegetables. There were many more complaints than the few that follow: 
At my place has no room for a garden, so small only, just a cement carport, 
then the house, then at the back a small 3’x 6’ cement section. I dry my clothes 
inside the house as not enough room outside. At back outside entrance is the 
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toilet, the plumbing, before fence and the 2’ longkang [drain]. Then the 
neighbours house backs on to mine, the same design. There are three small 
bedrooms and one toilet only. My house is so small but so expensive! (P1 
IWFS) 
I didn’t do gardening due to only limited area, just got a fence and parit [drain] 
at the back of my house. (P3 MWMS) 
We have no garden around our house, at the back just a very small space then 
parit [drain]. My mum used to have garden at her place last time planted 
vegetables and fruits but now she has stopped gardening due to her heart 
problem and old age. (P27 CWMS) 
Now usually we plant in pots as not enough room for a garden. (P20 CBFR) 
My house is a terrace house with no garden just rubbish in Senadin. (P10 
IWMS) 
I always do some gardening but near the house [on the reserve area by road]. I 
also plant some kangkuk manis, sawi and daun ubi [local green, leafy 
vegetables]. (P5 IBFR) 
In front of my house on the reserve, I plant some fruit trees. (P18 MBMR) 
In my garden I have planted logan and mango at back and in front of the house 
on reserve have planted banana. My children help in the garden. (P9 IBMS) 
Male vs. Female.  There were no great differences in the comments made by female 
and male participants except that a number of women raised curious issues of concern:  
No smoking and no drinking tuak [rice wine] no betal nut, only drink coffee. I 
don’t know why my sister get diabetes, I get high blood pressure or my brothers 
get kidney failure. We are all skinny and have worked hard on the farm all our 
lives. (P22 IBFR) 
While I still farming, I felt healthier, because I moved and sweat a lot ... Last 
time I used to garden and sell vegetables and fruit to Miri but now I can’t 
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because I always sick … I feel sick now, because of no gardening, but I don’t 
want to manja [whine like a spoilt child] … Now since I got sick I could not go 
out to the farm, I feel sick and the children asked me to stay at home. All I do is 
just sitting on the ruai [veranda] and I feel so bored. (P22 IBFR) 
On health information, I do not know anything. The only thing I noticed is that 
so many of the longhouse folks are suffering from kidney dialysis but we do not 
know what causes it. (P23 IBFR) 
My brothers, one 40 and one 44 years old, saw the doctor for medical checkup 
when they wanted to work offshore, but they were told have to do dialysis 
already, we also don’t know what is the reason of their kidney failure. The 
doctor never gave information to us. Now in the other long houses like ours in 
the Bekenu area also having a lot of people on kidney dialysis. (P22 IBFR) 
I don’t know the reason why my mom has kidney problem, but doctors says it’s 
because of her smoking – but so far she don’t smoke since she was a teen. Other 
doctors say using the spray, always this gardening spray that what they suspect 
my mother using the weedicide causing the kidney problem. But she’s the only 
one in my family with it, how can? (P5 IBFR) 
Others expressed similar concerns to these, and this prompted an adjustment of the 
qualitative interview schedule to include this line of questioning. 
Ethnicities.  The qualitative interviews identified a number concerns with regard to 
agrochemicals. DDT [dichlorodiphenyltrichloroethane] was used to reduce mosquitoes 
causing malaria and dengue fever: 
When I was younger until the middle of the 1980s the government also did come 
to our long house every year to spray the longhouse with DDT for eradication 
of mosquitoes. (P16 IBMR) 
I sometimes use pesticide - gastrofed at my oil palm and they use it in the 
kampong too and before that we used DDT. I also sometimes use weedicide to 
get rid of the lalang [strong, resistant weeds]. (P2 IWMR) 
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The council does fogging around the kampung and my house for mosquitoes. 
(P31 MBMS) 
The council fogs around our area for mosquitoes. (P19 CBFS) 
My wife got dengue fever it’s not nice, very sick, and don’t want the children to 
get it. (P18 MBMR) 
My children seldom go outside and we only use air-conditioners in our house so 
have less mosquitoes. (P19 CBFS) 
A range of herbicides and pesticides were mixed and sprayed by participants, including 
named products: 
As a farmer, I did used weedicides Gramazone [paraquat] and Roundup 
[glyphosate]. I prefer gramazone because it’s stronger and I want the grass to 
die quickly. It’s called Gramazone and Spark. The government gives a free 
subsidy for racun [poisons - including herbicides, fertiliser, pesticides] but 
sometimes if finished I buy for myself at the shop. It is easily available. (P16 
IBMR) 
 Sometimes I do use the pesticide for the bugs, a lot of these insects, but not 
always to use it. The brand I use is Malathion. I like it because other brands are 
not effective. Sometimes we spray the weeds. We use the Roundup and 
Gramazone. We use Gramazone around the edges for the lalang [tough variety 
of weed] grass there it gets rid of it better, Roundup not the same, not so good. 
(P5 IBFR) 
Majority all of other longhouse folk also use the same weedicide called 
gramazone, plus now they plant the oil palm so mostly will use the gramazone 
as very effective. It’s sold to all the kampungs. Sometimes they will cover their 
face and hands, but sometimes they don’t bother to cover up. They got 
information that if not cover up it is racun [poison] to them. They don’t have a 




Some use coveralls and face masks when spraying, some do not: 
My daily routine work is planting, harvesting and spraying the weed around the 
oil palm trees. The weedicide I always use is Supermore… I cover up dress 
when I do spraying. (P24 IBMR)  
I always cover up and use a mask now. In my younger days on my father’s farm 
I never did. Gramazone is what I use as very popular to use in Sarawak and it’s 
so easy to get in the kampungs and the oil palm companies use it. (P31 MBMS) 
I do contract work, when the area needs to spray with ant poison, around the 
walls of the house. I did use cover up dress when I use pesticide but sometimes 
hard for me to avoid from breathing the poison, because the smell is too strong. 
I did use the mask but still can breathe it in. (P18 MBMR) 
Some of the reasons given for not covering up when using agrochemicals: 
I am a farmer since young and I do farming on my own land, but now I not 
doing any farming because of my present condition ... I do not use cover-up or 
boots during using the poison as too hot and I sweat a lot. (P23 IWFR) 
I frequently pee, very annoying so I don’t drink water much [daughter said, 
‗very annoying when you are spraying‘]. (P22 IBFR) 
The agrochemicals are also used on home gardens: 
I use herbicide most places, around the paddy field before the paddy is planted, 
the vegetable garden and I use around the pepper plants and I also use 
pesticide at my pepper plants area, can’t remember the name of the pesticide. I 
also use it at home. (P23 IWFR).  
We  grow vegetables and eat cendawan [mushrooms] and midin [fern tips] that 
grow around the plantation trees [which have been sprayed with 
agrochemicals]. (P15 IWFS) 
And on their children: 
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Every time I came home from boarding school for holidays mum would rub 
spray chemicals in my hair and hands to kill kutu rambut [hair lice] and kudis 
buta [scabies] and it worked. (P12 IBFS) 
For suicide: 
A girl from my kampung drank it when she upset over something. So painful 
way to die. No one should die like that. (P1 IWFS) 
Longhouses are almost without exception built beside a large river, for water for the 
longhouse and for transport:  
Normally the kebun is far from the longhouse and now mostly children are at 
school or sit in the longhouse watching television. Cannot swim in river or they 
get itchy skin. Cannot go fishing as no more fish live in river any more. (P22 
IBFR) 
The following comments are by those who never used agrochemicals:  
When we grew up my parents had a large garden and my mum used fertilisers 
but the herbicides were only used by the gardener. Here people always look for 
the easy way out so like they would prefer to use strong chemicals to kill the 
lalang rather than cut or pull them out. (P32 MBFR) 
We have some fruits in the garden, like longan and we use not the artificial 
fertiliser but the hormone enzyme to make it fruit three months later. We never 
use the racun rumput [herbicide], we don’t even spray for mosquitoes and now 
even to clean the floor we don’t use strong chemicals. (P28 CWFR)  
There were many comments on the vegetables the participants chose to eat: 
I have a big garden at my house and I grow my own vegetables, quite a few 
types. I never use chemicals in my garden. It’s all organic, 100%. In the 80’s 
Brunei refused to buy vegetables from Miri because of too much chemicals used 
when growing vegetables. (P26 CBMR) 
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In our garden at the house in Sungei Adong Pujut we don’t use weedicide or 
pesticides. I don’t mind holes in the leaves of the vegetables. (P4 IWMS) 
My wife washes the vegetables many times to get rid of the pesticides on the 
leaves. (P25 CBMS) 
I grow some vegetables that don’t take up much rook in the garden so we don’t 
have to buy so much vege from the kedai. I prefer vegetables with holes in it as I 
know it’s got not poison on it. (P21 CWMR) 
I read one article it said that once a vegetable has a lot of holes it is already 
very weak, it’s a very weak vegetable and when you eat it you don’t get a lot of 




Figure 7.5  Summary of sub-theme 5: uninformed vs choice / no choice 
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7.5.4 Main Differences seen Between Groups:  
 The first degree relatives group, the metabolic syndrome worst scores and the 
Indigenous voiced the most frustration with land issues that were out of their 
control.  
 The worst metabolic syndrome scores are those who live in the low-cost 
housing and do not have a garden. Many grow vegetables and fruit on the 
council verge or on a farm one or more hours outside Miri. 
 The Iban ladies made comment about the health of some in their longhouses 
which prompted further enquiry.  
 Indigenous ethnicities used agrochemicals much more than the Malay or the 
Chinese. Although knowing the agrochemicals are poisonous, many do not 
cover up when using it because of the sweltering tropical climate. 
7.6 Summary of Key Findings in Qualitative Phase Two 
7.6.1  Sub-themes identified 
Five sub-themes emerged from the interviews and one major theme was identified. 
Allegiance Versus Betrayal: Transitional changes in their kampungs of origin had 
generated torn loyalties in participants of all ethnicities, usually those with land or 
parents still living there. They endeavoured to maintain ties with their kampung. 
Traditional Versus Modern: Participants were conflicted about whether to follow the 
traditional system of health beliefs and behaviours of their parents and culture, or to 
mix cultures, or solely to follow the modern system. 
Confusion Versus Compromise: Transitioning generations living in the ‗new urban‘ 
found themselves confused about correct health information. They often had to make 
health compromises in order to look after their extended families and dependants. 
Distress Versus Acquiescence: There was evidence of an aging population for whom 
longevity did not necessarily correlate with a good quality of life. Participants found 
that by their 50s they were starting to develop a chronic non-communicable disease and 
at the same time were having to look after sickly aging spouses or parents.  
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Uninformed Versus Choice / No Choice: Environmental concerns, were 
predominantly voiced by the Indigenous participants, many who are mourning the loss 
of their homelands and their health. They feel disempowered and have no self 
determination. 
7.6.2 Major theme identified 
Health-seeking anxiety best describes the participants‘ trepidation concerning their 
and their family‘s health conditions. Figure 7.6 illustrates the complex interactions of 
the sub-themes with the major theme.  
 
Figure 7.6 Health-seeking anxiety model 
 
To alleviate their anxiety they need to be given accurate information, understanding 
and support to cope with their health circumstances. People who comprehend their 
medical condition are more likely to exercise autonomy in its management and this 
may prevent, or if already present, delay its progress. People who are empowered to 
take responsibility are more likely to make life-long changes and to be better able to 
control health-related behaviour. The next chapter discusses the integration of the two 
data sets and how the qualitative influences the quantitative information. 
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Chapter 8 Discussion and Integration of the Two Data Sets 
Mixed methods is distinctive in that it chooses the most appropriate study design, 
involving both quantitative and quantitative data gathering and analysis, to conduct a 
research study (Teddlie & Tashakkori, 2010). The methodology is pre-planned and 
deliberately integrates the data sets to investigate thoroughly a ‗phenomenon of 
interest‘ (Teddlie & Tashakkori, 2010).  
The headings for the quantitative results, found in Chapter 5, guide this discussion and 
are explained, supported or rejected by the qualitative findings, the headings found in 
Chapter 7. The quantitative results are presented as tables (Tables 5.1 –5.6). The 
qualitative findings, information and quotes are presented by participant number.  
The quantitative discussion outlines the statistically significant differences between the 
first degree relatives‘ and the spousal control group‘s socio-demographic 
characteristics, anthropometric results, behavioural lifestyle factors and socio-economic 
factors. The participants‘ chronic kidney disease biochemical results and the metabolic 
syndrome clinical and biochemical results are highlighted. The multiple logistic 
regression analysis identifies a number of factors associated with chronic kidney 
disease and the metabolic syndrome, and the reported links between metabolic 
syndrome and early kidney deterioration are discussed.  
The qualitative discussion is wrapped around the quantitative discussion in order for 
the two phases to be truly integrated in accordance with a Mixed Methods design. The 
thread that ran through all of the participant interviews was that of being in a 
transitional dilemma that caused emotional conflict and often resulted in a personal 
identity crisis. A number of sub-themes that emerged from the interviews can be seen 
to have a direct relationship with and influence on the quantitative results. The 
interviews revealed the participants‘ desire to comprehend their medical condition in 
order to make rational health decisions, although most portrayed a state of 
bewilderment and anxiety when asked about their health. The major theme identified, 
relating to all the sub-themes, is ‗health-seeking anxiety‘ concerning their lifestyle and 
medical circumstances. The chapter concludes with a summary of the outcomes for the 
quantitative and qualitative objectives. 
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8.1 Discussion  
8.1.1 Beliefs, attitudes, behaviours and barriers  
A number of beliefs, attitudes, behaviours and barriers were identified from the Phase 
Two interviews and will be addressed throughout the discussion as some may influence 
the health and behaviour of participants. These barriers may be erected by the 
participants themselves or be hindrances outside their control that are ignored, 
neglected or imposed on them by others. A review of Canadian haemodialysis centres 
listed the following barriers to patient-centred care and patient engagement: ‗conflict 
with other priorities; lack of training and fear of change; the unequal balance of power 
between patients and providers; physician culture and behaviour; the fee-for-service 
model of physician compensation; slow implementation of electronic health records; 
and fear of accountability‘ (Bear & Stockie, 2014, p. 5). Many of these can be 
identified in Miri. Bear and Stockie (2014) noted that there is inadequate consideration 
given to this area. There is even less consideration given to the first degree relatives 
and their spouses, who sacrifice so much as providers, carers and supporters of a family 
member with end-stage renal disease. Phase One of this study determined that the first 
degree relatives are associated with the metabolic syndrome (Table 5.6), which may 
well be an important factor driving chronic kidney disease in Miri. In this study the 
NVivo intersections indicated that participants from both the first degree relatives and 
the spousal control group had the worst scores for chronic kidney disease and metabolic 
syndrome; many expressed their frustration at the number of obstacles impeding them 
from maintaining good health.  
8.1.2 Allegiance versus betrayal  
In this study were three major racial groups, Malay, Chinese and Indigenous, each 
comprising many minor ethnic groups. For instance, six different Chinese dialects and 
more than twelve different Indigenous ethnic groups with individual dialects were 
represented by the participants in Phase One. Of the 32 participants recruited for Phase 
Two, only two were ‗generation 1‘, and thirty were ‗generation 0‘ living in Miri. Most 
came to Miri as young adults. For men the main reasons for moving to Miri were to 
search for employment, make more money, or because their company transferred them 
there; many of the women, followed their husbands to Miri or moved because they, or 
their parent or child, needed medical attention not available in the kampung. 
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A Malaysian kampung does not have the same connotation as a Western country‘s 
village or town where one lives an independent nuclear family lifestyle. In a kampung 
everyone is known, often are related and have in-laws, live in extended family groups 
and share equipment and responsibilities, including difficult agricultural work. There is 
an intrinsic support and survival system. Many participants felt they had betrayed their 
home, and were torn between their kampung of origin and their assimilation into Miri 
as their home. On their identity cards they had their kampung of birth registered as 
‗home‘ and never changed the address even if they had no intention of returning to live 
there. In fact, the former Sarawak Director of Immigration Datuk Robert Lian-Saging 
advised young people who were not born in the kampung but had parents from there, to 
register the kampung as their home. This was to ensure that links to the community 
continued for posterity. In addition, unless people have an officially recognised link 
with the community they have no voice in how the community land is used. This is a 
contentious issue as those who have moved to cities are often dismissed by politicians, 
community leaders and persons with ulterior motives as having no authority or right to 
speak on kampung matters.  
The Indigenous Iban are likely to live in a longhouse within one or two hours‘ drive of 
Miri. The Indigenous Orang Ulu, however, in an attempt to stay involved in the 
community and hold onto their kampung land, shuttle between two homes even though 
the journey is arduous (Ch.7 P16), causes financial strain (Ch.7 P15) or are very busy 
with work (Ch.7 P10). If a longhouse household (one door) does not light a fire in their 
fireplace at least once a month, the Iban custom is for a penalty to be paid to the 
kampung head; if the fire remains unlit for an extended time, the household loses 
‗membership‘ in the community (Soda, 2007a). In the Orang Ulu community, for 
example the Kelabit tribe, persons who have abandoned their household and land must 
return it to the kampung land committee so it can be utilised by someone resident in the 
community in need of land to feed his family members (R. D. Mattu, 2014). 
Urban centres have been the focus of development in Sarawak and rural communities 
have been sidelined, as demonstrated by studies showing the economic benefits small-
holder farmers receive when good roads are connected to large towns and cities 
(Windle & Cramb, 1997). Timber roads, the basis of road transport in rural areas, are 
not maintained once the timber is extracted, and become impassable. In the guise of 
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development, oil palm plantation conglomerates have replaced timber companies, often 
taking over ‗idle‘ Native Customary Rights land and not involving the local 
communities in executive decision making (Cooke, 2002). These land grabs often go 
unchallenged in an expensive, protected legal system whereby Dayaks have to prove 
the land was theirs prior to 1958 (Cramb, 2007b).  
There are approximately 2.3 million documented foreign workers and 4 million 
undocumented foreign workers in Malaysia, and Home Minister Datuk Seri Ahmad 
Zahid Hamidi has announced that 1.5 million more will be brought into Malaysia to 
meet demands in oil palm plantations in Sabah and Sarawak (Teh, 2015). Isolation 
from lack of adequate, safe roads means that people in remote areas cannot get their 
goods and agricultural produce, including rice, to market. It takes 16 hours on 
dangerous timber roads over mountainous terrain to drive the 310 kilometers from 
Bario to Miri. Inadequate rural development, cheap foreign labour and not wishing to 
work hard for large oil palm companies on their own land (Cramb, 2007a) has driven 
young Dayaks to the cities for work. This modern-day exodus of Indigenous people has 
created a new order whereby rural-to-urban migrants endeavour to retain their 
membership of both kampung and city life (Soda, 2007b). The study by Soda (2007b) 
is based on the Iban of the Rejang River and Sibu, but this current study too supports 
this observation, true of all Indigenous participants from the Baram River and 
tributaries and Miri. A new concept of ‗double belonging‘ has developed, whereby 
membership of both urban and rural communities (Soda, 2007b) can be generalised to 
all Indigenous ethnicities of Sarawak and possibly also Sabah. 
The Malay and Chinese participants in this study whose families own, or once owned, 
land in their kampung or town of origin, or whose parent or parents still live there, also 
hold a strong attachment, do not sever their community ties, and return as often as they 
are able. All the participants in this study held their ethnic and religious ceremonies in 
deep respect and devotion, and many endeavoured to return to their village of origin for 
celebrations. Miri has many active Malay, Chinese and Indigenous ethnic associations, 
set up to support clans who have relocated to the city from a common geographical area 
and share mutual dialects and background. These associations provide an avenue for 
those dislocated from their kampung to still participate in community discussion and 
activities. They are also used as a political means for two-way interaction with 
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government officials. Government funds are channelled through these associations for 
community development, often apparently as a reward for voting loyalty to the ruling 
party (Soda, 2007a). 
The perception is that life is easier living in the city:  
Kampung is very difficult to get money … Life is easier in town if you have a 
job. (Ch.7 P1).  
Physically this may be true, but psychosocially it takes a toll, especially on those who 
are unable to return to their kampungs. A cross-sectional survey of 1,000 rural-to-urban 
migrants in Beijing found that psychological distress negatively influenced their quality 
of life (Wang, Li, Stanton, & Fang, 2010). The survey found that pre-migration 
preparation was important as migrants were better able to cope, had real expectations, 
better quality of life and good mental health (Wang et al, 2010). Some participants in 
this study expressed regret, and some felt they would betray their parents and 
community if they did not go back regularly (Ch.7 P15). A longitudinal study, the 
Indonesian Family Life Survey, compared urban migrants‘ health with that of those 
who remained in the rural village and found that rural-to-urban migration had an 
economic gain but no physical health benefits and a high psychological cost in stress 
and depression (Lu, 2010). Large amounts of urban migrants‘ earnings were remitted to 
their villages (Lu, 2010); in this study also many participants admitted to this, like one 
Malay migrant:  
I am now able to sponsor and support my family with money. (Ch.7 P3).  
Both males and females were unanimous in wanting to have their children attend better 
schools than were available in their kampung:  
Coming to live in town means I can pay for my children to go on in school. If 
my children don’t have education they just stay in kampung at home on farm. 
(Ch.7 P2) 
Their connection to the land is so strong that many Indigenous participants mentioned 
they planned to return to their kampung when they retired and their children were 
independent. A number who had already retired, however, were unable to return 
 
209 
because they no longer had kampung land (Ch.7 P20; Ch.7 P3), were caretakers of sick 
relatives (Ch.7 P6, P11; Ch.7 P9), had children still living with them (Ch.7 P5), lived 
with their children to help with the grandchildren (Ch.7 P4) or were ill themselves 
(Ch.7 P22). One participant expressed the dilemma facing him: 
I don’t go back with them [family] as [I am] working. When my father passes on 
I will have to look after his land for him. I seldom go back to the kampung. 
(Ch.7 P10) 
The regular two-way flow of Miri city-dwellers returning to their kampung or town of 
origin keeps open marriage opportunities with those still residing there; in time these 
new partners and family are likely to migrate to urban areas. Intermarriage with other 
ethnic groups is also common in Sarawak, and the desire to spend money on the 
kampung and to return there every holiday may not be fully understood by the spouse 
and their urban-raised children. This creates further conflict and the sense of a two-way 
betrayal: to the family in the kampung, and to the urban family. 
8.1.3 Socio-demographic characteristics  
The quantitative results of the socio-demographics of participants were statistically 
similar (Table 5.1) so it can be surmised that the socio-demographic profiles for both 
the first degree relative cases and the spousal control group are alike. Altman (1991) 
remarked that groups being compared should be similar apart from the study concern. 
The introduction of bias and over-matching, however, also needs to be considered and 
addressed (Wacholder, Silverman, McLaughlin, & Mandel, 1992). In this study a 
spousal control group excluding the spouse was recruited, the rationale being that these 
often share a similar ethnicity, culture and environment as the case group without 
having the genetic component. The first degree relatives of those with end-stage renal 
disease and on dialysis were matched with a non-genetic member of their in-law 
family. The participants all had knowledge of the difficulties experienced by their 
family or in-law member having dialysis and thus were highly motivated to participate 
in this study. 
A number of studies have investigated the link between end-stage renal disease patients 
and their first degree relatives. One large case-control study in the United States 
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concluded that the risk of developing end-stage renal disease increased within families 
(Lei, Perneger, Klag, Whelton, & Coresh, 1998). Following a population-based sample 
of incident end-stage renal disease cases in the United States, Freedman et el. (2005) 
cautioned physicians that there is a marked familial aggregation of end-stage renal 
disease in patients with chronic kidney disease. Another American population study 
found that a familial component for chronic kidney disease or end-stage renal disease 
was not significant amongst second degree relatives (Goldfarb-Rumyantzev et al., 
2006), although a cross-sectional study in Taiwan found that first and second degree 
relatives and their spouses had a significantly higher prevalence of chronic kidney 
disease (albuminuria or low estimated glomerular filtration rate) than two sex- and age-
matched controls (Tsai, Chen, & Hwang, 2010), suggesting that in households where 
there is a person with end-stage renal disease, shared environmental and health 
behaviours may be a causal risk factor in non-genetic relatives developing chronic 
kidney disease. This is reflected in the current study, where the proportion of chronic 
kidney disease was similar in both cases and controls (Table 5.4). The socio-
demographic results show similarities within all categories, and no factor is 
significantly different between the first degree relatives and the spousal control group 
(Table 5.1). 
A recent study of 1,062 first degree relatives and 450 spouses of end-stage renal disease 
patients on dialysis in four Chinese cities, sex- and age-matched with general 
population controls from Beijing found that the first degree relatives had a higher 
prevalence of albuminuria (X. Kong, Liu, Zuo, Yuan, Li, Li et al., 2013). This was also 
found in the Taiwan study (Tsai et al., 2010) and in the Kidney Early Evaluation 
Program (KEEP) study (Brown et al., 2003). This current study also shows first degree 
relatives to have a high albumin-to-creatinine ratio compared with the spousal control 
group (p=0.030), but not of the estimated glomerular filtration rate or chronic kidney 
disease (Table 5.4). It has been suggested that findings like this may be due to familial 
susceptibility to hypertension, type 2 diabetes and other known renal risk factors of 
albuminuria as well as to shared environmental factors (Lei et al., 1998; X. Kong et al., 
2013). Familial clustering through metabolic disorders may be applicable to the Miri 
first degree relatives as well, but this study design cannot prove a causal link, and can 
only suggest a correlation. Microalbuminuria is not included in the metabolic syndrome 
assessment, and more research in this area is needed.  
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In the Phase One questionnaire, the participants gave a self-reported family history and 
a personal medical history (Table 5.2). There were limitations to this as many did not 
know what diseases their parents and grandparents had had; nor did they know what 
medications their parents and grandparents were taking and whether they were 
compliant. The family history (Table 5.2), when compared to that of the spousal control 
group (34.8%), revealed that a significant number of first degree relatives (52.6%) had 
a family history of diabetes (p=0.007) (Table 5.2). Although more than half of the first 
degree relatives and a third of the spousal control group knew they had a family history 
of diabetes, 21.5% of the first degree relatives and 16.3% of the spousal control group 
had not been tested themselves and were ‗not sure‘ if they had diabetes (Table 5.2). 
There was no statistically significant difference between the first degree relatives and 
the spousal control group for a family history of hypertension (Table 5.2) or for a self-
reported personal high blood pressure (Table 5.4). It should be noted that 75.6% of the 
first degree relatives and 64.4% of the spousal control group acknowledged their 
parents had hypertension, yet 15.6% of the relatives and 17.0% of the control group 
were ‗not sure‘ if they had it themselves (Table 5.2). This study shows the first degree 
relatives (43%) have a significantly greater probability of having a family history of 
high cholesterol (p=0.014) compared with the spousal control group (33.3%) (Table 
5.2). The multiple logistic regression analysis of factors associated with metabolic 
syndrome found that compared with those without a family history of cardiovascular 
disease, those with a family history of the disease were 2.65 times more likely to have 
metabolic syndrome (Table 5.6). To have a family history for any chronic disease 
increases the first degree relatives‘ risk of inheriting that disease (Yoon, Scheuner, & 
Khoury, 2003) so knowing the family‘s medical history can forewarn an individual to 
take measures. The issue of not knowing, or not wanting to know, one‘s risk of a 
chronic non-communicable disease emerged from the qualitative interviews and will be 
discussed later in this chapter. 
The multiple logistic regression to determine factors associated with the metabolic 
syndrome (Table 5.6) showed that the first degree relatives were 2.41 times more likely 
to have metabolic syndrome than the spousal control group (Table 5.6). McClellan et 
al. (2007), in a cross-sectional study of participants in the Stroke (REGARDS) Renal 
Cohort Study, found that with an increasing number of components for the metabolic 
syndrome there was a strong positive trend for having a family history of end-stage 
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renal disease. This study concurs with these conclusions, as the socio-demographic and 
socio-economic factors of both groups were similar, with no differences for chronic 
kidney disease. It may be deduced that there is a genetic factor involving metabolic 
disturbances as the metabolic syndrome was greater among the first degree relatives.  
Age is a predisposing factor for many chronic non-communicable diseases, and this 
was reflected in the multiple logistic regression analysis. Age was found to be 
significant for both chronic kidney disease and the metabolic syndrome. It was also 
found to be a significant factor of chronic kidney disease: with every year older, having 
chronic kidney disease increased by almost 5% (Table 5.5). As the combined mean age 
of all participants in this study was 42.94 ± 14 years (Table 5.1), the development of 
kidney disease and the worsening of chronic kidney disease may become greater with 
age (CDCP, 2010). Although not entirely understood, both aging and having chronic 
kidney disease independently increase the risk of death from cardiovascular disease 
(Parfrey & Foley, 1999). For the multiple logistic regression analysis of the metabolic 
syndrome, the odds of having metabolic syndrome increased by between 0.5% and 
4.9% for every one year increase in age (Table 5.6); thus the metabolic syndrome and 
its associated chronic non-communicable disease comorbidities are likely to deteriorate 
further as susceptible individuals grow older. 
8.1.4 Distress versus acquiescence  
In the qualitative interviews, participants revealed degrees of adjustment depending 
upon their age, length of time living in Miri, family life, work stage or retirement, and 
the condition of their health. In Sarawak ‗retirement‘ in the Western sense is virtually 
non-existent. There are very few old-age homes and no retirement villages in Sarawak. 
In Miri there is one private Chinese old-age home, for those without family. All 
ethnicities look after their older folks in an extended household; if they are Indigenous 
with family still living in the longhouse, the aged prefer to live the remainder of their 
life there with their friends. For all ethnicities it is almost inconceivable, and considered 
shameful, to allow and pay for, their parents to live in an aged-care facility; yet many 
cannot cope with their family situation. The participants in this study highlighted the 
impact on the family when their aged parents were on dialysis or had an advanced 
chronic non-communicable disease or cardiovascular disease:  
 
213 
Now my mum-in-law live with us because she has high blood pressure and 
kidney problem, and she’s been on dialysis … Very hard, my wife is upset about 
her mum. Mum-in-law cannot go home anymore to longhouse as too far and no 
dialysis there. (Ch.7 P9)  
This problem will only get worse as the population ages. 
Most participants had been living in Miri for many years when interviewed. The 
exception were older Indigenous folk who had only recently joined their children in 
Miri: because their spouse died, their land had been sold, they were looking after their 
grandchildren while their children worked, or they were too old to live on their own in 
the kampung. The older Indigenous participants were obviously homesick for their 
kampung, lonely after living in an atmosphere as vibrant as a longhouse, and out of 
their ‗comfort zone‘ in town (Ch.7 P6; P7). People in the kampung are grateful for 
modern appliances and if there is electricity from a micro-hydro or solar panel they use 
washing machines, rice cookers and even have hot water to shower in. These facilities 
are usually supplied by their children who work in the city. The younger generations 
appreciate the comforts of modern material items, fashion items and nice vehicles and 
houses. Sadly the infrastructure-building days of the Miri oil industry are over, and 
during the 1990 recession years many who had a car and a house loan, were laid off. 
There was a reverse migration to the kampungs as there was no work to be found in 
Miri. Suicides took place when older folk who considered this a failure taunted their 
children for returning to the villages. A second wave of rural to urban migration began 
again in the early 2000s and has lasted to the present, as off-shore platform contract 
jobs become available and young Indigenous people began to earn large wages again. 
There were also plenty of timber camp and oil palm plantation managerial jobs 
available for those who enjoyed working in the rural areas and the interior. 
Most participants were somewhere along the age continuum between recognition and 
acceptance of their situation. When the participants first came to Miri to live there was 
an adjustment phase during which they found a place to live, took on work, found 
schools and established contacts (Ch.7 P6; P1; P7). The middle-aged participants were 
more settled, but voiced anxiety about their busy lives and having to consider measures 
to avoid a chronic non-communicable disease from worsening (Ch.7 P18; P10; P3), 
especially when their work was affected:  
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I was sent back off-shore last week for high blood pressure and I cannot go off-
shore again till it is lower and stable. (Ch.7 P31).  
Being in their fifties for many coincided with being diagnosed with a chronic non-
communicable disease and also with having to care for aging, sometimes sickly, 
spouses and parents. Participants expressed distress when their parents or spouse 
commenced dialysis (Ch.7 P14; P9; P27) and they had to become both providers and 
carers. Some of the over-60 participants clung to their independence (Ch.7 P15; P26) 
while others were frustrated with their health and with having to live with their children 
(Ch.7 P15) although most accepted their situation, and turned their energies to 
improving their diet and starting an exercise program—although some admitted to 
laziness (Ch.7 P21). Sometimes this happened after a health scare, as for the gentleman 
who had a heart operation (Ch.7 P26). The older age group mentioned annoyance that 
their adult children did not take health and lifestyle advice from them (Ch.7 P21; P26), 
but most expressed a sense of resignation rather than passion or anger about their 
situation. 
In the quantitative results of this study, ethnicity was found to be positively associated 
with chronic kidney disease but not with the metabolic syndrome. Compared with the 
Chinese people, having chronic kidney disease was 5.67 times higher for Malay people 
and 2.35 times higher for Indigenous people (Table 5.5). In a multi-ethnic national 
cross-sectional population-based survey (n=17,211) it was found that Indigenous 
Sarawakians have a higher prevalence of metabolic syndrome at a younger age than 
other ethnic groups (S. Rampal, Mahadeva, Guallar, Bulgiba, Mohamed, Rahmat et al., 
2004). The current study reflects this anomaly for Malay and Indigenous ethnicities 
(Table 5.5) and forecasts that if obesity, metabolic syndrome and type 2 diabetes 
develops before middle age, individuals will be at high risk of cardiovascular disease, 
chronic kidney disease and consequently end-stage renal disease in their retirement 
years. Disturbingly, one third of those in this study were already classified as having 
metabolic syndrome (Table 5.4; Table 5.5), meaning they had at least three metabolic 
abnormalities. 
Freedman et al. (2005) has stated that darker coloured ethnicities show more 
susceptibility to renal disease, although other studies show no such relationship: for 
example, a case-control study from Brazil finds a familial risk for first degree relatives 
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of end-stage renal disease patients but no association with ethnicity (Madeira, Santos, 
Santos, daSilva, MacIntyre Innocenzi & Santoro-Lopes, 2002). An article from Johore 
Bahru, Peninsular Malaysia, found that Malays have a much higher incidence of end-
stage renal disease than Chinese or Indian ethnicities (Liu & Hooi, 2007); however, a 
descriptive study from Penang found similar percentages of end-stage renal disease 
patients for Malays (47.0%) and Chinese (48.7%) (Shaza, Rozina, Izham, & Azhar, 
2005). The majority of Malaysia‘s Indian community resides in West Malaysia and 
only one person of Indian heritage was on dialysis in Miri at the time of this study 
(MRC, 2010). 
8.1.5 Anthropometric results  
The Westernisation of Asian-Pacific countries including Malaysia, has brought with it 
the escalation of obesity and obesity-related diseases (comorbidities for the metabolic 
syndrome) has escalated. Of peculiar concern is that these comorbidities occur at a 
much lower body mass index than for European ethnicities (WHO-WPR, 2007). This 
has implications for Miri, as it means that the onset of chronic non-communicable 
diseases may occur before the individual appears to be excessively overweight or 
obese. A New Zealand study has found ethnic differences for body fat, muscularity, 
bone mass and leg length between European, Maori, Pacific Island and Asian Indian 
adults (Rush, Freitas, & Plank, 2009). Rush et al. (2009) found that Asian Indian 
people had more abdominal fat but less skeletal muscle and lower bone density. This 
means that two people with the same body size may have different proportions of fat, 
muscle and bone. It is not known what proportional differences Malaysian Indian, 
Malay, Chinese and Indigenous ethnicities have, but if they carry a normal-looking 
body size they may not be offered tests for type 2 diabetes and hypertension by the very 
busy poliklinik doctors. This may be one reason why a number of participants in this 
study, who did not look over-weight to a Western eye, had advanced type 2 diabetes 
and/or hypertension but did not know it. 
In the anthropometric measurement for metabolic syndrome (Table 5.3) the female 
groups were similar but the male first degree relatives had a significantly larger waist 
circumference than the men in the spousal control group (p=0.002) (Table 5.3), and 
there was a greater percentage of obesity and morbid obesity among the male first 
degree relatives. They had a statistically significant greater weight (p=<0.001) and 
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body mass index (p=<0.001) (Table 5.3) than the spousal control group. Of concern is 
that in both groups, most of the men and women participants were above the normal 
cut-off points for abdominal obesity (90 cm for Asian men and 80 cm for Asian 
women) (Table 5.3). These three factors, waist circumference, weight and body mass 
index, may suggest an increased likelihood for the development of cardiovascular 
disease in the first degree relatives if they also have abdominal obesity. It was non-
significant however, when all participants were combined in the multiple logistic 
regression analysis for metabolic syndrome. 
8.1.6 Chronic non-communicable diseases and food transition  
When they meet people for the first time, Sarawakians instinctively know their general 
ethnic family by their facial features, body proportions and vocal cadences. They can 
identify whether people are Malay or Melanau, which Chinese clan they belong to, 
whether Indigenous people are from highland, lowland, interior or coastal areas. There 
are variations between ethnic groups in their adat (communal laws) as well. Native 
customary land includes uncultivated community rainforest, vital for the hunting and 
gathering of food (Bulan & Locklear, 2008), but the adat controlling these areas can 
differ. For example, although both the Iban and the Kelabit adat dictate that all land is 
communal, the Iban practice of slash and burn allows individuals to cultivate land they 
clear from virgin jungle (Bulan & Locklear, 2008), while among the Kelabit native land 
is distributed to community members by a kampung land committee, to ensure that all 
families have enough to grow fruit trees, rice and vegetables, and rear domestic animals 
(R. D. Mattu, 2012). To supplement their subsistence living, many Indigenous people 
bring the wild meats, fruits, nuts and herbs they have sourced from the rainforest and 
the excess food they have grown on their farms to the town markets to sell (Soda, 
2007b). The dilemma many Borneo Indigenous tribes people face today involves 
inadequate infrastructure in remote areas, such as efficient transportation of products 
into and out of rural and remote areas. During the last general election the government 
made marketing of rural products a priority, but improvements have yet to be seen and 
many rural folk continue to move into towns because they cannot transport their 
products to market. There are also decisions to address such as whether to convert to 
modern farming techniques, often at the expense of ancient methods; for example, with 
rice production decisions have to be made about whether to continue using buffalo or to 
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mechanise, which requires using agrochemicals. Should they open their land for 
agricultural and pastoral development, or sell their land to large plantation 
corporations? With a better communication and transport infrastructure, modern work 
opportunities including industries that are eco-friendly, sustainable, profitable and 
micro-hydro electricity, perhaps more Dayaks would stay in the villages and make a 
good living, and be healthier (R. D. Mattu, 2012). 
Borneo is a very rugged island, and physical barriers and weather play a part in rural 
people being unable to see a doctor, especially those living in remote interior areas. The 
Flying Doctor service is irregular and usually only in a crisis. The plight of rural 
women in labour is well documented (Jegasothy, 2002) ,and emergency situations often 
end in tragedy. Rural people do not have the money or time to travel to Miri for 
hypertension or diabetes medication especially if they feel fine. One lady knew she had 
hypertension and diabetes that needed medication, but was told to see the doctor at the 
Desa Klinik near her longhouse. There was no doctor located there (Ch.7 P23). The 
poliklinik is subsidised by the government, as this lady noted:  
20 years already got tablets from the doctor … from the poliklinik so it’s not so 
expensive. (Ch.7 P1).  
The long travel time to Miri and a long waiting time at the poliklinik (Ch.7 P22) mean 
that many people do not bother to go. Private doctors‘ fees and pharmacy medication 
are too expensive for poor people (Ch.7 P1), especially for women who have lost a 
wage-earning partner (Ch.7 P21; P29). 
There are also establishment barriers. Government clinics and NGO dialysis centres are 
understaffed and their doctors, medics and nurses overworked, but generally they are 
efficient and committed to providing good patient care. However, there were a number 
of complaints from participants regarding the service or advice they had been given. 
Participants who were less educated and poorer were often treated in a condescending 
manner by medical staff:  
Sometimes I cannot stand the pain, but don’t want to see a doctor so just tough 
it out because they only say its wind or gastric problem. I asked for 
investigation but they said no need just cut down on coffee and tea. (Ch.7 P15)  
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One lady never goes to the clinic to see a doctor because  
If I go to see a doctor they only give me vitamins, so no need go-lah. (Ch. 7 P5)  
Some of the participants in this study felt patronised when ignored and their medical 
problems were not explained to them:  
The doctors and nurses at the dialysis centre never discussed or advised us our 
family about kidney disease when my sister was there and I think they should 
support us more. (Ch.7 P20)  
All haemodialysis centres have a duty of care to their patients, but it should not be 
difficult for the centres to extend support in the form of advice to those who help staff 
in the dialysis hall to tend to their relatives with end-stage renal disease.  
A common complaint from those who attend the poliklinik was that every time they 
went they saw a different doctor (Ch.7 P5; P4), and because there was no relationship 
with the doctor it made them feel awkward. A number of first degree relatives noted 
that, although their parent was on dialysis, this study was the only time they had had 
their kidneys or blood glucose tested (Ch.7 P14; P18). 
For a variety of reasons many Indigenous people are transferring from rural living to an 
urban lifestyle (Sarawak Government, 2011). In fact, all people who have relocated and 
set up family life in Miri have had to adjust in many aspects of their lives, including 
having to modify the kinds of food they eat. A number of Orang Ulu mentioned that 
they return to their kampung to harvest their rice and to collect fruits and vegetables 
from their farms (Ch.7 P4; P1), and a number of Indigenous, Malay and Chinese noted 
that they have gardens outside Miri to grow food (Ch.7 P2; P5; P9). Of particular 
interest were those who commented on how their food had changed over the last 
generation, a Malay man (Ch.7 P3), a Malay woman (Ch.7 P17), an Indigenous man 
(Ch.7 P5), an Indigenous woman (Ch.7 P15), a Chinese man (Ch.7 P21), and a Chinese 
woman (Ch.7 P28). 
A food transition occurs as people exchange home-grown farm and rainforest foods for 
urban fast-fried foods. Many participants described how their food composition and 
intake had changed since living in Miri, because they were faced with heavy offshore 
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food (Ch.7 P4), worked in the hospitality industry (Ch.7 P9), often travelled (Ch.7 
P27), cooked and looked after others (Ch.7 P5; P15), dieted (Ch.7 P32), changed diet 
in response to a medical condition (Ch.7 P21; P28), ate out in the market too much 
(Ch.7 P27; P25), attended too many functions and celebrations (Ch.7 P26; P32) and 
enjoyed fried fast foods (Ch.7 P14; P12). 
Rapid, unplanned urbanisation and changing lifestyles has led people to consume 
processed foods containing high-energy fats, sugars, and salt, and to have inadequate 
servings of vegetables and fruits (WHO, 2013b). Lukito and Wahlqvist (2006) 
postulate that with regard to food transition in a different environment, it takes a 
number of factors, including time, before body composition disorders become manifest 
in those who have migrated compared to those of the same ethnic group remaining in 
their geographical origins. This may explain this study‘s quantitative results. This study 
identified those in low-cost housing as having the greatest association with the 
metabolic syndrome (Table 5.6). Those who had come from country areas usually lived 
a number of years in the lower socio-economic housing areas (Huu, Abd Latif, & Nasir, 
1999) until they became established. The quantitative results in this study agree with 
this: by the time the participants moved from self-build or shanty areas to low-cost 
housing, their diet and food had transitioned from kampong to city style and they might 
also have become obese. 
Lipoeto, Geok Lin & Angeles-Agdeppa (2004) commented that in Malaysia, although 
traditional food patterns remain the same, the composition of recipes has changed with 
the addition of more animal products, palm oil and sugar, and that this is probably 
contributing to increasing obesity rates. Interestingly, he concludes that in Indonesia, 
the Philippines and Malaysia, rapid food transition and obesity are more due to 
increasing availability, variety and the purchasing power of people than a shift to 
Western fast food preferences. This is supported in the qualitative findings of this 
study: many participants said they preferred kampung food or spicy local food (Ch.7 
P17; P16; P5; P4) rather than fried fast foods. 
It is now established that urbanisation and an improved economic outlook in 
developing countries corresponds with increasing obesity and metabolic syndrome 
(Misra & Khurana, 2008). One can speculate from this current study that by the time 
people living in Miri reach middle age, they have a stable job, are upgrading their 
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home, have more disposable income, have an established social life which includes 
eating out more, but are busy working often offshore or travelling, don‘t exercise as 
much as they used to or should, and have developed a chronic non-communicable 
disease. 
8.1.7 Chronic kidney disease biochemical results  
To assess the status of chronic kidney disease in Phase One, all participants had their 
urine and blood taken and their estimated glomerular filtration rate (Table 3.3) and 
ACR (Table 3.4) calculated using the formulae described in Chapter 3, then their 
chronic kidney disease (Table 3.5) staging calculated (as described in Chapter 3.3.3). 
chronic kidney disease was determined by taking into account the ACR and the eGFR 
results; and the staging followed Kidney Health Australia (KHA-CARI, 2006) (KHA, 
2007) and KDIGO (2012) recommendations. Many of those recruited, in particular the 
first degree relatives, mentioned that they had never been tested for any chronic non-
communicable diseases, for chronic kidney disease, or for microalbuminuria even 
though their relatives were undergoing haemodialysis. 
The glomerular filtration rate / estimated glomerular filtration rate was calculated to 
determine kidney insufficiency. Initially results derived from four different methods, 
namely 4-variable MDRD eGFR, CKD-epi eGFR, Cockcroft-Gault Creatinine 
Clearance and rMDRD ‗175‘, were calculated and compared. Those participants who 
had a true normal kidney function were determined so they could be considered for 
selection for Phase Two, separate from those who had some kidney function 
deterioration but were still above >60 mL/min/1.73m
2
. The rMDRD ‗175‘ formula 
(Mathew et al., 2007) had the greatest number separation for stages 1 and 2, 4 and 5 
chronic kidney disease; therefore this formula was chosen. When reviewed against 
other studies in the region (Mathew, Corso, Ludlow, et al., 2010; Mau, West, Shara et 
al., 2007; O‘Dea, 2005; Tsai et al., 2010) this formula was deemed best suited to the 
Miri population group and the purposes of this study, especially as it included Chinese 
and Indigenous ethnicities. For the chronic kidney disease biochemical results (Table 
5.4), a present or absent one cut-off point was used at >/<60 mL/min/1.73m
2
 to screen 
participants for any association with chronic kidney disease. Comparing the first degree 
relatives to the spousal control group found no significant difference in glomerular 
filtration rate or chronic kidney disease (Table 5.4). 
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The urine ACR was used to calculate kidney damage (KHA-CARI, 2006) in the 
participants. Studies show that inadequately controlled diabetes mellitus and 
hypertension exacerbate chronic kidney disease and increase the risk of progression to 
end-stage renal disease (CDCP, 2010). In a study from Kuching, Sarawak that 
considers a similar demographic profile as this one, 48% of the diabetic patients had 
proteinuria or microalbuminuria and were at risk of developing diabetic nephropathy 
(Wong, 2005). Investigators for the Microalbuminuria Prevalence (MAP) study in 
Malaysia have recommended that all hypertensive type 2 diabetics be routinely 
screened for microalbuminuria to safeguard against cardiovascular disease 
complications and retard progression to end-stage renal disease due to diabetic 
nephropathy (N. Kong, Chia, Khalid, Juwita, Samiah Yasmin, Yap et al., 2006); 
however, this is not regularly practised. Freedman et al. (2005) have advised that 
screening the first degree relatives of end-stage renal disease patients will help pick up 
clinically silent proteinuria or chronic kidney disease. In this study there was a 
statistically significant difference between the first degree relatives and the spousal 
control group in the ACRn results (Table 5.4). The first degree relatives were more 
likely to have microalbuminuria than the spousal control group, and this reinforces the 
need for the first degree relatives to be screened for microalbuminuria, especially if 
they have type 2 diabetes. If these relatives are only being screened for 
macroalbuminuria using a dipstick, valuable time may be wasted instead of delaying 
their progress to end-stage renal disease. The ACRn can also be used as an indicator or 
marker of treatment adequacy and patient compliance. In a study including different 
ethnicities in the USA found that a single random ACRn measurement of men with 
higher muscle mass and in certain ethnic groups may underestimate microalbuminuria 
(Mattix, Hsu, Shaykevich & Curhan et al., 2002). Many Indigenous people in this study 
were physically active in their villages before they moved to Miri and many now work 
in manual jobs, so Mattix et al.‘s finding may also be valid for this study, and suggests 
a direction for future research. 
There were a number of possible risk factors leading to the development of chronic 
kidney disease. It was projected that the first degree relatives would have a greater 
association with developing chronic kidney disease (less than <60 mL/min/1.73m
2)
 
(Table 5.4) than the spousal control group. The results, however, show that both groups 
have a similar low percentage. As the mean age of participants was the early 40s (Table 
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5.1), the participants may not have been old enough for chronic kidney disease to have 
progressed to stages 3, 4 or 5. It would be useful to follow up these participants in ten 
years‘ time. As the groups are not statistically significantly different to each other, the 
question is whether environmental factors are coming into play. Death may also play a 
part for the over-50s and over-60s. For adults with chronic kidney disease, death from 
cardiovascular disease is actually more common than reaching end-stage renal disease 
(Alebiosu & Ayodele, 2005) and more prevalent than in the general population 
(Rashidi, Ghanbarian, Azizi &Adler, 2007b), creating much debate on whether the 
causation for cardiovascular disease is chronic kidney disease or its sequelae, especially 
type 2 diabetes and hypertension.  
Proceeding to the multiple logistic regression analysis to determine if there were any 
factors contributing to a predisposition for chronic kidney disease, it was determined 
that neither group was associated as a risk factor for chronic kidney disease (Table 5.5). 
Of the four factors associated with chronic kidney disease, the first three, age, ethnicity 
and alcohol, which was suggestive of being protective (Table 5.5), have already been 
discussed. The fourth factor, metabolic syndrome, was identified among this population 
group. There are also non-diabetic factors leading to the development of chronic kidney 
disease and end-stage renal disease in tropical countries (Almaguer et al., 2014; 
Weeraratna, 2012).  
8.1.8 Uninformed versus choice / no choice  
Each Dayak ethnic community of Sarawak and Sabah follows its respective adat, born 
out of their tribal history, cultural and religious traditions (Bulan & Locklear, 2008). 
These customs are the basis of ‗territorial domains‘ which connect the tribes people to 
their ancestral lands (Bulan & Locklear, 2008). If an Orang Ulu family moves to 
another location it must be with permission of the receiving kampung, who gives them 
an area to cultivate (Talla, 1979). Indigenous land is traditionally not allowed to be sold 
but is inherited by subsequent generations as long as members of that family reside in 
the kampung (R. D. Mattu, 2011). However, younger generations now have begun to 
petition for permission to sell their family land, and this is being supported by the new 
chief minister of Sarawak, Tan Sri Adenan Satem (Bernama, 2014), much to the 
dismay of tribal elders. When this occurs there is no returning to the kampung for the 
petitioners, and their migration to town becomes irrevocable. 
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A number of seemingly irreversible predicaments face the Baram population, some by 
choice and some by situations forced upon them. There are three reasons for the 
displacement of peoples in the Baram area. First is the declaration of forest reserves in 
the name of conservation, only to have timber concessions for some of these areas 
awarded to timber companies. Second is the building and impoundment of twelve 
hydroelectric dams to be developed along the Baram River by 2020. Between 25,000 
and 30,000 Indigenous people are expected to lose their ancestral lands when the next 
phase of the Baram dams is undertaken. Even among the small sample of people in 
Phase Two of this study, a number of the Orang Ulu declared their anguish over their 
families‘ impending displacement. Some have already had their lands flooded (Ch.7 
P6) and others are from kampungs that will be displaced when new dams commence 
impoundment (Ch.7 P16; P5). Third, the rapid advancement of vast monoculture oil 
palm estates is likely to escalate rural migration to Miri and other towns in Sarawak. 
Temporary occupation licences on native customary lands are awarded by the State 
Government Land and Survey Department to these companies (Sarawak Government, 
1996; State Attorney-Generals Chambers, 1999; Fong, 2001). In the past few years this 
has caused clashes between longhouses and company workers. Villagers who take the 
court route find it frustrating: 
The oil palm company … my mum and dad were forced off their traditional land 
... we took them to high court, 4 years already. The oil palm company keeps 
postponing it, every time go to high-court appeal. So many delays so much 
money to pay the lawyer. (Ch.7 P1)  
In the past among Indigenous tribes of Sarawak, headhunting was often associated with 
the advancement of tribal territorial claims (Ritchie & Langgu, 2009, p 35) and the 
protection of ancestral land, but now these people are disenfranchised (Colchester, 
1993) because their native customary land is not recognised. One Malay participant 
(Ch.7 P3) and one Melanau participant (Ch.7 P15) also had their family lands annexed 
by the Land and Survey Department and given to large companies to develop. The 
qualitative interview transcripts and the NVivo intersections reveal that the majority of 
those disenfranchised in Phase Two were the first degree relatives or those who had the 
worst chronic kidney disease and metabolic syndrome scores. 
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Comments by some Indigenous Iban ladies in Phase Two prompted a deeper 
exploration of agrochemicals in the interviews. This is in keeping with the methods of 
qualitative semi-structured interviews, which are flexible and allow questions to be 
adjusted as they progress to better uncover the living experiences of the participants 
(Saks & Allsop, 2013). These ladies spoke of an apparently large number of people 
from the longhouses in their area suffering from kidney disease and on dialysis (Ch.7 
P22; P23); another participant mentioned that a doctor suggested her kidney problem 
could have been from the spray she had been using (Ch.7 P5). One lady noted, 
I don’t know why … my brothers get kidney failure. We are all skinny and have 
worked hard on the farm all our lives. (Ch.7 P22).  
Agrochemicals used in tropical developing countries have been linked with chronic 
renal failure. Called chronic kidney disease of Unknown Aetiology in Sri Lanka, it is 
associated with not having diabetes, heavy metals, fertilisers and pesticides that 
promote the growth of blue-green algae toxins (Weeraratna, 2012). and drinking 
contaminated water and engaging in harmful toxic agrochemical practices, such as not 
wearing protective clothing, are implicated (Wimalawansa & Wimalawansa, 2014). 
These detrimental factors have also been identified in Central America named 
Mesoamerican nephropathy; it is most often seen in young male agricultural workers 
(Almaguer et al., 2014; Trabanino et al., 2002). 
Three quarters of the participants interviewed in Phase Two used multiple chemicals on 
a regular basis. The NVivo intersections showed that those participants who had the 
best chronic kidney disease scores knew how to handle agrochemicals properly (Ch.7 
P22; P31), followed safety precautions (Ch.7 P18; P24), or hired gardeners to use the 
agrochemicals (Ch.7 P32). A number of negative findings arising from the interviews, 
however, need to be followed up with more research so they may be properly 
addressed. 
Indigenous Iban, Kenyah and Kayan are the ethnic groups who predominantly work in 
the agriculture and plantation sectors and who were most often exposed to 
agrochemicals (S. Mattu, Lewis, & Soares, 2014; ‗The Different Types of Pesticides 
Available‘, 2014). A number of Iban participants in this study were from longhouses in 
the Sui District; they disclosed that they were mixing and spraying a variety of 
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fertilisers, pesticides and herbicides (Ch.7 P2; P5; P16; P22; P24; P31). Participants 
noted that agrochemicals, banned by WHO, are readily available at shops throughout 
Sarawak (Ch.7 P16). One study of the oil palm plantations in Sarawak (‗The Different 
Types of Pesticides Available‘, 2014) confirmed that a cocktail of agrochemicals is 
being used regularly in the Sui District. 
It was found that a number of participants using agrochemicals were not following 
standard safety procedures. This meant that they had direct exposure to the 
agrochemicals, and even if they used protection, it was not total protection (Ch.7 P18). 
They held risky beliefs; some were unaware of the toxicity of the agrochemicals, while 
others who knew still did not use protective gear (Ch.7 P23). The sprayers drank very 
little water while working and become very dehydrated (Ch.7 P22). A number of 
studies agree that pesticides are more readily absorbed through damp, sweaty skin (I. 
Fernandez et al., 2002) especially if the sprayer is severely dehydrated (Chavkin, 2013; 
Correa-Rotter et al., 2014), facilitating the absorption of the chemicals through the skin. 
Multiple applications of agrochemicals are widely used on and around the gardens and 
farms supplying fruit, rice, corn and vegetables destined to the Miri market. (Ch.7 
P23). Herbicides are sprayed around oil palm trees to keep them free of weeds; then the 
mushrooms and ferns that grow around the base of the trees are eaten (Ch.7 P15) or 
sold as favourite local foods to Miri restaurants. More medical research is needed to 
determine the dose-response of agrochemicals (C. C. Kuo et al., 2013) and whether it is 
the agrochemicals or the ‗inert additives‘, such as the solvents and surfactants used 
with the product, that lead to kidney disease over time (Azman, 1997). More research is 
needed in Sarawak on agriculture and plantation workers‘ habits. Education programs 
targeting those who use agrochemicals, and food safety awareness, intervention and 
enforcement (Watts, 2012) (Howard et al., 1981) are fundamental to ensure safe food 
consumption for the people of the Miri district. 
One older longhouse participant lamented that the children  
cannot swim in river or they get itchy skin. Cannot go fishing as no more fish 
live in river any more. (Ch.7 P22)  
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This is supported by the Sui District study (‗The Different Types of Pesticides 
Available‘, 2014). The agrochemical surplus is washed off into rivers during heavy 
rain, where it has polluted the waters and poisoned the fish. Drinking water has to be 
trucked in. For special guests the longhouse folk supply bottled water, an expensive 
gesture from people earning a minimum wage. Paradoxically, sugary soda drinks and 
beer are less expensive than bottled water and more commonly consumed in the 
longhouses. The virgin rainforests and rivers destroyed by timber and oil palm 
companies‘ activities are no longer a source of nuts, vines, fruits, wild animal meat and 
fish for longhouse folk. Their rich natural food stores depleted, they turn to less 
nutritious, cheaper foods purchased at the kedais. Many of the kampung children have 
rotten teeth from eating sweet foods such as kropok and gula batu and drinking soft 
drinks. Fatty, cheaper cuts of farmed meat bought at market have replaced the protein-
dense meat of wild animals and kampung chickens. In the longhouse kitchens, instead 
of boiling food as in the past, the womenfolk nowadays deep-fry meat and vegetables 
in cheap palm cooking oil.  
In this study the quantitative results showed that Malays, followed by Indigenous 
participants, had the greatest association with chronic kidney disease (Table 5.5) and 
that those participants living in self-build or longhouse accommodation had a greater 
likelihood of developing metabolic syndrome than Chinese participants living in urban 
areas (Table 5.1). Independent of and discrete from the toxic route agrochemicals may 
have on the body‘s end-organs, environmental challenges imposed on longhouse 
occupants that forced a transition in food choices and cooking methods may be at the 
root of metabolic changes initiating obesity and chronic non-communicable diseases. 
Age and migration to an urban centre may ultimately promote the development of 
metabolic syndrome, as the participants living in low-cost housing, many of whom 
originally come from rural and remote areas, had the greatest probability of developing 
metabolic syndrome (Table 5.6). 
8.1.9 Behavioural lifestyle factors  
Smoking is top of the list as a self-sabotaging barrier to health and a known risk factor 
for chronic kidney disease (Briganti et al., 2002; Ejerblad et al., 2004). In this study 
17.0% of the cases and 12.6% of the controls were current smokers (p=304) (Table 
5.1). Hammond et al. (2008) have found that Malaysian teenagers who are daily 
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smokers are mostly male; 7% smoke Indonesian brands but the majority smoke 
Western brands, and there are no observable rural, urban or ethnic differences. This is 
not typical of the general Malaysian population, but early initiation predicts long-term 
dependency and use (Hammond et al., 2008) and is particularly damaging to the heart 
and kidneys (Orth & Hallan, 2008). In the qualitative portion of this study, although 
they admitted to smoking in the past, fewer first degree relatives still smoked. Many of 
those who smoked commented in the interviews that they commenced as young 
teenagers; the damage may now be starting to reveal itself. 
Obesity, smoking, and physical inactivity are significantly associated with risk of 
chronic kidney disease (Hallan, Mutsert, Carlsen, Dekker, Aasarød, & Holmen, 2006) 
and cardiovascular disease (Orth & Hallan, 2008).  Smoking is potentially within one‘s 
control and if smoking ceases some of the risks of chronic kidney disease are mitigated 
or even reversed (Halimi et al., 2000) and damage from macroalbuminuria in persons 
with type 2 diabetes may be lessened (Chuahirun et al., 2004). A population based 
survey of Asians living in Singapore found that although smoking was slightly higher 
amongst non-diabetics, there was no significant increase in cardiovascular disease risk 
for those with type 2 diabetes even though there were metabolic syndrome factors 
present (Hughes, Choo, Kuperan, Ong, & Aw, 1998). Although women are far less 
likely to smoke than men (Hammond et al., 2008) a Norway study has found that the 
risk factors for chronic kidney disease, obesity, smoking and physical inactivity are the 
same for men and women (Hallan, Mutsert et al., 2006). Clearly there are wide 
variations in study results. In the multiple logistic regression analysis of this study, 
smoking was found to be a factor associated with obesity and metabolic syndrome in 
the participants, and current smokers were 3.16 times more likely to develop this than 
non-smokers (Table 5.6). This result appears to be in contradiction to studies indicating 
that obesity is significantly higher in non-smokers in Peninsular Malaysia (L. Rampal, 
Rampal et al., 2007; Tan, Dunn, Samad, & Feisul, 2010), but concurs with a Korean 
study (Oh, Yoon, Lee, Kim, Park, Lee et al., 2005). Two major factors were persuasive 
in participants‘ giving up cigarettes: first, if a sibling or parent died of smoking-related 
lung infection or cancer (Ch7 P15), but second, and more significant, if they had been 
diagnosed with or experienced symptoms of a chronic non-communicable disease such 




There are a number of conflicting studies of the risk of chronic kidney disease from 
smoking or smoking and alcohol consumption. In a 2003 study of data from the second 
National Health and Nutrition Examination Survey (NHANES II), it was found that 
smoking contributed to the risk of chronic kidney disease but alcohol did not (Stengel 
et al., 2003). A 2006 study, however, found that heavy drinking was associated with 
chronic kidney disease and increased almost five-fold the odds of developing chronic 
kidney disease if the person was also a current smoker (Shankar, Klein, & Klein, 2006). 
The urge to smoke a cigarette is often triggered by an event such as eating a meal, 
having a cup of coffee or drinking alcohol (Benowitz, 2010). Surprisingly, in this study 
drinking alcohol was found to be a protective factor against developing chronic kidney 
disease, compared with people who never consumed alcohol (Table 5.5). No data was 
collected on the quantity of alcohol consumed, so although alcohol was suggestive of 
being protective in this study, this is not conclusive. It was suggested in one study that 
alcohol consumption, although not directly associated with chronic kidney disease, may 
contribute to morbid obesity and that this together with physical inactivity contributes 
to the risk of chronic kidney disease (Stengel et al., 2003). More research is needed into 
this topic; for even if alcohol is protective to the kidneys it may still contribute to liver 
disease.  
Miri has the most pubs of any town or city in Borneo, encouraging young people to 
spend their money on alcohol and pub food. As their wallets get lighter their bodies 
gain weight. A senior Chinese gentleman made an incisive social observation:  
We have a lot of natives who are educated, hard working and very 
knowledgeable and live a healthy life but too many others eat, drink and smoke 
too much and don’t look after their diabetes and hypertension, then end up on 
dialysis. (Ch.7 P25) 
Negative behavioural lifestyle factors may activate the development of type 2 diabetes 
and hypertension. As discussed in Chapter 3, obesity, which is often initiated by 
negative behavioural factors, may lead to the development of type 2 diabetes. The 
results of the oral glucose tolerance test were statistically similar for both the first 
degree relatives and the spousal control group (Table 5.4) and it is expected that the 
incidence of developing type 2 diabetes will increase as both groups age. 
Inconsistencies have between found in glucose readings using venous plasma blood or 
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capillary whole blood (Colagiuri, Sandbæk, Carstensen, Christensen, Glumer, 
Lauritzen et al., 2003) and the glucose in whole blood, as measured by a glucose meter, 
is unstable (Tonyushkina & Nichols, 2009). In this study a fasting plasma glucose and a 
two-hour post-glucose load of venous plasma (an oral glucose tolerance test) was taken 
to provide a definitive diagnosis of type 2 diabetes and hyperglycaemia, as 
recommended by the Australian Diabetes Society (Colman, 1999) and WHO (WHO, 
2006). 
For the multiple logistic regression analysis, the impaired fasting glucose and impaired 
glucose tolerance categories were combined using the cut-off point of >7.8 mmol/L. 
Compared with participants with normoglycaemia, those with impaired fasting glucose 
or impaired glucose tolerance, or type 2 diabetes, had a greater likelihood of having 
metabolic syndrome (Table 5.6). The deterioration of glucose tolerance corresponded 
with an increased probability of having metabolic syndrome in participants who had an 
estimated 3.57 times higher probability for impaired fasting glucose and impaired 
glucose tolerance and a 14.31 times higher probability for type 2 diabetes (Table 5.6) 
after controlling for and adjustment of potential confounders. This result is comparable 
to increasing abnormal glucose tolerance prevalence rates in Australia (Dunstan et al., 
2002) and in Kuala Lumpur, Peninsular Malaysia (Mustafa et al., 2011). 
The role of hypertension in chronic kidney disease is complicated as it is both a cause 
and an effect of chronic kidney disease (M. V. Rao, Qui et al., 2008) and is also 
associated with other chronic diseases linked with chronic kidney disease, particularly 
diabetes mellitus and coronary heart disease (Bakris et al., 2009). This study found no 
statistically significant difference between the first degree relatives and the spousal 
control group blood pressure readings (Table 5.4): both groups had poor readings 
although the Phase One questionnaire revealed that many were on medication for 
hypertension - meaning they had uncontrolled hypertension. In the literature review 
(Chapter 3.3.2.2) it was noted that the leading cause of end-stage renal disease in 
Peninsular Malaysia was type 2 diabetes (58%) by a large margin (hypertension scored 
9%) (Y. N. Lim et al., 2011), while in Miri the leading cause of end-stage renal disease 
was hypertension (32.5%) then type 2 diabetes (30.4%) (MRC, 2010). There is need for 
a study to determine why there is such a difference in percentages, although a number 
of reasons may be postulated: for instance, there is a better doctor to population ratio in 
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the large urban cities of Peninsular Malaysia (MDOS, 2014) and the doctors may have 
more opportunities to test for and diagnose hypertension. Rural and remote people in 
Sarawak may not be screened for hypertension or type 2 diabetes and so are not given 
medication to impede progression of chronic kidney disease. Or perhaps those living in 
Miri who are diagnosed with hypertension are not compliant in taking their medication. 
8.1.10 Chronic disease and nutritional marketing  
In this study the patience, resilience and love shown by the first degree relatives who 
were caretakers of family members with end-stage renal disease is exemplary. This 
does not exempt them from the fear that one day this will be their destiny too. This was 
the biggest difference in concerns articulated by the spousal control group and the first 
degree relatives of all ethnicities, Malay (Ch.7 P18), Chinese (Ch.7 P25) and 
Indigenous (Ch.7 P5). No other studies have been found expressing the first degree 
relatives‘ fears of developing the disease, although in a study of diabetic patients, the 
participants expressed a personal fear of developing diabetes mellitus complications 
and a fear that their children would also develop type 2 diabetes (Rafique & Shaikh, 
2006). The first degree relatives have the experience of living with a close relative on 
haemodialysis. Their perspectives on end-stage renal disease and the family disturbance 
created by this unfortunate circumstance are telling. In public they display fortitude and 
hide the trauma of coping with end-stage renal disease in the family, and anxiety about 
their own health. The confidential interviews in this study gave them permission to let 
down their guard, allowing them to expose their grief, distress and despair. Many of 
these men and women cried.  
In this study, members of both groups in Phase One who scored poorly for both kidney 
disease and metabolic syndrome reported feeling unnerved when they found out they 
had an advanced chronic non-communicable disease. Had the blood tests not been 
sponsored they might never have known, for they had never been offered the tests and 
were unable to afford them. A qualitative study of end-stage renal disease patients and 
their partners‘ experience of dialysis found that the couples went through a number of 
stages: ‗anger, depression and hopelessness were evident in the patients, whilst a 
pervasive sadness, resentment, guilt and loss were prevalent in the partners‘, White and 
Grenyer (1999, p. 1312) exposing the emotional impact dialysis has on families as they 
adjust to the upheaval in their lives. A study reported that even five years after a renal 
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transplant, patients who had been on dialysis still held significant fears, prompting the 
authors to recommend interventions to be designed to promote quality of life for those 
on renal replacement (Fallen, Gould, & Wainwright, 1997). In the qualitative portion of 
this current study, those from both groups who had the best chronic kidney disease and 
metabolic syndrome scores appeared to have better jobs, more money, were not 
encumbered looking after a relative, were able to return to their kampung of origin 
regularly, and were happier. Those with poor scores wanted to understand ‗why me?‘. 
Stress is a significant barrier that affects one‘s health and quality of life. The difficulties 
of recent arrivals to Miri in adjusting to urban life, or of those dealing with family 
dynamics complicated by end-stage renal disease, coupled with stress at work, have 
been previously discussed. Responsibilities generating stress may be a barrier to 
participants‘ seeing a doctor and being diagnosed: participants most often cited ‗lack of 
time‘ or ‗too busy at work‘ as an excuse not to see a doctor. Sometimes a little 
misinformation or knowledge led participants to decide that they knew better than the 
doctor (Ch.7 P3; P32), and this obstructed diagnosis and timely treatment for a chronic 
non-communicable disease. Other self-imposed barriers included non-compliance 
(Ch.7 P22; P15; P12), discontinuation of medication (Ch.7 P31; P5; P1) and buying 
medicine from a pharmacy without seeing a doctor first, as in this case: 
Last time I bought medicine from outside but later doctor tested me and found I 
had high blood pressure and also I had kidney problem and my legs were all 
swollen. I don’t take the medicine from pharmacies now but just what the 
doctor gives me. (Ch.7 P28)  
Early recognition, diagnosis and treatment depend upon seeing the doctor. One man, 
assessed as having metabolic syndrome, knew his blood and urine results indicated he 
needed to be followed up medically, but  
I don’t feel ill so can’t get off work and not much time to go to see a doctor. 
(Ch.7 P10)  
This illustrates the insidious nature of type 2 diabetes, hypertension and chronic kidney 
disease in the early stages. The quantitative results of this study show that those with 
the poorest metabolic syndrome results (Table 5.5) are 3.06 times more likely to be 
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associated with chronic kidney disease; the first degree relatives are 2.4 times more 
likely to be associated with metabolic syndrome (Table 5.5). These are the people the 
qualitative NVivo intersections identified as the ones most influenced by nutritional 
supplement sales companies and marketing. This may be an important area to 
investigate further. 
Many participants fully believed the nutritional information provided by nutritional 
products. The companies marketing these supplements, and the pharmacies promoting 
them, are tapping into the fear that many people, including relatives of ill people and 
those with a chronic non-communicable disease, have for their health. Some 
pharmacies in Miri hire young form 5/6 (year 11/12) girls of different ethnicities, 
dressed in white medical coats, to persuade customers to buy nutritional supplements. 
Their sales pitch is very convincing and the market is fertile. One particular product 
was mentioned by eleven of the participants with the worst chronic kidney disease and 
metabolic syndrome scores from both groups, but not mentioned at all by the best 
scorers. Upon investigation it was found that the product, Monavie, was being 
promoted as a protein shake and supplement for weight loss. One participant with type 
2 diabetes said,  
Monavie, very expensive … doctor said that Monavie is not suitable for diabetes 
patients due to high sugar level it contains. (Ch.7 P15) 
Participants on hypertension, diabetes or cholesterol medication were trying to lose 
weight by taking this supplement rather than following an exercise and diet program. 
As this first degree relative participant said,  
There are a lot of seminars on diabetes and hypertension in the community but 
mostly organised to sell supplements and such but doesn’t really help us to 
learn how to change our lifestyles like what foods to eat or not. (Ch.7 P21).  
There are few dietitians in Sarawak, and public nutrition seminars in Miri are often 
organised to promote and sell nutritional supplements backed by claims based on half-
truths. More rigorous research is needed to endorse or disprove their claims. 
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8.1.11 Traditional versus modern  
The use of traditional (Malay, Chinese and Indigenous) doctors and medicines 
contrasted with participants‘ attitudes towards Western doctors and medicine, leading 
to complex and profound contradictions. In Malaysia each ethnicity has its own 
particular traditional medical system, and although Western-style clinics and health 
centres have been established, both urban and rural people still look to traditional 
practitioners as either a sole or complementary medical provider (P. C. Y. Chen, 1975). 
The participants in this study were not shy about talking about their family practices 
even when they appeared to be torn between the heritage of their parents and, 
especially in the under 50s, a more Western world approach to medicine. Traditional 
medical knowledge is passed down through the generations, is often mystical as well as 
empirical, and is deeply rooted in the cultural practices of each ethnic group (P. C. Y. 
Chen, 1975;) no two systems are the same (P. C. Y. Chen, 1981b). This is evidenced by 
the spiritual attachment many participants in this study had for traditional practices, 
described differently by Iban (Ch.7 P24), Melanau (Ch.7 P31) and Chinese (Ch.7 P21). 
The groups least likely to follow traditional methods and consult traditional 
practitioners was the Orang Ulu whose parents had converted to Protestant Christianity 
during colonial rule (Ch.7 P1; P16), and those whose parents and themselves had 
attained higher education (Ch.7 P20, P25; P28).  
Some participants were purists:  
I only eat Malay traditional jamu (herbal) products. (Ch.7 P10)  
I only take the Chinese herbs. (Ch.7 P27)  
It was more common for participants to mix medical systems. One Chinese lady said,  
I am a Christian (RC). Traditional practices, we still believe in the Chinese 
traditional doctor [Sinseh] ... Maybe if really sick we’d go to hospital. (Ch.7 
P19) 
Many participants fence-sat like this, not sure which way to fall: not wanting to offend 




In Peninsular Malaysia an ill individual may seek treatment from one or a combination 
of the Western doctor, the Malay bomoh, the Chinese sinseh, the Indian or the Orang 
Asli medicine men. It is not uncommon for a person, not satisfied with the advice given 
them by one medical practitioner, to seek treatment from another from a different racial 
group and medical system (P. C. Y. Chen, 1981b). In Borneo there are many 
Indigenous medicine systems as well, providing different modalities. In this small 
study sample participants had parents or grandparents who were a Chinese sinseh (Ch.7 
P20), a Malay bomoh (Ch.7 P14) and a Melanau medicine sharman (Ch.7 P31). The 
participants in this study appeared to separate the spiritual side of traditional medicine 
from traditional practices and the taking of traditional herbs. For instance, an Iban lady 
said,  
I am still a pagan [Animist]. We follow traditional belief and practices, but I 
never take herbs for my hypertension, and if I am sick I see the government 
doctor. (Ch.7 P22)  
There is a sense of hedging one‘s bets by counterbalancing one method with another - 
if one method doesn‘t work, maybe the other will. 
Some Western-trained doctors combine systems: for example, a Chinese physician may 
use acupuncture (Heggenhougen, 1980); this is common practice in Miri. Apart from 
cultural forces, political and economic forces created by a two-tiered poor-public rich-
private system (Chan, 2014) may influence a person to choose a traditional practitioner 
in preference to a Western doctor (P. C. Y. Chen, 1981b). Medical pluralism in 
Malaysia is unlikely to change in the near future although there are calls to incorporate 
traditional healers into the government health-care system (Heggenhougen, 1980). A 
Chinese participant best articulated the path that most followed: 
I practise Buddhism but it’s like this, since it’s inherited from my parents we 
just follow on. We don’t burn incense at home. I don’t practise Tai Chi. (Ch.7 
P26)  
Most participants declared loyalties divided between their ethnic, religious or parental 
practices and what they considered more modern. Higher education and many years 
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living in the city appear to be the ‗deal breakers‘ for switching exclusively to Western 
trained doctors and Western medicine. 
Traditional, complementary and alternative medicine have received much press 
attention, both positive and negative, in recent years. There are more than 12,000 
registered traditional and complementary medicine practitioners in Malaysia (Abuduli, 
Ezat, & Aljunid, 2011). Six universities and colleges are now running traditional and 
complementary medicine programs. Political and public interest has led the Traditional 
Complementary Medicine (TCM) Division of the Malaysian Ministry of Health to 
establish integrated hospitals in 2006, allowing herbal preparation, acupuncture and 
traditional massage to be practised in the hospitals (Abuduli et al., 2011). Kuching 
Hospital is the only one with a traditional and complementary medical unit in Sarawak. 
A survey found that 69.4% of the Malaysian population had used traditional and 
complementary medicine (P Y Lee, Taha, Bennett, Lin, Ghazali, Almashoor et al., 
2007). A survey conducted in primary care clinics in Kuching, Sarawak noted that 51.4% 
patients had used traditional and complementary medicine with  47.8% of those 
patients had used multiple medicines (Siti, Tahir, Farah, Fazlin, Sondi, Azman, et al., 
2009). The participants in this current study demonstrate that traditional and 
complementary medicines are widely used across all ethnicities, ages and socio-
economic stratum in Miri as well. 
Abuduli et al. (2011, p. 2) make the claim that ‗T&CM has been proven to be 
successful in treating numerous diseases and conditions with less side effects. For 
example HIV/AIDS, certain kind of cancer, malaria, SARS, hepatitis B, insomnia, 
anxiety, depression and some chronic diseases and conditions‘ ( Abuduli et al., 2011, p. 
2), but offer no evidence except to say that more research is needed in these areas. This 
claim sounds similar to the Orang Ulu participant in this study who said  
I take herbs called Sabah Snake Grass... also take the herbs from ulu (remote, 
upper reaches) Baram from the Penan but don’t know where it comes from. 
Function of those herbs is to reduce the blood pressure, cholesterol, diabetes 
and blood poisoning—cures everything. (Ch.7 P16) 
One bottle of Sabah Snake Grass costs RM78.00 for 60 capsules from a direct 
salesperson. The label says that it will ‗help: overcoming constipation, anti-cancer, 
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remove toxin, reduces uric acid, reduce exhausted, keep kidney, reduces cholesterol, 
drop in a sugar, overcome the inflammation of the prostate, launch her period‘ and ‗it 
has been approved by the bureau pharmaceutical Malaysia‘. Local knowledge and 
observation often align traditional herbs with certain diseases and cures but there has 
been very little evidence-based research conducted to prove an association so far. 
Chinese herbs, mostly boiled and drunk as a tea, were commonly consumed by almost 
all Chinese participants and by many of the other ethnicities in this study. Food 
prepared with local herbs and spices is prized, and all ethnicities promote their unique 
dishes and flavours throughout Sarawak. Three examples are Ka Ca Ma, a Chinese 
chicken and herb dish eaten during the post-natal period, bamboo stuffed with chicken 
and herbs then smoked over an open fire by Iban persons, and Kikid Kering, a Kelabit 
speciality herb porridge. There are more than 1,000 types of Malay, Chinese and 
Indigenous traditional herbs regularly consumed by Sarawak locals, and 50,000 wild 
herbs with commercial value identified in Malaysia‘s rainforests (‗Gain knowledge of 
herbs,‘ 2015). 
A Malaysian survey found that 70% of the population accept traditional herbal 
medicine because they believe that it will not bring about side-effects and is 
comparable to Western medicine (‗Gain knowledge of herbs,‘ 2015). The reasons most 
often mentioned by the participants in this study were that it had no side-effects and 
was comparable to Western medicine; in fact, there was a strong belief that it was 
better (Ch.7 P28) (Ch.7 P21).  
A little disconcerting is the statement that ‗although great numbers of people use 
T&CM recently, many people are not aware of the side effects of T&CM. Some people 
hesitate in using T&CM concurrently with conventional medicine or as alternative 
therapies‘ (Abuduli et al., 2011, p. 2). A number of participants in this study said they 
mixed herbal with Western medicine (Ch.7 P16) (Ch.7 P21) and most said they never 
informed their doctor of this (Ch.7 P3). When queried they said they were never taken 
together; but this did not mean that they were not consumed within a few hours of each 
other. High steroid content is known to be present in some herbal products in Miri 
(Ch.7 P3) and can interact with Western medicine given to patients. Overdosing can 
occur if patients consume both herbal and Western medicines containing steroids, or if 
women take herbal supplements containing phytoestrogens and hormone replacement 
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therapy at the same time. Chui et al. (2009) warn that toxicity and interactions with 
anti-cancer drugs can occur in cancer patients taking traditional and complementary 
medicines at the same time as receiving chemotherapy. They too found that few 
patients of Asian ethnicity actually informed their doctors that they were taking 
traditional or complementary medications (Chiu et al., 2009). If medical pluralism is 
going to be accepted and herbal medicine is to be integrated into the general hospital 
system in Malaysia, research and dissemination of results is urgently needed on herbal 
pharmacologic dosages, the contents and active ingredients in the traditional and 
complementary medications, the washout period, contraindications, and their 
interaction with Western medicines. 
The first degree relatives recorded the most suspicion towards Western doctors and 
Western medicine. A few of the more educated participants suspected that traditional 
and complementary medications and supplements had a placebo effect (Ch.7 P32) 
(Ch.7 P10). In the interviews the women never mentioned having massages and the 
men never mentioned having acupuncture, but from observation in Miri these practices 
are common among both genders. Some of the participants mentioned Bario salt (Ch.7 
P5) (Ch.7 P16), which has a high potassium to sodium ratio and a high iodine content; 
the rural or remote communities who eat this spring salt do not get iodine deficiency 
goitre or children with cretinism (P. C. Y. Chen, 1981a; A. Osman, 2003). A number 
said they cooked with cheap non-iodised salt in Miri. Miri is on the coast, and seafood, 
prawns and shrimp, made into a paste (belacan), are common foods and a good source 
of iodine. Ikan bilis (anchovies), a high purine food, is enjoyed by all Sarawakians. 
Indigenous and Chinese people love to eat pork organ meats, and the Malay people eat 
a lot of beef and lamb red meat—also high in purine. Many of the men mentioned they 
drank alcohol. If they experience gout, they change their diet radically and stop 
drinking alcohol (Ch.7 P10) as this participant said:  
Recently not well because of gout … But I getting better at controlling what I 
eat now days. (Ch.7 P7)  
For those with chronic non-communicable diseases, there may not be pain or another 
reminder to alter ones‘ lifestyle; so motivation and desire have to be factored into 




doctors should do more free talks for the community. I taught myself about 
diabetes and the changes you need to do in lifestyle in order to control it. For 
me it’s very difficult to advise others and have to give them time to change their 
diet and lifestyle. (Ch.7 P21) 
8.1.12 Metabolic syndrome clinical and biochemical results  
Metabolic syndrome is perplexing. Rather than a single component of the syndrome 
leading to chronic kidney disease, it is more likely that a cluster of factors all contribute 
(Rashidi, Ghanbarian and Azizi, 2007a). In this study, for the multiple logistic 
regression analysis to determine the associated factors for chronic kidney disease, it 
was found that people with metabolic syndrome have a 306% (Table 5.5) increased 
likelihood of developing chronic kidney disease compared with the healthy 
participants. Metabolic syndrome also forewarns of the risk of cardiovascular disease in 
those with chronic kidney disease (Prasad, 2014). Further multiple logistic regression 
analysis was performed to determine what factors contributed to metabolic syndrome in 
the participants. 
In the multiple logistic regression analysis in this study there were a number of 
possibilities leading to an association with having metabolic syndrome, after 
adjustment for potential confounders. Significant factors associated with metabolic 
syndrome in the participants (Table 5.6) which have already been discussed, include 
aging, being a first degree relative of an end-stage renal disease patient, having a family 
history of cardiovascular disease, being a current smoker, and having type 2 diabetes. 
The final factor, living in terraced or low-cost housing, can also be said to incorporate 
socio-economic and environmental aspects. 
The benchmark for screening was the International Diabetes Federation metabolic 
syndrome clinical parameters with South East Asian ethnic-specific measurements for 
abdominal obesity (Alberti, Eckel et al., 2009). In this study the metabolic syndrome, 
waist circumference, clinical and biochemical results were calculated for each 
participant and their likelihood of developing metabolic syndrome determined. 
Metabolic syndrome was more likely to be present in the first degree relatives group 
(37%) than the spousal control group (23%) (p=0.012) (Table 5.4). The clinical and 
biochemical results revealed no statistically significant difference between the first 
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degree relatives and the spousal control group for their systolic or diastolic blood 
pressure readings (Table 5.4). Waist circumference (determining abdominal obesity) 
predisposes a person to multiple chronic non-communicable diseases (IDF, 2006) and 
contributes to high triglycerides and low HDL-C in persons at risk for cardiovascular 
disease (Alberti, et al., 2005). The first degree relatives had significantly higher levels 
than normal for triglycerides (p=0.012) and for TC : HDL-C Ratio (p=0.025) (Table 
5.4). These results translate to an increased associated likelihood for the development 
of cardiovascular disease in the first degree relatives with abdominal obesity and 
metabolic syndrome. 
A study found that in Asian Chinese populations, this study‘s reference group, 
metabolic syndrome is an important risk factor for chronic kidney disease (J. Chen, Gu 
et al., 2007). Although the debate as to what element, or group of elements, initiates 
chronic kidney disease first continues, it is increasingly clear that components of the 
metabolic syndrome are implicated (Ritz, 2007), and that multiple components of the 
metabolic syndrome lead to or exacerbate the development of chronic kidney disease 
(Rashidi, Ghanbarian &Azizi, 2007a). One unifying underlying causal factor for the 
metabolic syndrome has not been identified, although insulin resistance, to which 
obesity contributes, is often associated with metabolic syndrome and predicts type 2 
diabetes and cardiovascular disease (Alberti et al., 2005). As described in Chapter 
3.4.4.2, persons with insulin resistance often have abdominal obesity and impaired 
glucose tolerance or hyperglycaemia (Kaur, 2014). Metabolic syndrome is a risk factor 
for both chronic kidney disease and cardiovascular disease (J. Chen, Gu et al., 2004), 
independent of diabetes and hypertension; and in a vicious spiral, chronic kidney 
disease may aggravate insulin resistance and hypertension (Guarnieri et al., 2010). Ritz 
(2007) cites a number of international studies linking metabolic syndrome to early 
kidney deterioration. The juxtaposition of obesity, insulin resistance and metabolic 
syndrome associated with chronic kidney disease and end-stage renal disease may be a 
clue why renal deterioration and microalbuminuria commence before hypertension and 
diabetes become apparent (Iseki, 2008); they may even be a trigger for renal 
dysfunction (Wahba & Mak, 2007). This is a strong reason to promote having first 
degree relatives with metabolic syndrome screened for chronic kidney disease and 
microalbuminuria, and indicates the need for regular community public health 
awareness campaigns to promote maintaining a healthy weight, controlling type 2 
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diabetes and hypertension, complying with medical intervention, and preventing or 
reverting metabolic syndrome. 
8.1.13 Aging and compliance  
Malaysia is becoming an aging population. The population of Malaysia is projected to 
reach 32.4 million by 2020, with one million more men than women, and 10% will be 
over the age of 60 (MDOS, 2014). The Malaysian government conducts a nation-wide 
census every ten years, and the last one in 2010 found that the average life expectancy 
has risen to 71.05 years for men and 76.73 years for women (MDOS, 2014). This is 
largely due to health-care improvements and the outreach of medical clinics, an 
increase in medical staff, widespread vaccination of infants and children, and control 
and medication for infectious diseases; all of these have contributed to the improved 
health of the nation. Unfortunately, longevity does not always bring good quality of 
life, and over the past few decades the incidence of chronic non-communicable diseases 
has been steadily mounting. Malaysia has no medical insurance or social welfare old-
age pension, and when people retire it is stressful and expensive if they become ill or 
have a chronic illness, especially if they have limited savings. For the elderly who 
become sick in Malaysia, the burden of their medical expenses usually falls on their 
family. Apart from one Chinese nursing home, there is no fall-back support of nursing 
homes or retirement villages for other ethnicities in Miri. The supporting family 
members and, as this study has shown, the spousal control group are also affected, need 
the tools of knowledge and skill to help them cope with their circumstances. It is 
essential that local and state governments consider health awareness, education and 
prevention strategies in the under-50 age groups to avoid the ramifications of an aging 
population with chronic non-communicable diseases and cardiovascular disease which 
will place stress on the health care system in the future. Rafique and Shaikh (2006, p. 
347) have asserted that ‗understanding needs and expectations of people with diabetes 
is essential in initiating and improving the outcomes of education program for diabetes 
self care‘. 
A number of compliance issues were divulged by the participants. Some felt that Miri 
doctors over-prescribed and said they did not take the medicine (Ch.7 P32), a number 
said they stopped taking medication as soon as they started to feel better (Ch.7 P12; 
P5), some said they keep some medicine for ‗next time‘ (Ch.7 P1) and some felt the 
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medicine was no good or made them worse and so stopped taking it (Ch.7 P22; P3). 
Most participants resisted the idea of taking medicine for the rest of their lives, yet 
were not compliant with exercising: 
Doctor did advise me go for exercise but I didn’t follow his advice. (Ch.7 P14)  
or choosing healthy food options:  
At first I followed a diet after the doctor advised me to cut out fat, salt and 
sugar in my food but I got tired of it and it didn’t last long as I wanted to eat 
more tasty foods. So I stopped and now days I not really worry about my diet at 
all. (Ch.7 P4)  
It is important for persons with a chronic non-communicable disease to make changes 
with the aim that they will be life-long. Unless they commit to a lifestyle paradigm shift 
there will be no health gain, and this needs to be factored into intervention programs. It 
is easy to assume that ‗people know‘, but the reality is that unless they are told and 
shown - unless they comprehend why they need to change, they will never change. For 
instance, recently at an Iban longhouse, where some of the participants in this study 
who have hypertension lived, many ladies attended a cooking session organised to 
demonstrate how to cook healthy versions of local dishes. One lady commented after 
the session,  
When the doctor told me to cut out fat and salt in my diet I did. I now use oil 
instead of lard and replaced salt with pati ayam (stock cubes). I never knew 
salt, sugar and fat hides in food. I cook and eat kicap, chilli sauce and soy 
sauce with everything!  
This sentiment was echoed by a number of participants with spouses who had type 2 
diabetes and two whose spouses had commenced dialysis since Phase One:  
A dietitian sometimes advises my husband but not me yet I’m the cook. 
Sometimes difficult to get protein and water balance right. (Ch.7 P14)  
It is recommended that Malaysia start preparing for the consequences that come with an 
aging population. High rates of chronic non-communicable diseases, chronic kidney 
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disease and cardiovascular disease will have an impact on the national economy, and in 
particular the health care system. The qualitative intersections in this study identified a 
lack of compliance by participants across all age groups. This area of convergence may 
be an important contribution to the quantitative results for diabetes and metabolic 
syndrome (Table 5.6). Rates will not improve unless pharmacological compliance by 
patients is achieved. Health awareness and education programs need to address this 
issue, emphasising the importance of a life-long program of diet, exercise and 
medication to help slow the progression of all chronic non-communicable diseases. 
8.1.14 Confusion versus compromise  
This study identified many beliefs and fears of those who have, or who are supporting 
family members with, a life-impacting chronic non-communicable disease, chronic 
kidney disease or cardiovascular disease.  
The Indigenous groups were more likely to mention health changes they had 
experienced since moving to Miri:  
When I was living in the kampong I felt healthy then first time come to Miri I 
felt weak. (Ch.7 P6)  
The Chinese participants were the most vocal on the subject of stress. There is implicit 
pressure on the family provider, and often they sacrifice their health for the benefit of 
their family. A stressful job with responsibility, long hours and time away from home 
takes a toll on family life and personal health, but unless the provider is able to provide 
for the family, they literally go hungry, go without medical care and go without 
material things. It is hard on older members of a family when a provider or those 
sharing financial responsibilities die, and they themselves are too old or sick to work 
(Ch.7 P21). Participants from younger generations also expressed fear of this 
happening (Ch.7 P27). 
In Malaysia there is still a stigma connected with mental health, and mentioning that a 
family member has a mental issue is deemed to bring shame and disgrace to the family. 
Only those with severe mental health problems are provided for by the government 
health system, and psychiatrists, psychotherapists and psychologists are few in 
Sarawak. Doctors are the first point of contact for many, as at present there are no 
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private counselling services available. Counselling services for relationship, stress and 
addiction problems are most often run by volunteer or religious groups. Interestingly 
there were a number of suggestions offered by the participants to reduce stress, 
including using supplements (Ch.7 P18), sharing with family (Ch.7 P19), religion and 
reading (Ch.7 P28), smoking (Ch.7 P18) and exercise (Ch.7 P31). It has been reported 
that for some people, stress amplifies abdominal obesity (L. E. Kuo, Kitlinska, Tilan, 
Li, Baker, Johnson et al., 2007), and a prospective cohort study of 10,308 participants 
in London concluded that chronic work stress can lead to metabolic syndrome 
(Chandola, Brunner, & Marmot, 2006). It is important that carers of end-stage renal 
disease dependants, especially, are supported by their families and, if they do not have 
family living in Miri, by the dialysis centre staff. 
All the participants knew the main reasons for obesity are lack of exercise or activity 
and eating an unbalanced diet high in fats and carbohydrates. Unfortunately, knowledge 
does not always lead to healthy behaviour. Many participants had tried fad diets and 
supplements to lose weight, only to regain it and more. As one participant noted,  
My biggest hindrance to following a healthy diet is my will power, or should I 
say won’t power [laughs] and all the distractions from my colleagues at work, 
we all feed each other. (Ch.7 P32)  
The participants often felt they were letting themselves and their family down. The 
replies given by one particular participant during the interview exemplified this and 
underscored the desperation and despondency felt in response to uncontrollable 
circumstances:  
I still can cope because I’m still working but once I stop working I’m scared. If 
anything happens, everything depends on me, if I stop working we stop eating, 
very stressful. (Ch.7 P27)  
My job covers both Sarawak and Sabah so a lot of travelling and I eat out a lot 
and skip meals often. (Ch.7 P27) 




I do very little exercise, not for a year, because I am very busy and travel a lot 
... I am too busy writing reports. I guess I have to manage my time more and fit 
the exercise in there between the busy schedule … last few years I’ve gained 
quite a bit. (Ch.7 P27) 
No padang around just terrace housing. (Ch.7 P27)  
This 40 year old is on medication for hypertension and has been assessed as having 
metabolic syndrome. If he does not stop compromising on his health now, his 
prognosis is not good. He was not the only participant to show this behaviour pattern. 
Lack of health information is a barrier which needs to be addressed through public 
health awareness and intervention strategies. Participants with a chronic non-
communicable disease requested more information regarding their particular medical 
condition and how to implement dietary and lifestyle changes (Ch.7 P21). Some said 
they were confused by the advice given to them (Ch.7 P7). The first degree relatives 
and spouses helping their in-laws wish for encouragement from the medical staff (Ch.7 
P20) and support groups run by medical professionals need to be established (Ch.7 
P27). The government organises a diabetes camp in Kuching once a year, and one man 
who had attended one said  
I learn a lot about diabetes and how to control my diet. (Ch.7 P2)  
More need to be organised for citizens in Miri. Health-related barriers impeding early 
recognition and diagnosis of a chronic non-communicable disease, in particular chronic 
kidney disease, should be acknowledged by health authorities and dialysis centres. 
Health awareness and intervention programs and strategies need to match the level of 
education, health literacy and circumstances of the target audience and solicit their 
involvement and participation. With good investment and policy making these can 
make a difference to the lives of anyone with a chronic non-communicable disease. It is 
difficult setting up long-term programs for end-stage renal disease patients and their 
families, but the problems can be overcome with committed leadership and the 
development of information-based implementation plans (Bear & Stockie, 2014). The 
aim should be to improve each person‘s comprehension of their medical condition in 
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order to empower them to implement lifestyle changes and to be compliant with their 
doctor‘s instructions. 
8.1.15 Socio-economic factors  
In Sarawak the towns are predominantly populated by the Chinese and Malays while 
the majority of people living in the rural and remote areas are Indigenous (Sarawak 
Government, 2003); for them treatment for end-stage renal disease remains impossible 
unless they relocate to towns where there are dialysis centres and family members with 
better paying jobs. Participants in this study comprised urban-born Chinese, urban and 
urban fringe-born Malay, and Indigenous ethnicities (Table 5.1), more than half of 
whom had been born and raised in remote longhouses (Table 5.1) and migrated to Miri 
as adults. Rural to urban migration initiates an often irreversible transition for a family 
and engenders a host of positive and negative psychosocial and behavioural changes. 
The category self-build / longhouse (Table 5.1; 5.6), necessitates some explanation. 
Self-build includes rural farm houses, houses built by their inhabitants on a free-
settlement lot allocated by the local council, and those who have built in an illegal 
urban shanty area. In this study there was no statistically significant difference between 
the first degree relatives and the spousal control group in the type of housing they lived 
in (Table 5.1). Many people moving from rural areas to the city initially stay with 
extended family members who have already settled in the city, until they find work and 
their own accommodation. There is the possibility that they will crowd into poorly built 
or rented shanties in the lower socio-economic areas and remain there for many years. 
In this study those born in urban areas were more likely to own a detached house, and 
those born in the rural/remote areas were more likely to live in a terrace, low-cost 
house, or a self-build or longhouse (Table 5.1; Table 5.6). Those participants listed as 
‗semi urban‘ lived in longhouses, farm houses and low-cost houses, between one and 
two hours‘ drive from the Miri city centre. 
The development of low-cost housing estates has been encouraged by the government 
(Huu et al., 1999) and this allows the middle-income earner, or two relatives who 
combine their income, the opportunity to own their own homes, although it is still more 
common to rent them from wealthier businessmen. The multiple logistic regression 
analysis for this study shows that compared with people living in detached houses, 
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those living in terraced or low-cost houses were 5.08 times more likely to have 
metabolic syndrome, and those who lived in the self-build / longhouses were 3.77 times 
more likely (Table 5.6). This brings into question the food quantity and quality, and the 
levels of physical activity, of those living in lower socio-economic housing groups. 
Shariff and Khor (2005) found that in West Malaysia overweight and obesity in rural 
women correlated with food insecurity and low income and socio-economic status. 
Conversely, this study reveals that the middle-income group, living in terraced and 
low-cost houses, had the greatest probability of having metabolic syndrome (Table 
5.6). Only a few studies have been found that consider the socio-economic trends of the 
Indigenous people of Sarawak and Malaysian, and none on their housing 
demographics. Freedman et al. (2005) have noted that although heredity and non-socio-
economic factors appear to predominate, lower socio-economic status and associated 
familial clustering may be more important with regard to kidney disease. Income 
equates with the affordability of items such as food, cars, medical treatment, tuition, 
furniture and the like, whereas housing is indicative of environmental and living 
conditions. Being able to afford a bank loan to purchase a semi-detached or detached 
house is a clear indicator of one‘s employment type and level of income: a person 
needs to have high-paying work to afford a detached house mortgage. In this study the 
multiple logistic regression analysis showed that income and housing followed the 
same trend (Table 5.1); therefore, housing may be considered a surrogate marker for 
income and the probability of developing metabolic syndrome (Table 5.6). Perhaps by 
using housing and location as a socio-economic indicator for standard of living, the 
data collected is more trustworthy as it circumnavigates the discomfit, even 
embarrassment, some people feel at having to reveal their income, and better describes 
their circumstances and the environment they live in. 
8.1.16 Environmental constraints  
The qualitative interviews revealed some reasons why the quantitative results show 
metabolic syndrome as significantly greater among participants living in terraced and 
low-cost housing estates (Table 5.6). This study found that those persons with 
professional or managerial jobs and higher wages, and who were more established in 
Miri, were more likely to live in a detached or semi-detached house with a large garden 
and to hire gardeners to look after the grounds. A few participants with high wages said 
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they lived in condominiums and had nice, managed facilities to enjoy. Government 
incentives to contractors to build low-cost housing so people can own their own home 
are good, but such houses provide the bare minimum most do not have a garden (Ch.7 
P6; P1; P27; P20; P3); if there is a little back garden it is often full of contractors‘ 
building rubbish (Ch.7 P10). People are fortunate if they own a corner house (Ch.7 P9). 
There are very few children‘s playgrounds, padang or parks to exercise in; there are no 
footpaths, and the roads are dangerous to walk along (Ch.7 P30; P1; P7). From the 
interview intersections, those who do not have chronic kidney disease / metabolic 
syndrome were more likely to have an attached garden with their house. The poorer 
scoring participants grew fruit and vegetables in a garden elsewhere, sometimes over an 
hour from their houses (Ch.7 P2; P5). The Indigenous Iban shuttle between their 
longhouse and their work in Miri, but many families relocate to town when their 
children attend secondary school (Ch.7 P2). This study confirms that those who have 
moved to Miri from the rural and remote areas often initially stay in the free settlement 
or slum areas (Ch.7 P6), renting, building their own place or sometimes living with 
relatives already settled in Miri (Ch.7 P6; P7). After some years they secure regular 
work and, maybe with a spouse who is also working, are able to get a mortgage and 
move into low-cost housing (Ch.7 P18; P1). There are compromises to make, such as 
room size and garden space - and yet this is the population most likely to have a large 
extended family living together. 
A Cameroon study of 999 women and 727 men concluded that the recent migration 
history and exposure to poor urban environmental conditions lead to decreased physical 
activity, dietary changes and psychological stress (Sobngwi, Mbanya, Unwin, Porcher, 
Kengne, Fezeu, et al., 2004). These factors, over time, contribute to the development of 
type 2 diabetes and hypertension (Sobngwi et al., 2004). One participant in the present 
study, living in a low-cost housing estate, was so scared of being burgled she never left 
her house (Ch.7 P15). WHO (2013b) has listed several urban environmental factors 
that are unfavourable to people being more active, including fear of violence, high-
density traffic, and the lack of parks, sidewalks and sports and recreation facilities. 
These factors were spoken of by the participants in Phase Two as barriers preventing 
them from exercising regularly. Fenton (2005) has emphasised that 30 minutes of 
physical activity is needed every day in order to reduce the risk of a chronic non-
communicable disease morbidity and early death. He advocated healthy environments 
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that promote physical activity to counteract a sedentary lifestyle (Fenton, 2005). In 
promoting better town planning, footpaths, bicycle tracks, safer streets, more parks, and 
more trees and shrubs are recommended for healthier living environments, and 
preferably include sustainable development and be culturally sensitive (Burden, 2001). 
Adequate house environments are very important in promoting mental and physical 
health in the population and public health is a priority. Every low-cost housing estate in 
Miri should include a garden with every house, or at the very least a community 
vegetable garden, footpaths, playgrounds, sports ovals and facilities within easy reach 
of all.  
A Peninsular Malaysian study (n=17,392) found that higher wages, city living and 
physical inactivity brought on by lifestyle changes was highly prevalent amongst urban 
adults and contributed to glucose intolerance, hypertension and obesity in Malaysia (T. 
O. Lim, Ding, Zaki, Merican, Kew, Hamid et al., 2000) and this current Sarawak study 
concurs with their results. Metabolic syndrome and obesity-related diabetes and 
hypertension are preventable diseases and potentially treatable (Iseki, 2006). A number 
of mechanisms whereby the metabolic syndrome may contribute to chronic kidney 
disease have been identified (Prasad, 2014), and Bagby (2004), in a review of the effect 
of obesity-initiated metabolic syndrome on the kidney, notes that intensive exercise and 
weight loss especially in the earliest stages of obesity-initiated metabolic syndrome 
may be renal protective if undertaken before kidney damage becomes permanent. 
Oddly, participants who did have somewhere to go to exercise, or who lived near the 
beach, often did not use the advantage (Ch.7 P32):  
all sorts of excuses not to! We don’t have this kind of habit so don’t. (Ch.7 P28) 
Older people worked hard on their farms and in their gardens, but for those in towns it 
was considered inelegant and undignified to exercise or run. Malaysia is a Muslim 
majority nation and even non-Muslims tend to wear long trousers, long skirts and long 
sleeves in this tropical country. Older obese women especially are embarrassed about 
their weight, worry about modesty, and their clothing makes exercising uncomfortable. 
The Chinese and Indigenous younger generations may change the status quo for their 
ethnicities, but media fashion reports suggest that young Malay female adults are using 
the tudung (female Muslim veil or headscarf) and full cover at all times in public now, 
 
249 
and not just for official wear as in the past. The Malay participants in this study were 
5.67 times more likely to be associated with chronic kidney disease (Table 5.5), many 
with a family history of a chronic non-communicable disease and themselves having 
metabolic syndrome. Current research on health issues concerning Muslim women who 
wear the burka (coat covering a woman except for her eyes and hands) have revealed 
that they are at significant risk for Vitamin D deficiency (Masood & Iqbal, 2008), 
obesity and metabolic syndrome (Reyaz & Islam, 2012), hypertension and 
cardiovascular disease (Stroope, 2015). Malay female politicians and community 
leaders have a role to play in persuading young Muslim women to start an exercise 
routine for health benefits now and when they are older. All Malaysian females need to 
be encouraged to exercise regularly; possibly by forming groups will help overcome 
shyness and will persuade them to. 
This study has indicated that middle income earners with terrace and low-cost housing 
are at greater risk of metabolic syndrome (Table 5.6) and need to have more exercise 
parks and facilities. Lack of physical activity is the part of the health equation most 
often neglected, but without exercise it is very difficult to reduce weight and maintain 
healthy body proportions throughout life. Lifestyle intervention studies point out the 
difficulty people have in losing weight and keeping it off. Goldstein (1992) has argued 
that even with a weight reduction of 10% or less, chronic non-communicable diseases 
and metabolic syndrome would lessen, increasing longevity and reducing the risk of 
cardiovascular disease. Obese persons who are able to achieve a weight loss of only 5% 
still gain health and emotional benefits (Blackburn, 1995). For obese people with type 2 
diabetes the degree of weight loss at one year is strongly (P < 0.0001) associated with 
improvements in their risk for cardiovascular disease; those who lose greater than 10–
15% of their body weight reap greater benefits (Wing, Lang, Wadden, Safford, 
Knowler, Bertoni et al., 2011). A number of participants in the current study said that 
their doctor had asked them to exercise and lose weight to reduce their hypertension 
(Ch.7 P5) and type 2 diabetes (Ch.7 P21), but as previously noted, participants were 
not always compliant (Ch.7 P14). 
There is some debate on whether exercise without diet is useful for long-term weight 
loss and improvement of hypertension and type 2 diabetes in the obese. In this study 
some participants noticed the effect exercise had on their hypertension (Ch.7 P1; P28). 
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It has been found that 60 minutes of moderately intense exercise five times a week, 
without weight loss, reduced visceral fat and lipids in skeletal muscle in both obese and 
type 2 diabetic men (S. Lee, Kuk, Davidson, Hudson, Kilpatrick, Graham et al., 2005). 
Another study of 52 obese men with waist circumferences of 110.1 ± 5.8 cm found that 
weight loss from daily exercise without dieting could reduce obesity and insulin 
resistance, decrease abdominal fat, and prevent weight regain (Ross, Dagnone, Jones, 
Smith, Paddags, Hudson, et al., 2000). A study of eleven obese women, using walking 
as exercise and with no dietary restrictions, found that weight loss only occurred when 
walking exceeded 30 minutes a day; the weight loss was slow and graded to the amount 
of time taken (Gwinup, 1975). Another study found that diet alone produces a greater 
weight loss than exercise alone, but much of the loss was from lean body mass; it 
recommended combining dietary restrictions with exercise for a weight loss that 
promoted better body fat distribution (Blair, 1993). A meta-analysis of diet and 
exercise interventions compared with diet alone found that at one year follow-up 
participants had regained half their initial weight loss; diet with exercise gave a better 
long-term outcome (Curioni & Lourenco, 2005). 
One Chinese participant (Ch.7 P26) commenced an exercise program after heart 
surgery. He commented that he was frightened at the beginning but felt well now. Heart 
surgery should not prevent a person from exercising, even if only gently, but this does 
underscore the need for doctors to monitor and encourage those with advanced chronic 
non-communicable diseases and cardiovascular disease when they embark on an 
exercise program. The results of a study to determine the best way to reduce 
cardiovascular disease risk in obese women (n=40) found that an increase in daily 
physical activity, a structured aerobic exercise program and a low-fat diet of 1,200 
kilocalories per day was best (Andersen, Wadden, Bartlett, Zemel, Verde, & 
Franckowiak, 1999). Another study found that for obese individuals, diet and exercise 
counselling combined with behavioural interventions and motivation resulted in 3–5 
kilograms of sustained weight loss after one year (USPSTF [United States Preventive 
Services Task Force], 2003). Moderate weight loss gives health benefits such as 
improved blood pressure and lower blood glucose and lipid levels, but intensive  
counselling and support is needed to sustain long-term weight loss in the obese 
(USPSTF, 2003). A multiple risk factors approach to intervention and medication (T. O. 
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Lim et al., 2000) and recommendations for intensive exercise and weight loss (Bagby, 
2004) especially targeting those at high risk for chronic kidney disease is required for 
obese and type 2 diabetes patients. For the best lifestyle intervention results a program 
must be individualised and intense enough to allow the person to achieve and allow the 
adhere to long-term outcomes (DPPR [Diabetes Prevention Program Research Group], 
2002). The Diabetes Prevention Program Research Group recommend that the program 
be structured and should address ethnically diverse people, and especially their food 
and cooking methods (DPPR, 2002). To maintain a 7% weight loss and to improve type 
2 diabetes, 700 calories (± 30,000 kilojoules) per week of physical activity is 
recommended (DPPR, 2002). Anderson, Wadden, Bartlett, Zemel, Verde and 
Franckowiak (1999) advocated enough physical activity to derive health benefits, 
recommending at least 30 minutes of exercise most days of the week: even short 
episodes of moderately intense activity, such as using the stairs instead of the elevator, 
could counteract a sedentary lifestyle and help avert weight gain. Active and fit 
overweight men and women appear to have lower morbidity and mortality rates than 
unfit overweight persons; therefore, even if one does not lose weight exercise is 
beneficial (Blair, 1993). Regular walking, or swimming if there is joint pain, is 
worthwhile. Handicapped people should also be encouraged to exercise within their 
limitations. For muscle and joint injuries a professional fitness instructor is invaluable 
in showing how to continue exercising while allowing the injury to recover. 
Some of the participants in this study merely needed encouraging and convincing that a 
regular exercise program would do them good (Ch.7 P18). Having a reliable social 
support system is very important. Weight loss is greater and maintained longer if there 
is a ‗buddy-system‘ of friends or family members also participating (Wing & Jeffery, 
1999). Aids such as pedometers, computer programs and mobile phone applications 
have been found to help obese persons with type 2 diabetes feel empowered, and self-
controlled, and help their management of their chronic non-communicable disease 
(Piette, 2007). It takes determination and often a life-changing personal crisis to initiate 
and maintain weight loss. Lifestyle counsellors need to be sensitive and if clients do not 
lose weight, they should be supported and encouraged to continue to comply with 
medication, eat healthy foods, and exercise regularly for the positive physical and 
mental effects these bring, and to help control hypertension and type 2 diabetes and 
prevent these conditions from deteriorating. Even for end-stage renal disease patients, 
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regular gentle daily exercise helps prevent muscle atrophy, strengthens the heart, averts 
constipation, and improves one‘s mood and outlook on life. In Asian societies where 
there is fast-paced socio-economic change, Lukito and Wahlqvist (2006) have warned 
that in order to reverse obesity and diabetes trends, weight management must not 
narrowly focus on energy balance but should span generations and encompass the 
nutritional status of mothers at pre-conception, during inter-uterine growth, and later in 
maternal and child health programs; life-long public health strategies which address 
adverse living conditions should also be designed. Community nutrition and health 
advocacy is needed to address and correct inadequacies and inequalities, particularly in 
the areas contributing to the development of obesity, type 2 diabetes and cardiovascular 
disease, and government health policies need to be planned to cover decades if they are 
to succeed in the long term (Wahlqvist, 2008). 
There were many excuses from participants, and it often took a medical crisis in a 
family member (Ch.7 P9; P14; P26), or themselves (Ch.7 P18; P31) before they would 
begin a regular exercise program. For many participants there was confusion (Ch.7 P7) 
misunderstanding and exasperation as they gained, lost, then regained their weight 
(Ch.7 P26; P15; P13). Women in this study were more likely to admit to laziness (Ch.7 
P17; P14). Men especially wanted to be good role models for their children (Ch.7 P9; 
P31) but were thwarted by work commitments. A number of participants had out-of-
control situations to deal with, like this lady: 
I don’t have time to walk around and have put on weight. I don’t know how to 
control myself. (Ch.7 P5)  
Those who are exercising regularly appear healthier and happier (Ch.7 P26; P20). 
There are plenty of gyms (with expensive membership) in Miri but for those not 
wanting to use a gym the two barriers inhibiting exercise are lack of facilities such as 
footpaths and parks near their homes, and lack of time or bad time management. Some 
participants expressed anxiety regarding their health. Some said that they knew what to 
do, but were unable to do it for many reasons and therefore had to make compromises 
with own health and fitness (Ch.7 P27). This should not be the case; they need to be 
advised appropriately to eliminate any confusion they may have, and encouraged not to 
compromise their health but to follow a holistic lifestyle management program for life. 
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8.2  Conclusion 
In accordance with Mixed Methods protocol, the two data sets were integrated in order 
to explain cohesively those aspects of the qualitative Phase Two that converged with, 
and might influence, aspects of the quantitative Phase One. 
The quantitative analysis of this study identified many participants, from both the first 
degree relatives and the spousal control group, as having a modifiable chronic non-
communicable disease. Some had three or more chronic non-communicable diseases 
and were classified as having metabolic syndrome; a few had chronic kidney disease. 
Metabolic syndrome was the only modifiable factor found to be strongly associated 
with chronic kidney disease.  
Many participants did not know they had a chronic non-communicable disease until 
they received their Phase One laboratory reports. A dominant concern raised in the 
interviews was that they had never been screened for a chronic non-communicable 
disease or for chronic kidney disease before this study. The first degree relatives in 
particular were anxious that they might end up like their parent on dialysis, but most 
participants were confused about the correct course of action to take to prevent or delay 
progression of a chronic non-communicable disease or chronic kidney disease. The 
major theme emerging from the sub-themes of the qualitative data analysis was ‗health-
seeking anxiety‘, as the participants were anxious about their health, confused about the 
causes of chronic non-communicable diseases and chronic kidney disease, and unsure 
of the best practice for the prevention of and treatment for their disease. 
The qualitative findings of this study exposed poor health literacy, non-compliance, 
environmental constraints, incorrect health beliefs and attitudes, barriers to seeking 
medical treatment and unhealthy lifestyle behaviour among the participants. These 
factors intersected or converged with, and might have contributed to, the poor results 
identified in the quantitative analysis. The integration of the two data sets has revealed 
negative beliefs, behaviours and attitudes that are likely to be detrimental to long-term 
health and good quality of life. The participants‘ beliefs, behaviours, attitudes and 
barriers to seeking medical treatment are significant intersections where the Phase One 
quantitative results and the Phase Two qualitative findings integrate and require more 
investigation. These are areas that should be targeted by government policy review and 
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lifestyle intervention strategies, and if addressed will benefit the health and welfare of 
all living in the Miri and Baram communities. Local knowledge, cultural sensitivity, 
self-monitoring by the participants, empowerment of communities, and focusing on the 
positive, progressive aspects illuminated in this study will enhance participation and aid 
in achieving the objectives of health awareness and intervention programs. Individual 
counselling and public health awareness campaigns involving medical professionals 
will ensure the delivery of truthful, accurate information regarding chronic kidney 
disease and the metabolic syndrome. 
 
Photograph 8.1  Batu Lawi, Pulong Tau National Park, central Borneo 
Photograph by researcher‘s husband (from helicopter) 
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Chapter 9 Conclusions and Future Directions 
This, the concluding chapter for this thesis, presents the significant study conclusions 
including insights into the reasons why some of the participants may have developed 
metabolic syndrome and chronic kidney disease. The outcomes for the study objectives, 
the strengths and limitations of this study are summarised. The chapter concludes with 
some recommendations for various community stakeholders about future directions for 
public health practice and future research challenges. 
9.1 Study Conclusions 
In this study, a Mixed Methods sequential design was chosen to investigate health 
related beliefs, behaviour and knowledge contributing to the metabolic syndrome 
comorbidities that might initiate the development of chronic kidney disease in 
participants at risk. The integration of the quantitative and qualitative phases is unique 
to Mixed Methods and the interface or convergence point between the two methods are 
of particular interest (Teddlie & Tashakkori, 2010). 
In Phase One the non-modifiable factors associated with chronic kidney disease were 
identified as age and ethnicity. Metabolic syndrome, with its chronic non-
communicable disease comorbidities, was found to be the modifiable factor for chronic 
kidney disease. The non-modifiable factors associated with the metabolic syndrome 
were identified as age, a family history of cardiovascular disease, and being a first 
degree relative of someone with end-stage rensl disease. The modifiable factors for the 
metabolic syndrome were smoking, living in a low-cost house and having type 2 
diabetes. This study found that persons of Malay and Indigenous ethnicity who are 
diagnosed with metabolic syndrome have a greater possibility of developing or having 
chronic kidney disease with age than someone without metabolic syndrome who is of 
Chinese ethnicity. Such high-risk ethnic populations should be made aware of a 
possible genetic propensity to chronic kidney disease, especially if they have metabolic 
syndrome, and should be offered health awareness education. Lifestyle changes 
amongst urban Malaysian adults contribute to glucose intolerance, hypertension and 
obesity (Khambalia & Seen, 2010; T. O. Lim et al., 2000; Mustafa et al, 2011), and this 
study has identified the first degree relatives as having a greater association with these 
factors and with metabolic syndrome than shown by the spousal control group. As the 
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metabolic syndrome, or its chronic disease components, may lead to chronic kidney 
disease, it is recommended that all first degree relatives of end-stage renal disease 
patients be screened for type 2 diabetes, hypertension and chronic kidney disease. 
Phase Two provided an opportunity for selected participants to voice their opinions, 
beliefs, behaviours and frustrations; they gave me a deep appreciation of their lived 
experience. This facilitated a better understanding of the key drivers behind the Phase 
One results. The integration of the quantitative and qualitative data was strongly 
correlated in the areas of food transition and obesity, nutritional marketing companies 
targeting those with chronic non-communicable diseases, and non-compliance in taking 
medication. Differences in attitudes and opinions were noted for different age groups. 
There were also a number of beliefs, behaviours and environment constraints identified 
as contributing to the nutritional and physical activity inadequacies of the participants. 
Of concern was participants‘ meagre knowledge of occupational health and safety 
issues when handling agrochemicals. A number of barriers, both self-sabotaging such 
as being too busy to see a doctor, and from the establishment for example no doctors 
being available at the rural clinics, identified in the qualitative interviews, may 
influence the quantitative results. The participants‘ beliefs and attitudes may also be 
barriers to their following a healthy lifestyle, attending a clinic or seeing a doctor. 
These barriers need to be addressed by government authorities, health officials, medical 
personnel and dialysis centre staff in order to identify the first degree relatives with a 
chronic non-communicable disease in order to delay its development and the 
progression to metabolic syndrome and chronic kidney disease. If these obstacles, or 
some of these obstacles, are overcome the community will benefit and it will also, in 
the long-term, alleviate pressure and expense on the health department. 
Marginalised groups, including the dialysis community, need to be given an 
opportunity to express themselves and to be part of political decision-making processes 
in matters that concern them (Clark, 2008). It is imperative that this thesis be used as an 
indispensable avenue for their voices to be heard and for protocols to be reviewed and 
changed. Future intervention campaigns need to be devised that will persevere with the 
goal of empowering end-stage renal disease patients and their families to gain more 
control over their circumstances. This study has uncovered evidence to show that if the 
first degree relatives in particular, are not screened and do not know they have a 
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chronic non-communicable disease, they cannot perceive nor consider feasible their 
risk of needing dialysis in the future. If they are identified early, before symptoms 
appear, they can be counselled to modify their behaviour before it becomes too late to 
mitigate the disease. 
Having a family member commence dialysis is a traumatic and life-changing event for 
all in the immediate family. Parallel with population growth and urbanisation, end-
stage renal disease in Malaysia is increasing exponentially and is forecast to greatly 
increase the economic impact on the healthcare system (Hooi, Wong et al., 2005). 
Based on this study‘s outcomes, screening of end-stage renal disease patients‘ extended 
family members and those with type 2 diabetes, using the ACR and the estimated 
glomerular filtration rate, is recommended. Community health awareness campaigns by 
non-doctors, using the metabolic syndrome criteria as a marker, to detect those at high 
risk of developing a chronic non-communicable disease which may develop into 
chronic kidney disease, is recommended. 
Chronic non-communicable diseases are usually degenerative, resulting in a poor 
quality of life; however, apart from the genetic aspect, most can be prevented or 
improved with lifestyle changes (NCCDPHP, 2009). The major chronic non-
communicable diseases are cardiovascular disease, cancer, chronic respiratory diseases 
and diabetes (WHO, 2013a). With unhealthy lifestyles, aging populations are 
exacerbating the problem (WHO, 2014), and unless all countries address the burden 
created by these chronic non-communicable diseases, health-care costs will continue to 
soar (WHO, 2013a).  
Government health care policies and management need to be coherent and consistent, 
and to span all generations. Intervention programs with advice on nutrition, exercise 
and weight loss can be initiated from the outcomes of this study. Best practices for 
chronic kidney disease and metabolic syndrome management, has been discussed in the 
literature review, and these need to be incorporated into preventive intervention 
measures. Every person who can prevent and delay the onset and progression of a 
chronic non-communicable disease, metabolic syndrome or chronic kidney disease, by 
being compliant in taking medicine on a doctor‘s advice and following a healthy 




9.2 Summary of the Outcomes for the Study Objectives 
9.2.1 The quantitative objectives 
A number of strategies and instruments were employed to achieve the forecast outcome 
for the objectives (Table 4.3). This was weighed against the actual outcomes achieved; 
all targets were met. We cannot control age, ethnicity or family history, but we can 
control other factors that place populations at risk of developing chronic kidney 
disease. The non-lifestyle predisposing factors of genetic susceptibility, age and 
ethnicity were discussed, and the socio-demographic characteristics identified. The 
lifestyle factors of smoking, drinking alcohol and having type 2 diabetes were 
discussed. Further exploration of other lifestyle and cultural behaviours and habits were 
carried forward to Phase Two; these were discussed in the qualitative section. The 
examination of housing had an interesting outcome, and this should be researched in 
more depth. Questions on the environment were carried forward for further exploration 
in the Phase Two semi-structured interviews, and a number of illuminating aspects 
emerged. Participants with chronic kidney disease were identified. Alcohol was found 
to be protective for chronic kidney disease in this study; however, it must be noted that 
the respondents who answered ‗yes‘ to drinking alcohol admitted only to moderate 
alcohol consumption and the exact quantity consumed is not known.  
The factor associated with chronic kidney disease, metabolic syndrome, is a composite 
of metabolic disorders which to a certain extent are lifestyle driven. Although 
challenging, making behavioural lifestyle changes in the early stages can mitigate 
complications and delay the progression of a chronic non-communicable disease. The 
metabolic syndrome and metabolic disturbances in participants were determined. Being 
a first degree relatives of a person with end-stage renal disease, having a family history 
of cardiovascular disease, and age are pre-disposing factors and cannot be altered. 
Smoking is an unhealthy lifestyle habit, and type 2 diabetes is a disease initiated by an 
unhealthy lifestyle; but both these risk factors for metabolic syndrome can be altered 
with lifestyle-altering behaviour changes. A number of unpleasant habits and unhealthy 
lifestyle choices and practices were found to be associated with metabolic syndrome 
and may be playing a role in its high prevalence rate in Miri. To better understand this, 




9.2.2 The qualitative objectives  
A number of strategies and instruments were employed to achieve the forecast outcome 
for the objectives (Table 6.4). This was weighed against the actual outcome achieved; 
all targets were met. The participants had diverse belief systems ranging from totally 
traditional to totally Western. Their behaviours were dictated by their belief systems. 
The many stress factors affecting participants, particularly those first degree relatives 
caring for a relative on dialysis, were discussed. Those from the kampung had 
conflicting loyalties. There were many barriers impeding them from seeing a Western 
doctor, from being diagnosed with a chronic non-communicable disease when they did 
see a doctor, and from being compliant with the doctors‘ instructions, medication and 
follow-up treatment. It was found that participants were anxious and confused about the 
correct medicine and treatment for their particular disease, often choosing to take both 
Western medicine and traditional herbal medicine at the same time. This could affect 
the progression of their non-communicable disease and, if they had it, of their chronic 
kidney disease. Many participants were swayed by modern marketing myths and spent 
large sums of money on nutritional supplements in preference to Western medicine 
prescribed by a doctor.  
A number of high-risk localities and vulnerable groups were identified. Those in low-
cost housing did not have an environment conducive to healthy living. Those using 
agrochemicals, at work or in their own gardens and farms, needed better health 
awareness and safety instructions on using toxic agrochemicals safely. 
9.3 Strengths of this Study 
This Mixed Methods study is ground-breaking and innovative. The advantages of using 
quantitative methods are that it is ‗measurable, has rigour, holds internal validity, 
generalizability and replicability‘ (Saks & Allsop, 2013, p. 23). The data collected and 
analysed in Phase One gave rise to questions that could not be answered using 
quantitative methods alone. The advantages of using qualitative methods are that it has 
‗flexibility in thinking, flexibility in research process, has rich description, 
compensation and validity‘ (Saks & Allsop, 2013, p. 27). Had this study used only one 
method, the correlation of data would not have been possible. 
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Mixed Methods compensates for the weaknesses and draws on the strengths of each 
methodology; and by corroborating its findings a study is given greater validity (Saks 
& Allsop, 2013). This study greatly benefited from using Mixed Methods. The 
qualitative Phase Two supported and complemented the quantitative Phase One by 
allowing greater detail, such as about the beliefs, behaviours and lifestyle habits of the 
participants, to be revealed. These explained the reasons underlying the quantitative 
results and gave insight into aspects that need to be considered and targeted when 
planning health awareness and intervention programs. 
9.4 Limitations of this Study 
One limitation to this study is that it was not possible to include a random community 
control group for comparison with the first degree relative cases and the spousal control 
group. However, it is impractical to collect data and determine risk factors for rare 
medical conditions such as end-stage renal disease from the general population (Hulley 
et al., 2007).  
Another limitation was that none of the participants had a medical background and may 
have been confused by the terminology in the Phase One questionnaire, especially if 
their mother tongue was a different dialect. In the areas of family and personal medical 
history, chronic non-communicable diseases and medication, the participants may have 
been unfamiliar with the medical words used. 
This study is a screening study and the food questions in the Phase One questionnaire 
were not exact, and this may have compromised analysis of food items, food quantities 
consumed, cooking methods used in the home, eating out habits, changes in physical 
activity, exercise habits, and changes in medical health. 
9.5 Future Directions for Public Health Practice 
Based on this pioneering research, community stakeholders and key policy makers will 
be sent an executive summary outlining the important findings and study conclusions 
and indicating the suggested interventions and areas for change.  
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9.5.1 Informing the educators  
All health-care providers, nurses and staff working in haemodialysis centres, and those 
who are caretakers of persons with end-stage renal disease need to be adequately 
trained. In-house training should be conducted by the centres to further ensure the best 
duty-of-care for all patients receiving haemodialysis. 
An American study found that health care providers and primary care physicians had 
inadequate knowledge of early recognition of chronic kidney disease in their patients 
(Israni, Shea, Joffe, & Feldman, 2009) yet if the disease is picked up early the 
progression can be retarded (C. H. Fox, Brooks, Zayas, McClellan, & Murray, 2006). A 
mentoring system for all young medical doctors should be set up early in their careers, 
as often renal patients are not referred to nephrologists until they are quite advanced, in 
stage 4 or 5. If the patient is identified in stage 2 or 3, medication and lifestyle 
management may delay their progression to end-stage renal disease and dialysis. 
In Sarawak doctors need to be aware that even though their patients pay for the 
medicine given to them for hypertension and type 2 diabetes, they may not take it, may 
mix it with traditional herbal medicine, may not renew their prescriptions, or may 
discard it and solely take traditional herbal medicine or supplements. They need to 
enquire into their patients‘ compliance history and to impress upon them the serious 
need to follow instructions, renew prescriptions and the need to regularly return for 
followup assessment. They need to make sure that their patients understand that even 
though they feel fine, if their diabetes or hypertension is not under control, kidney 
damage may be occurring.  
9.5.2 Health awareness and education 
Health awareness programs should focus on educating the first degree relatives and 
empowering individuals and families to make positive lifelong healthy behaviour 
changes in order to prevent or delay a chronic non-communicable disease or chronic 
kidney disease. 
Diabetes and hypertension, the two main medical conditions leading to end-stage renal 
disease, may cluster in families, therefore children of parents who have type 2 diabetes 
or hypertension should be given advice on lifestyle factors influencing the development 
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of these diseases. According to the National Kidney Foundation, 2.5 million 
Malaysians suffer from kidney disease and 60% of these are diabetic (Cruez, 2014). 
Schools could offer healthy lifestyle programs to instruct young people on the 
importance of maintaining an ideal body weight, following a healthy diet, and 
undertaking regular physical activity. 
This study found that medical doctors held the most influence in persuading 
participants to change their lifestyles. Patients want clarification and comprehension of 
their medical condition so they can be more knowledgeable when addressing unhealthy 
lifestyle habits. The medical profession should take the lead in delivering health 
education, both by spending time with their patients and by using public forums, 
including television and public talks, to highlight the consequences of chronic kidney 
disease, chronic non-communicable diseases and metabolic syndrome. Registered 
dietitians, nutritionists and health educators should be employed by medical centres so 
that busy doctors can refer patients to them for lifestyle medicine as this will improve 
patient‘s outcomes and enhance their quality of life. 
9.5.3 Intervention planning and programs  
This study has identified the need for Miri citizens to change their risky lifestyle 
behaviours. I propose that, as a public community campaign, the Ministry of Health 
initiate intervention strategies to address this issue. Medical and health professionals, 
experts in the area of behavioural modification, and the media should be involved in 
raising awareness that chronic kidney disease and metabolic syndrome are lifestyle 
behaviour choices that can be prevented. 
9.5.4 Clinical practice and screening programs 
 I suggest that the criteria for the metabolic syndrome be used as a screening tool to aid 
local health care (non-doctor) workers target and identify individuals at increased risk 
of a chronic non-communicable disease, in particular type 2 diabetes, hypertension, 
cardiovascular disease and chronic kidney disease, in Miri. The familial susceptibility 
of first degree relatives and the abnormal clinical parameters of the metabolic 
syndrome need to be recognised to prevent the progression of chronic kidney disease. 
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Barriers such as lack of staff or time to discuss their medical conditions with patients 
need to be acknowledged and overcome. 
9.5.5 Participants, end-stage renal disease patients, first degree relatives and the 
spousal control group  
Phase Two participants who were first degree relatives of people with end-stage renal 
disease were aware of the difficulty and stress of having a relative needing dialysis in 
order to survive. However, most had limited knowledge of the causes of kidney 
disease, or how to prevent chronic kidney disease or its progression to end-stage renal 
disease. This needs to be addressed. The best access to the first degree relatives is 
through the dialysis centre dealing with their end-stage renal disease relatives. First 
degree relatives and those with metabolic syndrome are potentially at risk and should 
be targeted for screening; intervention should commence before or in the early stages of 
a chronic non-communicable disease or chronic kidney disease. 
9.5.6 Haemodialysis centres  
Local politicians have said that Miri needs to increase its number of haemodialysis 
units, both government and private, launch satellite dialysis centres, and raise funds to 
meet the rising needs of those with end-stage renal disease (MRC, 2014). Supported by 
evidence from this study I advocate that efforts to screen, prevent and delay the 
development of end-stage renal disease should be part of every Miri haemodialysis 
centres‘ overall objective. Early detection of chronic kidney disease and metabolic 
syndrome will relieve the burden of disease in the future. Efficient screening programs 
for the first degree relatives specifically, and for anyone who is obese and has 
metabolic syndrome generally, is cost effective for families and the community in the 
long-term. 
9.5.7 Local Miri community council  
This study provides new information and insights into the difficulties experienced by 
participants in transferring to Miri, which are generalisable to the whole of Sarawak. 
Those relocating from rural or remote areas should not be neglected when they settle in 
poorer urban areas. They need proper facilities and health awareness to avert future 
chronic non-communicable health problems in their community. The World Health 
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Organization (2013a, p 19) notes that ―the underlying determinants of non-
communicable diseases often lie outside the health sector‖. A paradigm shift in rural 
and urban development is obligatory for sustainable healthy environments to have 
priority over profits. Municipal councils should be able to moderate latent negative 
outcomes of rural to urban migration by innovative town planning aimed at preventing 
unhealthy lifestyle risks for all its citizens. 
9.5.8 State departments  
The economic burden of end-stage renal disease on the healthcare system is escalating 
and this study will make a significant contribution in aiding local health authorities to 
develop sound intervention strategies targeting high-risk groups. This study supports 
recommendations that the Sarawak Health Department screen all the first degree 
relatives of end-stage renal disease patients having type 2 diabetes by the ACR method 
for determining microalbuminuria. Macroalbuminuria, detected using a dipstick, 
indicates that kidney damage is advanced. If irreversible impairment to the kidneys 
have already occurred the chance of preventing end-stage renal disease by medication 
and lifestyle intervention is diminished. The ACR is also a measure of chronic kidney 
disease deterioration and useful for determining the progression of the disease. 
It is advisable for the Agriculture Department to organise intensive agrochemical 
occupational safety and health campaigns aimed at rural longhouse folk working in 
agriculture and the oil palm plantations, as this study has identified them as likely to be 
exposed to agrochemicals and to not follow safety regulations. The agrochemicals they 
use may have direct or indirect toxic effects on end-organs such as the kidneys. The 
environmental impact of agrochemicals on the traditional food and water sources of 
communities is also of concern, and should be addressed by the department. 
9.5.9 The federal ministry 
In providing low cost housing for the people, healthy surroundings should be an 
important part of the planning. Plans should take into account provision of 
playgrounds, parks, footpaths and cycle paths in addition to all other necessary 
amenities. There are many developers who will ignore these aspects to reduce costs and 
increase profits. Conditions requiring adequate road parking spaces, gardens and 
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community parks should be established when the state gives contractors land to 
develop at low cost. It is proposed that all plans by developers comply with regulations; 
an independent body may be needed to enforce a high degree of compliance. 
9.6 Future research challenges 
I have created a chronological record of all proceedings, including data collection and 
analysis for future revisitation and planning of intervention strategies; this is available 
for use by other researchers. 
A validated quantitative food frequency questionnaire and a physical activity 
questionnaire followed up by qualitative observation would give a more accurate 
assessment of participants‘ food and exercise behaviours. Quantitative research on the 
exact quantities of cigarettes and alcohol consumed by participants would be of value 
in determining the associated risk for chronic kidney disease. 
Many of the participants who had medication prescribed for diabetes, high blood 
pressure and cholesterol by a medical physician did not take the medication as advised, 
but chose instead to mix it or solely to take traditional herbs and supplements. Studies 
are needed to understand barriers to compliance and the reasons for choosing between 
traditional and modern medication. 
Many participants viewed traditional herbs and supplements as more natural and just as 
good as Western medicine; however, research shows this may not always be true. 
Rigorous scientific studies are needed to ascertain safety parameters for all who take 
these products. 
Many questions arose from this study, particularly in the area of rapid food transition 
and consequential obesity, showing middle income earners with terrace and low-cost 
housing, to be at greater risk of metabolic syndrome-associated chronic disease 
comorbidities. This is contrary to Peninsular Malaysian studies showing lower income 
earners are at greater risk (Saibul et al., 2009). Further research is needed to investigate 
this anomaly. 
Ideally a study with a random community control group is needed to determine whether 
the environment is masking genetic factors. Changes in lifestyle such as poor diet and 
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lack of exercise, plus new environmental factors such as lack of housing space, no 
available garden, no green space or recreation facilities nearby, and other modern 
factors are affecting everyone, both the cases and the controls. If all environmental 
factors were removed, alternatively if all environmental factors were ideal, would the 
genetic factors of ethnicity, family history predisposition to diabetes, dyslipidaemia or 
hypertension appear highly significant in the first degree relatives of those with end-
stage renal disease? These questions need further investigation. 
This study has uncovered health disparities and susceptibilities of an East Malaysian 
population and, of significance, emerged the impact of urbanization on health. The state 
and local governments have a responsibility to address all negative socio-economic and 
environmental determinants of health affecting its population. It is well-advised for the 
State Planning Unit to recurrently collaborate with local university researchers. 
Contemplation of evidence-based transformative research and evaluation studies, 
advocating health-promoting environmental policies, planning and management; 














We have the means and the capacity to deal with our problems,                                                                                         
if only we can find the political will. 
Kofi Annan 
 
This study demonstrates that kidney disease encompasses all socio-demographic 
variables. The age of the participants in this study ranged over three generations and, 
during the interviews, all mentioned the challenges of adapting to various transitional 
changes in their lives and the stress of family responsibilities. This stress is amplified 
radically if one of their family members is receiving haemodialysis therapy. The first 
degree relatives of children, siblings, spouses or parents with end-stage renal disease, 
need dependable social support. These primary caregivers, silently apprehensive that 
they too may eventually end up needing renal replacement therapy like their loved 
ones; are also the people shown in this study to be the most susceptible for metabolic 
syndrome and for living in environmentally-unfriendly low-cost housing estates.  
The tragic consequences chronic non-communicable diseases incur on individuals were 
highlighted by the participants throughout the interviews. As a whole, both the case and 
control groups showed a lack of elementary knowledge regarding metabolic syndrome 
and how to prevent or mitigate comorbid chronic non-communicable diseases, 
including chronic kidney disease. Malaysia is leading the region for obesity and type 2 
diabetes therefore, medical, health and dietetic professionals, not marketing companies, 
should organize and provide recurrent health awareness seminars with the aim of 
empowering individuals to make positive behaviour changes and healthy choices. This 
study provides sufficiently strong evidence for the State Government in the Planning 
Unit to sanction only health-promoting environmental policies for residential planning. 
As society transitions, humanity, stewardship and virtuous political will are integral in 
creating healthier surroundings; conducive to practicing healthy lifestyles therefore 
improving the quality of life for all. The equality, dignity and wellbeing of all Sarawak 
citizens, free of health-seeking anxiety, will be a valuable legacy to leave for posterity.  
We will miss one more of our elders who had been in the unique position of 
being in the transition period between the ‘old way’ and the modern era. 




OUTCOMES FROM THIS RESEARCH 
Appendix A:  Asian Pacific Academic Consortium for Public Health (APACPH) 
International Conference, Bali, Indonesia. Oral Presentation and Abstract in 
Conference Magazine, October 2010.  
RISK FACTORS FOR CHRONIC DISEASE IN SARAWAK MALAYSIA: A 
MIXED METHODS STUDY. 
Sheryl J. Mattu, Janice Lewis & Mario J Soares. 
School of Public Health, Curtin Health Innovation Research Institute,  
Curtin University, Perth, Western Australia 6845. 
The aim of this study is to inform future intervention programs for the prevention of 
chronic disease. End-stage renal failure (ESRF) is a debilitating condition that accounts 
for significant morbidity and mortality. Immediate family members (IFM) of such 
patients are expected to be at greater risk for chronic kidney disease (CKD) and other 
lifestyle conditions. This study is being conducted in Miri, Sarawak Malaysia, to 
understand the ethnic, demographic and socio-economic influence on potential 
predictors of CKD and associated morbidity. The study employs a two-phase Mixed 
Methods Sequential Explanatory Design. Phase 1 involves a comparison between IFM 
of ESRF patients and a control group. Clinical and socio-demographic parameters for 
CKD, diabetes, hypertension and cardiovascular disease will be measured. This 
analysis will determine what exposures of interest warrant further exploration. Phase 2 
will comprise of a qualitative, in-depth interviews of participants from Phase 1, chosen 
for low or high risk. This aspect will include examining the beliefs, behaviours, 
knowledge and their correlation to environmental and socio-demographic variables. 
The rationale for this mixed methods approach is to facilitate a deeper understanding 




Appendix B:  Nutrition Society of Australia (NSA), Scientific Meeting, Perth, 





Appendix C:  Mark Liveris Student Research Seminar Program, The Faculty of 
Health Sciences, Curtin University, Western Australia. Abstract, November 2014. 
RISKY HEALTH BELIEFS AND BEHAVIOURS OF PERSONS USING 
AGROCHEMICALS: A QUALITATIVE STUDY IN SARAWAK, MALAYSIA. 
Presented by: Sheryl Mattu, School of Public Health 
Course: Doctor of Philosophy 
Supervisor: A/Prof Mario Soares, School of Public Health  
A/Supervisor: Dr JA Lewis  
Background/Aims: There is increasing evidence linking the excessive use of synthetic 
agrochemicals with Chronic Kidney Disease (CKD) in tropical developing countries. 
The study aim was to explore and identify beliefs and behaviours of participants at risk 
of chronic kidney disease, with regard to chemical use. 
Methods: Thirty-two participants were identified as the sixteen best and sixteen worst 
scores of a quantitative survey that screened for CKD. CKD was based on kidney 
function (estimated glomerular filtration rate <60 mL/min/1.73 m
2
) and/or kidney 
damage (Urine albumin : creatinine ratio >25 mg/mmol). They were invited to 
participate in semi-structured qualitative interviews that enquired about the 
participant‘s home environment, work and gardening-related practices. Translators 
interviewed the participants in their preferred tongue. The data was analysed for themes 
by the NVivo software. 
Results: Seventy-five per cent interviewed used multiple chemicals on a regular basis. 
The group with the best CKD scores had a greater knowledge of agrochemicals, were 
more likely to adhere to safety precautions or hired others to do the work. Our overall 
findings were as follows: Indigenous people predominately worked in the agriculture 
and plantation sectors; They mixed and sprayed an assortment of fertilisers, pesticides 
and herbicides; They mostly did not follow standardised safety regulations to minimise 
direct exposure to the chemicals; Many held mistaken beliefs or were unaware of the 
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toxicity of the agrochemicals; The crops they grew were subjected to multiple 
applications of agrochemicals. 
Conclusions: Food safety awareness, occupational health and safety intervention and 
education campaigns are needed in Sarawak, Malaysia. 







Appendix D:  Mark Liveris Student Research Seminar, The Faculty of Health 
Sciences, Curtin University, Western Australia. Oral Presentation and Static 




Curtin University is a trademark of Curtin University of Technology 
CRICOS Provider Code 00301J 
Recommendations:  Food safety awareness, occupational 
health and safety intervention, and education campaigns 
need to target vulnerable groups in Sarawak, Malaysia. 
Talk by:                                        
Sheryl Joy Mattu 
PhD candidate – 
School of Public Health, 
Curtin University, WA. 
Photos of plantation 
sprayers in Borneo. 
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Appendix E:  Nutrition Society of Australia (NSA) 38th Annual Scientific 
Meeting, Hobart, Tasmania. Poster Presentation with Short Talk, November 2014. 
 
  
RISKY  HEALTH  BELIEFS  AND  BEHAVIOURS  OF  PERSONS  USING  
AGROCHEMICALS:  A  QUALITATIVE  STUDY  IN  SARAWAK,  MALAYSIA. 
SJ Mattu, JA Lewis, MJ Soares. 
Sarawak Shell Berhad funded the study. We 
thank Dr RD Mattu, the translators and the study 






Figure 6:  This Indigenous lady sprayer is not following safety 
regulations regarding toxic exposure to agrochemicals. 
Food safety awareness, occupational health 
and safety intervention and education 
campaigns need to target vulnerable groups 
in Sarawak, Malaysia. 
Findings that emerged from the interviews: 
•  Indigenous people predominately worked 
in the agriculture and plantation sectors;  
•  They mixed and sprayed an assortment of 
fertilizers, pesticides and herbicides;  
•   They mostly did not follow standardized 
safety regulations to minimize direct 
exposure to the chemicals;  
•   Many held mistaken beliefs or were 
u n a w a r e o f t h e t o x i c i t y o f t h e 
agrochemicals;  
•   The crops they grew were subjected to 
multiple applications of agrochemicals. 
Results: 
Seventy-five percent interviewed used 
multiple chemicals on a regular basis. The 
group with the healthiest CKD scores had  
•  a greater knowledge of agrochemicals,  
•   were more likely to adhere to safety 
precautions  
•  or hired others to do the work.  
The participants were invited to participate 
in semi-structured qualitative interviews that 
enquired about their home environment, 
work place activities and gardening-related 
attitudes and practices.  
Translators were given training in 
qualitative interview techniques and 
interviewed the participants in their 
preferred tongue.  
They were blinded to the participant’s 
disease condition, socio-demographic or 
economic profiles.  
The data collected was analysed for themes 
using the NVivo software. 
1.Sarawak Government State Planning Unit, Chief       
       Ministers Department. Facts and Figures 2012  
       [updated 2012; cited 30 April 2014];   
        Available from: http://www.sarawak.gov.my  
2.Howard JK, Sabapathy NN, Whitehead PA. A  study 
       of the health of Malaysian plantation workers  with 
       particular reference to paraquat spray men. British journal of 
industrial medicine. 1981;38(2):110-6. 
3.Fernandez I, Joshi A, Network PA. Poisoned and silenced: a 
study of pesticide poisoning in the plantations: Tenaganita and 
Pesticide Action Network (PAN) Asia and the Pacific; 2002. 
Report No.: 9839381245 Contract No.: Document Number|. 
4.International Development Research Centre, editor. Impact of 
pesticide use on health in developing countries. Ottawa, 
Canada; 1990. 
5.Creswell JW, Plano Clarke VL. Designing and Conducting 
Mixed Methods Research. Thousand Oaks, USA: Sage 
Publications, inc; 2007. 
6.Kidney Health Australia - Caring for Australians with Renal 
Impairment. Classification of chronic kidney disease based on 
evaluation of kidney function. 2006 [updated 2006; cited June 
11, 2011]; Available from: http://www.cari.org.au  
Directorate of Nutrition, Dietetics & Food Technology, School of Public Health, Curtin University, Perth, Western Australia. 
Recruitment: 
This report is on phase two of a Mixed 
Methods Sequential Explanatory Design5.  
Thirty-two participants were identified as the 
sixteen best and sixteen worst scores of a 
quantitative survey that screened for CKD. 
CKD was based on kidney function 
(estimated glomerular filtration rate <60 mL/
min/1.73 m2) and/or kidney damage (Urine 
albumin:creatinine ratio >25 mg/mmol)6.     
Figure 1:  Monoculture Oil Palm plantations are being developed 
on thousands of hectares of land throughout Sarawak. 
Figure 5:  600 people live in this Indigenous longhouse. Workers 
use agrochemicals in the surrounding Oil Palm  plantation. 
Miri, Sarawak, East Malaysia, is located on 
the equatorial island of Borneo and has an 
ethnic mix of Malay, Chinese, Indian and 
27 main Indigenous Tribal groups1.  
Over the past few decades, after an area of 
rainforest is logged, it is replaced with oil 
palm plantations where various agro-
chemicals are used2. In Malaysia, there are 
agrochemical regulations in place, however 
they are not always rigorously enforced.  
In the hot, humid climate workers are 
sweaty, do not use protective clothing and 
gear and are dehydrated2. Herbicides and 
pesticides are readily absorbed through 
damp skin and dehydration increases the 
body’s sensitivity to the chemicals3.  
There is accumulating evidence linking the 
excessive use of synthetic agrochemicals 





The study aim was to explore and identify 
beliefs and behaviours of participants at risk 
of CKD, with regard to chemical use. 
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Appendix F:  European Journal of Clinical Nutrition (EJCN), article (pending 
acceptance). Abstract. 
METABOLIC SYNDROME IN FIRST DEGREE RELATIVES OF PATIENTS 
WITH END-STAGE RENAL DISEASE: A CASE-CONTROL STUDY IN 
SARAWAK, MALAYSIA. 
Background: Family members of patients with End-Stage Renal Disease (ESRD) have 
a higher risk of renal and other diseases. The metabolic Syndrome (MetS) is linked to 
deterioration of kidney function.  
Objective: The objective was to investigate the role of socio-demographic, lifestyle 
factors and glucose intolerance in the predisposition to metabolic syndrome in First 
Degree Relatives (FDR) of ESRD patients. 
Design: One hundred and thirty FDR relatives of ESRD patients from Miri in Sarawak, 
Malaysia were compared to a Spousal Control Group (SCG) (n= 135) of similar age, 
gender, ethnicity and without family history of kidney disease. All subjects underwent 
biochemical tests, anthropometric measurements and completed a medical history 
questionnaire in their local language. The study received approval from Curtin 
University Perth, Australia.  
Results: First degree relatives had a significantly greater prevalence of MetS but were 
similar in ethnicity, socio-demographic characteristics and markers of Chronic Kidney 
Disease (CKD) to the spousal control group. Multiple logistic regression analysis 
indicated that (1) age, (2) being a first degree relative, (3) having a family history of 
hypertension, (4) smoking, (5) added salt intake, (6) glucose intolerance, and (7) 
residing in terraced or low-cost housing were independently associated with greater 
odds for MetS. 
Conclusion: The study highlights tangible targets for the early detection and 
attenuation of MetS in this population group.  






Appendix G:  Permission to Reproduce Table 3.5  
RE: Copyright Permission 
SCHN-CHW-CARI (SCHN-CHW-CARI@health.nsw.gov.au) 
 To: Sheryl Mattu, SCHN-CHW-CARI 
 
Hi Sheryl 
 That is fine considering your acknowledgement of the source. 
Regards 
David Tunnicliffe 
David Tunnicliffe | KHA-CARI Research Officer | Centre for Kidney Research Clinical 
t: (02) 9845 1470 | f: (02) 9845 1491 
| e: david.tunnicliffe@health.nsw.gov.au | w: www.schn.health.nsw.gov.au 
Cnr Hawkesbury Road and Hainsworth Street, Westmead, NSW Australia 
Locked Bag 4001, Westmead 2145, NSW Australia 
 From: Sheryl Mattu [mailto:sheryl_joy@hotmail.com]  
Sent: Tuesday, 3 November 2015 7:39 PM 
To: SCHN-CHW-CARI 
Subject: Copyright Permission 
 Dear Madam/Sir, 
 I am a PhD (Public health) student with Curtin University Perth Australia. My thesis focuses on Chronic 
Kidney Disease and metabolic Syndrome and is a case-control mixed methods study on end stage renal 
disease first degree relatives in Sarawak, Malaysia. I wish to ask permission to use the online KHA-CARI 
Guidelines, diagram b and c, duly acknowledged, of the Chronic Kidney Disease Guidelines ‘Diagnosis, 
Classification and Staging of Chronic kidney Disease May 2013’ Author David Johnston (written July 
2012) in my thesis literature review chapter as it clearly illustrates staging in the diagnosis of chronic 
kidney disease. I look forward to hearing from you with regard to this soon. Thank you. 
 Yours sincerely,  
 Sheryl Joy Mattu sheryl_joy@hotmail.com  
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Appendix I:  Permission to use STEPS Questionnaire: WHO 
From: Guthold, Regina  
To: mrcs_hru@streamyx.com  
Cc: Riley, Leanne ; Herren, Catherine E. ; Cowan, Melanie  
Sent: Thursday, December 11, 2008 11:33 PM 
Subject: RE: use of STEPS questionnaire 
 
Dear Sheryl, 
thank you very much for your message and interest in using the STEPS questionnaire. My 
name is Regina, and I work for the Surveillance team within the Department of Chronic 
Diseases and Health Promotion at WHO Geneva. 
I cc Leanne Riley who is our team leader, as well as my colleagues Melanie Cowan and 
Catherine Herren (Catherine is our assistant). You are most welcome to use the STEPS 
instrument in your study. However, please note that this instrument has been developed for 
large population-based surveys that aim to determine levels of risk factors for chronic diseases, 
so it is fine to use it if you want to determine these levels in your population. The STEPS 
instrument (although capturing blood pressure and blood glucose values) has not been 
developed to diagnose individuals suffering from diabetes or hypertension. 
Usually, we recommend countries to use sample sizes of several thousand individuals as 
STEPS data normally gets reported in 10-year age groups. For small sample sizes like yours, 
levels of risk factors should only be reported for the whole sample as otherwise sizes get too 
small. 
I hope this information helps. It would be great if you could keep us up-to-date on how you are 
going with the instrument. Please note that programs are available to analyse STEPS data in 
EpiInfo, these are available at http://www.who.int/chp/steps/resources/database/en/index.html 
All the best and good luck with the study! 
Regina 
Regina Guthold, MPH 
STEPwise approach to surveillance 


















ETHICS DOCUMENTS: PARTICIPANTS 
Appendix L:  Invitation letter given to end-stage renal disease patients 





Appendix M:  Invitation Letter: For the first degree relatives‟s and Spouses 
AN INVITATION TO PARTICIPATE IN THE 
MIRI KIDNEY RESEARCH STUDY 
THE RESEARCH – I am researching the local risk factors associated with Chronic 
Kidney Disease (CKD) among First Degree Relatives (FDR) of End-Stage Renal 
Disease (ESRD) patients who are receiving dialysis at the Miri Red Crescent Dialysis 
Centre, the Haemodialysis Unit of the Miri General Hospital and the Miri City Medical 
Centre Dialysis Unit. The hope is that local information regarding socio-demographic, 
lifestyle and metabolic factors that increase risk for developing chronic kidney disease 
and ultimately end-stage renal disease, in the end-stage renal disease patient‘s first 
degree relatives in particular, will be identified. Please read the Information Sheet on 
this study and ask your family members to read it also. 
THE STUDY DESIGN – This is a Case-Control study. I would like to invite you to 
participate as either a Case or a Control in this study. If you are over 18 years of age 
and willing to participate in this study, please fill out the attached CASE or CONTROL 
form.  
Cases – Are the first degree relative‘s of the end-stage renal disease patient and 
includes being their parents, their siblings and their children. 
Controls – Are the non-genetic relatives of the first degree relative‘s spouse, the first 
degree relatives‘s sibling‘s spouses, the first degree relatives‘s sibling‘s children‘s 
spouses and the first degree relatives‘s children‘s spouse‘s family and relatives. The 
Control needs to be matched by age, ethnicity and if possible by gender to the Case. 
For example, if the first degree relatives‘s brother aged 53 years is available to be a 
Case in this study then the spouse‘s families need to be asked to find a male aged 
around 53 years old and who is willing to participate as a Control in this study. If they 
agree, please fill out the attached CONTROL form. Likewise for your child or parent.  
It is hoped that at least two (2) first degree relatives of the end-stage renal disease 
Patient and two (2) in-laws agree to participate as cases and controls in this study. 
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Please call, sms or email as soon as possible for an appointment for you to come for 
data collection. You must make an appointment in order to participate. All the 
assessments and laboratory blood and urine tests will be taken at  Gribbles Pathology 
Laboratory, Miri. Both the case and control should come to the laboratory at the same 
time. All tests will be free of charge to participants. A limited number only. First come, 
first serve basis. 
Please call, sms or email to make an appointment, if you request more information or 
have questions regarding this research: 
 
The Health Researcher: 















CASE AND CONTROL FORM  
CASE No:………….... First degree relative of the end stage renal disease patient, ie. parents, siblings and children. 
Must be over 18 years of age. Able to travel to Gribbles Pathology Laboratory (Columbia Asia) . 
Name:……………………….…….…………………………….. New I.C. No:………...….………….. 
Age:………………....……Gender:…………………..……….Ethnicity:…………………..……… 
Language prefer to use in this study: Spoken………………………Written…………………...  
Contact numbers: House Phone…………………………Hand Phone…………..……….……... 
Where do you live? ..................................................................................................................... 
Tests will only be done at the Gribbles Pathology Laboratory, in the mornings between 8.00-11.00am. Which days 
suit you best for an appointment? :………………………………………... 
You will be contacted by either house phone or hand phone and an appointment date made.  
Signature ………………………………...…........................ Thank you for participating in this worth-while project. 
CONTROL No:………….... The spouse’s relatives. In-laws not genetically related to the end stage renal disease 
patient. Must be over 18 years of age. Matched by age, ethnicity and/or gender to the Case. Able to travel to 
Gribbles Pathology Laboratory (Columbia Asia). 
Name:…………………………….……………………….. New I.C. No:…………………..….….. 
Age:………………..……Gender:…………………………….Ethnicity:………….…….…………… 
Language prefer to use in this study: Spoken……………...……Written……………………...  
Contact numbers: House Phone………….…….…………Hand Phone………………………... 
Where do you live? ................................................................................................................... 
Tests will only be done at the Gribbles Pathology Laboratory, in the mornings between 8.00-11.00am. Which days 
suit you best for an appointment?:………………………………………… 
You will be contacted by either house phone or hand phone and an appointment date made.  




JEMPUTAN UNTUK MENGAMBIL  
BAHAGIAN DALAM KAJIAN PENYELIDIKAN  
PENYAKIT BUAH PINGGANG MIRI. 
PEYELIDIKKAN – Saya merupakan penyelidik yang menjalankan kajian mengenai 
risiko masalah penyakit buah pinggang yang sering kali berlaku di kalangan ahli 
keluraga bagi pesakit buah pinggang yang menerima rawatan di pusat dialisis bulan 
sabit merah, unit rawatan Haemodialisis hospital Miri dan Unit Dialisis Miri City 
Medical Centre. Ini berharap dengan maklumat yang diterima dapat membantu 
mengetahui mengenai socio-demographic, gaya-hidup, dan faktor metabolik 
peningkatan risiko pekembangan penyakit buah pinggang (chronic kidney disease) 
serta yang tahap kronik (end stage renal disease). Sila baca maklumat mengenai 
penyelidikkan dan kongsikan maklumat penyelidikkan bersama ahli keluarga yang lain. 
TUJUAN KAJIAN PEYELIDIKKAN – Penyelidikkan ini adalah mengenai kajian kes-
kawalan penyakit buah pinggang. Dengan ini,saya ingin mengajak anda untuk menjadi 
peserta dalam kajian penyelidikkan ini. Jika anda berumur l8 tahun ke-atas dan 
berminat untuk mengambil bahagian dalam kajian penyelidikkan ini, anda diminta 
untuk mengisi borang kes atau kawalan yang telah disediakan. 
Kajian Kes – Terdiri dari dikalangan ahli keluarga (first degree relatives) pesakit buah 
pinggang tahap serius (end stage renal disease) dan termasuklah ibu/bapa, adik-beradik 
dan anak-anak pesakit sendiri. 
Kajian Kawalan – Bukan terdiri dari dikalangan ahli keluarga, seperti ahli keluarga 
sebelah pihak suami/isteri, saudara-mara ataupun sahabat anda. Bagi kajian kawalan 
ini, persamaan umur, keturunan dan jantina, untuk dibandingkan dengan kajian kes 
adalah diperlukan, Mencontohi, jika abang kepada (first degree relatives) yang berumur 
53 tahun berminat mengambil bahagian sebagai kajian kes, maka isteri kepada abang 
(first degree relatives) diminta untuk mencari individu dari ahli keluarga sebelahnya 
atau saudara-mara yang sama jantina, dan keturunan sekitar umur 53 tahun. Dimana ia 




Ini berharap peserta yang mengambil bahagian sekurang-kurangnya dua (2) first degree 
relatives bagi pesakit end stage renal disease dan dua (2) ahli saudara pihak suami/isteri 
ataupun sahabat yang bersetuju mengambil bahagian sebagai kes dan kawalan dalam 
penyelidikkan ini. Sila hubungi, sms atau menghantar email kepada kami secepat 
mungkin untuk mendapatkan temujanji bagi mengumpul maklumat data anda dan 
sebagai peserta anda mestilah mendapatkan temujanji. Bagi semua sampel darah dan 
air kencing,ia akan diambil di Makmal Gribbles Pathology Miri. Bagi kedua-dua 
peserta kes dan kawalan,meraka dipinta datang pada masa yang sama. Semua ujian 
yang dilakukan adalah percuma. Penyertaan ini adalah terhad. 
Sila menghubungi, sms atau menghantar email bagi membuat temujanji ataupun jika 
ada sebarang pertanyaan mengenai kajian. Dengan merujuk maklumat dibawah; 
 
The Health Researcher 
H/Ph : 0198856233 Fax : 085-653135 











BORANG KES ATAU KAWALAN 
NO KES: .…………………. : Ahli keluarga bagi pesakit buah pinggang tahap akhir (end stage renal disease), sprt. 
Ibu / bapa, adik-beradik serta anak yang berumur lebih daripada 18 tahun ke-atas. Dapat mengunjungi Makmal 
Pathologi Gribbles (Columbia Asia). 
Nama Kes : ……………………………. No Kad Pengenalan (Baru): …………..……………….. 
Umur: …………………… Jantina: …………………….…. Bangsa: ……………..……………….. 
Pilihan bahasa yang digunakan dalam kajian penyelidikkan ini : Percakapan ……. Tulisan……. 
Hubungi nombor : Telefon Rumah ……………………… Telefon Bimbit …………………………. 
Dimanakah tempat kediaman anda sekarang? ……………………………………………….......... 
Ujian ini hanya akan dijalankan di Makmal Pathologi Gribbles, pada sebelah pagi dalam masa pukul 08:00 pg-
11:00pg. Apakah masa terbaik sesuai bagi anda untuk temu janji? ………………………….…… 
Anda akan dihunbungi ke nombor talian rumah atau telefon bimbit setelah temu janji dibuat. 
Tandatangan ………………Terima kasih bagi penyertaan anda dalam menjayakan projek ini. 
NO KAWALAN : …………..... : Saudara-mara sebelah suami/isteri, sebaiknya bukan terdiri daripada ahli keluarga 
pesakit buah pinggang tahap akhir (end stage renal disease). Semestinya berumur lebih daripada 18 tahun ke-atas. 
Dapat mengunjungi Makmal Pathologi Gribbles (Tingkat 2 Columbia Asia Specialist Clinic). 
Nama Kes : ………………………………. No Kad Pengenalan (Baru): ………………………….. 
Umur: …………………… Jantina: …………………………. Bangsa: …………………………….. 
Pilihan bahasa yang digunakan dalam kajian penyelidikkan ini : Percakapan….…. Tulisan……. 
Hubungi nombor : Telefon Rumah ……………………… Telefon Bimbit …………………………. 
Dimanakah tempat kediaman anda sekarang? ……………………………………..………........... 
Ujian ini hanya akan dijalankan di Makmal Pathologi Gribbles, pada sebelah pagi dalam masa pukul 08:00 pg-
11:00pg. Apakah masa terbaik sesuai bagi anda untuk temu janji?:………………………………… 
Anda akan dihunbungi ke nombor talian rumah atau telefon bimbit setelah temu janji dibuat. 
Tandatangan ………………………....…………Terima kasih bagi penyertaan anda dalam menjayakan projek ini. 
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Appendix N:  Information sheet for participants  
Study Focus 
 The First Degree Relatives of End Stage Renal Disease patients. 
 Screening for the main risk factors and causes of end stage renal disease in 
Malaysia: Chronic Kidney Disease, diabetes, hypertension and cardiovascular 
disease. 
 Using the metabolic Syndrome set sup-off points to determine the abnormal clinical 
parameters for the risk factors. 
 The socio-demographic and lifestyle exposures of interest. 
 Beliefs, behaviour and health-related lifestyle choices with regard to risk factors for 
chronic kidney disease. 
 
Quantitative Phase One Research Methods include the following:  
 Laboratory investigations: the metabolic syndrome set cut-off points will be used to 
identify abnormal clinical parameters for central obesity; HDL; LDL; triglycerides; 
blood pressure; plasma glucose; endothelial function; and microalbuminuria. 
 Anthropometric measurements: height; weight; waist circumference; waist-hip 
ratio; body mass index; skinfold fat.  
 A standardised self-administered questionnaire: socio-demographic, lifestyle, 
medical history, diet and physical activity. 
 
Data Collection will be undertaken at the Gribbles Pathology Laboratory Miri (Above 
Columbia Asia Hospital). If persons are unable to come, or have failed to fast 
overnight, they will be excluded from the study. 
Qualitative Phase Two Research Methods requires a qualitative interview. Inclusion 
criteria for Phase Two will be participants selected from the low normal and high 
abnormal clinical parameters of both the cases and the controls as determined from 





 Voluntary Participation: There will be no coercion to participate and those 
approached will have the right to refuse without explanation. There will be no 
remuneration given, however the laboratory tests (blood, urine and oral glucose 
tolerance test) will be free of charge to all the participants.  
 Informed Consent: Forms will be signed by the participant prior to both data 
collection sessions.  
 Ethical Guidelines: Ethical approval has been obtained from the Curtin Human 
Research Ethics Committee (HREC) and the guidelines (HREC, 2008) are 
acknowledged.  
 Confidentiality: Clinical measurements and laboratory tests will be handled with 
strict confidentiality. Privacy will be respected and participants will be protected 
through anonymity. No names, IC numbers or any identifying features will be used in 
any publications. Only group anonymous results will be released. 
 
The benefit to the individual participating in this study 
The study participants will be asked to complete a series of screening tests 
conducted to identify those persons who are at higher risk for developing metabolic 
syndrome, cardiovascular disease, Type 2 diabetes, hypertension and chronic kidney 
disease. Following the Malaysian Ministry of Health guidelines, all laboratory reports 
for each patient will be issued to them personally.  
The assessment of the anthropometric measurements and the laboratory / 
medical report on the participant‘s oral glucose tolerance test , urine and blood tests 
will be made available for them (only) to take to their own doctor for discussion and 
follow-up. These tests will be done free of charge to the participant however, should 
they withdraw from the study after the blood and urine tests have been conducted, the 
person will be asked to pay Gribbles Pathology Laboratory. At the completion of the 
research the participants will be given the summary, conclusions and recommendations 




The value of this study to the general Miri community  
Analysis of the results will identify if there are any predisposing local 
anomalies that may be associated with an increased risk for the development of chronic 
kidney disease, in Miri.  
Appropriate community intervention programs and strategies may need to be 
developed to target, screen and educate high risk groups identified in the study. 
Measures of prevention will be devised to delay the onset and rate of progression of 
chronic kidney disease, and reduce the development of complications of chronic kidney 
disease and end stage renal disease. 
INFORMASI 
Fokus Kajian 
 Ahli keluarga pesakit buah pinggang/ginjal tahap akhir. 
 Mengkaji punca utama faktor risiko penyebab bagi berlakunya end stage renal 
disease (Penyakit Buah Pinggang/Ginjal tahap akhir) di Malaysia. 
 Menggunakan Set pemotongan markah metabolic syndrome untuk menentukan 
abnormal parameter klinikal bagi faktor risiko penularan. 
 Membuka minat dalam sosio-demographic dan gaya hidup yang sihat. 
 Kepercayaan, tingkah-laku serta gaya-hidup yang sihat dan dapat membuat pilihan 
yang baik bagi mengindahkan faktor risiko masalah serius penyakit buah pinggang 
berlaku. 
 
Kaedah penyelidikkan secara kuantitatif bagi fasa pertama ini termasuklah seperti 
berikut: 
 Makmal Penyiasatan: menggunakan set metabolic syndrome untuk mengenalpasti 
abnormal parameter klinikal bagi HDL; LDL; Triglycerides; tekanan darah tinggi; 
plasma glukosa; fungsi endothelium dan mikro-albuminuria. 
 Sukatan anthropometric: ketinggian, berat badan, BMI, lingkaran pinggang, 
pinggang-hip ratio serta lapisan lemak. 
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 Soalan yang ditanya telah ditetapkan mengenai: sosio-demographic, gaya-hidup, 
latar belakang perubatan, diet dan aktiviti fizikal.  
 
Pengumpulan Data. Bagi pengumpulan data, proses ini akan dilakukan di Makmal 
Pathologi Gribbles Miri. (Tingkat 2 Columbia Asia Sepecialist Clinic). Jika ahli peserta 
tidak dapat menghadirkan diri dalam proses pengumpulan data, ataupun gagal berpuasa 
semalaman, mereka masih lagi termasuk sebagai peserta dalam kajian ini. 
Kaedah Kajian Penyelidikan kuanlitatif Fasa Kedua. Dalam kajian fasa kedua, 
temuduga secara quanlitatif akan dilakukankan, dengan bertujuan untuk mengetahui 
kategori yang berkaitan dengan kesihatan yang mempengaruhi gaya-hidup seharian 
dimana ia menjadi penyebab dalam pencegahan chronic kidney disease. 
Kriteria Rekrut Fasa Kedua. Bagi kriteria rekrut fasa kedua, ia melibatkan peserta 
yang mempunyai daya ketahanan badan peringkat berisiko tinggi dan sederhana normal 
dalam parameter klinik, dengan menentukan kedua-dua kajian kes-kawalan, dari kajian 
fasa pertama. 
Pengumpulan Data. Data akan dikumpulkan bagi proses penilaian, dengan membuat 
temuduga secara bergilir-gilir. Bagi kajian fasa kedua, temujanji akan dibuat untuk 
mengunjungi kediaman peserta yang mengambil bahagian. 
PERTIMBANGAN DARI SEGI ETIKA  
 Penyertaan Sukarela – Bagi mereka yang datang dengan penyertaan secara 
sukarela untuk mengambil bahagian, setelah memahami tujuan kajian dilakukan 
tanpa mendapat penerangan. 
 Persetujuan Informal – Borang akan diberikan untuk ditandatangani bagi kedua-
dua penyertaan kajian kes-kawalan semasa sesi pengumpulan data. 
 Garis Panduan Dalam Etika – Etika kebenaran ini diperolehi dari Curtin Human 
Research Ethics Committee (HREC) serta panduan (HREC,2008) yang dibenarkan. 
 Kesulitan – Keputusan ujian sukatan klinikal dan makmal akan dirahsiakan secara 





Faedah bagi individu yang mengambil bahagian dalam kajian penyelidikkan 
Peserta kajian penyelidikkan ini, akan diminta untuk menglengkapkan siri ujian 
skrin bagi mengetahui individu yang berisiko tinggi dalam pekembangan syndrom 
metabolik, cardiovascular disease, Diabetis jenis kedua, tekanan darah tinggi dan 
chronic kidney disease (Penyakit buah pinggang tahap serius). Dengan berpandukan 
Kementerian Kesihatan Malaysia, kesemua keputusan ujian makmal akan diberikan 
secara sulit/peribadi kepada pesakit.  
Bagi penilaian sukatan anthropometrik dan makmal, keputusan akan diberi 
kepada peserta oral glucose tolerance test , dimana sampel air kencing dan darah akan 
diambil untuk dibawa kepada doktor mereka sendiri untuk perbincangan dan rawatan 
selanjutnya. Ujian makmal ini akan diberikan secara percuma kepada peserta. Jikalau 
peserta ini menarik diri, setelah ujian dijalankan, mereka akan diminta untuk 
membayar-balik kesemua kos ujian makmal ke Makmal Pathologi Gribbles. Akhir 
sekali, ringkasan, kesimpulan, dan rujukan mengenai kajian penyelidikan ini akan 
diterangkan kepada peserta yang mengambil bahagian. 
Nilai bagi kajian penyelidikan kepada komuniti umum Miri 
Keputusan analisis akan dikenalpasti jika terdapat tanda-tanda jangkitan yang 
berkaitan dengan peningkatan risiko pekembangan penyakit buah pinggang di Miri. 
Komuniti-komuniti perlu mengambil target dalam program dan strategi untuk 
mengetahui bagaimana cara mengalakkan kajian skrin dan mengenalpasti risiko 
pemulaan peningkatan penyakit ini berlaku dalam kelompok.langkah-langkah bagi 
mencegah penularan penyakit adalah diambil-kira bagi mengurangkan pekembangan 







Appendix O:  Informed consent agreement for participants in Phase One 
INFORMED CONSENT AGREEMENT : STUDY PARTICIPANTS – Phase One 
 
My name is ……………………………….………..… My I.C. number is …………...…-………-…….…. 
My home address is ………………………………………………………………...……………………… 
 I have read (or had an interpreter read / explain) the information sheet regarding this research.  
 I understand fully what this study is investigating and how I am involved in the data collection. 
 I agree to attend the Gribbles Pathology Laboratory for the research study data collection at the 
agreed date and time. 
 I am willing to participate in the (please tick the box)  
 Self-administered written questionnaire of Phase One 
 The one on one interview session and, if selected Phase Two 
 I consent to having / giving an (please tick the box) 




 I am willing for the principal investigator to (please tick the box) 
  Include me for selection for the Phase Two interview session. 
  Able to attend the interview at Dr Mattu Clinic. 
 I would like to receive the (please tick the box) 
    Laboratory / medical report on my urine and blood tests 
    Summary, conclusions and recommendations from this study. 
 I understand that I am giving this information voluntarily and will not be paid in cash or given any 
kind of gift for my participation in this research study. 
 I understand that I can ask questions regarding this research study at any time. 
 I understand that all my questionnaire and interview answers will be kept confidential and that 
my identity will not be connected to my answers. Code numbers will be used on all forms other 
than this consent form.  
 I agree for the principal investigator to use my questionnaire and interview answers in reports 
and publications so long as my name and answers will be anonymous. 
 I understand that this research study relies on the participant in completing all segments of 
Phase One of the study. 
 I understand that if I do not complete all of the data collection, my participation in this research 
study will be withdrawn.  
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 I understand that I may withdraw from this research study at any time without explanation. 
 I understand that all clinical measurements and laboratory tests will be handled with strict 
medical confidentiality. These measurements and tests will be available for me (only) to take to 
my own doctor for discussion and follow-up. 
 I agree for the principal investigator to use my clinical measurements and laboratory tests in 
reports and publications so long as my name and test results are anonymous. 
 I understand that I may not be selected for, or may decline participation in Phase Two. 
 
…………………………………………………… (Signature / Thumb Print) Date:…………………………… 
 Please tick the box if you would like a photocopy of this form. 

















PERJANJIAN MAKLUMAT PERSETUJUAN : PENYERTAAN KAJIAN 
 
Nama saya …………………..……………………….... No Kad.Pengenalan ……….…-………-……….…. 
Alamat Rumah ……………………………………………………………...…………………………………….. 
 Saya ada membaca ,borang maklumat mengenai kajian penyelidikkan ini.  
 Saya telah difahamkan mengenai kajian ini adalah dengan tujuan penyiasatan dan dengan ini 
saya sama sekali akan terlibat dengan pengumpulan data.  
  Saya bersetuju untuk menghadirkan diri di pusat dialisis bulan sabit merah,Unit makmal 
penyelidikkan untuk pengumpulan data bagi kajian penyelidikkant dengan masa dan tarikh yang 
telah ditetapkan.  
 Saya bersetuju untuk menjadi peserta (Sila tandakan didalam kotak))  
 Menulis pertanyaan peribadi fasa pertama. 
Membuat sesi temuduga bergilir-gilir di rumah sendiri,jika dipilih di 
fasa kedua. 
 Saya bersetuju mengambil/memberi (Sila tandakan didalam kotak))  
Ujian lisan bagi mengetahui kandungan gula 
sukatan anthopometri       sample air kencing      sample darah 
 Saya bersetuju dengan ketua penyiasat (Sila tandakan didalam kotak) 
  Memasukkan saya dalam temuduga sesi kedua. 
 Saya ingin mendapatkan (Sila tandakan didalam kotak)  
   Keputusan makmal bagi ujian air kencing dan darah yang telah 
dijalankan keatas saya. 
   Ringkasan,kesimpulan dan rujukkan mengenai kajian  penyelidikkan 
ini. 
 Saya memahami bahawa maklumat yang saya bagi adalah sukarela dan tidak untuk dibayar 
mahupun menerima sebarang ganjaran dalam penglibatan saya dalam soal selidik ini.  
 Saya faham bahawa saya boleh menanyakan sebarang soalan berkaitan dengan soal selidik ini 
pada bila bila masa. 
 Saya faham bahawa semua soalan dan jawapan temu duga saya adalah sulit dan identiti saya 
tidak berkaitan dengan jawapan saya. Nombor kod akan digunakandalam semua borang selain 
dari borang persetujuan.  
 Saya bersetuju dengan ketua penyiasatan untuk menggunakan soalan dan jawapan temu duga 
untuk laporan dan publisiti selagi nama saya tidak didedahkan dalam apa cara sekalipun. 
Jawapan saya akan dirahsiakan.  
 Saya difahamkan bahawa kajian siasatan ini bergantung pada pengilbatan pesakit dalam 
memenuhi semua sektor Fasa Pertama dalam kajian. 
 Saya difahamkani bahawa jika saya tidak menghabiskan proses kesemuaan pengumpulan data, 
penglibatan saya dalam kajian ini akan ditarik balik.  




 Saya difahamkan dimana kesemua sukatan klinikal dan ujian makmal akan dikendali dengan 
rahsia dan sulit. Sukatan dan ujian ini hanya dijalankan ke atas saya serta hanya saya seorang 
sahaja yang dapat membawa kesemua keputusan ujian kepada doctor untuk tujuan 
pembincangan dan rawatan selanjutnya. 
 Saya bersetuju dengan ketua penyiasatan menggunakan sukatan klinikal dan keputusan ujian 
makmal dalam laporan dan publisiti selagi nama saya tidak didedahkan dalam apa jua keadaan. 
Sukatan dan keputusan ujian akan dirahsiakan dari pengetahuan umum.  
 Saya difahamkan jika saya tidak terpilih atau penyertaan saya ditolak dlm temuduga sesi fasa2. 
 
 …………………………………… (Tandatangan / Cap jari) Tarikh:…………………………… 
      Sila tandakan dalam kotak jika anda ingin mendapatkan salinan borang ini.  




Appendix P:  Informed Consent: Agreement for Participants in Phase Two 
INFORMED CONSENT AGREEMENT: INTERVIEW – Phase Two 
My name is ………………………………...…………..…… My I.C. number is ……...…-………-……….…. 
My home address is ……………………………………………………………………...…………………….. 
 I have read (or had an interpreter read and explain) the information sheet regarding this research 
study.  
 I understand fully what this research study is investigating and how I am involved in the Phase 
Two interview. 
 I agree to participate in this interview. 
 
 I am willing to participate (please tick the box if you agree)  
  In the interview. 
 I am willing for the principal investigator to (please tick the box)  
Talk to anyone in my household who requests more information 
on this study.  
 I would like to receive the (please tick the box) 
      Summary, conclusions and recommendations from this study. 
 I understand that I am giving this information voluntarily and will not be paid in cash or given any 
kind of gift for my participation in this interview. 
 I understand that I can ask questions regarding this interview at any time. 
 I understand that anything I say will be kept confidential and that my identity will not be 
disclosed.  
 I understand that I may refuse to, or withdraw from, participating in this trial, without explanation. 
 
…………………………………..………………. (Signature / Thumb Print) Date:…………………………… 
Please tick the box if you would like a photocopy of this (signed and dated) form. 






PERJANJIAN MAKLUMAT PERSETUJUAN : SESI PERCUBAAN TEMUDUGA 
Nama saya …………………………...…………..…… No. kad pengenalan ……….…-………-……….…. 
Alamat rumah …………………………………………………………..…………………...………………….. 
 Saya telah membaca kesemua borang maklumat berkaitan dengan kajian ini. 
 Saya memahami sepenuhnya mengenai kajian penyelidikan adalah bertujuan untuk siasatan 
dan saya akan terlibat sekali dalam percubaan sesi temuduga. 
 Saya bersetuju mengambil bahagian dalam percubaan sesi temuduga.  
 
 Saya bersetuju untuk mengambil bahagian (sila tandakan dalam kotak )  
           Dalam sesi percubaan temuduga. 
 Saya bersetuju dengan ketua penyiasatan untuk ( sila tandakan dalam 
kotak )  
Berbual dengan sesiapa sahaja dalam ahli keluarga yang ingin 
mendapatkan maklumat kajian ini.  
 Saya ingin mendapatkan ( sila tandakan dalam kotak )   
Ringkasan,kesimpulan dan rujukkan mengenai kajian 
penyelidikkan ini,  
 Saya telah difahamkan bahawa segala maklumat yang diberikan adalah dengan sukarela tanpa 
dipaksa, dibayar atau memberi ganjaran untuk penyertaan dalam sesi percubaan temuduga. 
 Saya telah difahamkan bahawa saya boleh mengemukakan pertanyaan soalan mengenai sesi 
percubaan temuduga pada bila- bila masa. 
 Saya telah difahamkan bahawa apa sahaja yang diperkatakan oleh saya adalah dirahsiakan dan 
segala identiti saya tidak akan didedahkan. 
 Saya difahamkan bahawa saya tidak boleh menarik diri dalam mengambil bahagian bagi sesi 
percubaan ini tanpa penjelasan.  
 
…………………………………………………… (Tandatangan / Cap jari) Tarikh:…………………….. 
Sila tandakan dalam kotak jika anda ingin mendapatkan salinan borang ini.  
     













































Appendix T: Data Collection: Procedure and Explanation 
PHASE ONE DATA COLLECTION PROCEDURE AND EXPLANATION 
 (For Assistants’ information. Assistants are to explain clearly to the participants, in 
their preferred dialect, the procedure, especially regarding fasting, prior to coming for 
data collection in Phase One. They are to follow-up all participants who registered.)  
Prior To The Appointment: 
1. Household family members identified by ESRF patients will be contacted and asked if they 
would be willing to participate in this research study. 
2. If they agree to participate in the study a mobile phone contact number will be asked for 
and their age, gender and ethnicity will be noted. The language preferred will be noted and 
a translator, if needed, speaking that dialect will be allocated to assist during data collection 
sessions. As far as possible, gender appropriate assistants / translators will be used to 
eliminate cultural gender sensitivities.  
3. An appointment date and time for the Phase One data collection to be taken at the 
Malaysian Red Crescent: Health Research Unit laboratory will be discussed and allocated 
to the study participants.  
4. For those who are employed, a signed letter asking permission from their employer to 
allow them to participate in this research study without having to take annual leave on the 
morning of the data collection appointment, will be given to the study participants. 
5. Data collection procedure is expected to take three hours, including registration and 
refreshments. Participants please be available for your appointment otherwise you may be 
excluded from the study as the laboratory technicians and translators are only available for 
certain time periods. 
6. The study participant must fast overnight and refrain from eating or drinking breakfast 
on the morning of the data collection for the research study. If they have broken their fast 
they will be excluded from the study. They must bring with them a first-void morning urine 
sample in the container they were given. 
7. The study participant must be available for their appointment date otherwise they may 
be excluded from the study as the laboratory technicians and translators will only be 





On The Day Of The Appointment: 
8. The study participant must fast overnight and refrain from eating or drinking breakfast 
on the morning of the data collection for the research study. If they have broken their fast 
they will be excluded from the study. They must bring with them their first-void morning 
urine sample in the container they were given. 
7. The study participant must arrive on time at the MRC,HRU laboratory otherwise they 
may be excluded from the study as the laboratory technicians and translators will only be 
available for a certain time period. 
8. They will read the Information Sheet. If they decide not to sign the Informed Consent Form 
they will be excluded from the study. The participant may withdraw from this research 
study at any time without explanation however, they will be asked to pay for any laboratory 
samples taken. 
9. Once the Informed Consent Form is signed, a number will be given and they proceed to the 
laboratory to have their data collection session. 




All clinical measurements and laboratory tests will be handled with strict medical 
confidentiality. These will be available for the study participant (only). No participant identity 
will be revealed in any report.  
Measurements And Laboratory Screening Tests Explained 
 Anthropometric measurements will be taken to determine the participant‘s body mass index 
(BMI) and waist circumference (WC). The measurements are used in calculating their risk 
of having metabolic syndrome. 
 Blood pressure readings (the average of three) will be taken to establish the absence / 
presence of high blood pressure (hypertension) among the participants. 
 A fasting blood sample is needed for the oral glucose tolerance test and laboratory tests. 
Participants please fast 8-12 hours overnight and please do not eat or drink anything on the 
morning of the data collection for the research study. If you break fast you will be excluded 
from the study. You will be given food and drink after completion of the data collection. 
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 The oral glucose tolerance test will take two hours to complete. While waiting the two 
hours the participant will be asked to complete the minimal questionnaire and have the 
anthropometric measurements and laboratory tests done. 
 The Oral Glucose Tolerance Test will be administered to establish the absence / presence 
of Type 2 Diabetes among the selected participants. (oral glucose tolerance test and plasma 
glucose) 
 Blood and urine tests will be carried out to establish the absence / presence of kidney 
disease among the selected participants. (Microalbuminuria, serum creatinine and estimated 
glomerular filtration rate) 
 Blood tests will be carried out to establish the lipid profile of the selected participants. 
(Triglycerides, HDL, LDL and ratio, total Cholesterol)  
 The oral glucose tolerance test will be administered, the urine sample collected and the 
blood samples will be drawn by properly trained laboratory technicians from Gribbles 
Laboratory Malaysia. 
 
PHASE TWO INTERVIEW SESSION 
Those selected from Phase One and invited to participate in Phase Two will be 
contacted and provided with an information sheet and have the qualitative study explained. A 
mobile phone contact number will be asked for and an appointment date and time made for the 
qualitative interview to be delivered. The participant‘s current place of residence is where the 
data collection for Phase Two will take place. Signed consent will be sort before commencing 
data collection.  
In the second phase of the study, data will be gathered by in-depth, one on one semi-
structured interviews. I will conduct all interview sessions. A translator, if needed, will 








DATA COLLECTION INFORMATION 
Appendix U:  Phase One Self-administered Questionnaire 
For reporting accuracy, a linguistic and culturally appropriate standardise self-
administered questionnaire for Malaysia has been obtained from the Malaysian 
Ministry of Health. 
The „Malaysian NCD Surveillance 2006: NCD Risk Factors in Malaysia‟,  
http://www.who.int/chp/steps/MalaysiaSTEPSReport.pdf 




and is validated for a Malaysian population by the Disease Control Division, Malaysian 
Ministry of Health. It is available in English, Bahasa and Mandarin Languages. 











Appendix U  continued… WHO Steps 
 












The WHO STEPwise approach to noncommunicable disease 
risk factor surveillance (STEPS) 
 
World Health Organization 
20 Avenue Appia, 1211 Geneva 27, Switzerland 
For further information: www.who.int/chp/steps  
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Appendix W:  Multiple logistic regression analysis of factors associated with the 
metabolic syndrome including dietary factors 










First degree relatives  No 135 1 1 




Family history of 
hypertension 
No 55 1 1 












House Detached  120 1 1 
 Terraced /  
low-cost 
86 2.038  
(1.098, 3.782)  
4.380  
(2.022, 9.489) 
 Self-build / 
longhouse 
64 2.169  
(1.113, 4.226)  
3.276  
(1.432, 7.494) 
Added salt intake Never 39 1 1 




 Often 56 2.507  
(0.975, 6.446)  
4.270  
(1.382, 13.198) 
Smoking No 230 1 1 









 116 2.296  
(1.287, 4.096)  
3.636  
(1.809, 7.307)  
 Diabetic  24 7.000  
(2.750, 17.820)  
17.103  
(5.463, 53.545) 
-2 log likelihood = 309.735, d.f =11. 
All variables of interest were included in the full model in the initial step and then forward selection procedure was 
applied to obtain the final model, using 5% critical value of χ2 test for the appropriate degrees of freedom. 
*Non-significant variables were gender, ethnicity, income, alcohol drinking status, chewing betel nuts, chewing 
tobacco, family history of diabetes, family history of high cholesterol, family history of stroke, fried food intake, 
MSGc intake, prawn/fish intake, preserved food intake, meat intake, sugar intake, supplement intake, total amount of 
vegetables and fruit intake, fitness status, times doing moderate/vigorous activities per week, Urine_ACR and eGFR 
(adjusted_rMDRD).  
 
†OR =Odds Ratio ; ‡CI= Confidence interval;  
 
aIFG Impaired Fasting Glycaemia defined by (Twigg et al., 2007); bIGT Impaired Glucose Tolerance defined by 
(Twigg et al., 2007); cMSG Monosodium Glutamate.   
 
319 

























Appendix X : 6.1 : Matrix for Phase Two Recruitment 
  
 
    
RACIAL 
GROUP 
WORST  CKD                           
Male - FDR 
WORST  CKD                          
Female - FDR 
WORST  CKD                        
Male - SCG 
WORST  CKD                      
Female - SCG 
Chinese Interview 21 Interview 28 Interview 27 Interview 30 
  78 /64 36 / 56 45 / 39 37 / 40 
  Mon. 13th May. 2013 Thu. 6th Jun. 2013 Sat. 8th Jun. 2013 Sat. 8th Jun. 2013 
  Recorded in - Mandarin Recorded in - English Recorded in - English Recorded in - English 
Malay Interview 13 Interview 17 Interview 3 Interview 29 
  250 / 24 100 / 73 247 / 44 126 / 32 
  Mon. 15th Apr. 2013 Thu. 9th May. 2013 Fri. 8th Feb. 2013 Sat. 8th Jun. 2013 
  Recorded in - Malay Recorded in - Malay Recorded in - English Recorded in - Malay 
Indigenous Interview 7 Interview 6 Interview 4 Interview 1 
Orang Ulu 163 / 69 164 / 60 113 / 62 42 / 32 
  Sat. 16th Feb. 2013 Sat. 16th Feb. 2013 Fri. 15th Feb. 2013 Mon. 4th Feb. 2013 
  Recorded in - Kayan Recorded in - Kayan Recorded in - Kelabit Recorded in - English 
Indigenous Interview 2 Interview 23 Interview 10 Interview 15 
Iban 156 / 49 182 / 67 239 / 41 149 / 43 
  Wed. 6th Feb. 2013 Mon. 13th May. 2013 Sun. 17th Feb. 2013 Sat. 27th Apr. 2013 
  Recorded in - English Recorded in - Iban Recorded in - English Recorded in - Iban 
RACIAL 
GROUP 
BEST  CKD                         
Male - FDR 
BEST  CKD                           
Female - FDR 
BEST  CKD                                 
Male - SCG 
BEST  CKD                         
Female - SCG 
Chinese Interview 26 Interview 20 Interview 25 Interview 19 
  124 / 70 59 / 44 84 / 58 218 / 42 
  Thu. 9th May. 2013 Sun. 12th May. 2013 Thu. 6th Jun. 2013 Sat. 11th May. 2013 
  Recorded in - Hokkian Recorded in - Fuchau Recorded in - English Recorded in - Mandarin 
Malay Interview 18 Interview 32 Interview 31 Interview 14 
  129 / 38 199 / 42 269 / 43 132 / 44 
  Thu. 9th May. 2013 Sat. 24th Aug. 2013 Thu.8th Aug. 2013 Tue. 16th Apr. 2013 
  Recorded in - Malay Recorded in - Malay Recorded in - English Recorded in - Malay 
Indigenous Interview 16 Interview 5 Interview 11 Interview 12 
Orang Ulu 158 / 57 94 / 49 266 / 43 160 / 36 
  Thu. 9th May. 2013 Fri. 15th Feb. 2013 Fri. 5th Apr. 2013 Fri. 5th Apr. 2013 
  Recorded in - Kayan Recorded in - English Recorded in - English Recorded in - Kelabit 
Indigenous Interview 24 Interview 22 Interview 9 Interview 8 
Iban 189 / 41 184 / 60 240 / 38 230 / 37 
  Mon. 13th May. 2013 Mon. 13th May. 2013 Sun. 17th Feb. 2013 Sun. 17th Feb. 2013 

























Appendix X : Continued.  Categories for Matrix and Codes 
 
     1. WORST scores from the First Degree Relatives (FDR) CASES 4 MALES 4 FEMALES 
   
1. Chinese    2. Malay 1. Chinese    2. Malay 
   
3. Orang Ulu    4. Iban 3. Orang Ulu    4. Iban 
2. WORST scores from the Spousal Control Group (SCG) CONTROLS 4 MALES 4 FEMALES 
   
1. Chinese    2. Malay 1. Chinese    2. Malay 
   
3. Orang Ulu    4. Iban 3. Orang Ulu    4. Iban 
1. BEST scores from the First Degree Relatives (FDR) CASES 4 MALES 4 FEMALES 
   
1. Chinese    2. Malay 1. Chinese    2. Malay 
   
3. Orang Ulu    4. Iban 3. Orang Ulu    4. Iban 
2. BEST scores from the Spousal Control Group (SCG) CONTROLS 4 MALES 4 FEMALES 
   
1. Chinese    2. Malay 1. Chinese    2. Malay 
   
3. Orang Ulu    4. Iban 3. Orang Ulu    4. Iban 
     
 
INTERVIEW  STRUCTURE  :  WORST  CKD  Scores 
RACIAL GROUP WORST  Male - FDR WORST  Female - FDR WORST  Male - SCG WORST  Female - SCG 
Chinese (T-P21 CWMR) (T-P28 CWFR) (T-P27 CWMS) (T-P30 CWFR) 
Malay (T-P13 MWMR) (T-P17 MWFR) (T-P3 MWMS) (T-P29 MWFS) 
Orang Ulu (T-P7 IWMR) (T-P6 IWFR) (T-P4 IWMS) (T-P1 IWFS) 
Iban (T-P2 IWMR) (T-P23 IWFR) (T-P10 IWMS) (T-P15 IWFS) 
          
 
INTERVIEW  STRUCTURE  :  BEST  CKD  Scores 
RACIAL GROUP BEST  Male - FDR BEST  Female - FDR BEST  Male - SCG BEST  Female - SCG 
Chinese (T-P26 CBMR) (T-P20 CBFR) (T-P25 CBMS) (T-P19 CBFS) 
Malay (T-P18 MBMR) (T-P32 MBFR) (T-P31 MBMS) (T-P14 MBFS) 
Orang Ulu (T-P16 IBMR) (T-P5 IBFR) (T-P11 IBMS) (T-P12 IBFS) 
Iban (T-P24 IBMR) (T-P22 IBFR) (T-P9 IBMS) (T-P8 IBFS) 




Appendix Y:  Phase Two Semi-structured Interview Schedule  
HEALTH BELIEFS AND BEHAVIOUR OF A POPULATION SCREENED FOR 
CHRONIC KIDNEY DISEASE IN SARAWAK: A MIXED METHODS STUDY 
 
Topic : Open-ended questions to ask/prompt/enquire of the study participant  
 
Thanks so much for coming. As you participated in the study, I want to follow-up with 
you, to see how you are now and to give you some information regarding the study 
outcomes. Also I’d like to ask a few questions regarding your lifestyle and beliefs. 
Topic 1 Past History 
Origins:  Where were you born? Which kampong / town are you / your parents / your 
grandparents from? Were your parents / grandparents born in Miri or did they migrate 
to Miri? Are your parents still living on traditional family land in the kampong? How 
many generations back living on your family land can your mother/father remember? 
Does your mum / dad remember their great-grandparents names? 
Schooling / Training / Education:  Where did you do your primary schooling? 
Secondary schooling? Where did you do your tertiary education / job training?  
Working Life:  Where have you worked in the past? Did they provide training for 
you? How long have you worked at your last job? 
Family Roots:  Where have you spent the longest time / most years living? How many 
generations of your family have been living in urban areas? Are your parents still 
living? in the Kampong? Where are your parents living now? How often do they visit 
you here in Miri? How often do you go back to your Kampong / town to visit? Are you 





Topic 2 Transitional Changes 
Changes in Lifestyle:  What do you think has changed most for your parents now 
compared to living in the kampong? For you? What would you be doing if you were 
still living in the kampong? Have you still got many cousins and friends living in the 
kampong? How has your life changed? What has changed the most in your life since 
your grandparents time? Over the past ten years? What do you think needs changing in 
the next ten years to make your life more satisfied / happy / fulfilled? Do you have 
someone to help you look after the children? Housework? Garden work? 
Changes in Health Status:  Do you have brothers and sisters? Is everyone of your 
siblings healthy? If not, why not? Does anyone in your family have kidney problem? on 
dialysis? Is there anyone in your family with high blood pressure, diabetes, or heart 
problem?  
Changes in Diet / Eating Habits:  Has your diet / food changed in the past ten years? 
Or do you still eat the same traditional foods prepared the same way as your mother 
and your grandmother used to cook when you were living with them? Has your eating 
habits changed? Do you mostly cook and eat at home or do you eat out a lot? Do you 
bring take-away food home to eat? If you go out, do you like to eat at McDonalds, 
Kentucky and Pizza or prefer local kedai / coffee shop food? When you cook do you use 
salt? MSG? Do you drink water? Or prefer other drinks? What hinders you from 
consistently following a healthy diet? How many times a day / week do you eat away 
from home? 
Changes in Exercise / Physical Activity Habits:  Are you as active as when you were 
in your twenties? Are you active at your work place or do you mostly sit at a desk? Are 
you sometimes too tired after work to exercise? Do you consider it important to 
exercise every day? How often do you exercise? Do you get your children / cousins / 
friends to play sport or go for a run with you? Do you sit at a desk more than five hours 
per day? Do you watch more than 3 hours (sitting down) of TV / films per day? How do 





Topic 3 Environmental 
Housing Environment:  Do you own your own house? Or are you Sharing? Or 
Renting? Do you share the repayments? Or only your husband  make the repayments? 
What type of house is it?  
Living Arrangements:  Do you have dependants (children, aged parents, etc) you 
provide for? Living with you? Do you like the area where you are living? Or hope to 
move again one day? 
Gardening Space:  Do you have a garden / kebun / and grow your own vegetables? 
Fruit? Do you grow or buy most of your food? Would you have a garden if you had 
time to make one? Any reason not to? Have you every regularly used pesticides or 
weedicides around your house compound? 
Surrounding Environment:  So how far is it for you to walk from your house to the 
nearest padang (green space) where you can go for relaxation / jog / exercise / sport / 
fish in a pond etc.? Close or far? How many minutes to walk to the padang? Where do 












Topic 4 Health Beliefs 
Traditional Practices:  Are your grandparents / parents still following their 
traditional ways? Do you still practice your grandparents’ / parents’ traditions? For 
example, do you ever consult a traditional practitioner for massage? Herbs? 
Medicine? Advice? 
Alternative Medicines:  What age did you leave living with your mum and dad? Have 
your health beliefs changed from your mum and dad’s? Like if you have a headache 
your mum might say ‘take this herb’ or if you have a backache you do this? Have those 
beliefs changed at all since coming to Miri? Or do you still follow your mum’s practice 
/ advice? 
Medical / Alternate Preferences:  If you are not well what is your first choice – a 
traditional herbal practitioner or a medical doctor at the hospital or a clinic? What do 
you believe is the best options for your health? The most expensive? Do you think 
supplements are necessary for good health? Do you do or take anything to improve 
your quality of life? Do you take supplements? HRT? Do they work? Improve your 
health? 
Belief in Medical / Health Information:  With regard to health advice, do you always 
believe what you read on the internet? Newspaper? Advertising? From your friend? A 










Topic 5 Health Behaviours 
History of Compliance to Doctors Orders:  Do you go to the same doctor every time 
you are not well? Or to a clinic and see different doctors every time? Do you have a 
good rapport / relationship with a family doctor? Do you find it easy to see and talk to 
a doctor? Or is it difficult for you? If you go to the doctor and he gives you some 
Western medicine or tablets, do you eat keep taking the tablets - even when you feel 
better? Stop when feeling better? Don’t eat it? Would you rather take traditional 
herbs? If you see a medical doctor do you tell him if you are taking traditional herbal 
medicine? If you need a repeat dose / tablets where do you get it from? Doctor? 
Pharmacy? Over the counter? Drug store? Kedai?  
Health Habits:  Have you ever deliberately tried to change any of your health habits? 
Smoking? Drinking? Weight? Are you still trying? Have you lost any weight? What 
kind of problems did you face when trying to lose weight or get fit?  
Lifestyle Behaviour Changes:  Are you trying to lose weight (quit smoking) on your 
own? with anyone else? In a group? How are you doing it? Do you exercise more? 
Have you always been big size? When did you start to gain weight? What’s the hardest 
thing about trying to lose weight? Do you worry about the heat with sweating? Do you 
get itchy skin? What’s the best thing about losing weight? How do you feel? Do you 
feel sleepy after meals? What would help you most?  
(Are you trying to quit smoking on your own? with anyone else? In a group? How are 
you doing it? Using patches, etc?) 
Life Aims:  What would you say would be three defining moments of your life? What 
are three things that have influenced your life, but which were out of your control? 
What are three critical (life changing) decisions you have made in your life? What are 
three goals (1 long term, 1 medium term and 1short term) goals you are aiming to 
accomplish in the next ten years? 
Thanks so much for your time. Please feel free to email me if you want to know 
anything regarding the study or if you want some advice or information from me. 
 45 minutes. 
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Appendix Z:  Observation, Comments and Notes Sheet  
Notes from Quantitative Results:   Participant No:…………………. 
 Age     
 eGFR & ACR    
 metabolic Syndrome    
 Weight Changes   
 Blood Pressure Changes Similar  / 
 Cholesterol Changes   
 OGTT Oral glucose tolerance test Results    
Notes from Qualitative Interview:  
 Body Language Response   
 Changes in Health   
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